Systems biological analyses of intracellular signal transduction by Legewie, Stefan
Systems biological analyses  
of intracellular signal transduction 
 
D i s s e r t a t i o n 
 
zur Erlangung des akademischen Grades 
 
d o c t o r     r e r u m    n a t u r a l i u m 
 
( Dr. rer. nat.) 
 
im Fach Biophysik 
 
eingereicht an der 
 
 
Mathematisch-Naturwissenschaftlichen Fakultät I 
 






Herrn Diplom-Biochemiker Stefan Legewie 




Präsident/Präsidentin der Humboldt-Universität zu Berlin 
Prof. Dr. Christoph Markschies 
 
Dekan/Dekanin der Mathematisch-Naturwissenschaftlichen Fakultät I 







Gutachter:  Prof. Dr. Hanspeter Herzel  
Prof. Dr. Jens Timmer 
Prof. Dr. Olaf Wolkenhauer 
 
 



































































Intracellular regulatory networks involved in the sensing of extracellular cues are crucial to all 
living organisms. Signal transduction networks allow unicellular organisms sensing nutrient 
availability, finding mating partners and responding to stress. Moreover, intercellular 
communication is the fundamental basis for the functioning and homeostasis of multicellular 
organisms. Accordingly, many diseases including cancer are caused by deregulation of 
signal transduction networks.  Extracellular signals are typically transmitted rapidly from the 
cell membrane to the nucleus by activation of multi-level enzymatic cascades which 
ultimately elicit slow changes in gene expression, and thereby affect the cell fate. These 
signalling cascades are highly interconnected, thus giving rise to complex networks, that are 
hard to understand intuitively. In this thesis, a combination of kinetic modeling and analysis of 
quantitative experiments is applied to get insights into the principles of intracellular signalling.    
 
In the first part, the dynamics of enzymatic signalling cascades involved in transducing 
signals from the cell membrane to the nucleus are investigated. The Ras-MAPK cascade 
plays a central role in various physiological processes such as cell cycle progression, cell 
differentiation and cell death, and mutational cascade activation appears to be crucial for 
cancer development. Overexpression of wildtype Ras is also frequently observed in tumours, 
but its functional relevance remains unclear. By analysis of an experimentally validated 
kinetic model of Ras signalling, it is shown in Chapter 2 that the basal state MAPK signalling 
can be completely insensitive towards overexpression of the uppermost cascade member 
Ras. Thus, the simulations reveal a “kinetic tumour suppression effect” inherent to the Ras 
(de)activation cycle, and also explain experimental studies showing that overexpression 
events within the MAPK cascade, though phenotypically silent in isolation, frequently 
cooperate to bring about strong cellular deregulation (“oncogene cooperation”). In Chapter 3, 
it is analysed how an experimentally validated MAPK cascade model responds to more 
physiological, transient inputs and converts them into an all-or-none, irreversible cell fate 
decision. More specifically, it is shown that bistability arises in the core MAPK cascade by a 
previously unrecognised enzyme sequestration effect that establishes a hidden positive 
feedback loop. Chapter 4 is focussed on the proteolytic caspase cascades controlling 
apoptosis, a form of cell suicide activated in response to extracellular stress. The simulations 
suggest an unanticipated role for inhibitors of apoptosis proteins (IAPs): Simultaneous 
inhibition of multiple caspases by IAPs can result in strong positive feedback regulation, and 
may thus be essential to establish all-or-none and irreversible initiation of cell death.    
 
Cellular commitment to a new fate typically requires ongoing extracellular stimulation and/or 
intracellular signalling for several hours, so that the long-term dynamics of signalling 
cascades are important for cellular responses. In the second part of the thesis, it is 
investigated how slow signal-induced changes in gene expression feed back into the 
signalling network and modulate its dynamical activation pattern. In Chapter 5, the general 
design principles underlying transcriptional feedback regulation of mammalian signalling 
pathways are investigated by analysing the stimulus-induced gene expression profiles of 134 
intracellular signalling proteins. It turns out that transcriptional feedback regulation occurs in 
each of the five signalling cascades considered, and that negative feedback strongly 
dominates over positive feedback. Moreover, negative feedback exclusively occurs by 
transcriptional induction of a subgroup of signal inhibitors, termed rapid feedback inhibitors 
(RFIs), while downregulation of signal transducers plays no role. Systematic analysis of 
mRNA and protein half-lives reveals a remarkable separation of the signalling network into 
flexible and static parts: transcriptionally regulated RFIs are unstable at the mRNA and 
protein level, while other signalling proteins are generally stable. Kinetic modelling, also 
presented in Chapter 5, is employed to get insights into the functional implications of RFI-
mediated transcriptional feedback regulation. In Chapter 6, transcriptional feedback 
regulation of TGFβ signalling via Smad transcription factors is analysed in more detail in 
primary hepatocytes to confirm the physiological relevance of transcriptional feedback 
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regulation at the protein level. The TGFβ family of cytokines constitute major inhibitors of cell 
growth, and accordingly they play important roles in various physiological and pathological 
processes including development, tissue homeostasis, tissue regeneration, and cancer. 
Genome-wide microarray analyses and protein measurements in response to TGFβ 
stimulation (presented in Chapter 6) suggest that the SnoN oncoprotein is the central 
transcriptional feedback regulator in primary mouse hepatocytes. A mathematical model 
including TGFβ-induced Smad signalling and SnoN-mediated feedback is fitted to 
experimental data obtained under various stimulation conditions, and predictions derived 
from the model are then quantitatively confirmed in primary hepatocytes isolated from SnoN 
knock-out mice. The modelling results in Chapter 6 mechanistically explain how a small pool 
of SnoN proteins can efficiently regulate a much larger pool of Smad proteins, and further 
support the relevance of transcriptional negative feedback regulation in signal transduction.    
 
Cells face a specificity problem as different extracellular stimuli frequently engage the same 
set of intracellular signalling pathways even though they elicit completely different biological 
responses. Experimental evidence suggests that stimulus-specific biological information is 
frequently encoded in the quantitative aspects of stimulus-specific activation kinetics (e.g., 
signal amplitude and/or duration). If biological information is encoded in the quantitative 
characteristics of intracellular signals, proper cell fate decisions require that the downstream 
gene expression machinery is able to accurately decode signal amplitude and/or duration. 
Part III of this thesis deals with such decoding of upstream signals by the gene expression 
machinery, and thus represents a first step towards more integrated systems biological 
models that include both, upstream signal transduction and downstream phenotypic 
responses such as cell growth. The results presented in Section 7 identify competitive 
inhibition and regulated degradation as mechanisms that allow intracellular regulatory 
networks to efficiently discriminate transient vs. sustained signals. More specifically, a 
combination of mathematical modelling and quantitative experimental analyses reveals that a 
recently discovered small non-coding RNA, IsrR, establishes a pronounced delay and 
duration decoding in the cyanobacterial gene expression response towards iron stress. In 
other words, it is shown that the small non-coding RNA, IsrR, restricts the potentially harmful 
and costly expression of late-phase stress proteins to severe, prolonged and ongoing stress 
conditions. Many of the downstream target genes induced by signalling pathways are 
transcription factors, thus giving rise to a complex transcriptional regulatory network. 
Therefore, signal decoding at the level of gene expression cannot be fully understood by 
insights into the functioning of small transcriptional regulatory motifs, but additionally requires 
integrated analyses of multiple transcription factors. In Chapter 8, a recently proposed 
reverse engineering approach, called modular response analysis (MRA), is applied to derive 
the topology of an oncogenic transcription factor network from high-throughput and knock-
down data. Statistical analyses of the MRA results are used to derive predictions that can be 
verified experimentally, and also identify a key transcription factor cascade whose existence 
is supported by the published literature.  
 
In conclusion, this thesis shows how systems biological analyses can enhance our 
understanding of intracellular signalling networks. The approaches presented here include 
quantitative analyses of small regulatory motifs (Chapters 2, 3, 4 and 7), systematic 
investigation of high-throughput data (Chapters 5 and 6), kinetic modelling and thus 
integration of multiple time course experiments (Chapter 6), as well as reverse engineering of 






Intrazelluläre Regulationsnetzwerke, die an der Übertragung extrazellulärer Signale beteiligt 
sind, haben eine zentrale Bedeutung für alle Organismen. In Einzellern wird 
Signalübertragung zum Beispiel dazu genutzt, auf das extrazelluläre Nahrungsangebot oder 
auf Stress zu reagieren. In vielzelligen Organismen ist interzelluläre Kommunikation für das 
Überleben unverzichtbar und ist dementsprechend in vielen Krankheiten wie Krebs gestört. 
Extrazelluläre Signale werden gewöhnlich durch mehrstufige enzymatische Kaskaden 
innerhalb weniger Minuten von der Zellmembran bis in den Zellkern weitergeleitet. Dort 
bewirken die durch das Signal aktivierten Enzyme dann relativ langsame Änderungen der 
Genexpression und beeinflussen so das Schicksal der Zelle. Intrazelluläre 
Regulationsnetzwerke sind durch die vielen Interaktionen hoch komplex und somit intuitiv nur 
ansatzweise zu verstehen. In der vorliegenden Arbeit wird kinetische Modellierung in einem 
systembiologischen Ansatz mit der Analyse quantitativer experimenteller Daten verknüpft, 
um die Prinzipien der intrazellulären Signalübertragung besser zu verstehen.      
 
Im ersten Teil der Arbeit wird die Dynamik mehrstufiger Enzymkaskaden und somit die 
rasche Signalübertragung von der Zellmembran zum Zellkern untersucht. Die sogenannte 
Ras-MAPK-Kaskade reguliert verschiedene physiologische Prozesse (wie z.B. 
Zellwachstum, Zelldifferenzierung und Zelltod), und ihre permanente Aktivierung durch 
Mutationen der Kaskaden-Enzyme scheint eine zentrale Rolle bei der Krebsentstehung zu 
spielen. Des Weiteren wurde wiederholt die Überexpression des Ras-Proteins in 
Tumorzellen nachgewiesen, wobei die funktionelle Relevanz solch erhöhter intrazellulärer 
Proteinkonzentrationen jedoch angezweifelt wurde. Durch numerische Analysen eines 
experimentell validierten Modells des Ras-(De)Aktivierungszyklus wird in Kapitel 2 gezeigt, 
dass die basale Signalaktivität des Ras-Proteins komplett unbeeinflusst vom Ras-
Expressionslevel innerhalb der Zelle sein kann. Die Simulationen legen also nahe, dass es 
einen “Tumorsuppressionseffekt“ gibt, der durch die kinetischen Eigenschaften des Ras-
Zyklus entsteht. Das Modell kann außerdem erklären, wieso 
Proteinüberexpressionsereignisse innerhalb der Ras-MAPK-Kaskade, die an sich ohne 
Effekt sind, eine starke Deregulation in der Signalübertragung bewirken, wenn sie in 
Kombination auftreten (“Onkogenkooperation“). In Kapitel 3 wird genauer darauf 
eingegangen, wie die Ras-MAPK-Kaskade physiologische transiente Input-Signale 
prozessiert und sie in irreversible Alles-oder-Nichts Entscheidungen über das Schicksal der 
Zelle umwandelt. Genauer gesagt wird in Kapitel 3 beschrieben, wie ein positiver Feedback 
und Bistabilität durch einen zuvor unbekannten Kompetitionsmechanismus innerhalb der 
klassischen MAPK-Kaskade generiert werden kann. Kapitel 4 beschäftigt sich mit dem 
proteolytischen Caspase-Signalweg, der das zelluläre “Selbstmord-Programm“, die 
Apoptose, initiiert, wenn die Zelle durch Stress zu stark beschädigt wurde. Die Simulationen 
deuten auf eine unerwartete Rolle der sogenannten “inhibitors of apoptosis“-Proteine (IAPs ) 
hin: Durch die simultane Hemmung mehrerer Caspasen durch die IAPs entsteht ein 
versteckter positiver Feedback, der im physiologischen Parameterbereich eine wichtige Rolle 
bei der Alles-oder-Nichts-Entscheidung über den Zelltod zu spielen scheint.  
 
In den meisten Fällen muss eine Zelle über mehrere Stunden kontinuierlich stimuliert 
werden, um auf eine entsprechende phänotypische Antwort festgelegt zu sein. Also ist die 
Langzeit-Dynamik intrazellulärer Signalnetzwerke über mehrere Stunden entscheidend für 
zelluläre Antworten. Im zweiten Teil der Arbeit wird untersucht, wie langsame 
signalinduzierte Änderungen der Genexpression in das Signalnetzwerk rückkoppeln und 
somit die Langzeit-Dynamik beeinflussen. In Kapitel 5 werden durch eine Analyse 
signalinduzierter Genexpressionsmuster generelle Design-Prinzipien der transkriptionellen 
Rückkopplung in Säugetier-Signalkaskaden identifiziert. Die Untersuchung zeigt, dass 
transkriptionelle Rückkopplung in allen fünf untersuchten Signalwegen auftritt, und dass 
transkriptionelle Regulation nahezu ausschließlich negative Rückkopplung bewirkt. Des 
Weiteren weist die Analyse darauf hin, dass negative Rückkopplung einzig und allein durch 
die Induktion von hemmenden Faktoren (“Inhibitoren“) geschieht, während die Repression 
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von signalübertragenden Proteinen keine Rolle spielt. Ein Vergleich mit mRNA- und Protein-
Halbwertszeiten ergab eine bemerkenswerte Auftrennung des intrazellulären Signalnetzwerk 
in flexible und statische Protein-Spezies: die induzierten Inhibitoren sind sowohl auf mRNA- 
als auch auf Protein-Ebene instabil, während die restlichen, unregulierten Spezies generell 
lange mRNA- und Protein-Halbwertszeiten aufweisen. Zum Abschluss von Kapitel 5 werden 
die Effekte transkriptioneller Rückkopplung in Signalnetzwerken durch kinetische Modelle 
untersucht, und es werden Erklärungen erarbeitet, wieso transkriptionelle Rückkopplung 
nahezu ausschließlich durch Induktion von hemmenden Faktoren geschieht. In Kapitel 6 wird 
transkriptionelle Rückkopplung am Beispiel der TGFβ-Smad Signalkaskade eingehender 
untersucht, um die physiologische Relevanz transkriptioneller Rückkopplung auf Protein-
Ebene zu bestätigen. Der TGFβ-Signalweg spielt eine wichtige Rolle für physiologische und 
pathologische Prozesse wie Embryonalentwicklung, Regeneration, Homöostase und Krebs. 
Microarray-basierende Expressionanalysen und Messungen auf Protein-Ebene (präsentiert 
in Kapitel 6) legen nahe, dass dem SnoN-Onkoprotein eine zentrale Rolle bei der 
transkriptionellen Rückkopplungsregulation des TGFβ-Signalwegs in primären Hepatozyten 
zukommt. Ein mathematisches Modell des TGFβ-Signalwegs inklusive SnoN-vermittelter 
Rückkopplung wurde mit zeitaufgelösten Messungen des Smad-Signalweges kalibriert, und 
Modell-Vorhersagen wurden dann experimentell bestätigt, und zwar in primären 
Hepatozyten, denen ein funktionelles SnoN-Protein fehlt. Die Modellanalysen in Kapitel 6 
erklären wieso eine geringe Menge SnoN innerhalb der Zelle einen großen Überschuss der 
Smad-Proteine effizient hemmen kann und bestärken die physiologische Relevanz 
transkriptioneller Rückkopplung in der Signalübertragung. 
 
Es ist bisher nur ansatzweise verstanden, wie Spezifität in intrazellulären Signalnetzwerken 
entstehen kann, obwohl verschiedene extrazelluläre Stimuli meist die gleichen 
Signalkaskaden aktivieren. Experimentelle Studien weisen darauf hin, dass die quantitativen 
Aspekte wie Signalamplitude und Signaldauer entscheidend für stimulus-spezifische 
Antworten der Zelle sind. Das bedeutet aber wiederum, dass die unterhalb der Signalwege 
gelegenen genregulatorischen Netzwerke in der Lage sind, die quantitativen Aspekte der 
Signale zu interpretieren (“Dekodierung“). Im dritten Teil dieser Arbeit werden 
genregulatorische Netzwerke analysiert, und somit ein erster Schritt zu integrierten 
systembiologischen Modellen vollzogen, die sowohl Signalnetzwerke als auch die 
nachgelagerten genregulatorischen Netzwerke beinhalten. In Kapitel 7 werden kompetitive 
Hemmung und regulierter Abbau als Mechanismen beschrieben, die es intrazellulären 
Regulationsnetzwerken erlauben, kurze und lange Signale effizient voneinander zu 
unterscheiden. Durch quantitative Modellierung und experimentelle Analyse wird gezeigt, 
dass die kleine regulatorische RNA, IsrR, als kompetitiver Inhibitor sicherstellt, dass die 
potentiell gefährliche und energieaufwändige Expression eines zentralen Stressproteins nur 
unter starken und lang anhaltenden Stressbedingungen stattfindet (Amplitude- und 
Dauerdekodierung). Viele signalinduzierte Gene fungieren ihrerseits als 
Transkriptionsfaktoren, so dass in vielen Fällen ein eng vernetztes 
Transkriptionsfaktornetzwerk die Signaldekodierung vermittelt. Deshalb reicht ein 
Verständnis einfacher transkriptioneller Motive nicht aus, und es müssen neue integrative 
Methoden zum Verständnis von Transkriptionsfaktornetzwerken erarbeitet werden. In Kapitel 
8 wird eine Reverse Engineering-Methode (modular response analysis, MRA) angewandt, 
um die Topologie eines Ras-regulierten Transkriptionsfaktornetzwerks aus knock-down 
Experimenten und Expressionsdaten abzuleiten. Eine statistische Auswertung der MRA-
Ergebnisse erlaubt es, experimentell überprüfbare Hypothesen aufzustellen und zentrale 
Transkriptionsfaktorkaskaden zu identifizieren. 
 
Zusammenfassend zeigt diese Arbeit, wie systembiologische Ansätze das Verständnis 
intrazellulärer Signalnetzwerke vertiefen können. Die in dieser Arbeit angewendeten Ansätze 
beinhalten quantitative Analysen kleiner regulatorischer Motive (Kapitel 2, 3, 4 und 7), die 
systematische Untersuchung von Hochdurchsatzdaten (Kapitel 5 und 6), die integrative 
kinetische Modellierung vieler Zeitreihen (Kapitel 6) und das Ableiten von Netzwerk-
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1 General introduction 
 
Parts of this chapter will be published as a review in a forthcoming issue of Essays in 
Biochemistry. Parts of Section 1.2 are published as a supplement in [1] . 
 
 
1.1 Signalling from the cell membrane to the nucleus 
 
The intracellular signalling network transduces extracellular signals (e.g., growth factor 
stimulation) from the cell membrane to the nucleus, and ultimately mediates changes in gene 
expression to induce cellular responses. Information is typically transmitted through multi-
layered enzymatic cascades, and various signalling mechanisms including protein-protein 
interactions, covalent modification and nucleo-cytoplasmic shuttling are employed. The 
three-tiered mitogen-activated protein kinase (MAPK) signal transduction cascades are 
probably the best-characterised signalling pathways in eukaryotic cells. Active MAP kinases 
control various physiological processes and cell fate decisions in all eukaryotic cells, mainly 
by regulating gene expression.  
 
The classical, most studied Ras-MAPK cascade in higher mammalian cells is the pathway 
comprising the small G-protein Ras, and the serine/threonine kinases Raf, MEK and ERK 
(Fig. 1.1A; reviewed in [2] ). The activity of Ras is controlled by guanine nucleotide binding, 
while downstream kinase activity is regulated by (de)phosphorylation. Cascade activation is 
typically initiated by hormone binding to cognate transmembrane receptors. The resulting 
active receptor-ligand complexes employ various mechanisms to convert the small G-protein 
Ras from its inactive GDP-bound form into the active GTP-bound form. RasGTP then recruits 
the uppermost MAPK cascade member, Raf, to the plasma membrane, where it is 
phosphorylated and thereby activated. Phospho-Raf activates MEK by phosphorylating it at 
two residues, and phospho-MEK then in turn acts as an ERK kinase (Fig. 3.1A). Through 
double-phosphorylation, ERK is activated and translocates to the nucleus, where it 
phosphorylates several nuclear kinases and transcription factors, which change the 
expression of about one hundred genes. The Raf-Mek-Erk cascade received much scientific 
attention since it plays a central role in various physiological processes such as cell cycle 
progression, cell differentiation and cell death. Additionally, cascade activation is 
dysregulated in many diseases. Moreover, the system serves as the best-understood 
paradigm for biological regulation by protein phosphorylation/dephosphorylation cycles. The 
human genome encodes for about 500 kinases and 200 phosphatases [3,4] , so that insights 
into the design principles of MAPK cascades are expected to be applicable to cellular 
regulation in general. 
 
Many diseases are characterised by deregulated signalling. For example, growth-promoting 
signalling is constitutively elevated in many cancers, so that cells divide at a high rate, and 
are no longer dependent on external stimulation. The Ras-MAPK signalling cascade is 
central to tumour development, as it is deregulated in more than 30% of all cancers, and 
even more frequently in some specific types of cancer, such as pancreatic cancer (90%) [5] . 
Activating mutations in Ras and B-Raf are common in cancer, and were shown to be crucial 
for tumour progression [6] . Overexpression of Ras and downstream cascade members due 
to promoter deregulation and/or genomic amplification has also been observed in tumours, 
but the functional significance of such wildtype protein overexpression remains unclear  (e.g., 
[7,8,9] ). In Section 2, the role of Ras overexpression is studied theoretically by numerical 
analysis of an experimentally validated model of the RasGDP/GTP cycle [10] . It is shown 
that basal Ras signalling activity can be completely insensitive to the total Ras protein 
expression level, which might explain why overexpression of wildtype Ras is often insufficient 
to enhance downstream signalling and to transform cells. Interestingly, this “tumour 
suppression effect” is only observed in the weak stimulus regime, and disappears upon 
strong stimulation, so that Ras overexpression, though phenotypically silent on its own, can 
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prime cells for strong transformation by mutational activation of signalling pathways upstream 
of Ras. Cancer development is a multistep process, and it is well established that multiple 
oncogenic mutations often cooperate to bring about cellular transformation. The simulations 
presented in Section 2 explain experimental studies showing that overexpression events 
within the MAPK cascade, though weakly transforming in isolation, frequently cooperate to 
bring about strong cellular transformation (“oncogene cooperation”). The results hold for 
cellular signal transduction via activation-deactivation cycles in general, and are thus likely to 
be relevant for many intracellular signalling pathways.    
 
 
Figure 1.1: Signal transduction via MAPK and caspase cascades. 
(A) Schematic representation of signalling via the Ras-MAPK cascade. Solid arrows indicate mass transfer, while dotted lines 
denote regulatory control (typically by enzymatic catalysis) (B) Schematic representation of apoptosis signalling via caspase 
cascades (adapted from [11] ). Solid arrows indicate mass transfer, dotted lines indicate regulatory control, and blunted solid 
arrows indicate reversible inhibition by protein-protein interaction.  
 
 
Under physiological conditions, cells are typically exposed to transient extracellular 
stimulation. Provided that stimulation is sufficiently strong and/or sustained, cells become 
irreversibly committed to a new fate. Any biochemical signalling network involved in cell fate 
decisions must be able to reliably discriminate between physiological relevant signals and 
background fluctuations in order to avoid improper responses. Such filtering is typically 
realised by all-or-none, switch-like stimulus-response behaviour. These stimulus-response 
relationships are sigmoid, meaning that sub-threshold stimuli fail to elicit significant 
responses, while strong signalling is observed in response to supra-threshold stimulation. As 
these sigmoid curves are highly sensitive around the threshold, this phenomenon has been 
often referred to as ultrasensitivity. Three basic ultrasensitivity mechanisms have been 
described for biochemical signalling networks:  
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(i)  Multistep ultrasensitivity: Ultrasensitivity arises if an input regulates its downstream 
effectors at multiple points [12] . In the MAPK cascade, the kinases Raf and Mek 
phosphorylate their downstream effectors, Mek and Erk, at two sites, and thus 
establish multistep regulation (Fig. 1.1A). Such double phosphorylation can give rise 
to quadratic (instead of linear) kinase control over substrate phosphorylation [13] .  
(ii) Zero-order ultrasensitivity: Early theoretical work by Goldbeter and Koshland [14]  
showed that phosphorylation cycles can exhibit very strong ultrasensitivity if the 
catalyzing enzymes (i.e., kinase and phosphatase) operate near saturation, i.e., if the 
Michaelis-Menten constants (KM-values) of the enzymes are much smaller than the 
substrate concentration. This phenomenon has been termed zero-order 
ultrasensitivity to reflect that the (de)phosphorylation velocities are independent of the 
substrate concentration in the saturated regime. Recent studies however casted 
doubt on the physiological relevance of zero-order ultrasensitivity in mammalian 
MAPK signalling, as ultrasensitivity is strongly weakened if the enzyme and substrate 
concentrations are comparable, i.e., if the substrate is significantly sequestered on the 
catalyzing enzymes [13,15] .  
(iii) Inhibitor ultrasensitivity: A third way to generate ultrasensitivity is through competitive 
inhibition [16] . In the extreme case of strong inhibition, low-level pathway activation is 
completely suppressed by binding of the inhibitor. Once the concentration of the 
target molecule, however, exceeds that of the inhibitor, inhibition no longer occurs, so 
that the system suddenly switches on.  
 
Switch-like stimulus-response behaviour can be further enhanced if the basic ultrasensitivity 
mechanisms described above are embedded into a larger biochemical network. In particular, 
multi-layered signalling cascades such as the MAPK pathway typically show much stronger 
and more robust ultrasensitivity than each level in isolation [12,17,18] . Another way to 
amplify ultrasensitivity is positive feedback, as feedback signalling only starts to become 
significant once the threshold has been exceeded, thus making the near-threshold response 
even steeper [19] . An extreme manifestation of feedback amplification is bistability, where 
the system switches between two discrete states (on and off) in a true all-or-none manner. 
Bistable systems also display hysteresis, meaning that different stimulus-response curves 
are obtained depending upon whether the system began in its off or its on state. Thus, the 
systems’ behaviour is history-dependent, as the positive feedback can act as a memory 
device, which maintains high activity even if stimulation strength decreases. In some cases, 
the on state is maintained indefinitely after the stimulus is completely removed, so that the 
system shows irreversible activation [20] .  
 
Bistability is an important mechanism for noise-resistant cell fate decisions, and it has been 
proposed that bistability arises in the mammalian MAPK cascade, because Erk activates Raf 
in a positive feedback loop via PKC [21] . Intriguingly, recent theoretical work indicated that 
implicit positive feedbacks and bistability can emerge even in the core Raf-Mek-Erk module 
due to enzyme sequestration effects [22,23] . Single-cell measurements strongly suggest 
that the Raf-Mek-Erk module is bistable in mammalian neuronal precursors (PC12 cells), 
because all-or-none and irreversible Erk activation was observed in response to extracellular 
stimulation [24] . However, this phenomenon appears to be cell-type-specific, as Erk 
activation at the single-cell level was gradual but ultrasensitive in fibroblasts [25] . Taken 
together, these data suggest that filtering due to ultrasensitivity is a general property of the 
mammalian Raf-Mek-Erk module, while bistability appears to be a context-dependent 
phenomenon.     
 
The molecular mechanisms underlying ultrasensitivity and bistability in MAPK activation 
remain incompletely understood, but recent single-cell measurements suggest that bistability 
can arise within the core MAPK cascade [26] . Experimental studies revealed that 
unphosphorylated Mek and Erk form a stable complex in unstimulated cells, which 
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dissociates upon stimulation with growth factors (see, e.g., [27] ). In Section 3, the impact of 
such basal Mek~Erk association is analysed numerically using a mathematical model 
consisting of experimentally validated parameters. The simulations reveal that an implicit 
positive feedback and bistability can arise in the MAPK cascade from stimulus-induced 
dissociation of the Mek-Erk complex. Further simulations demonstrate that bistability due to 
Erk-Mek complex formation strongly cooperates with other potential bistability mechanisms in 
the MAPK cascade. In conclusion, the results in Section 3 help to explain how MAPK 
signalling can establish all-or-none and irreversible cell fate decisions in response to 
transient extracellular stimulation.   
   
Apoptosis, an evolutionary conserved form of cell suicide, allows multicellular organisms to 
eliminate damaged or excess cells in order to maintain tissue homeostasis (reviewed in [11] 
). Aspartate-specific cysteine proteases, also known as caspases, are the central 
executioners of apoptosis. In most cases, apoptotic stimuli activate initiator caspases, whose 
substrates, the effector caspases, ultimately cause cellular demise by cleaving various 
cellular substrates (e.g., nuclear DNA processing enzymes). Figure 1.1B schematically 
depicts the so-called intrinsic and extrinsic apoptotic pathways that elicit apoptosis by 
cleaving and thereby activating caspase-3, the major cellular effector caspase. The extrinsic 
pathway is initiated by ligand binding to death receptors (e.g., CD95), which then oligomerise 
and recruit various proteins, including pro-caspase8, into the so-called death-inducing 
signalling complex. Formation of the death-inducing signalling complex leads to 
autoprocessing of pro-caspase8 into active (initiator) caspase8, which then cleaves (effector) 
caspase-3. Cytotoxic stress (e.g., chemotherapeutic treatment) or death-receptor–stimulated 
caspase-8 engage the intrinsic, or mitochondrial, apoptosis pathway by inducing the 
translocation of pro-apoptotic Bcl-2 family members such as Bid to mitochondria. Pro-
apoptotic Bcl-2 family members permeabilise the mitochondrial membrane and thereby elicit 
the release of proapoptotic proteins (cytochrome c and Smac) into the cytosol. Cytosolic 
cytochrome c then induces the oligomerisation of Apaf-1 into an active high molecular-weight 
complex, the apoptosome, which recruits and stimulates (initiator) caspase-9, and thereby 
allows activation of effector caspases such as caspase-3. Smac and inhibitors of apoptosis 
(IAPs) such as X-linked IAP (XIAP) establish an additional layer of regulation in the intrinsic 
pathway: XIAP inhibits the catalytic activities of caspase-9 and caspase-3 through reversible 
binding, and cytosolic Smac relieves this inhibition by sequestering XIAP away from 
caspases. 
 
Experimental analyses revealed that apoptosis is an all-or-none process at the single-cell 
level [28,29,30] , and that cells are irreversibly committed to death once the apoptosis 
program has been initiated [31] . Previous theoretical analyses indicated that bistability might 
underlie rapid all-or-none and irreversible caspase activation in the extrinsic apoptosis 
pathway [32] , but the kinetic characteristics of the intrinsic caspase pathway have been less 
well studied. In Section 4, a mathematical model of the core intrinsic apoptosis pathway is 
derived based on published biochemical and kinetic measurements. Subsequent numerical 
analyses reveal an unanticipated role for the inhibitor of apoptosis (IAP) proteins, which 
simultaneously inhibit caspase-9 and its downstream effector caspase-3 (Fig. 1.1B): 
Caspase-3, once activated, sequesters XIAP away from caspase-9, and thus allows for 
further caspase-3 and -9 activation in a positive feedback loop. In other words, IAP proteins, 
though inhibitors of caspase enzymatic activity, might establish an implicit positive feedback 
loop similar to that discussed for MAPK signalling in Section 3.     
 
Taken together, the results in Part I provide insights into the steady state dose-response 
behaviour of signal transduction by rapidly acting post-translational regulatory mechanisms. 
The following parts of the thesis deal with much slower transcriptional feedback regulation of 
signal transduction (Part II), and with decoding of intracellular signals by the downstream 




1.2 Time scales of signalling and transcriptional feedback regulation 
 
Signalling networks employ post-translational regulatory mechanisms such as 
phosphorylation, ubiquitination and nucleo-cytoplasmic shuttling to transduce inputs from the 
cell membrane to the nucleus. These events typically occur on a time scale of seconds to 
minutes, and are thus much faster than transcriptional regulation. Thus, it might be expected 
that the dynamics of signalling networks are mainly governed by post-translational feedback 
mechanisms, while slow transcriptional feedback loops play no major role. Experimental 
evidence summarised in the following, however, suggests that transcriptional feedbacks are 
central to the regulation of decision making in mammalian cells.  
 
The c-fos proto-oncogene belongs to the group of immediate-early genes directly regulated 
by phospho-Erk, and c-fos protein starts to accumulate 20 – 40 minutes after growth factor 
stimulation [33,34,35] . Thus, the time scale of stimulus-induced gene expression and 
transcriptional feedback is beyond ~20 minutes. Depending on the cellular context and on 
the stimulus, signals are shorter than 20 minutes [36,37] , which suggests that transcriptional 
feedback does not play a role in these systems. Accordingly, it was explicitly shown in PC12 
cells that short-term Erk activation in response to EGF is not affected if de novo transcription 
is blocked by the general transcription inhibitor Actinomycin D [36] .  
 
Table A.1 summarises the experimentally observed signal duration ranges of several 
signalling pathways, and reveals that they frequently remain active over several hours under 
physiological conditions. Most importantly, Table A.1 also lists measurements in vivo, and 
reveals that signalling cascades are frequently active over several hours in living animals. 
These data strongly suggest that transcriptional feedback regulates the temporal dynamics of 
many signalling pathways under physiological conditions.  
 
The impact of transcriptional feedback cannot simply be shown by specific knock-down or 
inhibition of signalling proteins, as even constitutively expressed signalling proteins modulate 
the signal duration [38] . Three lines of evidence nevertheless strongly support that 
transcriptional feedback loops regulate the dynamics of signalling cascades. First, specific 
inhibition of signalling proteins that are transcriptionally induced upon stimulation does not 
affect early phase signalling and the peak amplitude of the signal, but selectively affects 
signal termination at later times [39,40,41] . Second, a knock-down of transcription factors 
mediating gene expression and thus transcriptional feedback regulation downstream of the 
JNK cascade was shown to affect JNK signal magnitude and duration in response to 
oxidative stress [39] . Third, the several signalling pathways show altered dynamics if 
downstream gene expression was blocked by pre-incubation with inhibitors of translation or 
transcription (cycloheximide, actinomycin D). Table A.2 summarises literature studies where 
protein biosynthesis inhibitors sustained signalling activity, and thus strongly supports the 
relevance of transcriptional negative feedback regulation in the mammalian signalling 
network.  
Late-acting transcriptional feedback loops can only be physiologically relevant if late phase 
signalling is required for phenotypic responses towards extracellular stimulation. Tables A.3 
and A.4 summarise published experimental studies where signalling was terminated by 
delayed addition of small-molecule kinase inhibitors or by delayed removal of extracellular 
ligands. The threshold times indicate the signal duration required to irreversibly commit the 
cell population to the given phenotypic response (stimulation occurred at t = 0 h). The data 
can be summarised as follows: The decision whether any (immediate-early) gene expression 
occurs or not is typically made within minutes [36,42,43] , while late-phase gene expression 
requires ongoing signalling for 30’ – 4 h (Tables A.3 and A.4). Importantly, the commitment to 
new cell fates such as apoptosis, differentiation or S-phase entry often requires ongoing 
signalling or stimulation for more than 5 h (Tables A.3 and A.4), even though a few seconds 
might already be sufficient in neuronal signalling [44] . It should be noted that Tables A.3 and 
A.4 summarise threshold times, i.e., the signalling time required to irreversibly commit to an 
event. In other cases, commitment is not observed and ongoing signalling over long periods 
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is required to maintain a phenotype. For example, differentiation of PC12 occurs after ~3 
days stimulation with NGF, but cells still de-differentiate if NGF is removed after 7 days [45] .  
 
In conclusion, different experimental approaches (i.e., pharmacological inhibition, ligand 
removal and stimulation with different ligand doses) strongly suggest that long-term, supra-
basal signalling over several hours is often required for cells to commit to phenotypic 
responses. This indicates that decision making in mammalian cells is profoundly affected by 
slowly acting transcriptional feedback mechanisms. In Section 5, the general design 
principles underlying transcriptional feedback regulation of mammalian signalling pathways 
are therefore investigated. Published microarray studies in response to extracellular 
stimulation were collected, and the stimulus-induced expression of 134 intracellular signalling 
proteins was investigated. The analysis revealed that transcriptional feedback regulation 
occurs in each of the five mammalian signalling pathways considered, and that negative 
feedback strongly dominates over positive feedback. Moreover, negative feedback 
exclusively occurs by transcriptional induction of a subgroup of signal inhibitors, termed rapid 
feedback inhibitors (RFIs), while downregulation of signal transducers plays no role. 
Systematic analysis of mRNA and protein half-lives reveals a remarkable separation of the 
signalling network into flexible and static parts: transcriptionally regulated RFIs are unstable 
at the mRNA and protein levels, respectively, while other signalling proteins are generally 
stable. Kinetic modelling, also presented in Section 5, suggests that this design principle 
allows for swift feedback regulation and establishes latency phases after signalling, and that 
it might be an optimal design due to a trade-off between energy efficiency and flexibility. 
  
The analyses presented in Section 5 confirm that rapid feedback inhibitors (RFIs) are 
induced at the mRNA level, but the physiological relevance of these feedbacks remains to be 
verified at the protein level. In Section 6, transcriptional feedback regulation was therefore 
analysed in more detail using TGFβ signalling in primary hepatocytes as an example. The 
TGFβ family of cytokines constitute major inhibitors of cell growth, and accordingly they play 
an important role in various physiological processes such as development, tissue 
homeostasis, and tissue regeneration. Moreover, TGFβ signalling is dysregulated under 
pathological conditions including cancer, organ fibrosis, and Marfan syndrome (reviewed in 
[46,47,48] ). TGFβ signalling is initiated by binding of extracellular TGFβ to transmembrane 
serine/threonine kinase type I and type II receptors. Ligand binding triggers receptor-
mediated phosphorylation of Smad2/3 transcription factors, which then homotrimerise or 
heterotrimerise (with Smad4), and subsequently translocate into the nucleus (Fig. 6.1). 
Nuclear Smad trimers control the expression of several hundred target genes, many of which 





Figure 1.2: The quantitative model of signalling specificity. 
(A) - (C) Signalling motifs mediating signal adaption. (A) Sequestration: Signal termination occurs when the activated molecule 
(X*) is sequestered into an inactive form (Xi*), e.g., through binding, internalisation or degradation. (B) Incoherent feed-forward 
loop: The stimulus first activates the molecule through a fast process, and then terminates signalling through a slow, delayed 
mechanism. (C) Negative feedback: The activated molecule inhibits its own production. (D) The signalling network from NGF, 
Glutamate and EGF stimulation to Erk activation. Various adaptation mechanisms control the duration of Erk activation in a 
stimulus-specific manner (see main text). 
 
 
Experimental evidence suggests that transcriptional feedback loops play an important role for 
the dynamics of TGFβ signalling via Smad transcription factors, and thus for phenotypic 
responses triggered by TGFβ: Smad activity remains elevated over several hours after TGFβ 
stimulation (Appendix A), thus being vulnerable for transcriptional feedback regulation. 
Accordingly, various transcriptional feedback regulators acting at all levels of the signalling 
cascade have been reported of TGFβ signalling (Appendix E). Moreover, Smad activation 
was shown to be prolonged upon incubation with protein synthesis inhibitors which block de 
novo  gene expression, and thus transcriptional feedback loops (Appendix A). In support for 
the relevance of transcriptional feedback regulation, it is known that sufficiently sustained 
Smad signalling over several hours is required for TGFβ-mediated inhibition of cell growth 
[49] . Genome-wide microarray analyses presented in Section 6 suggest that transcriptional 
feedback regulation exists in primary mouse hepatocytes stimulated with TGFβ, and 
measurements at the protein level indicate that the SnoN oncoprotein is the central feedback 
regulator. Theoretical predictions regarding the mechanisms of transcriptional feedback 
regulation are then confirmed in primary hepatocytes isolated from SnoN knock-out mice, 
thus further supporting the relevance of transcriptional negative feedback regulation in signal 
transduction.    
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Taken together, the results in Part II reveal how transcriptional feedback regulation shapes 
the dynamics of signal transduction. Part III is mainly focussed on the decoding of 
intracellular signals by the downstream gene expression machinery, as further outlined in 
Section 1.3.   
 
 
1.3 The quantitative model of signal specificity and decoding at the level of 
gene expression 
 
The quantitative model of signal specificity: Cells face a specificity problem as different 
extracellular stimuli frequently engage the same set of intracellular signalling pathways even 
though they elicit completely different biological responses. Experimental evidence suggests 
that stimulus-specific biological information is frequently encoded in the quantitative aspects 
of stimulus-specific activation kinetics. The Raf-Mek-Erk pathway serves as a paradigm for 
quantitative encoding of signalling specificity, as both the amplitude and the duration of Erk 
activation are critical determinants for the cell fate. The amplitude of the Erk signal seems to 
be important in fibroblasts, where low level Erk signalling induces proliferation, while cell 
cycle arrest is observed in response to strong Erk activation [50] . In neuronal precursors 
(PC12 cells), it seems to be mainly the Erk signal duration that matters, as these proliferate 
upon short-term Erk activation, but differentiate if Erk phosphorylation is sustained [51] . Yet, 
the fate of PC12 cells can be induced in a stimulus-specific manner, as EGF stimulation 
elicits transient Erk activation, while prolonged Erk signalling is observed in response to NGF 
(see Fig. 1.2B) [51] . 
 
Various mechanisms are thought to contribute to such stimulus-specific modulation of Erk 
signal duration. In simple terms, transient Erk activation is observed if the MAPK cascade or 
upstream pathways are subject to delayed negative regulation, which ensures efficient signal 
termination, also referred to as signal adaptation. In contrast, Erk exhibits sustained 
activation if such adaptation mechanisms are absent. Three basic regulatory mechanisms 
depicted in Fig. 1.2A – C are known to mediate signal adaptation in biochemical regulatory 
networks (sequestration/internalisation, incoherent feed-forward regulation and negative 
feedback regulation). All of them seem to be involved in the modulation of MAPK signal 
duration as discussed in the following.  
 
Growth factor receptors are taken up into the cell upon ligand binding, and are deactivated 
and/or degraded within intracellular vesicles and therefore the signal is terminated (arrow 1 in 
Fig. 1.2D). It is known that EGF receptors internalise more rapidly than NGF receptors, and it 
has been suggested that rapid receptor sequestration accounts for transient Erk signal 
duration in EGF-treated PC12 cells [52] . 
 
Glutamate induces transient Erk activation in neurons, whereas sustained signalling is 
observed in response to potassium chloride [53] . Strikingly, the rapid decline in Erk 
phosphorylation depends on glutamate’s ability to specifically activate PTP-STEP, an Erk 
phosphatase (arrow 2 in Fig. 1.2D). This kind of regulation is known as incoherent feed-
forward loop, because a common upstream regulator (i.e., glutamate) both activates and 
inhibits a downstream effector (i.e., Erk) via two independent branches. Incoherent feed-
forward loops generate transient signals if positive regulation (Erk phosphorylation by Mek) 
proceeds faster than negative regulation (PTP-STEP activation), as observed in glutamate-
induced neuronal MAPK signalling [53] .    
 
Early theoretical work indicated that differential feedback control in EGF vs. NGF signalling 
may underlie transient vs. sustained Erk signalling in PC12 cells [54] . A recent experimental 
and theoretical study confirmed that stimulus-specific feedback regulation indeed occurs in 
PC12 cells [24] . It was shown that EGF specifically induces negative feedback within the 
MAPK cascade and thereby induces early termination of Erk activity (e.g., arrow 3 in Fig 
1.2D). NGF signalling appeared to escape signal adaptation because strong initial Erk 
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activation (compared to EGF stimulation) specifically triggers a positive feedback which 
outweighs negative feedback regulation (arrow 4 in Fig. 1.2D). In particular, this positive 
feedback was shown to establish bistable and irreversible Erk activation, thus ensuring 
prolonged signalling [24] .      
 
Both theoretical and experimental studies demonstrated that a pathway consisting of the 
adaptor protein FRS and the small G-protein Rap plays a key role for sustained Erk 
signalling in NGF-treated PC12 cells [55,56,57] . Importantly, this pathway is specifically 
engaged by NGF for receptor-mediated Raf activation, but not by EGF [55,57] . Moreover, 
sustained activation of Erk in response to NGF is abolished if Rap signalling is blocked [57] . 
Accordingly, the FRS-Rap pathway shows sustained activation kinetics, while the functionally 
redundant Shc-Ras pathway that mediates EGF-induced Raf activation is only transiently 
active [55,57] . Various explanations have been proposed why the duration of Ras and Rap 
signalling differs: (i) incoherent feed-forward regulation via RasGAP limits signal duration of 
the Shc-Ras pathway (arrow 5 in Fig. 1.2D), but not that of the FRS-Rap module [55] . (ii) the 
Shc-Ras branch is subject to negative feedback control by Erk (arrow 3 in Fig. 1.2D), while 
no such feedback has been described for FRS-Rap signalling [54,57] . (iii) cytosolic adaptor 
proteins such as Shc are only functional when recruited to active transmembrane receptors, 
whereas signalling via membrane-anchored adaptors like FRS can continue even without 
such recruitment. Thus, the FRS-Rap pathway is expected to be less susceptible to signal 
termination by receptor downregulation, and should therefore exhibit more sustained 
activation [56] . A summary of the network shaping Erk activation upon stimulation with NGF, 
glutamate and EGF is shown in Fig. 1.2D. 
 
In conclusion, it appears that stimulus-specific upstream regulatory pathways (e.g., 
receptors, adaptors or small G-proteins) are major determinants of Erk signal duration, 
because they exhibit differential susceptibility to negative regulation and thus signal 
termination. Additionally, the shared MAPK cascade integrates incoming inputs and 
generates transient or sustained output depending on their amplitude.         
 
Decoding at the level of gene expression: If biological information is encoded in the 
quantitative aspects of intracellular signals, proper biological responses require that the 
downstream gene expression machinery is able to accurately decode their amplitude and 
duration. Amplitude decoding most likely occurs by the ultrasensitivity mechanisms 
discussed in Section 1.1 (i.e., inhibitor ultrasensitivity, zero-order ultrasensitivity and 
multistep ultrasensitivity). The mechanisms of duration decoding have been less well studied, 
even though the duration of intracellular signals is known to determine the characteristics of 
gene expression downstream of TGFβ signalling [49] , NF-κB signalling [43] , cAMP 
signalling [42] , glucose signalling [58]  and MAPK signalling (see above). 
 
Previous theoretical work indicated that multistep regulatory motifs such as the coherent 
feed-forward loop [59]  or multisite phosphorylation [15,60]  are able to discriminate transient 
and sustained stimuli. Moreover, it has recently been shown that bistable systems decode 
the input signal duration in an all-or-none manner [61] . A multistep regulation mechanism 
that has been implicated in the decoding of Erk signal duration is the simultaneous induction 
and stabilisation of the transcription factor c-Fos [5,34] . The transcription of c-Fos is induced 
by phosphorylated Erk. After translation, the protein is very unstable (half-life t1/2 ≈ 15 min) 
and cannot accumulate, unless it is stabilised by Erk-mediated phosphorylation (t1/2 ≈ 4 
hours). Thus, sufficiently sustained Erk signalling is required for accumulation of the c-fos 
protein. Such a mechanism, where Erk positively regulates c-Fos at two levels (transcription 
and protein stability), is known as coherent feed-forward loop [62] .  
 
The results presented in Section 7 identify competitive inhibition and regulated degradation 
as alternative mechanisms that allow intracellular regulatory networks discriminating 
transient and sustained inputs in an ultrasensitive manner. The temporal characteristics of 
the cyanobacterial iron stress response are analysed by mathematical modelling and 
 10 
quantitative experimental analyses. A recently discovered small non-coding RNA, IsrR, is 
shown to be responsible for a pronounced delay in the accumulation of isiA mRNA encoding 
the late-phase stress protein, IsiA. Moreover, it is demonstrated that sRNA-mediated 
regulation ensures a rapid decline in isiA levels once external stress triggers are removed. 
These kinetic properties allow the system responding selectively to sustained (as opposed to 
transient) stimuli. Thus, sRNA-mediated regulation establishes a temporal threshold which 
ensures that costly isiA accumulation is restricted to severe, prolonged and ongoing stress 
conditions. Non-protein-coding RNA regulators control diverse processes in metazoans 
including development, cell differentiation, and cell proliferation [63,64] , and also play 
important roles in bacterial stress responses [65,66] , so that the results presented in Section 
7 are likely to be of broader physiological relevance.   
 
Many of the downstream target genes induced by signalling pathways are transcription 
factors, thus giving rise to a complex transcriptional regulatory network [67] . Therefore, 
signal decoding at the level of gene expression cannot be fully understood by insights into 
the functioning of small transcriptional regulatory motifs, but additionally requires integrated 
analyses of multiple transcription factors. In Section 8, it is described how systems biological 
approaches allow to derive the topology of complex transcriptional regulatory networks from 
high-throughput and knock-down data. More specifically, modular response analysis (MRA), 
a recently proposed reverse engineering method [68] , is applied to get insights into a 
transcription factor network that is regulated by oncogenic Ras and involved in the regulation 
of cell division. Statistical analyses of the MRA results allow proposing new experiments that 
can be used to verify the predicted regulatory interactions. The results in Section 8 thus 
represent a first step towards an integrated model including both, upstream signal 
























                
 






























































The basal state activity of signalling pathways is deregulated in many diseases. For example, 
cancer cells show permanent activation of mitogenic signalling protein kinase cascades and 
thus proliferate constitutively. In many cases, however, even strong overexpression of 
signalling intermediates does not appear to initiate tumourigenesis although relatively minor 
pathway activation (5 – 10 fold) is typically sufficient to induce phenotypic responses such as 
cell division. This suggests that tumour suppression mechanisms exist which prevent 
permanent deregulation of signal transduction by protein overexpression. By theoretical 
analysis of an experimentally validated kinetic model of the Ras activation cycle, it is shown 
in this chapter that basal Ras signalling activity can be completely insensitive to the Ras 
expression level, which might explain why overexpression of wildtype Ras is insufficient to 
enhance downstream signalling and to transform cells. Interestingly, this “tumour 
suppression effect” is only observed in the weak stimulus regime, and disappears upon 
strong stimulation, so that Ras overexpression, though phenotypically silent on its own, can 
prime cells for strong transformation by mutational activation of signalling pathways upstream 
of Ras. Cancer development is a multistep process, and it is well established that multiple 
oncogenic mutations often cooperate to bring about cellular transformation. The simulations 
presented in this chapter explain experimental studies showing that overexpression events 
within a single signalling cascade, though weakly transforming in isolation, frequently 





Normal cells require extracellular mitogenic signals before they can move from a quiescent 
state into an active proliferative state. These signals are transmitted into the cell by 
transmembrane receptors that bind distinctive classes of signalling molecules: diffusible 
growth factors, extracellular matrix components, and cell-to-cell adhesion/interaction 
molecules. Cancer cells escape the requirement for extracellular stimuli by constitutive 
activation of intracellular mitogenic signalling pathways. Such aberrant signalling is typically 
induced by mutational activation or overexpression of signal transducers, or by deactivation 
as well as downregulation of signal inhibitors [69] . Thus, cancer cells are often characterised 
by deregulated steady state signal transduction in the basal state.  
 
The small GTPase Ras transduces signals from extracellular growth factors, and controls 
various cellular responses including proliferation, apoptosis and migration. The Ras protein 
binds to guanine nucleotides, and cycles between inactive and active states by switching 
between GDP- and GTP-bound forms. Guanine nucleotides bound to Ras are exchanged 
even in the absence of other proteins by slow association-dissociation reactions, and Ras-
bound GTP is hydrolysed to GDP by the weak intrinsic GTPase activity of Ras. Within the 
cell, these reactions are strongly enhanced by guanine nucleotide exchange factors (GEFs) 
and GTPase-activating proteins (GAPs), respectively. Growth factors enhance GEF activity 






Figure 2.1: Mathematical Modelling of Ras overexpression.  
(A) Schematic representation of the mathematical model. Ras cycles between the inactive GDP-bound state and the active 
GTP-bound state. Cycling occurs either by intrinsic nucleotide exchange and intrinsic Ras GTPase (grey arrows), or is catalysed 
by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP), respectively (black arrows). GEF- and 
GAP-catalysed reactions were modelled with Michaelis-Menten kinetics, and the intrinsic steps with first-order kinetics. GTP and 
GDP were assumed to be present in excess, and were thus treated as external variables, as described in more detail in the 
Supplement. (B) Effects of Ras overexpression on signal transduction. The steady state RasGTP concentration is plotted as a 
function of total Ras expression (i.e., the sum of RasGTP, RasGDP and Ras). A simple linear relationship is observed if only the 
first-order intrinsic reaction steps (grey arrows in A) are taken into account (grey line). The black lines show simulations using a 
model where GEF- and GAP-catalysed reactions were taken into account, while intrinsic rates were neglected, and thus reflect 
the situation in living cells, where Ras cycling typically seems to be dominated by GEF- and GAP-catalysed reactions (see text). 
The default kinetic parameters were taken from [10] , and the experimentally measured Ras expression level in living cells is 
indicated by the vertical dashed line. The KM-values for both GEF-catalysed reactions (i.e., RasGTP → RasGDP and RasGDP 
→ RasGTP) were simultaneously varied as indicated by the arrow (line 1: KM,GDP = 3.86 ⋅ 10-6 mol/l; KM,GTP = 3 ⋅ 10-6 mol/l; line 2: 
KM,GDP = 3.86 ⋅ 10-5 mol/l; KM,GTP = 3 ⋅ 10-5 mol/l; line 3: KM,GDP = 3.86 ⋅ 10-4 mol/l; KM,GTP = 3 ⋅ 10-4 mol/l; line 4: KM,GDP = 3.86 ⋅ 10-3 
mol/l; KM,GTP = 3 ⋅ 10-3 mol/l).    
 
 
Aberrant Ras signalling is a common feature of tumours, and is, for example, caused by 
enhanced GEF activity or by decreased GAP expression. Moreover, ~30% of all tumours are 
characterised by Ras mutations which impair GTPase activity, and thus lock Ras in the 
active GTP-bound state [6] . The oncogenic potential of Ras mutants is usually analysed in 
overexpression studies, and the cells are assayed for their ability to induce tumours in mice, 
to proliferate in starvation media, or to induce a tumour-like (i.e., a transformed) phenotype in 
cell culture. Hallmarks of transformed cells are anchorage-independent growth, focus 
formation and a lack of contact-inhibition. Based on these criteria, it seems that even a 
relatively low cellular Ras-GTP content activation is sufficient to promote normal cell 
proliferation and tumourigenesis: (i) Even saturating growth factor concentrations typically 
induce no more than 5-10-fold Ras activation in normal cells when compared to the starved 
basal state (e.g., [70,71] ). (ii) Heterozygous knock-in mice expressing mutant Ras under the 
control of the endogenous promoter develop tumours [72,73] . (iii) Overexpression of GEFs 
allows for transformation [74,75,76,77]  although Ras-GTP is only increased by 3 – 4-fold in 
these cells [74,77] ; (iv) Neurofibromatosis patients do not express the NF1 GTPase-
activating protein, and it is thought that enhanced Ras signalling contributes to tumour 
formation in neurofibromatosis [78] . Yet, these tumours exhibit only a 3 – 10-fold increase in 
RasGTP content when compared to normal cells [78,79,80] .  
One would thus expect that even relatively minor (5–10 fold) overexpression of wildtype Ras 
(‘c-Ras’) should be sufficient to induce tumourigenesis in vivo and cellular transformation in 
culture, as a significant fraction of c-Ras is in the GTP-bound active form even under starving 
conditions (e.g., [57,81] ). In fact, even very strong overexpression of c-Ras does not induce 
cellular transformation or does so only very weakly in most cell lines and experimental 
settings [76,82,83,84,85,86,87] . Yet, the wildtype protein has, depending on the context, the 
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potential to induce transformation in culture [88,89]  or to induce the very same tumours as 
its mutant counterparts [90] .   
 
Biochemical studies of Ras-transfected cell lines revealed that the fractional activation of c-
Ras (i.e., the amount of Ras-GTP divided by the total Ras concentration) in the basal state 
decreases with increasing c-Ras expression in several cell lines [80,91] . This suggests that 
kinetic features of the Ras signalling network can suppress aberrant basal signalling in cells 
strongly overexpressing c-Ras. Accordingly, it was shown experimentally that c-Ras 
overexpression alone does not enhance downstream signalling in the unstimulated basal 
state [87] . In this chapter, an experimentally validated model of the core Ras activation cycle 
[10]  is analysed, and it is shown by kinetic modelling that the signal activity can be 
completely insensitive to the total Ras expression levels. The requirements for this ‘kinetic 
tumour suppression’ effect are derived analytically and the implications for cooperation 
among oncogenes are discussed. The results also account for experimental observations in 
the downstream MAPK cascade, and might explain why oncogene overexpression is 
generally inefficient for cellular transformation.  
 
 
2.2 Basal Ras signalling activity can be insensitive towards Ras 
overexpression 
 
The core Ras cycle (Fig. 2.1A) comprising the intrinsic and GAP-catalysed GTPase 
reactions, and spontaneous as well as GEF-catalysed nucleotide exchange has been 
intensively characterised by kinetic analyses of recombinant proteins in vitro. Stites et al. 
implemented a mathematical model for the core Ras activation using the kinetic parameters 
measured in vitro, and showed that the model predictions agreed well with experiments in 
living cells [10] . In this chapter, a slightly simplified version of their model, termed the 
“default model”, is analysed (Appendix B and Fig. 2.1A). The degree of DNA synthesis and of 
cellular transformation are known to be titrable functions of the intracellular Ras-GTP 
concentration [88,92,93] . Thus, the concentration of RasGTP is used as the physiologically 
relevant output of the model, and conclusions regarding cellular transformation are generally 
based on the assumption that transformation is proportional to the simulated RasGTP levels. 
 
The fraction of Ras protein in the GTP-bound state in starved cells ranges from less than 1% 
to 30% (e.g., [57,81] ). Some background stimulation most likely exist in vivo, so that even 
higher basal Ras activation levels are expected in the living animal. Intuitively, one would 
assume that the basal RasGTP concentration (i.e., basal Ras signalling) is proportional to 
the absolute Ras expression level. In other words, enhanced basal RasGTP signalling and 
thus cellular transformation might be inducible by Ras overexpression, especially because 
relatively minor (5 – 10 fold) increases in RasGTP already elicit phenotypic responses (see 
Section 2.1).  
 
To investigate the effect of Ras overexpression in the model, the basal steady state RasGTP 
level was simulated as a function of total Ras concentration. For some cells, it was shown 
that the intrinsic GTPase and exchange reactions predominate over the GEF- and GAP-
catalysed steps in the unstimulated basal state [71] . A corresponding simplified model solely 
consisting of the intrinsic grey reaction steps in Fig. 2.1A showed a simple linear relationship 
between the amount of GTP-bound and total Ras (Fig. 2.1B, grey line). Such direct 
proportionality is expected in this simplified model, because the intrinsic GTPase and 
exchange reactions occur with first-order kinetics (note that GTP and GDP are assumed to 
be in excess). Assuming that the amount of RasGTP governs cellular behaviour, one can 
conclude that sufficiently strong Ras overexpression induces phenotypic responses and 
cellular transformation, as long as the intrinsic reaction steps predominate basal Ras cycling. 
 
In most cells, however, basal Ras cycling in starvation media was shown to be dominated by 
the GEF- and GAP-catalysed reactions and/or is strongly affected by GEF and GAP knock-
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downs [78,79,80,94,95,96,97] , respectively. In the “GEF-GAP model” it was therefore 
assumed that the GEF- and GAP-catalysed steps are much faster than the spontaneous 
exchange and GTPase reactions, so that the model comprises only the black arrows in Fig. 
2.1A. Weak basal state signalling was modelled by assuming that maximal velocity of the 
GAP-catalysed reaction significantly exceeds that of the GEF-catalysed exchange reaction. 
The simulation result using the default kinetic parameters from the Stites-model (black line in 
Fig. 2.1B marked with default) reveals that basal state RasGTP level responds in a nonlinear 
fashion towards changes in Ras expression. More specifically, the RasGTP concentration no 
longer increases with increasing Ras expression, once the intracellular Ras expression is 
sufficiently high. This suggests that the kinetic features of the core Ras cycle can explain why 
in some cells the fraction of RasGTP decreases with increasing Ras expression [80,91] , and 
why Ras overexpression alone does not enhance downstream signalling in the basal state 
[87] .  
 
This ‘kinetic tumour suppression’ effect, however, requires strong Ras overexpression in the 
default model proposed by Stites et al. [10] , as the RasGTP level starts to become 
completely insensitive only for more than 10-fold Ras expression over the measured 
intracellular concentration (which is indicated by vertical dashed line in Fig. 2.1B). The kinetic 
requirements for saturation were therefore analysed in more detail to get insights into the 
physiological relevance of the proposed mechanism.   
 
 
2.3 Requirements for Kinetic Tumour Suppression 
 
In the Stites-model, the GEF- and GAP-catalysed reactions are modelled by reversible and 
irreversible Michaelis-Menten equations, respectively. Detailed numerical simulations (not 
shown) revealed that the behaviour of the Ras activation cycles does not appreciably change 
if the GEF-catalysed back-reaction (RasGTP → RasGDP) is eliminated from the model. A 
simplified GEF-GAP model comprising only irreversible GEF and GAP reactions was 
therefore analysed in order to derive an analytical expression for kinetic tumour suppression 
effect. For the half-saturation Ras expression level, where RasGTP reaches half of its 
saturation value, one obtains:  
 
M,GAP max,GAP max,GEF M,GEF
50
max,GAP max,GEF
K +2 V V K1Ras =
2 V V -1
⋅ ⋅
⋅        (2.1) 
 





V1Ras = K K
2 V
⋅ ⋅ +        (2.2) 
 
In the Ras activation cycle, the Michaelis-Menten constant of the GAP-catalysed reaction 
(KM,GAP) is typically lower than that of the GEF-catalysed reaction (and Vmax,GAP >> Vmax,GEF), 
so that the half-maximal Ras expression level is approximately given by Ras50 ≈ KM,GEF. One 
therefore expects that the Michaelis-Menten constant of the GAP-catalysed reaction should 
be a major determinant for the RasGTP insensitivity towards Ras expression. The predicted 
linear relationship between Ras50 and KM,GEF was confirmed by numerical simulations of the 
full GEF-GAP model with a reversible GEF reaction (black lines in Fig. 2.1B). 
 
The simulations in Fig. 2.1B strongly suggest that the proposed insensitivity mechanism is 
physiologically relevant: The Michaelis-Menten constant of the GEF-catalysed reaction used 
in the Stites model was measured for Cdc25Mm on unprocessed Ras [98] . However, it is 
well established that post-translational Ras farnesylation drastically enhances the Ras-GEF 
interaction [99,100,101] . Moreover, it is known that Michaelis-Menten constants of other 
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GEFs than Cdc25Mm are lower, especially if Ras is farnesylated [99,101,102,103] . Kinetic 
measurements taken from the literature (see Appendix B) indicate that the KM,GEF will often 
be two or more orders of magnitude lower than that used in the default Stites model. In other 
words, the KM,GEF will be close to or even below the intracellular Ras concentration, which 
suggests that the proposed kinetic tumour suppression effect operates in vivo.   
 
 
Figure 2.2: Ras overexpression primes cells for transformation.  
(A) Effects of Ras overexpression on signal transduction for varying upstream stimulus levels in a model comprising GEF- and 
GAP-catalysed reactions only (thus neglecting the intrinsic reaction steps, i.e., the grey arrows in Fig. 2.1 A). The RasGTP 
concentration is plotted as a function of total Ras expression (i.e., the sum of RasGTP, RasGDP), and the GEF concentration 
(i.e., the Vmax of GEF-catalysis) is varied. The GEF concentrations are 10-10, 2 ⋅ 10-9, 7 ⋅ 10-9 and 5 ⋅ 10-8 mol/l (this corresponds 
to Vmax,GEF / Vmax,GAP = 0.02, 0.4, 1.4 and 10). The Michaelis-Menten constants of the GEF reactions were set to KM,GDP = 3.86 ⋅ 
10-6 mol/l and KM,GTP = 3 ⋅ 10-6 mol/l. All other parameters were as in [10]  (see Appendix B) , and the experimentally measured 
Ras expression level in living cells is indicated by the vertical dashed line. Points A – D are described in B. (B) Schematic 
representation of phenotypically silent priming for strong transformation by overexpression of wildtype Ras. Normal 
untransformed cells are typically characterised by low upstream GEF activity, low Ras expression and accordingly low 
downstream MAPK activity (point A in panel A). Signalling can be enhanced to some extent by upstream pathway (GEF) 
activation (point B in panel A), resulting in a weakly transformed cell, which can be converted into a highly transformed cell by 
Ras overexpression (point D in panel A). The simulations in this chapter reveal that, in many cases, Ras overexpression alone 
is insufficient to enhance downstream signalling and to induce transformation (‘kinetic tumour suppression’; point C in panel A). 
However, these Ras expressing cells are primed for transformation in the sense that they can be directly converted from a silent 
state into a highly transformed state by a single mutational step resulting in minor upstream pathway activation (‘oncogene 
cooperation’; point C → point D in panel A).    
 
 
Taken together, the above simulations might explain why some cell lines can be transformed 
by overexpression of wildtype Ras, while others cannot (see Section 2.1). In some cells, 
basal Ras signalling increases linearly with the Ras expression level [104,105,106] . The 
results presented here suggest that the intrinsic GTPase and exchange rates dominate basal 
Ras cycling in these cells or that the Michaelis-Menten constant of the GEF-catalysed 
reaction significantly exceeds the intracellular Ras concentration. On the other hand, cells 
with Michaelis-Menten constants close to or below the Ras concentration are predicted to be 
insensitive towards Ras overexpression, and such insensitivity has also been reported 





2.4 Implications for oncogene cooperation 
 
Equation 2.1 suggests that insensitivity of signalling towards Ras overexpression is only 
observed under basal state conditions, as Ras50 becomes negative for Vmax,GEF > Vmax,GAP. 
Accordingly, numerical simulations of the full GEF-GAP model with a reversible GEF reaction 
(Fig. 2.2A) confirm that the insensitivity disappears for strong signalling (Vmax,GEF > Vmax,GAP). 
Moreover, it seems that Ras overexpression, though phenotypically silent in the basal state 
(point A → point C in Fig. 2.2A), primes cells for strong transformation by a mutational 
pathway activation event upstream of or at the level of GEFs. Here, priming means that the 
fold change in Ras activation by GEF activation is greater in Ras overexpressing cells  (point 
C → point D in Fig. 2.2A) than in wildtype cells (point A → point B in Fig. 2.2A). Thus, the 
simulation results is in accordance with previous work by Goldbeter and Koshland [14]  who 
showed that the sensitivity in covalent modification cycles increases with increasing enzyme 
saturation. Experimental evidence supports the existence of priming by Ras overexpression, 
as cellular transformation by transfection with constitutively active Sos GEF constructs is 
much more efficient in Ras-overexpressing cells than in wildtype cells, even though Ras 
overexpression alone was without effect [75,76] . Likewise, it was shown that basal MAPK 
signalling downstream of Ras is not affected by Ras overexpression in LNCAP cells, and that 
Ras overexpression drastically enhances EGF-induced MAPK activity, thus priming the 
signalling network for stimulus-induced activation [87] . Figure 2.2B summarises how Ras 
overexpression and GEF activation interact to bring about strong cellular transformation 
according to the kinetic simulations in Fig. 2.2A. A normal untransformed cell can either by 
weakly transformed by GEF activation, and transformation can be further enhanced by Ras 
overexpression (Fig. 2.2B, right), or phenotypically silent Ras overexpression (‘kinetic tumour 
suppression’) primes cells for strong transformation by subsequent GEF activation (Fig. 2.2B, 
left). 
 
The simulation results in Fig. 2.2, though generally applicable to activation-deactivation 
cycles, do not fully explain all experimental observations for the Ras activation cycle, at least 
in some cells. Experimental studies revealed that transfection with constitutively active GEF 
constructs elicits only negligible cellular transformation (as does overexpression of wildtype 
Ras), while co-transfection of GEF constructs with Ras induces strong transformation [75,76] 
. Hence, it seems that both ‘mutational’ events strongly cooperate similar to a logical AND-
gate for cellular transformation, a property that is not fully described Fig. 2.2A, where GEF 
activation has an effect (point A → point B in Fig. 2.2A). We have previously reported that 
sequestration effects can efficiently suppress signalling even upon strong stimulation, and 
that suppression is relieved in an ultrasensitive manner once the signalling intermediate 
concentration exceeds that of the sequestration species (‘ultrasensitization’) [107] . Such 
signal suppression effects due to Ras sequestration might explain why transfection with 
constitutively active GEF constructs alone fails to transform cells. In Figs. 2.1 and 2.2, the 
GEF- and GAP-catalysed reactions were modelled using the Michaelis-Menten 
approximation, which implies that sequestration of Ras in GEF- and/or GAP-containing 
complexes was neglected. In contrast, the simulations in Fig. 2.3 were obtained using the 
elementary-step description of the GEF- and GAP-catalysed reactions, and thus take 
sequestration of Ras in enzyme-substrate complexes into account. It can be seen in Fig. 
2.3A that neither Ras overexpression (point A → point C) nor GEF activation (point A → point 
B) alone has a significant effect on steady state Ras signalling, while both effects strongly 
cooperate (point D). Thus, the sequestration model can explain the experimentally observed 
logical AND-gate between GEF activation and Ras overexpression (as also summarised in 
Fig. 2.3B). This is due to the fact that signal suppression for low Ras expression levels and 
ultrasensitization for higher Ras expression levels (indicated in Fig. 2.3A) enhance the 
increase in sensitivity upon Ras overexpression which arises from zero-order ultrasensitivity 
(compare point A → point B with point C → point D in Figs. 2.2A and 2.3A). Experimental 
measurements revealed that RasGAP proteins are highly abundant at least in some cells, 






Oncogenes such as Ras are frequently overexpressed in tumours, e.g., due to genomic 
amplification or due to promoter deregulation [109] . However, in many cases, including Ras, 
the relevance of such overexpression remains unclear (e.g., [7,8,9] ). This chapter was 
focussed on the steady state basal activation level in an enzymatic futile cycle. Intuitively, 
one would expect that the basal activation level is proportional to the total concentration of 
the cycling substrate. Thus, strong overexpression might be expected to result in strongly 
enhanced basal signalling, and possibly in tumourigenesis. The modelling analyses revealed 
that the kinetic properties of enzymatic futile cycles can prevent deregulation of signal 
transduction by substrate overexpression, and thus identified a possible mechanism for 
tumour suppression. 
 
The differential equations of the model are based on the assumption that spontaneous Ras 
(de)activation occurs with first-order kinetics, while GEF- and GAP-catalysed reactions were 
assumed to proceed with Michaelis-Menten kinetics. Therefore, the results presented above 
also apply for covalent modification cycles (e.g., phosphorylation / dephosphorylation cycles) 
which might explain why mutational activation of oncogenic kinases is typically required to 
transform cells, and/or to activate downstream signalling, while even strong overexpression 
of wildtype proteins is insufficient  [110,111,112,113,114,115] . 
 
Experimental studies support that the proposed tumour suppression mechanism is 
physiologically relevant for protein kinase cascades: (i) Experiments with kinase or 
phosphatase inhibitors in starved cells [116,117]  suggest that the basal state activation level 
of cascade intermediates is mainly determined by the ratio of kinase and phosphatase 
activities. In other words, the basal state seems to be controlled by nonlinear Michaelis-
Menten kinetics, and not simply by linear auto(de)phosphorylation. (ii) Protein kinase 
cascade intermediates are typically expressed at concentrations close to (or even above) the 
KM-values of the upstream kinase. This implies that the kinetic requirements for insensitivity 
(Section 2.3) are often fulfilled in kinase cascades. (iii) Quantitative measurements revealed 
that more than 5% of total molecules of cascade intermediates are frequently activated even 
in serum-depleted medium [57,81,117,118,119,120] . Accordingly, even strong stimulation 
often induces only about 10-fold increases in kinase activation [19,25,57,117,121] , and 
biological responses can be induced by a 10-fold kinase activation in cell culture [57,122]  
and in vivo [123] . Thus, 10 – 20 fold overexpression of kinase cascade intermediates should 
be sufficient to induce biological responses unless the suppression effects such as those 
discussed in this chapter avoid deregulation of signalling by protein overexpression.     
 
Few theoretical studies thoroughly analysed basal state signalling so far [81,124] , even 
though it is the background activity (and not the dynamics) of signalling pathways is 
deregulated in many diseases. It is becoming increasingly clear that basal signal 
transduction serves to control important functions such as cell survival [125] , gene 
expression [126] , and cell adhesion [127] . The simulations in Sections 2.2 and 2.3 reveal 
how cells robustly maintain such background activity of signalling pathways, independent of 
fluctuations in protein expression. Other mechanisms that have been reported for robust 
signal transduction include assembly into multisubunit protein complexes [128] , negative 
feedback [129] , and co-expression of antagonistic enzymes [130] . Moreover, it is known 
that transcription factors often act as repressors in the inactive state, while being 
transcriptional activators in the active state (e.g., [131] ). Competition of active and inactive 






Figure 2.3: Implications for oncogene cooperation.  
(A) Effects of Ras overexpression on signal transduction for varying upstream stimulus levels in the “sequestration model” that 
takes Ras sequestration in enzyme-substrate complexes into account. The GEF- and GAP-catalysed reactions are modelled 
using an elementary step description of the irreversible Michaelis-Menten mechanism (E + S ↔ ES → E + P; Appendix B), and 
the intrinsic reaction steps (i.e., the grey arrows in Fig. 2.1 A) were neglected. The RasGTP concentration is plotted as a 
function of total Ras expression (i.e., the sum of RasGTP, RasGDP, the Ras-GEF complex and the Ras-GAP complex), and the 
total GEF concentration is varied. The total GEF concentrations are 3 ⋅ 10-8, 3 ⋅ 10-7 and 3 ⋅ 10-6 mol/l (this corresponds to [GEF] 
/ [GAP] = 0.04, 0.4 and 4). Note that the curve for [GEF] / [GAP] = 4 also applies for higher stimulus levels ([GEF] / [GAP] > 4), 
and thus represents the maximal effect induced by strong stimulation. The Michaelis-Menten constants of the GEF reactions 
were set to KM,GDP = 3.86 ⋅ 10-6 mol/l and KM,GTP = 3 ⋅ 10-6 mol/l, and the kcat,GEF, the KM,GAP, and the kcat,GAP were as in [10] . The 
undetermined off-rates of the GEF- and GAP-Ras complexes were estimated to be 10 s-1 (Appendix B). The experimentally 
measured Ras expression level in living cells is indicated by the vertical dashed line.. Points A – D are described in B. (B) 
Schematic representation of the logical AND-gate for oncogene cooperation. Normal cells (point A in panel A) remain 
completely untransformed by both, GEF activation (point B in panel A) and Ras overexpression (point C in panel A), but they 
become primed for strong transformation by a secondary mutational event (point D in panel A).   
 
 
The robustness mechanism (“kinetic tumour suppression”) presented here is similar to that 
discussed for bacterial two-component systems [132,133] . However, two component 
systems are topologically different from mammalian signalling cascades, as a single 
phosphate group is transferred from upstream proteins to downstream effectors, while no 
such mass transfer is observed in mammalian systems. Using an experimentally validated 
model of Ras signalling, it is shown in this chapter that robustness is observed for parameter 
values that are physiologically relevant for Ras signalling in mammalian cells. Moreover, the 
simulations reveal that the robustness in mammalian cells is restricted to weak stimulation, 
while it is observed for the full dose-response in two-component systems [133] . Figures 2.2 
and 2.3 indicate that loss of robustness upon strong stimulation might give rise to priming 
and oncogene cooperation effects in mammalian cancer development. The physiological 
relevance of priming and cooperation is further supported by a study focussing on cellular 
transformation by Ras and its downstream effector Raf: Transfection with either wildtype 
protein did not induce any significant phenotypic response, while strong transformation upon 
co-transfection of Ras and Raf [115] . The easiest way to test the model predictions 
regarding tumour suppression and oncogene cooperation is to mix recombinant Ras, GAP 
and GEF proteins in vitro, and to measure the steady state concentration of RasGTP as a 
readout.  
 
This chapter was focussed on the pathological deregulation of basal state signal 
transduction. More specifically, it was analysed how long-term alterations (e.g., at the 
transcriptional or the genomic level) affect information transfer via the basic motif of 
intracellular signalling networks, the activation-deactivation cycle. The following two chapters 
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(Section 3 and 4) deal with the question of how transient physiological signals are converted 
into persistent cell-fate decisions by the intracellular signalling network in the absence of 
slow transcriptional regulation. More specifically, the analysis is focussed on two signal 
transduction pathways (MAPK signalling and apoptosis signalling) that have been shown 
experimentally to remain irreversibly activated even after input stimuli were removed. In 
Sections 5 and 6, it is then investigated how slow transcriptional feedback regulation affects 
the signals generated by the signalling network. Therefore, Sections 5 and 6 extend the 
analyses presented here, as slow transcriptional regulation is no longer assumed to be an 






3 Competing docking interactions can bring about 
bistability in the MAPK cascade 
 





MAP kinases are crucial regulators of various cell fate decisions including proliferation, 
differentiation and apoptosis. Depending on the cellular context, the Raf-Mek-Erk MAPK 
cascade responds to extracellular stimuli in an all-or-none manner, most likely due to bistable 
behaviour. Here, a previously unrecognised positive feedback mechanism is described that 
emerges from experimentally observed sequestration effects in the core Raf-Mek-Erk 
cascade. Un-/monophosphorylated Erk sequesters Mek into Raf-inaccessible complexes 
upon weak stimulation, and thereby inhibits cascade activation. Mek, once phosphorylated 
by Raf, triggers Erk phosphorylation, which in turn induces dissociation of Raf-inaccessible 
Mek~Erk heterodimers, and thus further amplifies Mek phosphorylation. It is shown that this 
positive circuit can bring about bistability for parameter values that were experimentally 
measured in living cells. Previous studies revealed that bistability can also arise from enzyme 
depletion effects in the Erk double (de)phosphorylation cycle. It is demonstrate that the 
feedback mechanism proposed in this chapter synergises with such enzyme depletion 
effects to bring about a much larger bistable range than either mechanism alone. The results 
show that stable docking interactions and competition effects, which are common in protein 
kinase cascades, can result in sequestration-based feedback, and thus can have profound 





The three-tiered mitogen-activated protein kinase (MAPK) pathways are known to be crucial 
regulators of various physiological processes such as proliferation, differentiation, 
senescence, and apoptosis [2] . Cell-fate decisions such as differentiation are thought to 
occur in an all-or-none fashion and, once initiated, should be stably maintained in an 
irreversible manner. Theoretical and experimental work [134]  suggested that such switch-
like and irreversible signal transduction could arise due to bistability at the level of MAPK 
activation.  
 
Single-cell measurements confirm that both the Raf-Mek-Erk pathway and the JNK cascade 
are indeed activated in all-or-none manner in Xenopus oocytes [135,136] . Additionally, 
switch-like activation was recently shown to occur in the yeast mating MAPK signalling 
module [137,138] . In mammalian systems, all-or-none activation of the Raf-Mek-Erk 
pathway was observed in T cells [139] , in BHK cells [26] , in PC12-D2R cells [140] , in 
dopaminergic SN4741 neurons [140] , and in Hek 293 cells (Boris Kholodenko, pers. 
communication). In contrast, gradual MAPK activation at the single-cell level was seen in 
growth-factor-stimulated Swiss 3T3 fibroblasts [25] , in HeLa cells [141] , and in human 
foreskin fibroblasts [141] . The qualitative behaviour of Erk activation can also depend on the 
stimulus strength, being all-or-none at weak stimulation, but gradual upon strong stimulation 
in LβT2 gonadotrope cells [142] . Finally, the opposite, i.e., a gradual response upon weak 
stimulation and all-or-none activation at high stimulus levels, was reported to occur in PC12 
cells [24] .  
 
These single cell measurements reveal that MAPK cascades frequently exhibit all-or-none 
behaviour over a broad range of stimulus concentrations, which suggests that these 
pathways can indeed be bistable under physiological conditions. Bistable systems display 
hysteresis, meaning that different stimulus-response curves are obtained depending upon 
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whether the system began in its off or its on state [20,143] . Experimental studies confirmed 
hysteresis for the JNK cascade in Xenopus oocytes [135]  and for the Raf-Mek-Erk pathway 
in PC12 neuronal precursor cells [24] . Bistability is thought to require a positive signalling 
circuit, which may be established either by feedback activation of upstream pathway 
intermediates or by relief from upstream pathway inhibition [20,143] . All-or-none activation in 
the Mos-Mek-Erk MAPK cascade was indeed shown to depend on feedback pathway 
activation in Xenopus oocytes: Active phospho-Erk stimulates transcription and thereby 
upregulation of the constitutively active Raf homolog Mos, which is the uppermost member of 
the cascade [136] . Similar positive feedback loops, which rely on Erk-dependent Raf 
activation, have been proposed to exist in mammalian cells [41,134] .   
 
However, direct experimental evidence for functionally significant positive feedback loops is 
scarce. Transfection with constitutively active Mek seemed to activate Raf-1 in NIH3T3 cells 
[144]  and in Hek 293 cells [145] . In contrast, constitutively active mutants of Raf, Mek or Erk 
failed to activate their endogenous counterparts when exogenously expressed in C7 3T3 
cells (Raf, [146] ), in BHK cells (Mek, [26] ), in Hek 293 cells (Erk, [113] ), in PC12 cells (Erk, 
[113]  and in Cos7 cells (Erk, [147] ). These data suggest that functionally relevant positive 
feedback activation is the exception rather than the rule in the mammalian Raf-Mek-Erk 
pathway. Additionally, positive feedback activation does not seem to correlate with all-or-
none Erk activation at the single cell level, and is therefore unlikely to account for bistable 
behaviour in the mammalian MAPK cascade.  
 
Instead, these overexpression data support a model, where bistability arises from a positive 
feedback circuit that relies on elimination of upstream cascade inhibition, and not on 
upstream cascade activation. Such relief-from-inhibition is expected to be insufficient for full 
pathway activation in the absence of upstream input signals, and would thereby explain why 
overexpressed constitutively active mutants of Raf, Mek or Erk failed to activate their 
endogenous counterparts. A recent study suggests that such relief from upstream inhibition 
occurs downstream of Raf kinase, i.e., within the core MAPK cascade: All-or-none activation 
of the MAPK cascade was observed even if cascade activation was triggered by an 
exogenously expressed Raf construct, which would most likely overcome endogenous 
feedback mechanisms acting upstream of Raf [26] .    
 
Recent theoretical studies indicated that implicit feedback and bistability can indeed arise in 
the core MAPK signalling module: Markevich et al. [23]  described how relief from inhibition 
and hysteresis emerge in the basic motif of MAPK cascades, the double phosphorylation 
cycle, if realistic kinetic parameters are assumed. Additionally, it is shown in Section 4 that 
bistability due to relief from inhibition can be observed if two consecutive cascade members 
(e.g., Mek and Erk) are deactivated by the same phosphatase. This ‘shared phosphatase 
motif’ applies for the mammalian Erk-MAPK signalling module, as PP2A was reported to 
dephosphorylate both Mek and Erk [148] . However, these implicit mechanisms exhibit a 
relatively narrow range of bistability, and might thereby require amplification in order to bring 
about robust hysteresis in vivo.  
 
In this chapter a previously unrecognised relief-from-inhibition feedback mechanism in the 
core Raf-Mek-Erk cascade is described. Un-/monophosphorylated Erk is proposed to 
sequester Mek into Raf-inaccessible complexes upon weak stimulation, and thereby inhibits 
the cascade. Mek, once phosphorylated by Raf, triggers Erk phosphorylation, which in turn 
induces dissociation of Raf-inaccessible Mek~Erk heterodimers (relief from inhibition), and 
thus further stimulates Mek phosphorylation. The suggested mechanism is in accord with 
experimental studies, which showed that Mek and Erk form a stable complex under resting 
conditions, and dissociate upon Erk phosphorylation (see, e.g., [27] ). The simulations reveal 
that this positive circuit can bring about bistability for parameter values that were 
experimentally measured in living cells [149] . Additionally, it is demonstrated that the 
feedback mechanism proposed in this paper synergises with that implicit in double 
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3.2 Rationale and model implementation 
 
Rationale: Experimental studies revealed that unphosphorylated Mek and Erk form a stable 
complex in unstimulated cells, which dissociates upon stimulation with growth factors (see, 
e.g., [27] ). Such basal Mek~Erk association has been neglected in most mathematical 
models of the MAPK cascade. It was the aim of this work to study the impact of Mek-Erk 
complex formation in more detail.  
 
 
Figure 3.1: Proposed Bistability Mechanism and Model Structure. 
(A)-(C) Schematic representation of the proposed bistability mechanism. Upon weak stimulation (i.e., at low pRaf levels), Erk 
and Mek are mostly un-/monophosphorylated (indicated by white boxes), and pathway activation is suppressed by Mek 
sequestration into Raf-inaccessible (p)Mek~(p)Erk heterodimers (A). Stronger stimulation increases the amount of double 
phosphorylated ppMek, which then triggers Erk phosphorylation (B). Erk phosphorylation in turn induces dissociation of Raf-
inaccessible Mek~Erk heterodimers (relief from inhibition), and thus amplifies Mek phosphorylation in a positive feedback circuit 
(B), so that finally the pathway is completely activated (C). (D) Schematic representation of model topology (see Appendix C for 
differential equations). The black arrows indicate the previously described ‘basic model’ that includes Raf-mediated Mek 
phosphorylation, Mek-mediated Erk phosphorylation and the antagonizing phosphatase reactions [150] . The ‘sequestration 
model’ analysed in this paper additionally includes association of various Mek species with un-/monophosphorylated Erk (grey 
arrows), and the resulting Mek sequestration complexes (i.e., Mek~Erk, Mek~pErk, pMek~Erk, and pMek~pErk). 
 
 
Figures 3.1A-C show how a positive feedback circuit can arise in the core Raf-Mek-Erk 
cascade due to basal Mek-Erk association. At low levels of the phospho-Raf stimulus, Mek 
and Erk are mostly unphosphorylated or monophosphorylated (i.e., inactive) as indicated by 
the white (p)Mek and (p)Erk boxes in Fig. 3.1A. Stable heterodimer formation between 
inactive Mek and Erk molecules efficiently inhibits Raf-mediated Mek phosphorylation, and 
thereby suppresses pathway activation. Stronger stimulation results in the formation of some 
fully phosphorylated Mek and Erk as indicated by the black ppMek and ppErk boxes in Fig. 
3.1B. This depletes non-/monophosphorylated Erk pools, and thereby promotes the 
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dissociation of the Raf-inaccessible (p)Mek~(p)Erk complexes (relief from inhibition). In other 
words, Mek, once fully phosphorylated, triggers the release of monomeric, Raf-accessible 
Mek and hence further Mek phosphorylation in a positive feedback circuit (Fig. 3.1B). Upon 
sufficiently strong stimulation, all (p)Mek~(p)Erk are dissociated and almost all Mek and Erk 
molecules are fully phosphorylated (Fig. 3.1C). Previous studies [23,151]  suggested that 
such a relief-from-inhibition feedback mechanism could result in bistability. It will therefore be 
addressed in the following whether hysteresis can be observed in physiologically relevant 
parameter ranges.  
 
Model implementation: A mathematical model of the core MAPK signalling module, 
schematically depicted in Fig. 3.1D, was implemented (see Appendix C for differential 
equations). Here, the black arrows indicate the previously described MAPK model (referred 
to as ‘basic model’ hereafter) that includes Raf-mediated Mek phosphorylation, Mek-
mediated Erk phosphorylation and the antagonizing phosphatase reactions [150] . For 
simplicity, it was assumed that the phosphatases for Mek and Erk are less abundant than 
their substrates, and the corresponding phosphatase reactions were thus modelled using the 
Michaelis-Menten approximation. In contrast, kinase catalysis was modelled using the 
elementary step description in order to take possible sequestration and back-propagation 
effects into account [15,107,152] . Experimental studies revealed that Mek and Erk form 
stable heterodimers under basal conditions, and that these heterodimers dissociate upon 
stimulus-induced Erk phosphorylation [27] . To account for such complex formation, 
association of un-/monophosphorylated Erk (but not of bisphosphorylated Erk) with various 
Mek species was also considered in the ‘sequestration model’ (black and grey arrows in Fig. 
3.1D).  
 
In order to demonstrate that the proposed feedback mechanism is in fact responsible for 
bistability in the ‘sequestration model’, other possible sources of hysteresis were excluded 
(except for the results shown in Fig. 3.5). First, implicit positive feedback which could arise if 
both the Mek and the Erk cycles were deactivated by the same phosphatase [151]  was 
eliminated. This was accomplished by assuming that Mek and Erk proteins are 
dephosphorylated by different phosphatases. Second, it was excluded that bistability 
implicitly arises in double phosphorylation [23,153]  by assuming that similar reaction steps 
are characterised by the same kinetics. For example, the same kinetic parameters were 
assumed for the phosphorylation of the first and the second modification site in Mek (‘non-
cooperative phosphorylation’). Similar non-cooperativity was also assumed for Mek 
dephosphorylation, Erk phosphorylation and Erk dephosphorylation. Finally, the same 
association and dissociation rate constants were assumed for all Mek~Erk complexes (i.e., 
Mek~Erk, pMek~Erk, ppMek~Erk, Mek~pErk, pMek~pErk, ppMek~pErk). The resulting 
model comprised 10 kinetic parameters and three total protein concentrations (pRaf, Mek 
and Erk), all of which could be taken from a recent quantitative experimental study by Fujioka 








3.3 Structural and kinetic requirements for bistability 
 
Bistability Due to Mek Sequestration: Single-cell analyses revealed that the MAPK cascade 
can respond to extracellular stimuli in an all-or-none manner, most likely due to bistable 
behaviour of the system (see Section 3.1). Extracellular stimulation was simulated by varying 
the total concentration of active Raf protein (pRaf), and the amount of doubly 
phosphorylated, active Erk (ppErk) was analysed as the response. The system showed a 
simple, monostable stimulus-response (not shown) when simulations were run using the 
kinetic parameters and the protein concentrations, which were measured by Fujioka et al. 
[149]  in HeLa cells (Table 3.1; column ‘Fujioka et al.’). This result is in accordance with 
experimental measurements, as gradual Erk activation at the single-cell level was 
demonstrated in EGF-treated HeLa cells [141] . 
 
Table 3.1: Kinetic Parameters 
Parameter Notes Fujioka et al.  This Study 
    
Mektot Total Cellular Mek Concentration 1.4 µM 1 µM 
Erktot Total Cellular Erk Concentration 0.96 µM 10 µM 
kon,Raf~Mek Association Rate Constant of Raf~Mek complex 0.65 µM-1 s-1 0.65 µM-1 s-1 
koff,Raf~Mek Dissociation Rate Constant of Raf~Mek complex 0.065 s-1 0.065 s-1 
kcat,Raf~Mek Catalytic Turnover Constant of Raf~Mek complex 0.18 s-1 0.18 s-1 
(Vmax/KM)Mek-PPase First-order Rate Constant of Mek-Phosphatase 0.01 s-1 (0.01 s-1) 
Vmax,Mek-PPase Maximal Velocity of Mek-Phosphatase - 0.001 µM s-1 
KM,Mek-PPase Michaelis-Menten Constant of Mek-Phosphatase - 0.1 µM 
kon,Mek~Erk Association Rate Constant of Mek~Erk complex 0.88 µM-1 s-1 0.88 µM-1 s-1 
koff,Mek~Erk Dissociation Rate Constant of Mek~Erk complex 0.088 s-1 0.088 s-1 
kcat,Mek~Erk Catalytic Turnover Constant of Mek~Erk complex 0.22 s-1 0.22 s-1 
(Vmax/KM)Erk-PPase First-order Rate Constant of Erk-Phosphatase 0.014 s-1 (0.08 s-1) 
Vmax,Erk-PPase Maximal Velocity of Erk-Phosphatase - 0.04 µM s-1 
KM,Erk-PPase Michaelis-Menten Constant of Erk-Phosphatase - 0.5 µM 
        
The total protein concentrations and the kinetic parameters of the model depicted in Fig. 3.1D are listed (column ‘This Study’), 
and compared to the values that were measured by Fujioka et al. [149] . Fujioka et al. estimated the apparent first-order rate 
constant (Vmax/KM) of Mek and Erk dephosphorylation only. Saturated Michaelis-Menten kinetics were assumed in the model, as: 
(i) the time course data in [149]  indicates saturation in the dephosphorylation reactions; (ii) the KM-values of phosphatases 
towards full-length substrates are frequently in the sub-micromolar range [154,155] . See Supplement for differential equations 
of the model. 
 
 
The intracellular concentrations of Mek and Erk depend on the cellular context, and have 
been reported to be 0.6-40 µM [16,139]  and 0.8-30 µM [150,156]  in mammalian cells. Thus, 
bistability might still be observed in other cell types than HeLa cells, especially because 
phosphatase activity in the MAPK signalling module is known to be intensely regulated as 
well [157] . Importantly, bistability occurred within the physiologically relevant 
kinase/phosphatase concentration ranges. Figure 3.2A (grey line) shows a representative 
stimulus-response curve. Here, the total Erk concentration (10 µM) and the Mek-
phosphatase activity were increased relative to the default values measured in HeLa cells, 
while the total Mek concentration (1 µM) and the Mek-phosphatase activity were kept 
essentially unchanged (Table 3.1, column ‘This study’).   
Markevich et al. [23]  reported that hysteresis can implicitly arise in double 
(de)phosphorylation cycles even in the absence of allosteric feedback. In order to exclude 
that their mechanism is responsible for the observed bistability, Mek sequestration was 
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eliminated from the model. The resulting basic model (only black arrows in Fig. 3.1D) exhibits 
a simple, monostable response, which demonstrates that Mek sequestration into Raf-
inaccessible complexes (grey arrows in Fig. 3.1D) is indeed responsible for bistability. This 
conclusion also holds in general, i.e. regardless of the parameters chosen, because 
bistability in double phosphorylation cannot arise with non-cooperative protein 
(de)phosphorylation reactions [153] , which was assumed in the default sequestration model 
(see Section 3.2).  
 
 
Figure 3.2: Bistability Due to Mek Sequestration. 
(A) Bistable stimulus-response of the core MAPK cascade. Extracellular stimulation was simulated by varying the total 
concentration of active Raf (pRaftot = pRaf + pRaf~Mek + pRaf~pMek), and bisphosphorylated Erk (ppErk) was taken as the 
response. The black curve corresponds to the previously analysed basic model (black solid arrows in Fig. 3.1D), while the grey 
stimulus-response was obtained for the sequestration model, which additionally takes Mek sequestration by Erk into account 
(black solid and grey arrows in Fig. 3.1D). Kinetic parameters are given in Table 3.1 (column ‘This study’). (B) Mek release from 
inactive sequestration complexes upon cascade activation. The amount of sequestered Mek (i.e., Mek~Erk + Mek~pErk + 
pMek~Erk + pMek~pErk) and the total amount of bisphosphorylated Mek (i.e., ppMek + ppMek~Erk + ppMek~pErk) is shown as 
function of total active Raf for the kinetic parameters given in Table 3.1 (column ‘This study’).     
 
 
The amount of sequestered Mek (i.e., Mek~Erk + Mek~pErk + pMek~Erk + pMek~pErk) was 
analysed in more detail to further corroborate that the positive circuit described in ‘Rationale’ 
is responsible for the hysteresis. The corresponding simulations confirm a pronounced Mek 
release from Raf-inaccessible sequestration complexes upon switching from the lower to the 
upper steady state branch (Fig. 3.2B, grey line). This Mek release relieves the cascade from 
strong inhibition (compare black and grey lines in Fig. 3.2A), and allows for coordinated 
activation of Mek and Erk (grey lines in Fig. 3.2A and B). Taken together, these data reveal 
that Mek sequestration into Raf-inaccessible complexes and its subsequent ppMek-
dependent release are responsible for hysteresis in Fig. 3.2.  
 
Kinetic Requirements for Bistability: MAPK activation was shown to proceed in an all-or-none 
manner in some, but not in all cells (see Section 3.1). In order to get insights into such cell-
type specific behaviour, the requirements for bistability in terms of protein expression and 
kinetic parameters were investigated.  
 
The impact of alterations in kinase expression was analysed by classifying the stimulus-
response curves (similar to those in Fig. 3.2A) for varying total Mek and Erk concentrations 
into monostable and bistable. Figure 3.3A (grey area) shows that the stimulus-response is 
bistable over a relatively broad range of Mek and Erk expression levels, which match those 
previously measured experimentally (see above). Hysteresis seems to require that the Erk 
concentration exceeds that of Mek, as the bistable range is bounded by the dashed line in 
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Fig. 3.3A, which corresponds to equal Mek and Erk expression. Excess of Erk ensures 
efficient Mek sequestration into Raf-inaccessible complexes upon weak stimulation, and 
thereby strengthens the relief-from-inhibition feedback mechanism discussed in Section 3.2. 
Experimental studies confirmed that Erk is indeed more abundant than Mek in a variety of 
mammalian cell lines including CHO cells (Erk/Mek = 2.15 [16] ), Cos-1 cells (Erk/Mek = 2.03 
[158] ), Cos7 cells (Erk/Mek >> 1 [147] ), 208F cells (Erk/Mek = 2.5 [158] ), NIH3T3 cells 
(Erk/Mek = 12.86 [158] ), and Rat1 cells (Erk/Mek = 1.5 [158] ). Additionally, the yeast Erk 
homologues Kss1p and Fus3p were reported to significantly exceed their shared upstream 
activator, the Mek homologue Ste7p ((Kss1p + Fus3p)/Ste7p > 5.71 [16] ).  
 
 
Figure 3.3: Kinetic Requirements for Bistability. 
(A) Bifurcation diagram for alterations in kinase expression. The stimulus-response curves of the default model were calculated 
for varying total Mek and Erk concentrations, and were then classified into monostable (white area) and bistable (grey area). 
The dashed line corresponds to equal Mek and Erk expression. Default indicates the parameter set given in Table 3.1 (column 
‘This Study’). Point I indicates the situation, where the Mek concentration is low relative to that of the Erk phosphatase, so that 
Erk activation is completely abolished. Point II corresponds to a cell, which expresses high levels of Mek relative to Erk 
phosphatase. This provokes strong Erk activation before the Mek cycle is switched on, and therefore excludes coordinated 
activation of both kinases in a positive feedback circuit. (B) Bifurcation diagram for alterations in phosphatase expression. 
Similar to (A), but bistable behaviour was analysed for varying maximal velocities (i.e., varying expression) of the phosphatases 
that dephosphorylate Mek and Erk. See (A) for explanation of points I and II. Point III indicates the situation, where strong Mek-
phosphatase expression necessitates high levels of active Raf to elicit Mek phosphorylation. Under these conditions Mek is 
strongly sequestered by active Raf, and this abolishes hysteresis.   
 
 
The group of Gertraud Müller from the University of Stuttgart quantified the intracellular Erk 
concentration in Rat1 cells. They found 2.3 ⋅ 106 molecules per Rat1 cell using Western 
blotting and a calibration curve of recombinant GST-Erk fusion proteins as described 
previously [150] . Assuming a cell volume of 1 pl [16]  and a Erk:Mek ratio of 1.5 in these 
cells [158] , one arrives at Mektot = 2.56 µM and Erktot = 3.83 µM. These values lie within the 
range of bistability (Figure 3.3A), and therefore further corroborate the physiological 




Figure 3.4: Structural Requirements for Bistability. 
The sequestration model depicted in Fig. 3.1D was extended in order to study the topological constraints for bistability. More 
specifically, Raf-mediated phosphorylation of Erk-bound Mek (i.e., non-competitive binding of Raf and Erk to Mek) was taken 
into account. Additionally, ppErk binding to Mek, pMek and ppMek (i.e., by product inhibition in Erk phosphorylation) was 
considered. The stimulus-response curves of the resulting ‘extended sequestration model’ (see Supplement for differential 
equations) were classified into monostable and bistable for varying degrees of competition and product inhibition. The 
competition factor, c, equals the fold-change in Raf’s affinity for Mek brought about by Erk binding to Mek (and vice versa). 
Likewise, the product inhibition factor, p, quantifies how the affinity between Erk and Mek is altered by Erk double 
phosphorylation (relative to un-/monophosphorylated Erk). The grey bistability range was calculated using the default 
parameters given in Table 3.1 (column ‘This study’). The dashed black line indicates the bistable-monostable transition for a 10-
fold lower Michaelis-Menten constant of the Mek phosphatase (KM,Mek-PPase = 0.01 µM). 
 
 
It was also analysed how altered Mek- and Erk-phosphatase expression (i.e., changes in the 
corresponding Vmax-values) affect the qualitative behaviour of the stimulus-response curve, 
and it turned out that bistability is retained over a relatively broad range of phosphatase 
concentrations (Fig. 3.3B). The bifurcation analysis with respect to kinase and phosphatase 
expression (Figs. 3.3A and B) reveal several kinetic constraints for the existence of a bistable 
stimulus-response: (i) Too low Mek concentrations or too high Erk-phosphatase 
concentrations abolish any significant Erk activation and thereby also hysteresis (points I in 
Figs. 3.3A and B). (ii) Too high Mek levels or too low Erk-phosphatase levels provoke strong 
Erk activation before the Mek cycle is switched on, and therefore exclude coordinated 
activation of both kinases in a positive circuit (points II in Figs. 3.3A and B). (iii) Strong Mek-
phosphatase expression necessitates high levels of active Raf to elicit Mek phosphorylation. 
Under these conditions Mek sequestration by active Raf becomes significant and this 
abolishes bistability, because Mek activation is both subsensitive [15]  and submaximal [107]  
(point III in Fig. 3.3B). (iv) Bistability requires that the Mek and the Erk concentration exceed 
the dissociation constant (Kd) of the Raf-inaccessible (p)Mek~(p)Erk sequestration 
complexes, since otherwise Mek sequestration is relatively inefficient. Experimental evidence 
suggests that this requirement holds in living cells, as the measured dissociation constant (Kd 
= 30-300 nM) [149,159,160]  is indeed lower than typical intracellular Mek and Erk levels. 
 
Structural Requirements for Bistability: Two key topological assumptions were made when 
deriving the model depicted in Fig. 3.1D. First, it was assumed that Mek and Erk no longer 
associate once Erk has been fully phosphorylated by Mek, that is, product inhibition of 
ppMek-mediated Erk phosphorylation was neglected. This seems justified, since it has been 
shown that Mek and Erk form stable heterodimers under basal conditions, and that these 
heterodimers dissociate almost completely upon stimulus-induced Erk phosphorylation [27] . 
Second, it was assumed that Erk and Raf bind to Mek in a mutually exclusive manner (i.e., 
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competitively). Experimental studies revealed that Raf associates with a C-terminal domain 
in Mek [161] , while Erk is recruited to the N-terminus of Mek [162] . Importantly, the C- and 
the N-terminal domains adjoin to each other in the Mek crystal structure [163] , which 
suggests competitive binding, especially because both Raf (74 kD) and Erk (44 kD) are 
relatively bulky and are known to homodimerise. Competition of Raf and Erk for Mek is 
further suggested by the fact that the Mek proline-rich domain, which adjoins to the Mek C-
terminus [163] , has been implicated in both Raf and Erk recruitment [164,165] . Finally, 
mutually exclusive binding is also supported by biochemical analyses of the JNK pathway 
which showed that the Raf homolog, Mekk-1, competes with JNK for binding to the Mek 
homolog, JNKK1 [166] . 
 
 
Figure 3.5: Synergism of Bistability Mechanisms. 
A broad range of bistability is observed in the stimulus-response (curve 2) of the sequestration model (black and grey arrows in 
Fig. 3.1D) if the second step of Mek-mediated Erk phosphorylation proceeds faster than the first (‘positive cooperativity’). Such 
pronounced hysteresis can be explained by synergism of the feedback mechanism discussed in this paper with that described 
by Markevich et al. [23] , which arises from enzyme depletion effects in the Erk cycle. The grey lines correspond to the stimulus-
response curves of reduced models, where one of the two feedback mechanisms was eliminated, and thereby directly 
demonstrate such synergism. Curve 1 depicts the stimulus-response of the basic model (black arrows in Fig. 3.1D), which is 
devoid of Mek sequestration into Raf-inaccessible complexes. Curve 3 corresponds to a sequestration model (black and grey 
arrows in Fig. 3.1D), where positive cooperativity and enzyme depletion effects in the Erk cycle are eliminated. See Appendix C 
for differential equations and kinetic parameters.   
 
 
Taken together, these data suggest that the scheme depicted in Fig. 3.1D applies for the 
core MAPK cascade. However, scaffold proteins, which bring kinases and their substrates 
into close proximity, allow for cascade activation even if otherwise essential docking 
interactions are absent [162] , and might thus alleviate competition effects. To characterise 
the topological requirements of the proposed bistability mechanism more generally, an 
‘extended sequestration model’ was implemented. The extended sequestration model 
includes Raf-mediated phosphorylation of Erk-bound Mek (i.e., non-competitive Raf and Erk 
binding to Mek) as well as ppErk binding to Mek, pMek and ppMek (see Supplement). Nine 
additional molecular species (compared to Fig. 3.1D) are considered in the extended model: 
six ternary Raf-Mek-Erk complexes (i.e., pRaf~Mek~Erk, pRaf~pMek~Erk, pRaf~Mek~pErk, 
pRaf~pMek~pErk, pRaf~Mek~ppErk, and pRaf~pMek~ppErk) arising from non-competitive 
Raf and Erk binding to Mek, and three Mek~ppErk heterodimers  (i.e., Mek~ppErk, 
pMek~ppErk, and ppMek~ppErk), which can be considered as product inhibition complexes 
in Erk phosphorylation. Raf is assumed to catalyse Mek phosphorylation within the ternary 
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Raf-Mek-Erk complexes (e.g., pRaf~Mek~Erk → pRaf + pMek~Erk), so that Mek 
sequestration by inactive Erk no longer prevents cascade activation.      
 
Figure 3.4 shows the qualitative behaviour of the extended sequestration model for varying 
degrees of competition and product inhibition. It can be seen that bistability is abolished in 
the extended sequestration model if competition between Raf and Erk for Mek is too weak, 
and if product inhibition in the Erk phosphorylation becomes significant. The competition 
factor, c, equals the fold-change in Raf’s affinity for Mek brought about by Erk binding to Mek 
(and vice versa). Thus, hysteresis requires that Erk binding to Mek decreases the affinity 
between Raf and Mek (and vice versa) at least by a factor of 25 (c < 0.04). Likewise, the 
product inhibition factor, p, quantifies how the affinity between Erk and Mek is altered by Erk 
double phosphorylation (relative to un-/monophosphorylated Erk). According to Fig. 3.4, 
ppErk must have a 40-fold (p < 0.025) lower affinity for Mek than its un-/monophosphorylated 
precursors. 
 
These above constraints for p and c can be relaxed if one assumes kinetic parameters which 
differ from those given in Table 1 (column ‘This study’). The dotted line in Fig. 3.4 shows for 
example how the bistable-monostable border of the extended sequestration model is shifted 
if the Michaelis-Menten constant of the Mek-phosphatase is assumed to be 10-fold less than 
in Table 1 (i.e., KM,Mek-PPase = 0.01 µM). Such strong phosphatase saturation, which increases 
zero-order ultrasensitivity in the Mek cycle [14] , allows the system to filter out leakage from 
Raf-inaccessible sequestration complexes, and thereby broadens the range of bistability.  
 
In conclusion, it was shown in this section that significant competition between Raf and Erk 
for Mek, and pronounced release of doubly phosphorylated Erk from Mek is required for 
bistability to be observed.  
 
 
3.4 Synergism of Bistability Mechanisms 
 
Markevich et al. [23]  reported that hysteresis can implicitly arise in double 
(de)phosphorylation cycles if the kinetic parameters for the first and the second 
phosphorylation site differ (‘kinetic asymmetry’). More specifically, hysteresis is favoured if 
the kinase (ppMek) has significantly higher affinity for the unphosphorylated substrate (Erk) 
than for the monophosphorylated substrate (tyrosine-phosphorylated Erk) [153] . 
Experimental studies revealed that such kinetic asymmetry may occur in the Erk 
(de)phosphorylation cycle, as monophosphorylated Erk seems to have weaker affinity for 
ppMek than unphosphorylated Erk [27] .  
 
It was therefore analysed whether the bistability mechanism proposed in this chapter and 
that described by Markevich et al. [23]  synergise to yield a larger bistable region than either 
mechanism alone. Simulations were done using the model structure depicted in Fig. 3.1D. In 
contrast to the default model (see ‘Model Implementation’), it is now assumed that ppMek-
mediated Erk phosphorylation occurs with positive cooperativity. More specifically, the first 
phosphorylation step (Erk → pErk) is modelled with a low Michaelis-Menten constant, but 
with a slow catalytic rate constant. On the contrary, a higher Michaelis-Menten constant and 
a much faster catalytic rate constant were assume for the second phosphorylation step (pErk 
→ ppErk) as this should favour bistability in the Erk cycle [153] .  
These parameters yield a narrow bistable range for the basic MAPK model, which neglects 
Mek sequestration (Fig. 3.5, curve 3). Hysteresis of curve 3 in Fig. 3.5 can be attributed to 
the mechanism described by Markevich et al. [23] . Figure 3.5 (curve 2) shows that this 
narrow bistable region is strongly enlarged if Mek sequestration into Raf-inaccessible 
complexes is additionally taken into account. Thus, both feedback mechanisms in 
combination bring about much more pronounced bistability than enzyme depletion effects in 
double phosphorylation alone. It was also analysed how the bistable range of the 
sequestration model is affected if kinetic asymmetry in Erk phosphorylation is eliminated from 
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the model. This was done by assuming equal catalytic rate constants for the first and second 
phosphorylation steps. As expected, the bistable range got significantly narrower once kinetic 
asymmetry was removed from the model (Fig. 3.5, curve 1).  
 
Taken together, it was shown that the bistability mechanism proposed in this paper and that 
described by Markevich et al. [23]  synergise to yield a much larger bistable region than 
either mechanism alone. Generally, the bistable range due to Mek sequestration, which was 
analysed for the non-cooperative system in Figs. 3.2-3.4, can be enlarged if kinetic 
asymmetries in the Mek and/or Erk (de)phosphorylation cycles are taken into account. In this 
context, it has recently been discussed that strong positive cooperativity occurs in Raf-
mediated Mek phosphorylation [153] . Finally, Figure 3.5 demonstrates that positive circuits, 
which are bistable in isolation, cooperate to bring about even more pronounced bistability 
when combined in a network of nested positive circuits. Thus, bistability due to Mek 
sequestration might be even further enhanced by outer positive feedback circuits, which act 





In this paper, it was shown that bistability is caused by an implicit positive feedback circuit 
that emerges from the network structure of the core MAPK cascade: Un-
/monophosphorylated Erk sequesters Mek into Raf-inaccessible complexes upon weak 
stimulation, and thereby inhibits the cascade (see Fig. 3.1A). Mek, once phosphorylated by 
Raf, triggers Erk phosphorylation, which in turn induces dissociation of Raf-inaccessible 
Mek~Erk heterodimers (relief from inhibition) and thus further Mek phosphorylation (Fig. 
3.1B-C). The suggested mechanism is in accord with experimental studies, which showed 
that Mek and Erk form a stable complex under resting conditions, and dissociate upon Erk 
phosphorylation (see, e.g., [27] ). Positive feedback due to Mek sequestration can bring 
about bistability for experimentally measured parameters [149] , and is expected to enhance 
ultrasensitive behaviour of the MAPK signalling module outside the bistable range [19] . 
Experimental studies suggest that the MAPK cascade is frequently bistable even though 
overexpression of constitutively active Raf, Mek or Erk mutants does not result in positive 
feedback activation of their endogenous counterparts (see Section 3.1). The relief-from-
inhibition mechanism discussed in this chapter resolves this apparent contradiction (Section 
3.1). Markevich et al. [23]  demonstrated that relief from inhibition and bistability can arise in 
double phosphorylation cycles, but hysteresis was restricted to a relatively narrow parameter 
range. It is shown here that implicit feedback in double phosphorylation and feedback due to 
Mek sequestration synergise to yield a significantly larger bistable region than either 
mechanism alone.  
 
Feedback due to Mek sequestration can be verified experimentally by initial velocity analysis 
of Raf-mediated Mek phosphorylation in vitro. The proposed feedback mechanism requires 
that un-/monophosphorylated Erk, but not bisphosphorylated Erk acts as a competitive 
inhibitor of Raf-mediated Mek phosphorylation. Competitive inhibition can be shown by 
analyzing Lineweaver-Burk plots for varying Erk concentrations (see Biophysical Textbooks). 
Kinase-defective Mek and Erk mutants should be used in these assays in order to prevent 
Mek-mediated Erk phosphorylation and Erk-mediated feedback phosphorylation of Mek. 
Significant competitive inhibition of Raf-mediated Mek phosphorylation should be seen with 
unphosphorylated Erk as a competitor, but not with bisphosphorylated Erk. Bistability due to 
Mek sequestration can be directly proven in an in vitro reconstitution system. Mek, a Mek-
phosphatase (e.g., PP2A), Erk, and an Erk-phosphatase (e.g., MKP3) should be incubated 
with varying amounts of active Raf, and the stimulus-response is expected to exhibit true all-
or-none behaviour (Fig. 3.2A). Hysteresis can be shown by varying the time of phosphatase 
addition to the system: (i) a weak response is expected within the bistable range if the 
Mek/Erk-phosphatases are added simultaneously with Raf to Mek and Erk; (ii) a strong 
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response will be observed if the Mek/Erk-phosphatases are added after Mek and Erk have 
been fully activated by Raf.    
 
Recent theoretical studies revealed that sequestration-based feedback (i.e., feedback 
without explicit allosteric regulation) might be a common principle in signal transduction, and 
that it allows for bistable [23,151,167]  or oscillatory behaviour [138,168] . Feedback emerges 
in these systems due to high affinity protein-protein interactions, which appear to be an 
ubiquitous and robust means to achieve nonlinear behaviour in biochemical networks 
[32,151,169] . Sequestration-based feedback also requires that protein-protein interactions 
are competitive at least to some extent, because otherwise the bound protein can still 
participate in other cellular reactions (i.e., it cannot be sequestered). It seems likely that 
sequestration-based feedback is a common feature of protein kinase cascades: Enzyme-
substrate binding in these cascades is generally mediated by relatively stable 
docking/domain interactions in addition to transient recognition by the enzyme’s active site 
[170] . Additionally, cascade intermediates frequently engage a single binding site to recruit 
upstream kinases, phosphatases and downstream substrates in a competitive manner 
[170,171] . The results presented in this paper demonstrate that such competition effects 
profoundly affect the qualitative behaviour of protein kinase cascades. Scaffold proteins, 
which bring kinases and their substrates into close proximity, allow for cascade activation 
even if otherwise essential docking/domain interactions are absent [162] . It is tempting to 
speculate that scaffold proteins might alleviate competition effects within the MAPK kinase 
cascade, and thereby regulate the qualitative behaviour of the stimulus-response 
(monostable vs. bistable).  
 
The simulations in this chapter revealed how irreversibility can arise in the MAPK cascade, 
and the results generally apply for protein kinase cascades that operate via reversible 
(de)phosphorylation. Some signalling cascades such as the Notch pathway or the caspase 
pathway involved in apoptosis are activated by irreversible proteolysis of signalling 
intermediates, and their regulatory logic is thus fundamentally different from protein kinase 
cascades. Apoptosis, a regulated form of cell suicide, is activated in an all-or-none and 
irreversible manner, which means that cells, once committed to apoptosis, fully proceed 
through the death program. Commitment is thought to arise at the level of caspase 
activation. The requirements for bistability to be observed in a mathematical model of 
caspase regulation is analysed in Section 4, and it is shown that an implicit positive feedback 
similar to that discussed in the present chapter arises in the apoptosis cascade operating by 
irreversible proteolysis.  
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4 Simultaneous inhibition of initiator and effector 
caspases by XIAP establishes implicit bistability in 
caspase activation 
 





The intrinsic, or mitochondrial, pathway of caspase activation is essential for apoptosis 
induction by various stimuli including cytotoxic stress. It depends on the cellular context, 
whether cytochrome c (cyto c) released from mitochondria induces caspase activation 
gradually or in an all-or-none fashion, and whether caspase activation irreversibly commits 
cells to apoptosis. By theoretical derivation and analysis of a quantitative kinetic model, it is 
show that simultaneous inhibition of caspase-3 (Casp3) and caspase-9 (Casp9) by inhibitors 
of apoptosis (IAPs) results in an implicit positive feedback, since cleaved Casp3 augments its 
own activation by sequestering IAPs away from Casp9. It is demonstrated that this positive 
feedback brings about bistability (i.e., all-or-none behaviour), and that it cooperates with 
Casp3-mediated feedback cleavage of Casp9 to generate irreversibility in caspase 
activation. The calculations also unravel how cell-specific protein expression brings about the 
observed qualitative differences in caspase activation (gradual vs. all-or-none and reversible 
vs. irreversible). Finally, known regulators of the pathway are shown to efficiently shift the 
apoptotic threshold stimulus, suggesting that the bistable caspase cascade computes 
multiple inputs into an all-or-none caspase output. As cellular inhibitory proteins (e.g., IAPs) 
frequently inhibit consecutive intermediates in cellular signalling cascades (e.g., Casp3 and 
Casp9), the feedback mechanism described in this paper is likely to be a widespread 





Apoptosis, an evolutionary conserved form of cell suicide, allows multicellular organisms to 
eliminate damaged or excess cells in order to maintain tissue homeostasis. Deregulation of 
apoptosis is associated with various pathological conditions including cancer and 
neurodegenerative disorders. Aspartate-specific cysteine proteases, also known as 
caspases, are the central executioners of apoptosis. In most cases, apoptotic stimuli activate 
initiator caspases, whose substrates, the effector caspases, ultimately cause cellular demise 
by cleaving various cellular substrates [172] . Figure 4.1A schematically depicts the so-called 
extrinsic and intrinsic apoptotic pathways that elicit apoptosis by cleaving and thereby 
activating Casp3, the major cellular effector caspase. The extrinsic pathway is initiated by 
ligand-binding to death receptors (e.g., CD95), which then oligomerise and recruit various 
proteins including pro-Casp8 into the so-called death-inducing signalling complex (DISC). 
Formation of the DISC complex leads to autoprocessing of pro-Casp8 into active (initiator) 
Casp8, which then cleaves (effector) Casp3. Cytotoxic stress or death-receptor-stimulated 
Casp8 engage the intrinsic, or mitochondrial, apoptosis pathway by inducing the 
translocation of pro-apoptotic Bcl-2 family members such as Bax and Bid to mitochondria. 
This event, which is negatively regulated by anti-apoptotic Bcl-2 family members (e.g., Bcl-2), 
results in the release of pro-apoptotic proteins (cyto c and SMAC) from mitochondria into the 
cytosol. Cytosolic cyto c then elicits the oligomerisation of Apaf-1 into an active high-
molecular weight complex, the apoptosome, which recruits and stimulates (initiator) Casp9, 
and thereby allows activation of effector caspases such as Casp3. SMAC and inhibitors of 
apoptosis such as XIAP establish an additional layer of regulation in the intrinsic pathway: 
XIAP inhibits the catalytic activities of Casp9 and Casp3 through reversible binding, and 




Experimental studies revealed that the qualitative behaviour of caspase activation in the 
intrinsic pathway depends on the cellular context. Cyto c added to cytosolic extracts activates 
Casp3 in an all-or-none fashion in some cells [173,174,175,176,177] , while gradual 
activation was observed in other systems [178,179,180] . As cyto c release from 
mitochondria can be a reversible event [181] , which does not affect mitochondrial function 
[182,183,184] , it has been suggested that downstream caspase activation irreversibly 
commits cells to apoptosis [31,185] . Accordingly, cyto c-induced Casp3 activation remained 
elevated even after a strong decline in cytosolic cyto c [186]  or after apo-cyto c, an inhibitor 
of apoptosome formation, was added [187] . Furthermore, the time course of caspase 
activation via the intrinsic pathway equals that for irreversible commitment to apoptosis 
[31,185] , and caspase-inhibition allows for long-term cellular recovery and/or proliferation 
after removal of apoptotic stimuli [31,185,188,189,190,191] . Finally, Fas-treated Jurkat T 
cells, which enter apoptosis by the intrinsic pathway, escaped commitment to death as 
judged by maintenance of clonogenic potential if Casp3 was inhibited [192] . On the contrary, 
Casp3 activation was found to be a reversible event in glycochenodeoxycholate-treated 
hepatocytes [193] .  
 
These qualitative differences in caspase activation suggest that the intrinsic pathway is 
bistable in some cells, but monostable in others. While simple monostable systems respond 
in a gradual and reversible manner, complex bistable systems exhibit true all-or-none 
responses and in some cases irreversibility. Bistability is thought to require a positive circuit, 
which may be established either by positive feedback or by double negative feedback. Once 
a threshold stimulus is exceeded such positive circuits allow bistable systems to switch from 
low activation levels (off state) to high activation levels (on state) in an all-or-none fashion. 
Bistable systems display hysteresis, meaning that different stimulus-response curves are 
obtained depending upon whether the system began in its off or its on state. In some cases, 
the on state is maintained indefinitely after the stimulus is removed, so that the system 
shows irreversible activation [20] . Experimental studies confirmed that bistability indeed 
occurs in natural and artificial biological networks [20,194,195,196,197] .    
 
Recent mathematical modelling demonstrated that bistability can arise from ‘hidden’, or 
implicit, feedback loops that are usually not explicitly drawn in biochemical reaction schemes 
[23,198] . Similarly, it is shown here that inhibition of Casp3 and Casp9 by IAPs results in an 
implicit positive feedback and in bistability. As cellular inhibitory proteins (e.g., IAPs) 
frequently inhibit consecutive intermediates in cellular signalling cascades (e.g., Casp3 and 
Casp9), the mechanism described in this paper is likely to be a widespread principle how 
cells achieve ultrasensitivity, bistability and irreversibility (Appendix D). 
 
 
4.2 Model derivation 
 
Based on the published literature, a core model of the intrinsic apoptosis pathway was 
derived, which includes general regulatory mechanisms, while cell-type-specific events were 
not taken into account. The grey-shaded area in Fig. 4.1A indicates the regulatory 
interactions considered in the model: Active Apaf-1, which was taken as the input in most 
simulations, recruits and thereby stimulates (initiator) Casp9. Casp9 then in turn activates the 
output species, (effector) Casp3, by proteolytic processing. Additionally, Casp3-mediated 
cleavage of Casp9 results in positive feedback amplification. Finally, both Casp3 and Casp9 
are subject to stoichiometric inhibition by IAPs. For simplicity, only the most potent caspase 
inhibitor among the IAP family of proteins, the X-linked inhibitor of apoptosis (XIAP), was 





Fig. 4.1: Mathematical Model of the Intrinsic Apoptosis Pathway.  
(A) Schematic representation of intrinsic and extrinsic apoptosis pathways. Dotted lines indicate positive regulation (arrows) or 
negative regulation (blunted arrows), and the solid lines refer to release of SMAC and cyto c from mitochondria. The regulatory 
interactions considered in the model are highlighted in grey. The numbers 1-4 refer to additional feedbacks described in Section 
4.6 (B) Kinetic scheme of the model, where the following abbreviations were used: A* = activated Apaf-1, C9 = Casp9, C3 = 
Casp3, and X = XIAP. The reactions depicted in grey, which are involved in Casp3-mediated feedback cleavage of Casp9, were 
eliminated in the Casp9-mutant model in order to dissect the role of XIAP-mediated feedback.   
 
Cyto c released from mitochondria is known to elicit heptamerisation of Apaf-1 into active 
apoptosomes. As detailed kinetic measurements of apoptosome formation are currently 
lacking, apoptotic stimulation was modelled by altering the total concentration of activated 
Apaf-1 molecules assembled in apoptosomes (A*tot = A* + A*C9 + A*C9X + A*C9* + 
A*C9*X). Each active Apaf-1 monomer assembled in apoptosomes was shown to reversibly 
bind to a single Casp9 molecule [199] , and Casp9 is then auto-proteolytically processed at 
amino acid Asp-315 [200] . Importantly, Casp9 auto-proteolysis neither affects enzymatic 
activity of Casp9 [201] , nor its recruitment to apoptosomes [202,203] . Owing to these data, 
the model did not distinguish between auto-proteolytically processed and unprocessed 
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Casp9. The enzymatic activity of Casp9 is thought to be mainly determined by apoptosome 
recruitment, as apoptosome-bound Casp9 was shown to be much more active than free 
Casp9 [204,205] . It was therefore assumed in the model that reversible association of 
Casp9 (C9) and Apaf-1 (A*) (reaction 1) yields a highly active Apaf1-Casp9 complex (A*-C9), 
which cleaves pro-Casp3 (C3) much more efficiently (reaction 3) than free Casp9 (reaction 2; 
see Table 4.1). The latter reaction was nevertheless taken into account, since free Casp9 
was shown to have significant basal activity towards pro-Casp3 [199] .  
 
Processing of pro-Casp3 into mature Casp3 by upstream initiator caspases such as Casp9 
was reported to occur by a sequential two-step mechanism: Pro-Casp3, which has negligible 
enzymatic activity [206] , is initially processed by Casp9 into active p12-p20-Casp3, and this 
intermediate is subsequently auto-catalytically cleaved into active p12-p17-Casp3 [207] . As 
shown in Fig. 4.1B, Casp3 activation was modelled by a single-step mechanism (C3 → C3*). 
This seems justified, as the p12-p20-Casp3 intermediate and mature p12-p17-Casp3 exhibit 
similar catalytic activities [208] , and as they are both subject to inhibition by XIAP (see 
below).  
 
Casp3 is known to cleave its own activator, Casp9, at amino acid Asp-330 in vitro [201,209] , 
and in cytosolic extracts treated with cyto c [175,200] . As Casp9 processing by Casp3 was 
shown to significantly enhance Casp9 activity [201] , feedback cleavage by Casp3 results in 
auto-amplification of the apoptotic signal. The physiological relevance of this positive 
feedback loop was confirmed in several studies, which showed that inhibition of Casp3-
mediated cleavage of Casp9 prevented full activation of both Casp3 and Casp9 in response 
to cyto c [201,210,211] . Casp3-mediated feedback processing of Casp9 was modelled by 
assuming that active Casp3 (C3*) cleaves both free and Apaf1-associated Casp9 (reactions 
4 and 5), thereby generating the Asp330-cleaved Casp9 species, C9* and C9*-A*. These 
feedback-cleaved Casp9 species in turn cleave pro-Casp3 more efficiently (reactions 6 and 
7; see Table 4.1) when compared to their precursors, C9 and C9-A*, thus establishing a 
feedback amplification loop. Feedback-processed Casp9 (cleaved at Asp330) was shown to 
be associated with apoptosomes [201,203] , much like its precursors that are not cleaved at 
Asp330 (see above). It was therefore assumed in the model that the kinetics of Casp9-
binding to Apaf-1 (reactions 1 and 8) are unaffected by Casp3-mediated feedback cleavage 
(see Table 4.1). 
 
Inhibitors of apoptosis such as XIAP act as stoichiometric inhibitors of Casp3 and Casp9 [11] 
, and accordingly caspase inhibition can be described by simple reversible binding [212,213] 
. Experimental evidence suggests that XIAP can bind to and inhibit Casp9, even if the latter 
is associated with apoptosomes [201] . Accordingly, it was assumed in the model that active 
Apaf-1 (A*) and XIAP (X) bind to Casp9 in a non-competitive manner, so that  Apaf1-bound 
Casp9 intermediates (A*C9 and A*C9*) recruit XIAP with the same kinetics as free Casp9 
(C9 and C9*). Additionally, XIAP binding to Casp9 was modelled such that it is neither 
affected by Casp9 autocleavage (at Asp-315), nor by Casp3-mediated feedback cleavage (at 
Asp-330). As contradictory experimental results were obtained on how Casp9 cleavage 




Table 4.1: Kinetic Parameters.  
# Reaction k+ k- k- / k+ 
     
1 C9 + A* ↔ A*C9 2 * 10-3 nM-1s-1 0.1 s-1 50 nM [199]  
2 C3 + C9 → C3* + C9 5 * 10-6 nM-1s-1 [199]  - - 
3 C3 + A*C9 → C3* + A*C9 3.5 * 10-4 nM-1s-1 (70-times #2 [204] ) - - 
4 C9 + C3* → C9* + C3* 2 * 10-4 nM-1s-1 [214]  - - 
5 A*C9 + C3* → A*C9* + C3* 2 * 10-4 nM-1s-1 (same as #4) - - 
6 C3 + C9* → C3* + C9* 5 * 10-5 nM-1s-1 (10-times #2 [201] ) - - 
7 C3 + A*C9* → C3* + A*C9* 3.5 * 10-3 nM-1s-1 (10-times #3 [201] ) [215]  - - 
8 C9* + A* ↔ A*C9* 2 * 10-3 nM-1s-1 (same as #1) 0.1 s-1 (same as #1) 50 nM 
9 C9 + X ↔ C9X 10-3 nM-1s-1 10-3 s-1 1 nM [11,201]   
10 A*C9 + X ↔ A*C9X 10-3 nM-1s-1 (same as #9) 10-3 s-1 (same as #9) 1 nM 
11 C9* + X ↔ C9*X 10-3 nM-1s-1 (same as #9) 10-3 s-1 (same as #9) 1 nM 
12 A*C9* + X ↔ A*C9*X 10-3 nM-1s-1 (same as #9) 10-3 s-1 (same as #9) 1 nM 
13 C9X + A* ↔ A*C9X 2 * 10-3 nM-1s-1 (same as #1) 0.1 s-1 (same as #1) 50 nM 
14 C9*X + A* ↔ A*C9*X 2 * 10-3 nM-1s-1 (same as #1) 0.1 s-1 (same as #1) 50 nM 
15 C3* + X ↔ C3*X 3 * 10-3 nM-1s-1 [212]  10-3 s-1 [212]  0.3 nM [212,213,216,217] 
16 A* ↔ 10-3 s-1 0.02 nM s-1 (adjusted) 20 nM [218]  
17 C9 ↔ 10-3 s-1 (same as #16) 0.02 nM s-1 (adjusted) 20 nM [218]  
18 X ↔ 10-3 s-1 (same as #16) 0.04 nM s-1 (adjusted) 40 nM [32,202,219]  
19 C9X → 10-3 s-1 (same as #16) - - 
20 A*C9X → 10-3 s-1 (same as #16) - - 
21 A*C9 → 10-3 s-1 (same as #16) - - 
22 C3 ↔ 10-3 s-1 (same as #16) 0.2 nM s-1 (adjusted) 200 nM [219,220]  
23 C3* → 10-3 s-1 (same as #16) - - 
24 C3*X → 10-3 s-1 (same as #16) - - 
25 C9*X → 10-3 s-1 (same as #16) - - 
26 C9* → 10-3 s-1 (same as #16) - - 
27 A*C9* → 10-3 s-1 (same as #16) - - 
28 A*C9*X → 10-3 s-1 (same as #16) - - 
     
The reactions numbered according to Fig. 4.1B (Column ‘#’) are listed, and the corresponding reactants and products are 
indicated (Column ‘Reaction’). The column ‘k+’ contains the rate constants of the reactions from left to right, and the column ‘k-’ 
those for the opposite direction. The ratio of k+ / k- equals the dissociation constant for reversible bimolecular reactions, while it 
refers to the steady state protein concentration for synthesis and degradation reactions (#16-18 and #22). Similar reactions 
were assumed to proceed with same kinetics as indicated below the parameter values. References for parameters chosen are 
indicated in parentheses (e.g., [1]).   
 
 
Owing to the assumptions made in the previous paragraph, there is reversible recruitment of 
XIAP to all Casp9 species in the model (reactions 9-12), and also free exchange of Apaf1 
between the resulting Casp9-XIAP complexes (reactions 13-14). All Casp9-XIAP complexes 
were assumed to be catalytically inactive, which is in accordance with experimental studies 
[221,222] . Furthermore, Casp3-mediated feedback processing of XIAP-bound Casp9 was 
neglected in the model, as the Casp9-XIAP binding interface is nearby the corresponding 
cleavage site (Asp-330) [222] .  
 
It is well established that XIAP binds to both partially processed Casp3 (p12-p20) and to 
mature Casp3 (p12-p17), but not to its inactive precursor pro-Casp3 [213,223] . In 
accordance with experimental data [212,213] , reversible association between Casp3 and 
XIAP (reaction 15) was modelled to result in a catalytically inactive complex (C3*X). Due to 
the enzymatic inactivity of pro-Casp3 (C3) [206]  and of the Casp3-XIAP complex (C3*X), 
free active Casp3 (C3*) was taken as the response in the simulations.  
 
Finally, protein synthesis and degradation was included in the model (reactions 16 – 28). 
More specifically, the unmodified proteins A*, C9, X, and C3 are produced with a constant 
rate, and all molecular species in Fig. 4.1B are subject to first-order degradation. While the 
total cellular concentrations of Apaf-1, Casp9, Casp3 and XIAP (i.e., the ratio of protein 
synthesis and degradation rates) have been measured [32,202,218,219,220] , the kinetics of 
synthesis and degradation are not known. For simplicity, the same degradation rate was 
assumed for all molecular species in the model, and adjusted the synthesis rates in order to 
obtain previously measured protein concentrations (Table 4.1). This implies that the total 




From the model described above (Fig. 4.1B), which will be referred to as the ‘wildtype model’ 
in the following, molecular balances could be derived for each considered molecular species 
resulting in a system of 13 ordinary differential equations (Appendix D). In general, protein-
protein association (reactions 1, 4 - 6, 7, and 10 – 13 in Fig. 4.1B) was modelled as a 
reversible second-order process, and caspase-mediated cleavage (reactions 2, 3, 8, 9, 14, 
and 15 in Fig. 4.1B) as an irreversible second-order process. As many similar reactions (e.g., 
1 and 13 in Fig. 4.1B) were assumed to proceed with the same kinetics (see Table 4.1), the 
model comprises 16 kinetic parameters. The unknown kinetic parameters were set to 
reasonable values (Table 4.1) in order to reproduce the previously reported time courses of 
caspase activation (see Section ‘Time Course of Casp3 Activation’). 
 
Besides the wildtype model, two modified models were also analysed in order to get insights 
into the mechanisms that are responsible for bistability in caspase activation: (i) In the 
‘Casp9-mutant model’, which comprises only the black reactions in Fig. 4.1B, Casp3-
mediated feedback cleavage of Casp9 (reactions 8 and 9 in Fig. 4.1B) was eliminated from 
the wildtype model. (ii) Based on available experimental data (see Section 4.6), competitive 
(i.e., mutually exclusive) binding of Casp3 and Casp9 to XIAP was assumed in the wildtype 
model. By contrast, Casp3 and Casp9 were allowed to bind XIAP simultaneously in the ‘non-
competitive model’, that is, the wildtype model was extended by four ternary Casp9-XIAP-
Casp3 complexes (Appendix D).   
 
 
4.3 Dynamic and steady state characteristics of caspase activation 
 
Time Course of Casp3 Activation: Experiments in cytosolic extracts revealed that 
exogenously added cyto c induces maximal Casp3 cleavage within ~15 minutes in some 
cells [203] , while completion takes longer (up to ~60 minutes) in other systems 
[175,176,200,224] . More specifically, the Casp3 cleavage seems to be fast upon strong 
stimulation, but slower if stimulation is weak [176,220,225] . It was investigated whether the 
model was able reproduce these observations if previously measured protein concentrations 
of Apaf-1 (20 nM), Casp9 (20 nM), Casp3 (200 nM), and XIAP (40nM) were assumed 
[32,202,218,219,220] . Exogenous addition of cyto c was simulated by a step-like increase in 
the total amount of active Apaf-1 monomers, A*tot, as cyto-c-induced apoptosome formation 
was reported to be a very rapid process [203,205] . Such a step-input is also expected to 
reflect input characteristics within living cells reasonably well, since cyto c release from 
mitochondria was shown to complete within 5 minutes [226,227] . 
 
The results shown in Fig. 4.2A reveal that the simulated time courses of caspase activation 
agree well with those measured experimentally, and that simulated response time is indeed 
inversely related to the stimulus strength (Fig. 4.2A). Full activation of all cellular Apaf-1 
molecules (A*tot = 20 nM) elicits fast Casp3 activation, while a critical slowing down is 
observed near the threshold (A*tot ~ 3 nM; see Fig. 4.2B), as expected for a bistable system 
[32,196] . Notably, the slope of the time courses shown in Fig. 4.2A is only marginally 
affected by the onset time of caspase activation (i.e., by the stimulus level). This is in 
accordance with experimental results obtained in cyto-c-treated cytosolic extracts 
[175,203,224]  and in single living cells [29] , which showed that, once initiated, Casp3 






Fig. 4.2: Dynamic and Steady State Behaviour of the Caspase Cascade.  
(A) Time course of Casp3 activation (‘wildtype model’) upon a step-like increase in the amount of active Apaf-1 (A*tot) at t = 0 
from zero to the concentration indicated. (B) Steady state stimulus-response curves of the wildtype model (black line) and of the 
Casp9-mutant model (grey line), where Casp3-mediated feedback cleavage of Casp9 does not occur. Stable and unstable 
steady states are indicated by solid and dashed lines, respectively.  
 
 
Bistability in Caspase Activation: Experimental evidence suggests that cyto c-induced 
caspase activation can be bistable and irreversible (see Section 4.1). The simulated steady 
state Casp3 activity (C3*) was indeed bistable and irreversible (Fig. 4.2B, black line). The 
system exhibits three steady states, two stable (solid black lines) and one unstable (dashed 
black line), for A*tot between 0 and ~3 nM, and shows hysteretic behaviour: Starting from the 
resting state (point 1) the system retains low Casp3 activity even for increasing stimuli, A*tot, 
until a threshold (point 2) is reached, where Casp3 activity switches to the higher steady 
state (point 3) in an all-or-none fashion. The system remains at this higher steady state even 
if the stimulus is removed (point 4), so that caspase activation is irreversible, and thus 
represents the point of no return for apoptosis.  
 
The mechanism of bistability was addressed next, and it was hypothesised that Casp3-
mediated feedback cleavage of Casp9 was responsible, since bistability is thought to require 
a positive circuit [20] . Therefore, reactions 8 and 9 in Fig. 4.1B were blocked to simulate a 
mutant Casp9 (D330A), which is refractory to cleavage by Casp3 (‘Casp9-mutant model’). 
Unexpectedly, bistability was retained (Fig. 4.2, grey line), which suggests that a hidden 
positive feedback loop operates in the Casp9-mutant model.  
 
 
4.4 Mechanism of bistability and kinetic requirements 
 
XIAP Establishes an Implicit Positive Feedback in Caspase Activation: More detailed 
simulations revealed that XIAP establishes an implicit positive feedback in the Casp9-mutant 
model, and Fig. 4.3 schematically depicts how this mechanism contributes to irreversibility in 
the wildtype model: Upon weak stimulation (point 1 in Fig. 4.2B) the vast majority of Apaf1-
associated, highly active Casp9 molecules is inhibited by excess XIAP, so that cleavage of 
pro-Casp3 is negligible (top left in Fig. 4.3). As the stimulus strength is increased above the 
threshold (point 2 in Fig. 4.2B), active Apaf-1 also recruits some free Casp9 that is not 
subject to inhibition by XIAP, so that Casp3 activation is initiated (top right in Fig. 4.3). Active 
Casp3 then further promotes its own activation by sequestering XIAP away from Apaf-1-
associated Casp9 (‘redistribution’), so that finally the vast majority of XIAP is bound to Casp3 
(bottom right in Fig. 4.3). This XIAP redistribution results a positive feedback loop, which, 
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together with Casp3-mediated Casp9 feedback cleavage, suddenly switches the system from 
low to high Casp3 activity (transition from point 2 to point 3 in Fig. 4.2B). Caspase activity is 
maintained even if the stimulus is removed, as Casp3, once activated, retains XIAP, and 
thereby prevents full Casp9 deactivation (bottom left in Fig. 4.3). Additional simulations, 
which corroborate XIAP-mediated feedback can be found in Appendix D. 
 
 
Fig. 4.3: Schematic Representation of XIAP-mediated Feedback.  
At resting state (top left) Casp9 is efficiently inhibited by XIAP, so that Casp3 is inactive. Upon stronger stimulation (top right) 
some Casp9 escapes XIAP-mediated inhibition and activates Casp3, which then sequesters XIAP away from Casp9 
(‘redistribution’). This XIAP redistribution finally results in strong activation of both Casp9 and Casp3 (bottom right), and retains 
the system in an active state even if the stimulus is reduced (bottom left). The numbers on the top of each scheme correspond 
to those indicated next to the stimulus-response in Fig. 4.2B (black line).    
 
 
In order to determine how the protein concentrations in the caspase cascade affect 
bistability, the stimulus-response curves (similar to those in Fig. 4.2) were analysed for 
varying total Casp3 and Casp9 concentrations. Five types of qualitative behaviour in caspase 
activation could be distinguished in the physiological range of stimulus concentrations (A*tot = 
0-200 nM): (i) the system is essentially devoid of any Casp3 activation (MN; Fig. 4.4A); (ii) 
Casp3 activation occurs in a gradual manner (MG; Fig. 4.4B); (iii) the caspase cascade is 
bistable and reversible (BR; Fig. 4.4C); (iv) Casp3 activation is bistable and irreversible (BI; 
Fig. 4.4D); (v) constitutive Casp3 activity is observed (MB; Fig. 4.4E). The corresponding 
bifurcation diagram (Fig. 4.4F) reveals that bistability in the Casp-9 mutant model can only be 
observed if the total Casp9 concentration is below that of XIAP (40 nM), which ensures that 
the system is in the off-state as long as Casp3 is inactive. Additionally, Casp3 must be 
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significantly more abundant than XIAP, in order to sequester it away from Casp9, i.e., to 
establish positive feedback. 
 
 
Fig. 4.4: Determinants for Bistability and Irreversibility I.  
The dose-response curves of the Casp9-mutant model (F), those of the wildtype model (G), and those obtained for non-
competitive caspase binding to XIAP (H) were analysed for varying Casp3 and Casp9 expression levels. Five types of 
qualitative behaviour, which are schematically depicted in A-E, could be distinguished in the physiological range of Apaf-1 
expression levels (0-200 nM). The light and dark grey areas in F-H correspond to the bistable regions of the model (BR, BI), and 
the abbreviations MN, MG and MB indicate the qualitative behaviour outside the bistable region. Experimentally measured 
caspase concentrations (see Table 4.1) are highlighted by dashed lines in F-H.  
 
 
Determinants for Bistability and Irreversibility: The relative contribution of XIAP-mediated 
feedback and that of Casp3-mediated feedback cleavage (of Casp9) to bistability and 
irreversibility in caspase activation remained to be determined. To this end, the bifurcation 
plot of the wildtype model (Fig. 4.4G) was compared with those of mutant models, where 
either XIAP-mediated feedback (Fig. 4.4H; ‘Non-competitive model’) or Casp3-mediated 
feedback cleavage (Fig. 4.4F; ‘Casp9-mutant model’) was selectively blocked. XIAP-
mediated feedback is abolished in the non-competitive model (Appendix D), since XIAP was 
assumed to be capable of simultaneous binding to Casp3 and Casp9 in these simulations. 
As schematically depicted above Fig. 4.4H, this corresponds to a caspase cascade, which is 
controlled by the XIAP fragments, BIR1-BIR2 (specific for Casp3) and BIR3-RING (specific 
for Casp9), rather than by full-length XIAP. Figures 4.4F and 4.4H demonstrate that each 
feedback mechanism alone can bring about bistability for experimentally measured caspase 
expression levels (interception of dashed lines in Figs. 4.4 F-H). By contrast, irreversibility is 
restricted to a narrow range of caspase concentrations in both mutant models, and is never 
observed in the vicinity of experimentally measured caspase expression levels. Importantly, 
the wildtype model exhibits robust irreversibility in the physiological range of caspase 
expression levels, which suggests that irreversibility in caspase activation requires 





Fig. 4.5: Determinants for Bistability and Irreversibility II.  
The qualitative behaviour of caspase activation according to Figs. 4.4 A-E is shown as a function of the XIAP level, and of the 
competition ratio α. The competition ratio α equals the fold-change in XIAP’s affinity for Casp9 brought about by Casp3 binding 
to XIAP (and vice versa), and thereby quantifies the degree of competitive caspase binding to XIAP as indicated on the top (see 
also Appendix D).    
 
 
The computational results shown in Fig. 4.4G also explain why various cell types show 
qualitatively different patterns of caspase activation and unravel the underlying mechanisms: 
Casp3 activation is efficiently inhibited in cells, where the total XIAP concentration exceeds 
those of Casp3 and Casp9 (MN; Fig. 4.4A). Gradual Casp3 activation is predicted to occur in 
cells, where Casp9 expression is high compared to XIAP and Casp3 expression (MG; Fig. 
4.4B). In this situation XIAP is effectively sequestered by excess Casp9, and the remaining 
free Casp9 molecules efficiently cleave Casp3 as if XIAP was not present. In case that both 
caspases are expressed at intermediate levels, the feedback loops discussed above 
cooperate to reversibly switch on the system in an all-or-none fashion (BR; Fig. 4.4D). Even 
higher caspase expression levels relieve the cascade from XIAP-mediated inhibition, so that 
Casp3 can be highly active even in the absence of stimulation. Such constitutive activation 
either arises spontaneously (MB; Fig. 4.4C) or it requires previous suprathreshold Casp3 
activation (BI; Fig. 4.4E).  
 
The preceding conclusions could be confirmed by analyzing the qualitative behaviour of 
caspase activation as a function of the competition ratio α, and of XIAP expression (Fig. 4.5). 
The competition ratio α equals the fold-change in XIAP’s affinity for Casp9 brought about by 
Casp3 binding to XIAP (and vice versa), and thereby quantifies the degree of competitive 
caspase binding to XIAP (Appendix D). Figure 4.5 demonstrates that the range of bistability 
is significantly broadened even if the Casp3-binding to XIAP reduces XIAP’s affinity for 
Casp9 (and vice versa) less than 5-fold (α > 0.2). By contrast, reliable irreversibility requires 
significant competition of caspases for XIAP at least with the default protein concentrations 
(Table 4.1) assumed here. As shown in Fig. 4.5, high XIAP levels completely abolish 
caspase activation (MN), bistability is observed for intermediate XIAP concentrations (BR, 
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BI), and low XIAP levels fail to prevent caspase activation even in the absence of external 
stimulation (MB). 
 
The model simulations regarding the qualitative behaviour of caspase activation are 
supported by experimental data: (i) Overexpression of XIAP abolishes apoptosis and Casp3 
activation in response to microinjection of cyto c (type MN) [228] . (ii) Overexpression of 
Casp3 [229,230]  or Casp9 [200,231,232]  results in caspase activation and/or apoptosis 
(type MB). In contrast, Casp3 overexpression failed to elicit its own activation in another 
study [233] , and the model suggests that this may be due to low Casp9 expression (see Fig. 
4.4G). (iii) High levels of IAP antagonists such as SMAC were shown to activate the Casp9 
→ Casp3 pathway [234,235]  and to elicit spontaneous apoptosis [236]  even in cell types 
that are devoid of basal cyto c release or Casp8 activation (type MB). The inability of others 
to reproduce Casp3 activation by XIAP depletion or SMAC addition [237]  is probably due to 
the fact that the threshold BI → MB (Fig. 4.5) was not exceeded in these studies, e.g., due to 
the expression of SMAC-resistant IAP proteins such as NAIP [238] . (iv) Gradual Casp3 
activation (type MG) was observed in cyto-c-treated cytosolic extracts [178,179,180] , and 
also in flow cytometric analyses of living cells [239,240] . (v) The existence of bistable states 
(types BI and BR) is supported by all-or-none Casp3 activation in response to cyto c, and by 
the fact that Casp3 activation can irreversibly commit cells to death (see Section 4.1), 
although definitive proof for these types of behaviour is lacking (see Section 4.6).  
 
 
4.5 The mitochondrial pathway acts as an efficient integrator of multiple 
regulatory inputs   
 
In Section 4.4, it was demonstrated that excess of XIAP over Casp3 and Casp9 abolishes 
cyto-c-induced caspase activation even if high concentrations (200 nM) of the stimulus, 
active Apaf-1, were assumed (type MN). However, various experimental studies in cells, 
where Casp3 activation was inhibited downstream of cyto c release, have shown that 
caspase activation can be rescued by Apaf-1 overexpression (see [241]  and references 
therein). This suggests that Casp3 activation does not occur if the concentration of the 
bottleneck, active Apaf-1, is below the threshold stimulus concentration, where the bistable 
system switches from the lower to the upper steady state (point 2 in Fig. 4.2B). In support for 
such a threshold model, it was recently shown that a minor (~ 2-fold) decrease in Apaf-1 
expression dramatically decreases caspase activation in response to cyto c microinjection 
[241] . These studies also suggest that the apoptotic threshold can be regulated downstream 
of Apaf-1, as SMAC, an inhibitor of XIAP action, rescued cyto-c induced caspase activation 
in Apaf1-knock-down cells [241] . It was therefore investigated how the threshold of the 
bistable cascade is affected by transcriptional and post-transcriptional regulation of Casp3, 
Casp9 and/or XIAP. The corresponding simulation results are shown in Fig. 4.6: Starting 
from the default model (point of intersection), the predicted threshold stimuli, A*tot,T, of the 
bistable system were plotted as a function of Casp3 (grey dotted line), Casp9 (grey solid 
line), and XIAP (black solid line) expression. Additionally, simultaneous alterations of Casp3 
and Casp9 to the same relative extent was also considered (black solid line) in order to 
understand how the apoptotic threshold is affected by nitric oxide (NO), a covalent inhibitor of 
Casp3 and Casp9 active sites [172] . These simulations demonstrate that decreasing levels 
of Casp3 moderately increase the threshold, A*tot,T, while alterations in Casp9 shift the 
threshold more efficiently. Regulation of XIAP levels is predicted to allow even more effective 
control over the apoptotic threshold, and similar arguments also hold for NO-mediated 





Fig. 4.6: Binary Integration of Multiple Inputs.  
The threshold stimulus, A*tot,T, where the bistable system switches from the lower to the higher steady state (point 2 in Fig. 
4.2B), is plotted as a function of Casp3 (grey dotted line), Casp9 (grey solid line), or XIAP (black solid line) expression. 
Additionally, the impact of simultaneous alterations of Casp3 and Casp9 (black solid line) or of Casp3, Casp9 and XIAP (black 
dash-dotted line) to the same relative extent is shown. The intersection of the graphs corresponds to the default protein 
concentrations (see Table 4.1). The terms ‘linear’, ‘quadratic’ and ‘quartic’ indicate the relationship between protein expression 
and the apoptotic threshold, A*tot,T.     
 
 
The results regarding XIAP as an efficient modulator of an all-or-none threshold are in 
accordance with experimental studies, as a two-fold drop in XIAP expression was sufficient 
to allow cyto-c-induced Casp3 activation [242,243] . Moreover, increasing amounts of SMAC, 
a high affinity inhibitor of XIAP (Fig. 4.1B), elicited all-or-none Casp3 activation in cyto-c-
treated HeLa cell cytosol [237] . Finally, the threshold cyto c concentration that is required to 
achieve switch-like Casp3 activation was shown to be cell-type-dependent, and low 
thresholds correlated with low IAP expression levels [177] . The simulation results are also 
corroborated by the fact that PKB/Akt-mediated inhibitory phosphorylation of Casp9 
completely abolished cyto-c-induced Casp3 activation, even though Casp9 enzymatic activity 
was only partially suppressed [232] . Additionally, Casp3 overexpression sensitises cells to 
apoptosis in response to cytotoxic stress [233] , which is also in accordance with the 
simulations shown in Fig. 4.6. 
 
Thus, one can conclude that bistable behaviour in the mitochondrial caspase cascade serves 
to compute multiple regulatory inputs into a binary decision whether caspase activation 
occurs or not (‘binary integrator’). Further calculations, where relative changes in protein 
expression were related to relative changes in the threshold stimulus, A*tot, suggest that the 
following order of input potency holds in general: Regulation of active Apaf-1 < Casp3 
regulation < Casp9 regulation < XIAP regulation ≈ Simultaneous regulation of Casp3 and 
Casp9. The simulations also predict that the apoptotic threshold is essentially constant if all 
components (i.e., Casp3, Casp9 and XIAP) are simultaneously changed to the same relative 
extent (Fig. 4.6; black dash-dotted line). Hence, the life-or-death decision appears to be 
remarkably insensitive towards random fluctuations in gene expression, which are thought to 
result in correlated changes in cellular protein levels [244] . Additionally, these simulations 
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suggest that general inhibitors of protein synthesis or degradation, which are known to be 
inducers of apoptosis [226,233] , do not affect the threshold of the Casp9 → Casp3 cascade.  
 
 
4.6 Conclusions  
 
In this Chapter, it was shown that inhibition of Casp3 and Casp9 by IAPs results in an implicit 
positive feedback, since cleaved Casp3 augments its own activation by sequestering IAPs 
away from Casp9 (Fig. 4.3). Additionally, the simulations revealed that XIAP-mediated 
feedback cooperates with Casp9 cleavage by Casp3 to bring about bistable and irreversible 
Casp3 activation in the range of experimentally measured kinetic parameters and protein 
concentrations (Figs. 4.2, 4.4 and 4.5).  
 
Model Assumptions: XIAP-mediated feedback can only be observed if Casp3 and Casp9 
compete for binding to XIAP at least to some extent (Figs. 4.3 and 4.5). Such competition is 
supported by the fact that Casp3 and Casp9 cannot be co-immunoprecipitated in cells [202] . 
Casp3 (and not only Casp9) is recruited to the apoptosome at least in some cells [202] , and 
it is conceivable that this occurs by means of a sequential Apaf1-Casp9-XIAP-Casp3 
complex. Even if such a complex exists, it seems to be rather instable, as Casp3 can be 
eluted from the apoptosome (i.e., from Apaf-1) by low ionic strength [206] , while much 
higher ionic strength is required to elute Casp9 [199] . Recent co-immunoprecipitation 
experiments revealed the existence of a ternary Casp9-XIAP-Casp3 complex in vitro [245] . 
However, only minor amounts of Casp3 were found in the complex even if XIAP was 
incubated with excess Casp3 and Casp9. Taken together, these data suggest that Casp3 
and Casp9 significantly compete for binding to XIAP. Co-immunoprecipitation studies with 
Casp3, Casp9 and XIAP might underestimate the degree of competition of caspases for a 
single XIAP molecule (i.e., XIAP-mediated feedback), as IAP family members are often 
homodimers. In case that each XIAP molecule in a dimer independently couples to 
caspases, a ternary Casp9-XIAP-Casp3 complex will be seen, even if Casp3 and Casp9 
compete for a single XIAP molecule. Therefore, it is most reasonable to directly test for 
XIAP-mediated feedback in vitro. As further outlined in Appendix D, a Casp9 mutant 
(D330A), which is refractory to Casp3-mediated feedback cleavage, should be incubated 
with active apoptosomes and XIAP either in the presence or in the absence of pro-Casp3. 
Co-incubation with XIAP alone is expected to result in low Casp9 activity [201] , but excess 
pro-Casp3 should reverse this inhibition by sequestering XIAP away from Casp9. 
 
In the model it was also assumed in the model that XIAP inhibits all forms of Casp9, i.e., that 
the affinity between Casp9 and XIAP is neither affected by Casp9 autocleavage (at Asp-315) 
nor by Casp3-mediated feedback cleavage of Casp9 (at Asp-330). While it is clear that 
autoprocessed Casp9 (cleaved at Asp-315 only) is efficiently inhibited by XIAP 
[201,218,221,223,246] , some authors reported that XIAP also binds to and inhibits 
uncleaved pro-Casp9 [201,221,247] , at least partially [246,248] , but others could not 
reproduce these results [218,223] . As explained in the context of Fig. 4.3, bistability requires 
that XIAP binds to and inhibits Apaf1-activated Casp9 upon weak stimulation, so that low 
Casp3 activity can be maintained. Importantly, such XIAP-mediated control over Casp9 
activity will be ensured even if XIAP does not associate with uncleaved pro-Casp9, since pro-
Casp9 recruitment to the apoptosome was shown to result in its fast and complete 
autoprocessing (at Asp-315) [205,206] . Casp3-mediated feedback cleavage (at Asp-330) 
was reported to relieve Casp9 from inhibition by XIAP [218] , and might thereby establish an 
additional positive feedback, which would further broaden the ranges of bistability and 
irreversibility. As other experimental studies do not support the existence of this additional 
feedback [201,223] , the conservative assumption was made that XIAP inhibits feedback-
cleaved Casp9 as well.   
 
The core model of the intrinsic pathway presented in this Chapter considers only Casp3 and 
XIAP, but not functionally redundant molecules. For example, Casp7, which is activated by 
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Casp9 [175] , also mediates XIAP-mediated feedback, since it efficiently binds to IAPs [213] . 
Likewise, molecules such as c-IAP1, c-IAP2 and NAIP are functionally redundant to XIAP, as 
they inhibit both Casp3 and Casp9 [11,238] . In case that such functionally redundant 
proteins are expressed, the protein concentrations varied in the simulations (e.g., C3tot in Fig. 
4.3F-H) represent combinations (e.g., sums) of functionally redundant protein concentrations 
(e.g., C3tot and C7tot), so that the results given in the paper continue to hold.    
 
Input Signals: The concentration of active Apaf-1 assembled into apoptosomes was used as 
the varying input signal in the simulations, rather than the amount of cyto c released from 
mitochondria. This seems justified, as available experimental evidence suggests that 
apoptosome formation increases gradually with increasing cyto c concentration [180,204] , 
and that signal amplification occurs in the caspase cascade considered in this Chapter [180] 
. The present model explains how cells reject erroneous cyto c release from single 
mitochondria, and also predicts that reversible cyto c release can elicit irreversible caspase 
activation. It should be noted that cyto c release upon apoptotic stimulation was reported to 
be all-or-none under many [226,227] , but not all [249,250]  circumstances. Importantly, 
dose-response curves using active Apaf-1 as the input (e.g., Fig. 4.2B) are physiologically 
relevant even if cyto c release is all-or-none, as they help to explain why caspase activation 
is completely abolished for limiting Apaf-1 expression (see [241]  and references therein). 
More in general, the model provides insights into how the intrinsic pathway integrates 
multiple regulatory inputs including cyto c release, cyto c sequestration [206] , transcriptional 
regulation of Apaf-1 [241] , Apaf-1 sequestration [206] , transcriptional regulation of IAPs [11] 
, SMAC-mediated IAP sequestration [11] , Casp9 phosphorylation [232] , and caspase S-
Nitrosylation [172] . As shown in Fig. 4.6, the caspase cascade acts as a binary integrator in 
the range of bistability (BI and BR in Figs. 4.4 and 4.5). In contrast, gradual integration will be 
seen if the system resides in the ‘monostable-gradual’ (MG) range, and this is particularly 
relevant for apoptotic stimuli that directly regulate caspase cascade members (e.g., Apaf-1) 
in addition to releasing cyto c (‘feed-forward regulation’). For example, p53 is known to 
induce Apaf-1 expression [251] , and thereby can elicit gradual Casp3 activation even if cyto 
c release is all-or-none. Alternatively, gradual Casp3 activation, which was seen in flow 
cytometric analyses of living cells [239,240] , may be due to cell-to-cell variability in the 
intrinsic pathway. Such cellular heterogeneity seems to be significant, as cyto c injection 
alone or in combination with SMAC does not elicit Casp3 activation [252]  or cell death 
[228,253]  in all cells of a population. The present model provides a reasonable basis for 
further studies that focus on cell-to-cell variability in the intrinsic pathway.   
 
In Section 4.2. – 4.5, experimental studies were discussed, where SMAC, a competitive, high 
affinity inhibitor of IAP-binding to caspases [254] , was either added to cytosolic extracts or 
microinjected into living cells. In living cells, SMAC is eventually released simultaneously with 
cyto c from mitochondria [11]  (see Fig. 4.1A). Importantly, such physiological release of 
SMAC simply corresponds to decreasing XIAP levels in the model, as most experiments with 
caspase inhibitors have shown that SMAC release does not require caspase-mediated 
feedback [227,255,256,257] . Thus, the results shown in Fig. 4.6 explain why simultaneous 
release of cyto c and SMAC is required to elicit Casp3 activation in many cell types (e.g., 
[252] ), and predict that these two stimuli are integrated in an all-or-none manner.  
 
Upstream, Downstream and Feedback Signalling: In accordance with previous experimental 
studies (see Section 4.1), it was shown that, depending on the protein expression levels in 
the intrinsic pathway, caspase activation irreversibly commits cells to apoptosis (BI-regions in 
Figs. 4.4 and 4.5). However, some cells die by a delayed and morphologically distinct form of 
cell death, so-called caspase-independent cell death (CICD), even if caspases are inhibited 
[258] . As CICD is thought to be initiated at the level of mitochondria, the present simulations 
do not unravel the determinants for commitment to death in these cells, but only those for 
commitment to the fastest death pathway (i.e., apoptosis). As the precise kinetics of cell 
death may, for example, be important in development [258] , the present results are likely to 
be relevant even in cells subject to CICD. The physiological importance of the caspase 
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cascade considered in the model is further supported by the fact that Apaf-1, Casp9 and 
Casp3 knockout mice show morphological defects and die early in development [258] . 
Additionally, caspase inhibition, e.g. due to IAP overexpression, allowed for long-term cellular 
survival and mitochondrial recovery in response to cytotoxic stress [188,189,190,191,192]  
and/or after cyto c was released [31,181,183] . 
 
Other positive feedbacks than those included in the model have been described in the 
literature. For example, Casp3 was shown to induce processing of Casp6, which in turn 
cleaves Casp8, an activator of Casp3 [175]  (feedback 1 in Fig. 4.1A). This feedback is 
unlikely to account for bistable Casp3 activation via the intrinsic pathway, since Casp3 
activation in response to cyto c is unaffected when the delayed Casp6 → Casp8 pathway is 
abrogated [175] . This conclusion is likely to hold in general, as Casp8 cleavage alone is not 
sufficient to stimulate its catalytic activity, but recruitment to the DISC complex (i.e., ligand-
binding to death receptors) is required [231] .  
 
It has been suggested that active Casp3 amplifies cyto c release from mitochondria by 
directly cleaving upstream regulators such as Bid and Bcl-2 (feedbacks 2 and 3 in Fig. 4.1A), 
or by cleaving modulators of these Bcl2-family members such as Mekk1 [172] . However, the 
relevance of this feedback for the intrinsic pathway remains unclear, as experiments with 
caspase inhibitors revealed that cyto c release is caspase-independent in most cell types 
(e.g., [174,181,223,226,227,246] ). Furthermore, the concept of Casp3-induced cyto c 
release is inconsistent with the fact that Casp3 activation fails in various cell types even 
though large amounts of cyto c were released from mitochondria (see [241]  and references 
therein).  
 
XIAP was shown to be cleaved by Casp3 and/or Casp8 in response to apoptotic stimulation, 
and such XIAP processing may result in auto-amplification of Casp3 activity (feedback 4 in 
Fig. 4.1A) [259,260] . In line with a predominant role of Casp8, cleavage of XIAP seems to be 
especially pronounced when cells are subjected to death-receptor stimulation [259,260] . By 
contrast, moderate [260] , minor [202,203]  or even no XIAP processing [261,262]  was seen 
in response to apoptotic stimuli that initiate apoptosis via the intrinsic pathway. Additionally, 
Casp3 may also establish a positive feedback loop by cleaving inhibitors of XIAP auto-
ubiquitination and proteasomal degradation such as PKB/Akt (feedback 4 in Fig. 4.1A) 
[263,264] . Accordingly, the total XIAP abundance was shown to decrease during apoptosis 
(e.g., [264] ), but this seems to be a cell-type specific phenomenon, as the total amount of 
full-length XIAP remains essentially unchanged [260,261,262]  or even increases [265]  in 
other models of apoptosis.  
 
Owing to these data and due to the fact that most molecular species of the caspase cascade 
were shown to be continuously synthesised during apoptosis [265,266] , constant total 
protein concentrations were assumed in the model. In order to get insight into how Casp3-
mediated XIAP degradation affects the behaviour of the model, an extended model was also 
implemented, which takes such regulation into account (Appendix D). Importantly, Casp3-
mediated feedback cleavage of XIAP did not result in physiologically relevant bistability in a 
system devoid of other feedback amplification loops (Appendix D). Additionally, the 
qualitative conclusions drawn from Figs. 4.2, 4.4 and 4.5 were still valid when XIAP-mediated 
feedback was included in the wildtype model (Fig. 4.1B). However, these calculations also 
indicated that Casp3-mediated XIAP degradation may cooperate with the feedback loops 
discussed above, as it lowered the apoptotic threshold, A*tot,T, and significantly broadened 
the range of XIAP concentrations, where caspase activation is irreversible (BI in Fig. 4.5). 
 
Active Casp3 cleaves a variety of cellular substrates, and thereby initiates the execution 
phase of apoptosis [172] . Experimental evidence suggests that Casp3 activates multiple 
execution pathways in parallel and not in a sequential, cascade-like manner, since 
mutational inactivation of Casp3 cleavage sites abrogates specific features of apoptosis 
depending on the target mutated [172] . Some Casp3 substrates (e.g., PARP) are cleaved 
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almost simultaneously with Casp3, while the processing of others (e.g., Topo I) is delayed by 
several hours [267,268] . Taken together, these data suggest that transient activation of the 
branch point molecule, Casp3, elicits a partial apoptotic program, which might lead to 
potentially harmful cellular deregulation or tissue inflammation. Active Casp3 is known to be 
a rather unstable protein [269] , which suggests that irreversible behaviour of the caspase 
cascade is required to maintain Casp3 activation if upstream stimuli are removed. 
Experimental evidence indeed suggests that such transient stimulation occurs in living cells: 
(i) Cyto c release from mitochondria is thought to be a reversible as long as mitochondrial 
membrane potential (MMP) is maintained. As the MMP can remain unchanged long after 
caspases have been activated [173,174] , cytosolic cyto c (i.e., the stimulus) will decline as 
soon as the apoptotic trigger is removed (ii) Experiments with antibodies towards the 
caspase-activating form of cyto c, holo-cyto c, revealed that holo-cyto c is rapidly degraded 
after its release into the cytosol [186] . The irreversibility mechanisms described in this 
chapter ensure that apoptosis will fully proceed even after a decline in cyto c, and render 
apoptotic execution program insensitive towards survival signalling once apoptosis has been 
initiated. Such insensitivity is then further enhanced by delayed Casp3-mediated cleavage 
and thereby inactivation of various anti-apoptotic signalling proteins [263] .  
 
Proposed Experimental Verification of Bistability: The predictions regarding all-or-none and 
binary integration of multiple inputs behaviour in caspase activation (Figs. 4.2-4.5) can be 
addressed experimentally by analyzing Casp3 activation in cytosolic extracts or on a single-
cell level. In cytosolic extracts, depletion and re-addition experiments with various Apaf-1, 
Casp3, Casp9 and/or XIAP concentrations should result in all-or-none caspase activation in 
the BR and BI ranges in Fig. 4.4F, but the amount of fluorescent Casp3 substrates must be 
chosen carefully if enzymatic activity is used as a readout. Alternatively, such multivariate 
analyses can be performed by microinjecting these proteins together cyto c and/or SMAC 
into living cells. Caspase activation can then be determined using antibodies against active 
Casp3 either in flow cytometric measurements or in immunofluorescence microscopy. 
Bistability should be confirmed by adding cyto c in combination with appropriate antagonists 
such as anti-cyto c antibodies, apo-cyto c or Diarylureas, which are known to inhibit 
apoptosome activity [187,270] . In the range of bistability, simultaneous addition of 
suprathreshold cyto c levels and sufficient amounts of antagonist should yield low Casp3 
activity, while strong caspase activation should be observed if the antagonist is added after 
cyto c. Subsequent addition of a Casp9 inhibitor would break the feedback loops discussed 
in the paper, and is therefore expected to reverse Casp3 activation. The bistability 
measurements described above can be done on a population level (i.e., by Western Blotting) 
if caspase activation is irreversible, but require single cell tracking methods, e.g., real-time 
Casp3 assays or flow-cytometric cell sorting, in the bistable-reversible range.  
 
Concluding Remarks: In conclusion, a theoretical framework for quantitative experimental 
analyses of the intrinsic apoptosis pathway was presented. Previous mathematical models 
differ from the present study in (i) the choice of apoptotic pathways, (ii) the network 
properties focused on, (iii) the cell types analysed. Bentele et al. [271]  and Eissing et al. [32]  
concentrated on the extrinsic apoptosis pathway (see Fig. 4.4.1A), and analysed how switch-
like behaviour arises due to stoichiometric inhibition [271]  or due to positive feedback [32] . 
Fussenegger et al. [272]  have implemented a large-scale model of both intrinsic and 
extrinsic pathways, and analysed time course behaviour rather than bistability and apoptotic 
thresholds. Bagci et al. [273]  focussed on how Casp3-mediated feedback cleavage of Bcl2-
family members (feedbacks 2 and 3 in Fig. 4.1A) contributes to bistability in the intrinsic 
apoptosis pathway. As discussed above, these feedbacks appear to be restricted to 
particular cell types, where they might cooperate with those discussed here. Finally, Stucki 
and Simon [274]  concentrated on the regulation of Casp3 degradation. The mechanisms 
proposed in this chapter may be combined with those discussed by Bagci et al. [273]  and by 
Stucki and Simon [274]  in order to implement more realistic models of the intrinsic apoptosis 
pathway.  
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As summarised in Appendix D, cellular inhibitory proteins such as stoichiometric inhibitors, 
phosphatases and GTPase-activating proteins frequently inhibit consecutive intermediates in 
cellular signalling cascades. In general, positive feedback and bistability can arise in this 
‘shared inhibitor motif’ if: (i) the signalling intermediates compete for binding to the inhibitor at 
least to some extent; (ii) only the active form of the downstream intermediate (e.g., Casp3), 
but not its inactive precursor (pro-Casp3), binds to the inhibitor; (iii) the downstream 
intermediate (e.g., Casp3) is more abundant than the inhibitor (e.g., XIAP), which in turn 
needs to exceed the upstream intermediate (e.g., Casp9). As available experimental data is 
in accordance with these requirements, the feedback mechanism described in this paper is 
likely to be a widespread principle how cells achieve ultrasensitivity, bistability and 
irreversibility (Appendix D). 
 
Sections 2, 3 and 4 mainly dealt with the regulation of signalling networks by fast post-
translational mechanisms such as phosphorylation and dephosphorylation which operate on 
a time scale of minutes. In contrast, slow regulation by transcriptional induction or repression 
(operating on a time scale of hours) was excluded from the analysis or assumed to be so 
slow that it can be considered to be an external event. Many signalling pathways, however, 
remain activated over several hours (see Section 1.1 and Appendix A), so that slow 
transcriptional feedback regulation affect their dynamics. In Section 5, it is shown that 
transcriptional negative feedback regulation is a general design principle of mammalian 
signalling pathways. The transcriptional feedback regulation of TGFβ signalling is 
investigated in more detail in Section 6, and the functional relevance of transcriptional 
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5 Recurrent design patterns in the feedback regulation of 
the mammalian signalling network 
 
This chapter is the result of a collaboration with Nils Blüthgen from the University of 





Biochemical networks are characterised by recurrent patterns and motifs, but the design 
principles underlying the dynamics of the mammalian intracellular signalling network remain 
unclear. Decay rates of 134 signalling proteins were systematically analysed and their gene 
expression profiles in response to stimulation were investigated to get insights into 
transcriptional feedback regulation of signalling pathways. The analysis revealed a clear 
separation of the signalling pathways into flexible and static parts: for each pathway a 
subgroup of unstable signal inhibitors is transcriptionally induced upon stimulation, while the 
other constitutively expressed signalling proteins are long-lived. Kinetic modelling suggests 
that this design principle allows for swift feedback regulation and establishes latency phases 
after signalling, and that it might be an optimal design due to a trade-off between energy 





Signalling from the cell membrane to the nucleus typically occurs by post-translational 
regulatory mechanisms (such as phosphorylation), and thus occurs on a time scale of 
seconds to minutes. Within the nucleus, transcription factors are activated which induce 
changes in target gene expression on a time scale beyond 30 minutes. Some of the target 
genes are again involved in signalling, and thus slowly feed back into the signalling network. 
Given that such transcriptional regulation occurs on a time scale of hours, one might expect 
that transcriptional feedback regulation does not influence the dynamics of signalling 
networks. Experimental studies summarised in Appendix A reveal, however, that intracellular 
signalling pathways remain of active over several hours after stimulation. In other words, fast 
post-translational desensitisation mechanisms are often not strong enough to rapidly 
terminate the signal, so that transcriptional feedbacks are likely to play a role. Experiments 
with inhibitors of transcription and in cells harbouring reduced levels of signalling proteins 
due siRNA-mediated knock-down further support that transcriptional feedbacks affect the 
dynamics of intracellular signalling (Appendix A). Cellular decision making frequently requires 
ongoing signalling activity over several hours before the cell decides about commitment to a 
certain fate (Appendix A). This suggests that decision making in mammalian cells is 
profoundly affected by the slowly acting transcriptional feedback mechanisms. 
 
Evolution gave rise to recurring patterns and motifs in biological networks, e.g., in signal-
processing networks in bacteria, in metabolic networks, in neuronal networks and in 
ecological food-webs [62,130,275,276] . The recognition of these patterns helps to 
understand network optimisation principles, and to interpret the network structure. Despite its 
importance, no such general evolutionary footprints have been identified in the mammalian 
intracellular signalling network. In this chapter, design-principles in early transcriptional 





Figure 5.1:  Correlation between half-life and degree of induction after signal activation for signal 
transducers and signal inhibitors of five important signal transduction networks.  
Shown are stimulus-induced expression changes of 134 signalling proteins divided by the standard deviation of all log2-fold-
change values in the corresponding array dataset (z-value; horizontal dimension) in relation to the mRNA and protein half-lives, 
respectively (vertical dimension). Rapid Feedback Inhibitors (RFIs), defined as signal inhibitors whose the mRNAs are induced 
(z>1) within 4 hours after signal administration (grey box),  are generally characterised by mRNAs (squares) and proteins 
(circles) with very short half life (<2h). By contrast, signal transducers (filled symbols) and most long-lived signal inhibitors (open 
symbols) are not induced within 4h and have significantly longer half-lives than the RFIs.  
 
 
5.2 Expression and half-life data reveal design principles of transcriptional 
feedback  
 
The analysis presented in this chapter was focused on transcriptional feedback regulation of 
five major mammalian signalling pathways: growth factor signalling via MAPK cascades, 
growth factor signalling via PI3K, β-adrenergic signalling via cAMP, TGFβ signalling via 
Smads, and cytokine signalling via JAKs and STATs (Fig. 5.2). The analysis was restricted to 
early transcriptional feedback, i.e., to gene expression changes within less than four hours 
after extracellular stimulation. Published gene expression profiles from rat, mouse and 
human cell lines in response to stimulation were collected from the Gene Expression 
Omnibus (GEO) database. The expression values were log2-transformed, and for each gene 
and each stimulus duration in each dataset, the median value of replicas was calculated and 
the value for unstimulated cells was subtracted. The values were further normalised to 
account for different fold-changes in the different experiments. This was done by dividing by 
the standard deviation of all log2-fold-changes values in the array dataset, resulting in “z-
values”. A gene was marked as induced if the median z-value over all datasets, conditions 
and time-points was larger than 1. Expression data where the majority of replicas were 
reported as not expressed (absent call) were left out. 
 
Key regulators in transcription factor networks are characterised by unstable mRNAs [277] . 
The same might be true for rapid feedback regulators of signalling pathways, so that mRNA 
and protein half-life measurements were also included in the analysis. mRNA half-lives were 
taken from the genome-wide data-sets reported in [278]  and [279] . All three different 
treatment conditions in [279]  were considered, and the mRNA half-lives used are the median 
over all half-life measurements for each gene (including all conditions in [279] ). Protein half-
lives (listed in Appendix E) were collected from literature studies, which measured protein 
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decay after administration of the translation inhibitor cycloheximide or by pulse-chase 
assays. In some cases, the amount of protein decreased less than 50% within the 
measurement time, T. If the protein decayed to almost 50% within the measurement time, 
the half-life t1/2 = T + 2h was used for further analyses, while the value t1/2 = T + 4h was taken 
if the protein hardly decayed within the measurement time. For those proteins whose half-
lives were measured in multiple literature studies, the median of all measured half-lives was 
used in order to reduce the influence of outliers.  
 
Only proteins for which mRNA or protein half-life and microarray measurements were 
available were taken into account in the analysis. Figure 5.1 relates transcriptional induction 
in response to extracellular stimulation with half-life data, and thus summarises the results of 
the analysis. The expression of at least one of the mRNAs changes in each of the five 
pathways analysed, confirming that transcriptional feedback is a general design principle in 
biochemical signalling networks. 15 out of 134 signal proteins are significantly upregulated 
throughout all analysed pathways, with repression (negative values at the horizontal axis in 
Fig. 5.1) being rare. The half-life analysis revealed that the mRNAs and proteins of 
transcriptionally induced signalling species are all unstable (vertical axis in Fig. 5.1). On the 
other hand, mRNAs and proteins of non-induced signalling species tend to be stable  
 
Signalling proteins were classified into two functional categories (‘signal transducers’ and 
‘signal inhibitors’) in order to get further insights into the design principles of transcriptional 
feedback. The term signal transducer refers to proteins that are required to sense and to 
transmit the signal (e.g., kinases), while signal inhibitors attenuate information transfer, e.g., 
by catalyzing kinase dephosphorylation. 14 out of 51 signal inhibitors turned out to be 
induced in response to extracellular stimulation of their signal transduction chain (open 
symbols in Fig. 5.1), while only 1 out of 83 signal transducers was marginally upregulated. 
This revealed two design principles at once: (i) transcriptional negative feedback is the 
dominant general design principle in intracellular signalling in mammals, whereas positive 
feedback seems to play no major role and (ii) the negative feedback regulation is completely 
asymmetric in these biochemical signalling networks, i.e.,  negative feedback does not occur 
by downregulation of signal transducers, but relies on the induction of a subset of signal 
inhibitors (p<0.0001).  In the following, these induced proteins will be called ‘Rapid Feedback 
Inhibitors’ (RFIs).  
 
The vertical dimension of Figure 5.1 shows that the induced RFIs have very short average 
mRNA (with one exception) and protein half-lives (median 0.5 h and 1 h, respectively). The 
RFI mRNAs and proteins are significantly less stable than all other molecules analysed (both 
p<0.0005, two sided Mann-Whitney test). The average RFI half-lives are an order of 
magnitude shorter than those of signal transducers (median mRNA and protein half-life of 6 h 
and 12 h, respectively; both p<0.0005, two-sided Mann-Whitney test). The constitutively 
expressed, non-inducible signal inhibitors have a median mRNA and protein half-life of 2.6 h 
and 9 h, respectively, and are thus more stable than the inducible RFIs (both p<0.01, two-
sided Mann-Whitney test).  
 
It was analysed next whether RFIs differ from constitutively expressed signal inhibitors in 
terms of position or function in the mammalian signal transduction network. Figure 5.2 
depicts the signalling pathways considered in this study, with functional groups containing 
RFIs highlighted in grey. MAPK phosphatases (DUSPs) are induced in response to MAPK 
signalling [67] . Similarly, in all other analysed pathways RFIs were induced, such as protein 
phosphatase 1 (PPR15A), phosphodiesterases (PDE4B/D), Smad7, SnoN, and SOCS 
proteins. In all pathways RFIs attenuate signal transduction, often at multiple levels, ranging 
from cell-surface receptors to transcription factors. Moreover, there is no common mode of 
inhibition, as some RFIs inhibit catalytically (PDEs, DUSPs, PPR15A), others act by binding 
to their targets (Sprouty, SnoN, BAMBI, TGIF) and yet others may combine these 
mechanisms (SOCS, Smad7). In terms of their mode of action, RFI’s do not differ 




Taken together, the analysis revealed that early transcriptional feedback regulation in the 
mammalian signalling network is mediated exclusively by induction of a subgroup of signal 
inhibitors (RFIs). These RFIs are highly unstable in terms of mRNA and protein. This is 
consistent with the idea that rapid transcriptional regulation of steady-state protein 
expression requires short mRNA and protein half-lives (Section 5.3). It was surprising to see 
that negative feedback exclusively relies on rapid RFI induction, down regulation of signal 
transducers playing no role. Moreover, it was unexpected that the mRNAs and proteins of 
constitutively expressed signalling proteins are generally stable. Thus, the analysis reveals a 
clear subdivision of the mammalian signalling network into two parts: (i) a constitutively 
expressed static part comprising stable signalling proteins required to receive and transmit 
the signal; (ii) a flexible part that is transcriptionally induced upon stimulation, and mediates 
negative feedback regulation.     
 
 
5.3 Kinetic modelling of rapid feedback inhibitor (RFI) action 
 
The separation of the signalling network into flexible and static parts suggests that, as 
compared to signal transducer downregulation, RFI induction could be advantageous in 
achieving signal attenuation. This will be further investigated in the following by kinetic 
modelling. First, the kinetics of transcriptional regulation will be discussed, as gene 
expression is the rate-limiting step in RFI action. Then, the regulation of signal transduction 
by signal inhibitor induction will be compared to signal transducer downregulation to get 
insights into the kinetic implications of RFI action. Finally, the energetic aspects of protein 
turnover are investigated, and it will be discussed that feedback via RFI induction might be 
an optimal design due to a trade-off between energy efficiency and flexibility. 
 
Kinetics of transcriptional regulation: The expression of a gene into its protein is determined 
by four processes: transcription, translation, mRNA degradation and protein degradation 
(schematically depicted in Fig. 5.3A). The dynamics of gene expression may be described by 
two differential equations incorporating these four reactions (see Fig. 5.3A). The steady-state 
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If a gene is regulated at the transcriptional level (i.e., if the transcription rate is changed to k1 
at t=0) the time course of protein expression is given by: 
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Figure 5.2: Induction and lifetimes of signal transduction proteins (and their mRNAs) at various positions 
in signal transduction networks.   
Signal transducers and signal inhibitors were classified into groups of functionally similar proteins (e.g., Receptor Tyrosine 
Kinases). Post-translational regulatory interactions among these groups are indicated by arrows. Individual proteins are 
indicated by small boxes which are divided in three parts. The left part indicates whether the factor is transcriptionally regulated 
upon external activation of the pathway (red), while the centre and the right parts depict the protein and mRNA half-lives, 
respectively (see legend). Empty parts indicate missing data. Functional groups containing Rapid Feedback Inhibitors (RFIs) are 
highlighted in dark grey. RFIs possess short protein and mRNA half-lives and they regulate all levels of the signalling network, 
from receptors to terminal kinases.  
 
 
Thus, the response time, defined as the time required to reach the new steady state, is solely 
determined by the decay rates. The response time depends on both, d1 and d2, if the protein 
and the mRNA half-lives are of similar magnitude, while it is mainly set by the slowest decay 
in case mRNA and protein stability differ significantly from each other. This implies that for 
transcriptional regulation, both the mRNA and the protein have to be unstable in order to 
attain a new steady state rapidly.  
 
The activation of signalling networks can be modulated by transcriptional regulation of the 
concentrations of their components. The time required to attain a new signalling steady state 
by transcriptional regulation of a signalling protein is essentially determined by the stability of 
mRNA and protein (Eq. 5.2), as subsequent post-translational regulatory mechanisms are 
much faster than transcriptional induction. The behaviour is slightly more complex if feedback 
is involved: a negative feedback system subjected to activation reaches a steady state faster 
than expected from the decay rates of the feedback regulator, while no such acceleration is 
observed upon deactivation [62] . Rapid transcriptional feedback regulation of the signalling 
network requires that both the mRNA and the protein of the transcriptional feedback 
regulator need to be unstable, since otherwise: (i) feedback induction upon stimulus addition 
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implies continuously increasing feedback strength over many hours; (ii) long latency will be 
observed upon stimulus removal. 
 
Signal inhibitor induction vs. signal transducer downregulation: Transcriptional negative 
regulation of the signalling network can, in principle, occur by upregulation of signal inhibitors 
or by downregulation of signal transducers. The analysis presented in Section 5.2 revealed 
that RFI induction dominates the feedback regulation of the mammalian signalling network 
which suggests that upregulation of signal inhibitors might be more effective in achieving 
signal attenuation. Accordingly, it has previously been shown for the MAPK cascade that 
phosphatases exert stronger control on signal duration than kinases [38] . In the following, 
the dynamic behaviour of a generic protein kinase cascade will be compared for three 
different transcriptional regulatory designs to get insights into kinetic implications of RFI 
action: (i) repression of a kinase acting as a signal transducer (Fig. 5.3B, left); (ii) induction of 
a phosphatase acting as a catalytic RFI (Fig. 5.3B, middle); (iii) induction of a stoichiometric 
inhibitor acting as a non-catalytic RFI (Fig. 5.3B, right).  
 
In a weakly activated phosphorylation/dephosphorylation cycle (modelled with linear 
kinetics), the amount of active phosphorylated protein at steady state is proportional to the 
ratio of kinase to  phosphatase concentrations [280] . Thus, the signal can be reduced to 
10% of its original value, either by reducing kinase expression to 10% or by a 10-fold 
phosphatase upregulation. Figure 5.3B shows how the signal cascade activation level (i.e., 
the ratio of kinase and phosphatase activities) follows a slow change in kinase or 
phosphatase expression, when modelled according to Eq. 5.2 (with d1 = 2/h and d2 = 1/h). A 
10-fold phosphatase upregulation allows to switch off the signal much more quickly (Fig. 
5.3B, middle, solid line) when compared to 10-fold kinase downregulation (Fig. 5.3B, left, 
solid line). The recovery times if the kinase and phosphatase expression are regulated in the 
opposite direction were also analysed. In this case, kinase upregulation (Fig. 5.3B, left, 
dashed line) allows for faster disappearance of the signalling than phosphatase 
downregulation (Fig. 5.3B, middle, dashed line). Thus, the signalling activity immediately 
follows transcriptional regulation of kinase expression (due to direct proportionality), while 
phosphatases regulate signalling pathways asymmetrically, with a long latency for recovery 
(this is due to the inverse proportionality). Similar conclusions also hold for strongly activated 
kinase cascades, although the difference between phosphatase and kinase regulation 
becomes less pronounced. 
 
Several RFIs act as stoichiometric inhibitors, that is, they inhibit signal transduction non-
catalytically by binding reversibly to their targets (as depicted schematically in Fig. 5.3B, 
right). In the limiting case of strong stoichiometric inhibition the inhibitor binds to a kinase with 
very high affinity. Then, all available inhibitor I will be bound, unless the inhibitor is in present 
in excess over its target. Thus, the free, active concentration K of the targeted kinase with 
the total concentration KT is given by: 
 
( )TK max 0,[K ] [I]= −           (5.3) 
 
The cascade activity was assumed to be proportional to the free kinase concentration K (see 
above), and was analysed for slow inhibitor up- and downregulation according to Eq. 5.2 
(Figure, right; d1 = 2/h and d2 = 1/h). The change in the signal level (again 10-fold ultimately) 
immediately follows alterations in inhibitor protein expression. This statement holds true for 
as long as the inhibitor is not induced too strongly. Otherwise, the concentration I exceeds 
KT, so that the system shows some latency before it recovers. In any case, the signalling 
dynamics in response to inhibitor regulation do not differ from those observed upon kinase 





Figure 5.3: Kinetic modelling of RFI action.  
(A) Schematic representation of a minimal model of gene expression (left), and corresponding differential equations (right). (B) 
Comparison of three different transcriptional regulatory designs for a phosphorylation-dephosphorylation cycle: (i) repression of 
a kinase acting as a signal transducer (left); (ii) induction of a phosphatase acting as a catalytic RFI (middle); (iii) induction of a 
stoichiometric inhibitor acting as a non-catalytic RFI (right). The (de)phosphorylation steps were assumed to be fast relative to 
transcriptional regulation, so that the system response was taken to be proportional to the ratio of kinase to phosphatase 
concentrations [280] . The simulations show how the signal cascade activation level (i.e., the ratio of kinase and phosphatase 
activities) follows a slow change in kinase or phosphatase expression, which was modelled according to Eq. 5.2 (with d1 = 2/h 
and d2 = 1/h). The solid lines show the kinetics of cascade deactivation by kinase downregulation (left), phosphatase 
upregulation, and inhibitor upregulation (right). The recovery times if the kinase, phosphatase or inhibitor expression are 
regulated in the opposite direction were also analysed (dashed lines). The analysis reveals that signalling activity immediately 
follows transcriptional regulation of kinase expression (due to direct proportionality), while phosphatases regulate signalling 




Taken together, these simulations suggest that the design pattern of negative feedback 
regulation by a small group of RFIs might have been evolved to speed up the adaptation 
upon activation, and to introduce a lag phase upon deactivation in some (but not all) 
signalling pathways.  
Energetic aspects of RFI action: An alternative but not mutually exclusive explanation for the 
separation of the signalling network into flexible and static parts might be improved energy 
efficiency. Unstable proteins and mRNAs need higher translation or transcription rates, 
respectively, to reach the same steady state protein concentration (Eq. 5.1). Therefore their 
production consumes more energy, as the energy expenditure is proportional to the 
transcription and translation rates (k1 and k2⋅[mRNA]). Thus, a trade-off exists between 
making the protein network flexible (by increasing d1, and d2, and simultaneously increasing 
k1 and k2 to maintain the expression level), and making it energy efficient (by decreasing k1 or 
k2 and, to compensate, simultaneously decreasing d1 or d2).  
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In other words, the nodes in the network can either be designed in a flexible, rapidly 
responding manner (unstable mRNAs and proteins) or such that energy expenditure is 
minimal (stable mRNAs/proteins), but not both. The mammalian signalling network seems to 
circumvent this trade-off in an especially elegant manner; the network consumes only low 
amounts of free energy in the unstimulated state because constitutively expressed signal 
transducers required to receive the signal have stable mRNAs and proteins (static part). In 
contrast, the mRNAs and proteins of stimulus-induced RFIs are highly unstable, and thus 
allow for rapid stimulus-dependent negative feedback. This part of the network is flexible, 
and consumes energy only when the pathway is stimulated. 
Experimental evidence supports the physiological relevance of the proposed energy 
minimisation principle: Depending on the cellular context, protein turnover requires between 
30 and 70 % of the total cellular energy budget [281] . From quantitative experimental 
measurements one can estimate that signalling proteins make up ~5 % of the total cellular 
protein mass (Appendix E). The most abundant cellular proteins, i.e., house-keeping and 
structural proteins, are very stable with half-lives of up to 60 days [282]  and thus do not 
contribute strongly to the cellular energy budget. It therefore seems likely that signalling 
protein turnover consumes much more than 5% of the total energy spent for protein 
synthesis, and thus constitutes one of the dominant energy sinks in mammalian cells. The 
present analysis and literature data summarised in Appendix E showed that signalling 
pathways are transcriptionally regulated at multiple points by the induction of different (and 
possibly cell-type specific) inhibitors. If these flexible parts of the signalling pathway would be 
highly turned over constitutively, they would likely represent a strong energy burden. 
However, the analyses presented in this chapter show that the constitutively expressed 
signalling proteins are generally stable. Thus, an energy minimisation principle might have 
contributed to an evolutionary selection pressure favouring this strategy of regulation.  
Kinetic modelling therefore reveals that the criteria of rapid feedback regulation and 
energy efficiency favour the same wiring of the regulatory network. Consequently, two 
explanations for the observed separation of the signalling network into flexible and static 





The simultaneous analysis of signal protein expression profiles and half-life data presented in 
this chapter revealed design principles of the mammalian network: (i) negative feedback 
dominates over positive feedback in the transcriptional feedback regulation of signalling. (ii) 
transcriptional feedback regulation is completely asymmetric, i.e., negative feedback does 
not occur by downregulation of signal transducers, but exclusively relies on the induction of a 
subset of signal inhibitors. (iii) signalling pathways are separated into flexible and static parts, 
as transcriptional feedback regulators are unstable, while constitutively expressed (i.e., 
unregulated) signalling proteins are generally long-lived.  
 
The modelling analyses presented in Section 5.3 suggest that swift feedback regulation and 
energy minimisation may underlie design principles ii and iii. Rapid transcriptional negative 
feedback (design principle i) might allow signal transduction cascades to tone down 
signalling (to ‘adapt’), as suggested by experimental studies where signalling persisted if 
transcriptional feedback was blocked by protein biosynthesis inhibitors ([67] ; see also 
Appendix A). Efficient signal adaptation might enable signalling cascades to induce 
controlled pulses of gene expression in a robust manner, independent of environmental 
variations and transcriptional noise [62,283,284,285] . Consistent with a role in signal 
termination, many of the RFIs given in Fig. 5.2 are identified as tumour suppressors or, in the 
case of cytostatic TGFβ signalling, as oncogenes. Cellular decision-making frequently 
requires ongoing signalling activity over several hours (see also Appendix E). This suggests 
that RFIs are key regulators of the cell fate, while rapidly acting post-translational feedbacks 




A circuitry involving RFIs could also be beneficial for simpler eukaryotic organisms like yeast. 
Accordingly, it is known that all three yeast MAPK signalling cascades induce their 
phosphatases PTP2, PTP3 and MSG5 (reviewed by [286] ). Additionally, transcriptional 
feedback in response to cAMP signalling was analysed and specific upregulation of the 
signal inhibitor RGS2 was observed (see Appendix E). If yeast harbours RFIs, one expects 
these feedback-regulators to be unstable as well. Therefore a genome-wide dataset of yeast 
protein half-lives was analysed [287] . For the cell integrity, high osmolarity and cAMP 
pathways, all 20 analysed signal transducers had a protein half life of more than 15 min, 
while 4 out of 17 inhibitors were short-lived proteins with half lives of 15 min or less. 
Therefore, unstable proteins in these pathways are inhibitors (p<0.05, two-sided Fisher’s 
exact test). Moreover, transcriptional feedback occurs by induction of these unstable signal 
inhibitors, particularly via PTP2 with a half-life of only 3 min. This suggests that the yeast 
signalling network shows the same design pattern as mammalian cells.  
 
Analysis of the yeast pheromone signalling pathway revealed an exception to the finding that 
transcriptional regulation of signalling generally occurs through negative feedback: the 
transducers FUS3, STE12, STE2 in the MAPK pathway required to receive the pheromone 
signal are transcriptionally upregulated in response to pheromone stimulation, with rapid 
kinetics (<15 min) well below the cell-cycle time [288] . This is positive feedback therefore. 
Interestingly, for positive feedback the two possible selection criteria discussed (energy 
efficiency and quick feedback regulation) both predict that in the case of positive feedback 
induction of the transducer should be a better strategy than repression of the inhibitor, as 
constitutively expressed flexible inhibitors will require high amount of energy, while 
upregulated transducers require only high turnover when the cells are stimulated.  In 
pheromone signalling, some of the signal transducers are indeed short-lived proteins, much 
like the signal inhibitors involved in transcriptional negative feedback, which ensures that the 
pathway can be upregulated quickly. The pheromone pathway of yeast is different when 
compared to many other signalling pathways, as it is only required in certain phases of the 
cellular life cycle and therefore might require a positive feedback. However, the limited 
amount of available data does not allow us to substantiate this explanation. 
 
Taken together, the results presented in this chapter strongly support that transcriptional 
negative feedback regulation plays an important role for intracellular signal transduction. 
However, the physiological relevance of these feedbacks remains to be verified at the protein 
level. TGFβ-induced signalling via Smad transcription factors typically remains elevated over 
several hours after stimulation (see Appendix A), thus suggesting that transcriptional 
negative feedbacks are important determinants for the dynamics of this signalling pathway. 
Using a combination of theoretical and experimental approaches, TGFβ/Smad signalling in 
primary mouse hepatocytes is therefore analysed in Section 6. Genome-wide microarray 
analyses suggest that transcriptional feedback regulation exists in primary mouse 
hepatocytes, and measurements at the protein level indicate that the SnoN oncoprotein is 
the central feedback regulator. Theoretical predictions regarding the mechanisms of 
transcriptional feedback regulation are then confirmed in SnoN knock-out mice, thus further 
supporting the relevance of transcriptional negative feedback regulation in signal 












6 Transcriptional feedback regulation of TGFβ signalling 
 
This chapter is the result of a collaboration with Peter Nickel (DKFZ Heidelberg), Thomas 
Maiwald (University of Freiburg), Jens Timmer (University of Freiburg) and Ursula 
Klingmüller (DKFZ Heidelberg). All experiments mentioned were performed by Peter Nickel 
in the lab of Ursula Klingmüller. Thomas Maiwald from the group of Jens Timmer performed 
the microarray raw data analysis, provided the software environment for data-based 





Transforming growth factor β (TGFβ) acts as an important mitosis inhibitor and differentiation 
factor on hepatocytes both in the resting liver and during liver regeneration. Dysregulated 
TGFβ signalling can lead to liver fibrosis, cirrhosis and ultimately cancer. Extracellular TGFβ 
stimulation induces specific changes in gene expression by activating intracellular Smad 
transcription factors, and thereby affects the cellular phenotype. In this chapter, genome-
wide expression profiling at the mRNA level in response to stimulation was employed to 
identify transcriptional feedback loops of TGFβ-Smad signalling in primary mouse 
hepatocytes. Subsequent measurements at the protein level further narrowed down the 
number of potential feedback regulators, and suggested a key role for the SnoN oncoprotein, 
which inhibits signalling by reversibly binding to Smad proteins. A mathematical model of 
TGFβ-Smad signalling that was calibrated using multiple quantitative immunoblotting data 
sets suggested that SnoN-mediated feedback efficiently controls Smad transcription factor 
complexes in the nucleus and thus Smad-induced gene expression. Subsequent 
experiments in SnoN-depleted hepatocytes quantitatively confirmed these model predictions 
and thereby suggested that SnoN is the major negative feedback regulator during the early 
phase of TGFβ-Smad signalling in primary mouse hepatocytes. The mathematical model 
mechanistically explains how low levels of SnoN are able to efficiently regulate a much larger 
pool of Smad proteins, and provides a basis for further quantitative experimental analyses of 





Tight regulation of growth and differentiation processes requires the precisely coordinated 
interplay of growth stimulatory and inhibitory factors. The TGFβ family of cytokines constitute 
major inhibitors of cell growth, and accordingly they play an important role in various 
physiological processes such as development, tissue homeostasis, and tissue regeneration. 
Moreover, TGFβ signalling is dysregulated under pathological conditions including cancer, 
organ fibrosis, and Marfan syndrome. TGFβ signalling is initiated by binding of extracellular 
TGFβ to transmembrane serine/threonine kinase type I and type II receptors. Ligand binding 
triggers receptor-mediated phosphorylation of Smad2/3 transcription factors, which then 
homotrimerise or heterotrimerise (with Smad4), and subsequently translocate into the 
nucleus (Fig. 6.1). Nuclear Smad trimers control the expression of several hundred target 
genes, many of which are involved in cell cycle control (e.g., p21, c-myc, cdc25A). 
 
TGFβ signalling plays an important role for homeostasis of the normal liver, as injection of 
follistatin, an extracellular inhibitor of TGFβ family ligands, increases organ size in vivo [289] . 
Accordingly, cell culture experiments demonstrated that TGFβ inhibits hepatocyte 
proliferation in vitro [290] . The liver maintains its function after acute (i.e., short-term) 
intoxication by counterbalancing cell death with compensatory cell proliferation (‘liver 
regeneration’). Growth factors are released early during liver regeneration, and this triggers 
quiescent hepatocytes to re-enter the cell division cycle [291] . The proliferative response is 
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terminated once liver mass is restored. TGFβ seems to play a major role in the regulation of 
liver regeneration, as perturbations in TGFβ family signalling affect the initiation kinetics, the 
extent and/or the termination of hepatocyte DNA synthesis during liver regeneration 
[292,293,294,295,296,297,298] . However, hepatocytes are only sensitive towards TGFβ 
stimulation within a limited time period during liver regeneration. More specifically, it has 
been shown that hepatocytes no longer respond to TGFβ treatment during the intermediate 
proliferative phase of liver regeneration [299] . Yet, TGFβ expression and Smad 
phosphorylation are permanently elevated throughout liver regeneration [300,301] . This 
suggests that unidentified negative regulatory mechanisms downstream of receptor-
mediated Smad phosphorylation exist in the regenerating liver.  
 
 
Figure 6.1 Negative Regulation of TGFβ-Smad signalling.  
Schematic representation of negative regulatory mechanisms occurring at different levels of TGFβ-Smad signal transduction. 
General regulatory mechanisms are written in white letters, specific modulators in yellow letters. Figure taken from [47] . 
 
 
In this chapter, the negative regulatory mechanisms controlling TGFβ signalling in primary 
mouse hepatocytes are investigated. Various negative regulators have been described for 
TGFβ signalling, and they appear to act at all levels of the signalling cascade as 
schematically depicted in Fig. 6.1. Several of these signal inhibitors including BAMBI, GRK2, 
Smad7, Smurf2, SnoN, and TGIF are known to be induced upon TGFβ stimulation (see 
Table E.7 in Appendix E), so that this chapter was focused on transcriptional negative 
feedback regulation. The quantitative aspects of TGFβ signalling such as amplitude and 
duration are thought to be crucial determinants of the cellular fate. More specifically, it is 
known that pro-proliferative genes are specifically induced by transient Smad activation, 
while anti-proliferative genes require sustained Smad signalling [49] . Smad phosphorylation 
typically remains elevated for several hours after stimulation, and usually peaks late (at ~ 1 
h). The transcriptional feedback loops analysed in this chapter are therefore likely to control 
the Smad signal amplitude and duration, and may thus govern physiological responses 
towards TGFβ stimulation. Moreover, they are likely to play a role under pathological 
conditions, as constitutively elevated TGFβ levels are thought to contribute to liver damage 





6.2 mRNA expression profiling reveals transcriptional feedback 
 
Using microarray technology, mRNA expression in response to stimulation with 1 ng/ml 
TGFβ was measured by Peter Nickel in order to identify transcriptional feedback loops. Five 
time points (0, 1h, 4h, 8h and 12h) were considered and three replicates have been done for 
each time point. For hybridisation of RNA, the GeneChip Mouse Genome 430 2.0 platform 
(Affymetrix) comprising 45,100 probe sets representing 20,700 genes was used. The 
analysis and processing of raw data was done by Thomas Maiwald. Briefly, the RMA 
convolution approach was used for background correction [302] . Normalisation was done by 
imposing the same empirical distribution of intensities to each micorarray based on the 
averaged sample quantiles over all arrays [303] . For every available gene, i.e., probe set, a 
t-test is applied to compare the expression level of time point t>0 with the reference time t=0. 
In order to cope with the occurring multiple-testing problem for 45101 probe sets, the 
obtained p values are corrected with the false-discovery-rate method. In total, 2,500 genes 
were significantly up- or downregulated at one or more stimulation time points. A gene was 
considered to be unregulated at a given time point, if the absolute log2-fold change 
compared to the unstimulated state was less than 0.5 or the corresponding corrected p-value 
was larger than 0.05. 
 
A list of 114 genes functionally associated with TGFβ signalling was compiled and analysed 
for expression changes in order to get insights into transcriptional feedback regulation. The 
genes comprised the following functional categories (see Fig. 6.2): Ligands activating 
Smad2/3 signalling (TGFβ, Activins); proteins controlling ligand processing and activity; 
receptors for TGFβ and Activin; modulators of receptor activity and degradation; Smad 
transcription factors; and regulators of Smad activity. Some genes are assigned to more than 
one category in Fig. 6.2 (e.g., Smad7), because their protein products are known to regulate 
TGFβ signalling at multiple levels. 
 
Figure 6.2 schematically depicts the time course measurements for each of the 114 genes. 
The analysis indicated that repression plays no important role in the transcriptional feedback 
regulation of TGFβ signalling, as only 3 out of 114 genes were weakly downregulated (log2 
fold change between -0.5 and -1). On the other hand, 14 of the 114 genes were significantly 
upregulated in response to TGFβ signalling (log2 fold change > 0.5; Fig. II.1). Among these 
14 upregulated genes were TGFβ1, the TGFβ receptor I and several factors involved in 
ligand processing such as Thrombospondin 1 (THBS1), which suggested that TGFβ 
stimulation might induce an autocrine amplification loop. In line with literature studies [304] , 
gene expression profiling indicated strong induction of TIEG-1, a transcriptional coactivator of 
Smad transcription factors, which is thought to be required for feed-forward regulation of 
specific Smad target genes. Finally, the analysis revealed that known feedback regulators 
TGFβ receptor signalling (Smad7) and of Smad signalling (SnoN, Smad7 and Ski) are also 
transcriptionally induced in primary mouse hepatocytes. Interestingly, no significant 
upregulation of GRK-2, Smurf2, BAMBI and TGIF was observed, even though these proteins 
have been previously described as negative feedback modulators of receptor/Smad 





Figure 6.2 mRNA expression profiling of transcriptional negative feedback of TGFβ-Smad signalling in 
primary mouse hepatocytes.  
Alterations in mRNA expression of 114 genes functionally associated with TGFβ signalling after stimulation of hepatocytes with 
1 ng/ml TGFβ for 1 h, 4 h, 8 h or 12 h are expressed as log2 fold-changes relative to the unstimulated state. 
 
 
Taken together, gene expression profiling indicates that TGFβ might induce a positive 
feedback at the extracellular level (ligand/receptor), while negative feedback seems to 
predominate at the intracellular level (receptor/Smad). Two lines of evidence suggests that 
extracellular positive feedback amplification does not play a major role under the 
experimental conditions chosen: (i) Peter Nickel quantitatively measured the amount of 
processed TGFβ protein in the extracellular medium in the presence and in the absence of 
the general feedback inhibitor Actinomycin D, respectively (Fig. 6.5A). These analyses 
revealed that medium TGFβ monotonically decays over the 10 hour time course and that the 
decay kinetics were not affected by a blockade of transcriptional feedback. (ii) Previous 
studies in various cell types revealed ligand-induced TGFβ receptor downregulation at the 
protein level, while upregulation has never been reported (e.g., [305] ). It thus seemed likely 
that TGFβ receptor I mRNA induction merely serves to compensate ligand-induced receptor 
protein degradation, but does not result in positive feedback amplification. Owing to these 
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data, the following analyses (Section 6.3) will be focussed on intracellular negative feedback 
regulation via Smad7 and SnoN. 
 
 
6.3 Experimental verification of transcriptional feedback at the protein level  
 
By analyzing genome-wide transcriptional data on TGFβ-induced target genes, putative 
feedback regulators of the signalling system could be identified. Next, the central 
components of Smad signalling were quantified at the protein level by Peter Nickel. More 
specifically, quantitative immunoblotting was applied to estimate absolute cellular levels and 
to determine the relative abundance of reaction partners. Using serial dilutions of 
recombinant proteins (Fig. 6.3), it was estimated that each hepatocyte contains 
approximately 80 000 molecules of each, Smad2 and Smad4, while Smad3 was present in 
much lower amount (4000 molecules per cell). Time series analysis revealed that these 
levels were fairly unchanged upon stimulation with TGFβ (see below).  
 
Next, the putative negative regulators of Smad signalling, Smad7 and SnoN, which were 
both strongly upregulated at the mRNA level upon TGFβ stimulation, were analysed (Fig. 
6.3B). Smad 7 was already present in unstimulated hepatocytes at 80.000 molecules per 
cell. Surprisingly, these numbers slightly declined upon TGFβ stimulation, despite strong 
Smad7 induction at the RNA level (see Fig. 6.2). SnoN was induced ~4-fold at the protein 
level, which suggests that it represents a major negative feedback regulator of TGFβ 
signalling in hepatocytes. However, the absolute expression level was limited to 2300 
molecules per cell, even after stimulation (Fig. 6.3B).  
This raises the question of whether the much larger pool of Smad proteins can be 
efficiently regulated by sub-stoichiometric amounts of SnoN, which is thought to act as non-
catalytic inhibitor of Smad signalling. A mathematical model of Smad signalling and 




Figure 6.3 Absolute quantification of TGFβ-Smad pathway components using recombinant protein 
standards.  
Endogenous protein levels (n=5) of Smad2, Smad 3, Smad4, Smad 7 and SnoN were quantified by means of dilution series 
(n=3) of the respective recombinant calibrator proteins added to whole cell lysates prior to immunoprecipitation and quantitative 
immunoblotting. Lysates were either prepared from 2x106 unstimulated cells (black bars) or from 2x106 cells stimulated with 1 









An ordinary differential equation (ODE) model of TGFβ signalling in primary mouse 
hepatocytes, as schematically depicted in Fig. 6.4, was implemented (differential equations 
can be found in Appendix F). All reactions concerning receptor and Smad shuttling between 
subcellular compartments as well as protein degradation were modelled with 1st-order 
kinetics, and protein dimerisation and trimerisation were modelled as bi- and trimolecular 
reactions, respectively. Michaelis-Menten kinetics were assumed for enzyme-catalysed 
Smad2 phosphorylation and for Smad-mediated transcriptional induction of SnoN, since both 
reaction types are known to be saturable. Several protein species in the model are 
continuously synthesised and degraded even in the absence of stimulation. The basal 
protein concentrations which are determined by various kinetic parameters in the model, 
were calculated using analytical steady state equations as described in Appendix F.  
 
 
Figure 6.4 Dynamic model of TGFβ-Smad signalling.  
Schematic representation of biochemical reactions considered in the kinetic model of TGFβ-mediated signalling. The Receptor 
Trafficking module includes signal initiation by ligand binding to the cell-surface receptor, and also takes receptor shuttling 
between endosomal compartments and the plasma membrane into account. The core module (‘Smad Activation Cycle‘) 
comprises receptor-mediated Smad2 phosphorylation (S2 -> pS2), Smad2 homotrimerisation (3 pS2 <-> (pS2)3), Smad 
heterotrimerisation (S4 + 2 S2 <-> S4~(pS2)2), and considers nucleo-cytoplasmic shuttling of all Smad species. Nuclear Smad 
proteins are indicated by the prefix n. The SnoN feedback module includes Smad-mediated transcriptional induction of SnoN 
and subsequent feedback inhibition of Smad trimers by binding to SnoN protein.   
 
Three compartments (extracellular medium, cytoplasm and nucleus) are relevant for the 
chosen experimental setup. Microscopic analyses of primary mouse hepatocytes indicated a 
total cell volume of 10 pl (10-12 liters) and a ratio of cytoplasmic and nuclear volumes of ~ 20 
(Sebastian Bohl, unpublished). In the model, it was thus assumed cytoplasmic and nuclear 
volumes of 10 and 0.5 pl, respectively. The medium volume was taken to be 1000 pl per cell.   
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The following sections contain a description of how the model topology was derived from the 
published literature. The Smad3 protein was generally neglected in the model owing to its 
low expression level in primary mouse hepatocytes (Fig. 6.3), and only the much more 
abundant Smad2 protein was taken into account. Experimentally measured kinetic 
parameters and the parameter ranges used for the fitting procedure are summarised in 
Tables F.1 – F.3.     
 
 
6.4.2 Modelling receptor trafficking 
 
TGFβ initiates intracellular signalling by binding to its cognate transmembrane receptor, the 
TGFβ receptor [48] . Receptor-ligand association was modelled by a bimolecular and 
reversible reaction (T + R ↔ TR), as supported by Scatchard analyses [306,307,308] .  
TGFβ receptor trafficking between the endosomal compartment and the plasma 
membrane  was also considered in the model. The TGFβ receptor is known to constitutively 
shuttle between both compartments [309,310] , and the majority of TGFβ receptors resides in 
the endosome even in unstimulated cells [310] . Experimental studies revealed that the rates 
of TGFβ internalisation and recycling are not affected by ligand stimulation [309,310] . In the 
model, the same rate constant was therefore assumed for endocytosis of free and ligand-
occupied receptors (R → Re and TR → TRe). In accordance with previous mathematical 
models [311,312] , free and ligand-occupied receptors in the endosome are recycled back to 
the cell surface with the same recycling rate constant (Re → R and TRe → R). Recycling of 
ligand-occupied receptors was modelled to be accompanied by intracellular ligand 
dissociation/degradation (TRe → R), as the pool of internalised TGFβ was shown to be 
completely degraded [313] . 
 Lysosomal targeting and degradation of endosomal receptors and receptor-ligand 
complexes were also considered in the model. Experimental studies using inhibitors of 
lysosomal progression revealed that both, TGFβ [313,314,315]  and the TGFβ receptor [316] 
, are subject to degradation within the lysosome. Owing to these data, it assumed in the 
model that early endosomal receptor-ligand complexes eventually progress into late 
endosomes (TRe → TRle), and thereby escape recycling. These complexes are then in turn 
targeted to the lysosomal compartment, where they are ultimately degraded (TRle →). A 
degradation reaction for inactive endosomal TGFβ receptors (Re → ) was also considered in 
the model, because lysosomal targeting is thought to be an important degradation pathway 
for TGFβ receptors in unstimulated cells [316] . Other pathways ligand and/or receptor 
degradation pathways (e.g., raft-mediated internalisation; [310] ) were neglected in the 
model, as they appear to be cell-type-specific [309] , and were not required to accurately 
describe experimental data in hepatocytes. Transmembrane receptors such as the TGFβ 
receptor are synthesised via the secretion pathway (ER/Golgi). Thus, a constant influx into 
the pool of inactive endosomal receptors was included to model de novo synthesis of 
receptors (→ Re) 
 
 
6.4.3 Modelling the Smad activation cycle 
 
Smad Phosphorylation: Ligand binding induces autophosphorylation of the TGFβ receptor 
which in turn activates its receptor serine kinase activity towards cytosolic substrates such as 
Smad2/3 [48] . Receptor (de)phosphorylation occurs much faster than ligand binding and 
dissociation [48] , thus justifying a lumped reaction step in the model (T + R ↔ TR and TRe 
→ Te + Re). Most experimental analyses suggested that endosomal but not cell-surface 
receptors catalyse Smad2/3 phosphorylation [310,317,318,319,320,321,322,323] . For 
simplicity, it was thus assumed in the model that only endosomal receptor-ligand complexes 
catalyse Smad2 phosphorylation. Recent studies revealed that TGFβ receptors can remain 
active on their way to lysosomal degradation, i.e., in the late endosome [324,325,326] . 
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Owing to these data, the phosphorylation reaction S2 → pS2 is modelled to be additively 
catalysed by early and late endosomal receptors (TRe and TRle) with the same efficiency. An 
endosomal accessory protein, SARA, is thought to be required for recruitment of Smad2 to 
the TGFβ receptor, and thus for receptor-mediated Smad2 phosphorylation [323,327] . In the 
model, SARA was assumed to recruit Smad2 to the membrane with high efficiency. This 
implies that Smad2 binding to the receptor will essentially behave like an association 
between to membrane proteins. It has been shown theoretically and experimentally that co-
localisation of two proteins to the membrane drastically increases the apparent affinity of 
protein-protein interactions by a factor of ~1000 [328,329,330,331] . Low KM values for 
receptor-mediated Smad2 phosphorylation were thus allowed in the model, as further 
described in Table F.2. 
 
Smad Trimerisation: Receptor-mediated phosphorylation strongly favours Smad2/3 
multimerisation, and most experimental studies indicated that trimers are the predominant 
multimeric R-Smad species [332,333,334,335,336] . Heterotrimerisation of two Smad2/3 
molecules with one Smad4 molecule was shown to be more efficient than homotrimerisation 
of three Smad2/3 molecules [334,335] . More specifically, the heterotrimeric complex is 
slightly more stable than the homotrimer in vitro [334,335,336] , but this difference might be 
more pronounced in vivo [337] . Smad homo- and heterotrimerisation were modelled as 
reversible, single-step reactions (2 pS2 + S4 ↔ (pS2)2S4 and 3 pS2 ↔ (pS2)3), as the 
concentration of the Smad dimer intermediate was shown to be negligibly small in vitro [334] 
. The model was implemented such that heterotrimers preferentially formed over 
homotrimers (see Table F.2). Additionally, it was assumed that nuclear trimers are formed 
with the same kinetics as their cytosolic counterparts, because experimental studies 
demonstrated efficient Smad heterotrimer formation in the nucleus [338] . 
 
Smad Import: TGFβ stimulation induces translocation of Smad2/3 and Smad4 into the 
nucleus. Yet, the Smad proteins shuttle continuously between the nucleus and the cytoplasm 
even in unstimulated cells [339] . Recent studies indicated that the import rate of Smad2/3 is 
not affected by TGFβ stimulation [336,339,340] . Therefore, it was assumed in the model that 
all Smad2 monomer and trimer species are imported with the same import rate constant (S2 
→ nS2 ; pS2 → npS2; (pS2)2S4 → (npS2)2nS4 and (pS2)3 → (npS2)3). In contrast, the 
import of monomeric Smad4 was modelled to occur with a different rate constant (S4 → 
nS4). Thus, the model reflects the experimentally established fact that the nuclear import of 
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Of the 46 listed data sets 27 were used for fitting (F) and 13 for testing of model predictions (P). Six redundant standard 
stimulation data sets (grey) were used to introduce a common scaling for results from independent experiments. The relative 
concentrations of total Smad2, phosphorylated Smad2, total SnoN, as well as Smad4 and SnoN co-immunoprecipitated with 
Smad2/3 were measured by immunoblotting. The amount of processed TGFβ in the medium was determined by ELISA. Errors 
were either calculated from a cubic spline (Spline), based on a spline-derived linear error model (Model), estimated employing 
typical errors Eabs and Erel (Estimated) or calculated as the standard deviation of three independent measurements (StdDev). 
The definition of the observables in the model (according to the differential equations given in Appendix F.1) is given in the left 
column. In order to transform the simulated time courses into relative units, a common scaling factor was introduced for each 





Smad Export: TGFβ-induced Smad2/3 translocation into the nucleus is thought to be due to 
a decrease in the overall Smad2/3 export rate upon stimulation [339] . FRAP measurements 
indicated that this decrease might be due to selective immobilisation and thus retention of 
nuclear Smad trimers, e.g., by to binding to DNA [339] . Smad2/3 export has been reported 
to occur via Smad2/3 binding to Exportin 4, which functions as a nuclear export receptor 
[341] . Exportin 4 preferentially binds to unphosphorylated Smad2/3 [341] , and accordingly 
phosphorylated Smad2/3 is exported with low efficiency [340,341] . Thus, it appears that two 
independent mechanisms contribute to stimulus-induced nuclear translocation of Smad2: (i) 
retention of Smad trimers; (ii) inefficient export of phospho-Smad2. In the model, it was 
therefore assumed that only unphosphorylated Smad2/3 monomers can be exported from 
the nucleus (nS2 → S2), and an export reaction for monomeric Smad4 was also included 
(nS4 → S4). Thus, the model is in accordance with experimental studies which indicated that 
Smad4 can only be exported in monomeric form, but not when assembled in Smad trimers 
[336] . 
 
Smad Dephosphorylation: Smad2/3 dephosphorylation in the nucleus controls the amount of 
nuclear Smad trimers, and is therefore an important mechanism to control the magnitude and 
duration of Smad-mediated gene expression [342] . It is thought that the phosphorylation 
sites in Smad2/3 constitute the binding interface in Smad trimers [333] . In the model that 
Smad trimers can therefore not be attacked by phosphatases, and dephosphorylation occurs 
only for monomeric nuclear phospho-Smad2/3 (npS2 → nS2). Initial numerical analyses 
indicated that cytoplasmic Smad2/3 dephosphorylation is not required to describe 
experimental data obtained in primary mouse hepatocytes, so that this reaction was skipped 
from the model. 
 
Protein Synthesis and Degradation: Smad2 and Smad4 protein levels are typically not 
affected by TGFβ treatment [338,343,344] . In accordance with these data and with the 
microarray results show in Fig. 6.2, it was therefore assumed in the model that Smad2 and 
Smad4 are continuously synthesised (→ S2 and → S4). Degradation of all Smad species 
was also taken into account (S2 → ; S4 → ; nS2 → ; nS4 → ; pS2 → ; npS2 → ; (pS2)2S4 → ; 
(npS2)2nS4 → ; (pS2)3 → ; (npS2)3 → ). For simplicity, it was assumed that the stability of 
monomeric Smad4 does not differ in the nucleus and in the cytosol, so that the same rate 
constant for the corresponding reactions (S4 → ; nS4 →). Experimental studies indicate that 
Smad2 stability in the nucleus and in the cytosol may be different [345,346,347]  and that 
stimulus-induced proteasomal degradation of Smad2 might occur in the nucleus at least in 
some cells [345] . Different degradation rate constants were therefore assumed for nuclear 
and cytosolic Smad2 monomers, respectively (S2 → ; nS2 → ; pS2 → ; npS2 →). 
Experimental evidence suggests that Smad2 recruits ubiquitin ligases to Smad2/Smad4 
heterotrimers [348] . This suggests that Smad2 plays a dominant role for the degradation of 
Smad heterotrimers. In the model, it was thus assumed that all Smad trimer species are 
degraded with the same rate constant as their monomeric Smad2 counterparts ((pS2)2S4 → 
; (npS2)2nS4; (pS2)3 →; (npS2)3 →).  
 
 
6.4.4 Modelling negative feedback via SnoN induction 
 
Based on the microarray and the protein quantification analysis (Figs. 6.2 and 6.3), it seemed 
likely that SnoN is the major transcriptional feedback regulator of TGFβ signalling in primary 
mouse hepatocytes. SnoN-mediated feedback was therefore included in the model to 
quantitatively describe TGFβ signalling over a 10 h interval after stimulation.  
SnoN Localisation: The SnoN oncoprotein is confined to the nucleus in most cultured cell 
lines, but is additionally localised to the cytoplasm in some freshly-isolated primary cells [349] 
. A model comprising nuclear and cytoplasmic SnoN did not lead to significant advantages 
compared to exclusively nuclear SnoN, whereas a model where SnoN was restricted to the 
cytoplasm was unable to explain experimental data in primary mouse hepatocytes (not 
 
 69
shown). This suggested that the nuclear SnoN pool is most important in primary mouse 
hepatocytes, possibly because it is much more abundant than the cytoplasmic pool. For 
simplicity, it was thus assumed in the model that SnoN is exclusively localised to the nucleus. 
 
 
Figure 6.5 Model fits to extracellular TGFβ data and to whole-cellular Smad2/4 data under standard 
stimulation conditions.  
The kinetic parameters of the model were estimated by fitting the model to experimental data (data points) obtained for various 
stimulation conditions. Solid lines represent the corresponding simulated time series obtained for the best-fit parameters. (A) 
The level of active TGFβ in the medium under standard stimulation conditions (1 ng/ml TGFβ) was measured in the absence 
(black points) and the presence (grey points) of the generic transcription inhibitor Actinomycin D, respectively. (B) Same as A, 
but the level of phospho-Smad2 was measured in whole-cell lysates. (C) Same as A, but the level of Smad4 co-
immunoprecipitated with Smad2 was measured in whole-cell lysates. (D) Same as A, but the total level of Smad2 was 
measured in whole-cell lysates. Spline-based error estimates were used (Section 6.5.2). 
 
 
SnoN Synthesis: The SnoN gene is regulated by TGFβ-dependent and -independent 
mechanisms, and accordingly SnoN mRNA is constitutively expressed in most cell lines 
[300,343,350] . In the model, an unregulated synthesis term was thus included for SnoN, and 
the corresponding synthesis rate was adjusted such that basal SnoN expression matched 
the experimentally measured level (~600 molecules per cell; Fig. 6.3 and Table F.3). 
Experimental studies indicated that TGFβ-dependent SnoN induction is mediated by Smad2-
containing transcription factor complexes [350] . For simplicity, Smad homo- and 
heterotrimers stimulate SnoN synthesis in the model with the same efficiency (→ 
SnoNprecursor). Transcriptional induction is typically saturable (e.g., [351,352] ), so that Smad-
mediated SnoN induction was modelled as a Michaelis-Menten process with respect to 
Smad trimer concentration. During the fitting procedure, sub-nanomolar KM-values for SnoN 
induction were allowed (Table F.3), as multiple adjacent Smad-binding elements (SBEs) 
have been reported for the SnoN promoter [350]  to which Smad3 and Smad4 proteins are 
known to bind in a cooperative manner [353,354,355,356] . Due the multistep nature of 
protein biosynthesis, a delay ~20 minutes was included in SnoN protein production 
(SnoNprecursor → SnoN). 
 
SnoN-Smad2 complex Formation: The ability of SnoN to inhibit TGFβ signalling depends on 
its ability to form complexes with Smad2/3 [357] . It is known that SnoN and Smad2/3 
complex formation within living cells is strongly enhanced upon TGFβ stimulation [358,359] , 
and in vitro association studies indicate that SnoN selectively binds to phosphorylated R-
Smads and to Smad trimers, respectively [358,360] . In the model it was thus assumed that 
SnoN specifically binds Smad homo- and heterotrimers in a reversible, bimolecular reaction 
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(SnoN + (pS2)2S4 ↔ SnoN~(pS2)2S4 and SnoN + (pS2)3 ↔ SnoN~(pS2)3). Hence, the 
model reflects the experimental observation that SnoN and the related Ski protein do not 
disrupt Smad trimers [343,360,361] . 
 
 
Fig. 6.6 Model fits to whole-cellular Smad2/4 data under various stimulation conditions.  
The kinetic parameters of the model were estimated by fitting the model to experimental data (data points) obtained for various 
stimulation conditions. Solid lines represent the corresponding simulated time series obtained for the best-fit parameters. Cells 
were either stimulated with (A – C) 1 ng/ml TGFβ or (D – F) 0.05 ng/ml TGFβ or (G – I) with 1 ng/ml TGFβ and the 
TGFβ receptor inhibitor SB431542 was added after 50 min or (J – L) with 1 ng/ml TGFβ which was removed after 50 min by an 
exchange of cell culture medium. Relative concentrations of phosphorylated Smad2 (A, D, G, J), Smad4 co-immunoprecipitated 
with Smad2/3 (B, E, H, K) and total Smad2 (C, F, I, L) in whole cell lysates were determined by quantitative immunoblotting and 
are directly comparable between conditions due to common scaling. The experimental variability was estimated using the error 
model (Section 6.5.2). 
 
 
SnoN Degradation: It is well established that TGFβ stimulation strongly enhances SnoN 
degradation [343,358,362,363] . This seems to be due to the fact that trimers containing 
Smad2 or Smad3 recruit various ubiquitin ligases to SnoN, and thereby promote its 
proteasomal degradation [359,362,363] . Experimental studies indicate that Smad trimers 
‘catalyse’ SnoN degradation, as R-Smad stability is only marginally affected by SnoN 
overexpression [358,362] , while SnoN degradation is strongly enhanced by R-Smad 
overexpression [343,359] . Hence, it was assumed in the model that Smad-SnoN complexes 
decay into degraded SnoN and intact Smad trimers, while degradation of whole Smad-SnoN 
complexes was neglected. Experimental studies mapped SnoN-mediated transcriptional 
repression and Smad-mediated SnoN degradation to the same amino acids in SnoN 
[357,359] , and hence justify the model assumption that the same Smad-SnoN complexes 





6.5 Model calibration 
 
6.5.1 Experimental data for model calibration 
 
Various stimulation experiments were performed and several pathway components were 
monitored by Peter Nickel in primary hepatocytes as a premise for data-based modelling. 
The following five stimulation conditions were tested experimentally: (i) standard TGFβ 
stimulation (1 ng/ml), (ii) weak TGFβ stimulation (0.05 ng/ml), (iii) standard TGFβ stimulation 
in the presence of the generic transcriptional inhibitor actinomycin D, (iv) standard TGFβ 
stimulation with addition of the specific TGFβ receptor kinase inhibitor SB431542 after 50 
min, and (v) standard TGFβ stimulation with the ligand being removed after 50 min by 
medium exchange. Being central to TGFβ signalling, total SnoN, total Smad2, Smad2 
phosphorylation and the amount of Smad4 co-immunoprecipitated with Smad2/3 were 
measured in whole cell lysates. Total and phosphorylated Smad2 pools were additionally 
measured in cytosolic and nuclear extracts to get insights into the dynamics of 
nucleocytoplasmic shuttling. Moreover, the amount of processed TGFβ in the cell culture 
medium was measured in the presence and absence of actinomycin D. All time course data 
sets used to calibrate the kinetic model by global parameter estimation are summarised in 
Table 6.1. For background correction, the lowest value of a time course was generally 
subtracted from all data points for all observed species except for total Smad2, for total SnoN 




Fig. 6.7 Model fits to nuclear and cytoplasmic Smad2/4 data.  
The kinetic parameters of the model were estimated by fitting the model to experimental data (data points). Solid lines represent 
the corresponding simulated time series obtained for the best-fit parameters. Relative concentrations of phosphorylated and 
total Smad2 (A) in cytoplasmic extracts after stimulation with 1 ng/ml TGFβ in absence (black) or presence (grey) of actinomycin 
D and (B) in cytoplasmic and nuclear extracts after stimulation of cells with 1 ng/ml TGFβ were determined by quantitative 
immunoblotting. Spline-based error estimates were used (Section 6.5.2). 
 
 
Cytoplasmic Smad signalling +/- Actinomycin D 
Cytoplasmic Smad signalling (standard stimulation) 





6.5.2 Scaling factors and error estimation 
 
Scaling Factors: Western blot measurements are typically semi-quantitative in the sense that 
the results can only be expressed in arbitrary units, but not in absolute concentrations. Thus, 
scaling factors were introduced to fit the model (formulated in absolute concentrations) to 
time course data given in arbitrary units. An individual scaling factor was included for each 
observable (total Smad2, phosphorylated Smad2, Smad4 (CoIP), total SnoN, SnoN (CoIP), 
TGFβ) in the respective compartments, as indicated in Table 6.1, where each box 
corresponds to a single scaling factor. It is important to note that a single scaling factor was 
used for different stimulation conditions and for SnoN-depleted vs. wildtype cells in order to 
take biologically relevant scaling into account (Table 6.1). 
 
 
Fig. 6.8 Model fits to whole-cellular SnoN data under various stimulation conditions. 
The kinetic parameters of the model were estimated by fitting the model to experimental data (data points). Solid lines represent 
the corresponding simulated time series obtained for the best-fit parameters. Cells were either stimulated with (A) 1 ng/ml TGFβ 
or (B) with 0.05 ng/ml TGFβ or (C) with 1 ng/ml TGFβ and actinomycin D was added at 0 min or (D) SB431542 was added after 
50 min. Relative concentrations of total SnoN in whole cell lysates were determined by quantitative immunoblotting and are 
directly comparable between conditions (A-D) due to common scaling. Error estimation was based on a spline-derived error 
model (Section 6.5.2). 
 
 
The quality of a mathematical model is determined by its deviation from the data relative to 
the measurement error, so that the variability of the experimental data had to be estimated. 
All measurements listed  were performed at least twice with similar results. As replica 
measurements frequently differed in the observed time points, errors could not be directly 
derived by calculating standard deviations. The errors of 14 densely measured time courses 
(each comprising 18 or more time points) were therefore estimated by taking the distance of 
each data point from a cubic spline. From these spline-based error estimates linear error 
models were derived for the observables total Smad2, phosphorylated Smad2, Smad4 
(CoIP), SnoN (CoIP) and TGFβ. For each time series y(ti), these error models, considering 
relative errors Erel and absolute errors Eabs, had the form 
 




Here, the constant C is given by the 0.9-Quantile of the whole time course, i.e., C = 
Q.9(y(t1...ti)). These error models were used to estimate the errors in less densely sampled 
time courses (Table 6.1). For total SnoN, no spline-based error model could be derived from 
the measurements, so that typical values (Erel = 10%; Eabs = 15%) were applied. The 
relevance of SnoN-mediated feedback was confirmed by analyzing Smad signalling in cells 
harbouring reduced levels of functional SnoN (see below). The corresponding experiments in 
SnoN siRNA cells and in knock-in cells expressing mutant SnoN were performed in 
triplicates with identical time points analysed in each experiment, so that the errors could be 
estimated by calculating standard deviations. For a comprehensive overview of the error 
estimation for different data sets see Table 6.1. 
 
 
6.5.3 Parameter estimation 
 
Mathematical modelling was done using the multi-experiment fitting Matlab toolbox 
PottersWheel (www.potterswheel.de, Maiwald et al., under revision). The reaction scheme 
(Fig. 6.4) was translated into a set of 19 ordinary differential equations. The final model 
additionally included 9 auxiliary variables (see Equations F.1 and F.2), which were required 
to model a delay in SnoN induction and the mRNA decay in response to actinomycin D 
treatment. Several of the 57 model reactions were assumed to proceed with identical 
kinetics, so that 36 kinetic parameters were subject to fitting. All parameters were optimised 
globally, that is, a single parameter set was able to describe all time courses. During the 
parameter estimation, each parameter was restricted to the range specified in Tables F.1 – 
F.3. According to Table 6.1, there are 10 scaling parameters, all of which were also fitted, 
and allowed to vary in a large range (10-5 – 105). The initial conditions (i.e., the initial protein 
concentrations) are not subject to separate fitting, as they are determined by the kinetic 
parameters for basally expressed species (see Section F.3) or, in the case of the 
extracellular TGFβ concentration, by the experimental conditions (Section 6.5.4). The start 
values for the auxiliary mRNA species were also fixed and set to 1 (see Appendix F). Finally, 
the experimentally measured volumes of medium, cytosol and nucleus were set to 
experimentally measured values (see Section 6.4.1), and were also excluded from the fitting 











N is the number of all data points and σMeas(i) is the error of the i-th measurement, yMeas(i). In 
order to circumvent local minima, a two-step strategy was applied. First, 2800 quasi 
randomly distributed positions in the space of physiologically reasonable parameter values 
(see Supplementary Tables F.1 – F.3) were used as starting conditions. Fitting was applied 
with a deterministic trust region optimiser with a χ2 tolerance of 10-4, a fit parameter tolerance 
of 10-4, and a maximum of 600 iterations. Then, the best fit was disturbed and refitted 1600 
times, i.e., the fitted parameter values were transformed to pnew = pold × 10(s × e), with s = 0.3 
and e being normally distributed with variance 1 and mean 0.  
 
 
6.5.4 Input functions 
 
The model trajectories depend on the characteristics of five external input functions, termed 
u1 – u5 in the differential equations (Equations F.1 and F.2). The input u1 equals the initial 
TGFβ concentration, and thus determines the strength of stimulation. Ligand removal 
experiments by medium exchange were simulated by changing the input u5 from 1 to 0, 
which abolishes de novo ligand binding to TGFβ receptors in the model (see v7 in Equations 
F.2). The input u3 controls receptor-mediated Smad2 phosphorylation (v16 in Equations F.2), 
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and was changed from 0 to 1 to simulate addition of the TGFβ receptor kinase inhibitor 
SB431542. In some experiments, TGFβ signalling was monitored over 10h in the presence 
of the general transcription inhibitor, actinomycin D, and this was modelled by setting the 
input u2 = 1 (with u2 = 0 otherwise). The setting u2 = 1 induces an exponential decay of the 
auxiliary mRNA species (v1, v3, v5, v43 in Equations F.2) and inhibits Smad-induced SnoN 
synthesis (v45 in Equations F.2), thereby mimicking general inhibition of transcription in the 
model. Finally, experiments in SnoN-depleted hepatocytes were simulated by setting u4 = 1 
(with u4 = 0 otherwise), as this blocks both induced and basal SnoN expression (v44 and v45 in 
Equations F.2). The parameter k1 controls the effective degree of SnoN depletion, and was 
set to 1 in experiments with the Smad binding-deficient SnoN mutant (complete depletion), 
while the value was adjusted to 0.7 to simulate siRNA-mediated SnoN knock-down (partial 
depletion).   
 
 
6.5.5 Results of model calibration 
 
As shown in Figs. 6.5 – 6.8, the model could simultaneously be fitted convincingly to all data 
sets. The final best fit had a χ2 value of 355. Given N = 506 data points, the model 
hypothesis could not be rejected (p < 0.05). 
 
The amount of active TGFβ in the medium continuously decreases over the 10 h time course 
(Fig. 6.5A). This seems to be due to receptor-mediated ligand endocytosis and degradation, 
as the observed ligand decay can be quantitatively described by the model if experimentally 
measured kinetic parameters are assumed for the receptor trafficking module (Table F.1). 
Interestingly, the measured ligand decay time course is not affected by actinomycin D 
treatment (Fig. 6.5A), thus suggesting autocrine stimulation does not play a significant role in 
primary mouse hepatocytes, even though induction of TGFβ and of ligand processing 
enzymes was observed at the mRNA level (Fig. 6.2).    
 
Despite the strong decay in extracellular TGFβ levels, sustained Smad2 phosphorylation and 
Smad2-Smad4 complex formation occurred in primary mouse hepatocytes (Fig. 6.5B and C), 
and the model suggests that is due to strong saturation at the receptor level. Incubation of 
cells with actinomycin D induced some degradation of Smad2 (Fig. 6.5D). Yet, the level of 
phosphorylated Smad2 was not significantly affected by actinomycin D treatment (Fig. 6.5B), 
while the amount of Smad4 co-immunoprecipitated to Smad2 dropped to approximately half 
of the control (Fig. 6.5C). Thus, Smad2 phosphorylation and Smad2-Smad4 complex show 
distinct responses towards actinomycin D, while they behave very similarly under various 
other stimulation protocols (Fig. 6.6). This suggests that complex formation between Smad2 
and Smad4 (but not Smad2 phosphorylation) might be controlled by transcriptional feedback 
loops, as analysed in more detail below (Section 6.6).    
 
Immunoblot measurements of Smad signalling in nuclear and cytoplasmic compartments, 
respectively, revealed weak translocation of Smad proteins into the nucleus in TGFβ-
stimulated primary mouse hepatocytes (Fig. 6.6). In the model, the relatively small stimulus-
induced change in both, nuclear and cytoplasmic, Smad2 pools could only be explained if 
Smad2 was roughly equally distributed between both compartments in resting cells. In line, it 
has recently been reported in the literature that Smad2 is present at similar amounts in the 
cytoplasm and in the nucleus of unstimulated primary mouse hepatocytes [364] .   
 
The SnoN protein expression level was measured under various stimulation conditions (Fig. 
6.8). SnoN was induced with a delay of ~ 60 min in primary mouse hepatocytes (Fig. 6.8A), 
as reported previously for cell lines [343] . Actinomycin D incubation led to a rapid decline in 
SnoN protein levels (Fig. 6.8C). In the model this was mainly due to TGFβ-induced SnoN 
degradation mediated by phosphorylated Smad2 (see Section 6.4.4) which cannot be 
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Fig. 6.9 Experimental testing of model predictions for mutant SnoN form abrogating SnoN-Smad 
interactions.  
Primary hepatocytes from Smad binding deficient mSnoN knock-in animals or wild-type animals were stimulated with 1 ng/ml 
TGFβ for the indicated times. Relative concentrations of either SnoN or Smad4 co-immunoprecipitated with Smad2/3 (A and B) 
as well as phosphorylated and total Smad2 (C and D) in whole cell lysates were determined by quantitative immunoblotting 
(data points). Trajectories (dashed lines) represent model predictions for mSnoN (grey) or wt cells (black). Standard deviations 
of experimental data points were calculated from triplicates (see Section 6.5.2). 
 
 
explanation, i.e., very rapid degradation of constitutively expressed SnoN mRNA and thus 
swift termination of constitutive SnoN protein synthesis (without stimulus-enhanced 
degradation), seems unlikely in light of RNA experiments done by Peter Nickel under the 
same conditions (1 ng/ml TGFβ + actinomycin D). He found that the SnoN mRNA half-life in 
primary mouse hepatocytes is ~ 100 min, which is inconsistent with a half-maximal protein 
decay in actinomycin-treated cells within 50 min. SnoN measurements were also performed 
in cells where Smad signalling was terminated 50 min after TGFβ stimulation by addition of 
the TGFβ receptor inhibitor SB431542 (Fig. 6.8D). A very slow SnoN protein decay was 
observed after inhibitor treatment, most likely because Smad2-mediated SnoN degradation 
was blocked in addition to Smad2-mediated SnoN transcription.  
  
The core components of TGFβ signalling such as the TGFβ receptor, Smad2 and Smad4 are 
all characterised by relatively stable mRNAs and/or proteins (Tables F.1 – F.3). Thus, the 
alterations in Smad signalling done in the presence of actinomycin D are likely to reflect at 
least in part transcriptional feedback regulation, since actinomycin can be assumed to mainly 
inhibit Smad-induced de novo transcription. Actinomycin D had little impact on Smad2 
phosphorylation, but strongly affected the amount of Smad4 co-immunoprecipitated with 
Smad2. The observation that SnoN, a putative feedback regulator in hepatocytes, rapidly 
decayed in actinomycin-treated cells suggested that SnoN might be responsible for altered 
Smad heterotrimerisation. In Section 6.6, the impact of SnoN on Smad signalling was 
therefore investigated numerically and the model predictions were then confirmed 
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6.6 Testing the model predictions 
 
6.6.1 Prediction of Smad signalling dynamics in SnoN-depleted cells 
 
Experiments in the presence of the generic transcription inhibitor actinomycin D suggested 
that transcriptional feedback regulation might affect complex formation between Smad2 and 
Smad4 (Section 6.5.5). Experimental measurements of TGFβ–induced mRNA and protein 
expression indicated that SnoN is the major transcriptional feedback regulator for Smad 
signalling in primary mouse hepatocytes (Sections 6.2 and 6.3). Numerical simulations of a 
‘SnoN-/- model’ devoid of constitutive and induced SnoN expression were performed to 
investigate the role of SnoN in more detail. The simulated time courses, shown in Fig. 6.9 
(dashed lines), reveal that SnoN depletion selectively decreases complex formation between 
Smad2 and Smad4 (Fig. 6.9B), but does not affect Smad2 phosphorylation (Fig. 6.9C). Thus, 
the model predicted that: (i) altered Smad2-Smad4 heteromerisation in actinomycin-treated 
cells is indeed due to abrogation of transcriptional feedback regulation; (ii) SnoN efficiently 
modulates Smad signalling despite being present at sub-stoichiometric amounts when 
compared to Smad2 (Fig. 6.3). Interestingly, these model predictions were very robust, as 
very similar results were obtained for the top 100 fits of the global fit sequence (see Section 
6.5.3 and not shown). 
 
 
Fig. 6.10 Experimental testing of model predictions for siRNA-mediated SnoN knock-down.  
After transfection of SnoN siRNA or control siRNA primary hepatocytes were stimulated with 1 ng/ml TGFβ for the indicated 
times. Relative concentrations of either SnoN or Smad4 co-immunoprecipitated with Smad2/3 (A and B) as well as 
phosphorylated and total Smad2 (C and D) in whole cell lysates were determined by quantitative immunoblotting (data points). 
Trajectories (dashed lines) represent model predictions for SnoN siRNA (grey) or control siRNA (black). Standard deviations of 
experimental data points were calculated from triplicate measurements (see Section 6.5.2).  
 
 
To confirm the model predictions in Fig. 6.9, experiments were performed by Peter Nickel in 
a transgenic knock-in mouse model, kindly provided by Kunxin Luo (University of California, 
Berkeley). In these mice, both wild-type alleles for SnoN were replaced by the mutant form, 
mSnoN which was described to be deficient in binding to Smad2/3 and Smad4 [357] . 
Therefore, expression of mSnoN instead of the wild-type protein was expected to fully disrupt 
SnoN-mediated feedback regulation of TGFβ-Smad signalling. TGFβ time course 
experiments were performed using hepatocytes isolated from knock-in mice harbouring the 
mSnoN mutant and compared to the wild-type situation. As expected, no association of 
mSnoN with Smad2/3 could be detected (Fig. 6.9A), although full-length mSnoN was 
expressed at levels comparable to SnoN levels in wild-type cells (Peter Nickel, not shown). In 
line with the model predictions, total and phosphorylated Smad2 did not appreciably differ 
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between wild-type and mutant cells upon TGFβ stimulation (Figs. 6.9C and D). More 
importantly, levels of co-immunoprecipitated Smad4 were significantly lowered in mutant 




Fig. 6.11 Experimental testing of model predictions for SnoN-Smad interactions.  
Trajectories (dashed lines) represent model predictions for previously untested experimental conditions (data points). (A) 
Association of SnoN with Smad2/3 after stimulation with 1 ng/ml TGFβ in absence (black) and presence (grey) of actinomycin D. 
Association of SnoN with Smad2/3 after stimulation with (B) 1 ng/ml TGFβ or (C) 0.05 ng/ml TGFβ or (D) 1 ng/ml TGFβ and 
addition of TGFβ receptor inhibitor SB431542 at 50 min or (E) 1 ng/ml TGFβ and removal of ligand by exchanging medium after 
50 min. Relative concentrations of SnoN co-immunoprecipitated with Smad2/3 in whole cell lysates were determined by 
quantitative immunoblotting and are directly comparable between conditions (B-E) due to common scaling. In (A) spline-based 
error estimates and in (B-E) a spline-derived error model were used (see Section 6.5.2). 
 
 
An RNAi approach was employed by Peter Nickel to obtain an independent experimental 
confirmation of the model prediction that SnoN selectively modulates Smad2-Smad4 
complex formation. Primary hepatocytes were transfected with siRNA directed against SnoN 
mRNA prior to stimulation experiments in order to specifically knock-down SnoN expression. 
As a negative control, siRNA against Renilla luciferase was used. The experimental results 
again reveal a selective effect of SnoN depletion on Smad2-Smad4 heteromerisation (Fig. 
6.10), and thus further support the validity of the model predictions. It was then addressed 
whether the model was able to quantitatively predict the results in SnoN siRNA cells. The 
siRNA-mediated SnoN knock-down was simulated by decreasing basal and Smad-induced 
SnoN transcription to the same extent. The efficiency of knock-down was estimated by fitting 
the (basal and induced) SnoN transcription rates such that the model optimally matched the 
measurements shown in Fig. 6.10. The fitting results (dashed lines in Fig. 6.10) are in 
quantitative agreement with the measured data points. Moreover, the residual SnoN 
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expression level in the fitted model (~30% relative to wild-type control) was close to the 
experimentally measured value (~35% relative to wild-type control). 
 
Taken together, the model was able to quantitatively predict the dynamics of Smad signalling 
in SnoN knock-down and knock-in cells. Interestingly, the selective decrease in Smad2-
Smad4 complex formation (but not Smad2 phosphorylation) observed in SnoN-depleted cells 
(Fig. 6.10) is in quantitative agreement with the dynamical behaviour seen in actinomycin-
treated wildtype cells (Fig. 6.5). In other words, complete SnoN depletion pheno-copies 
generic inhibition of all transcriptional feedback loops, thus strongly suggesting that SnoN is 
the central transcriptional feedback regulator in primary mouse hepatocytes. 
 
 
Fig. 6.12 Model simulations of different nuclear Smad populations.  
(A) Relative levels of nuclear pSmad2 monomers (dotted line) and nuclear Smad trimers (solid line) as predicted by the best-fit 
model. The maximum level of pSmad2 monomers was set to 100%. (B) The effect of decreased SnoN expression in cells 
harbouring siRNA against SnoN on formation of nuclear Smad complexes. Levels of active nuclear Smad trimers (solid lines) 
and repressing SnoN-bound nuclear Smad trimers (dashed lines) are shown for the unperturbed state (black) and for simulated 
SnoN knock-down (grey). The parameters used for the knock-down simulations are the same as those in Fig. 6.10. The 
maximum concentration of active nuclear Smad trimers (i.e., the sum of free homo- and heterotrimers) in the unperturbed state 
was set to 100%. 
 
 
6.6.2 Analysis of SnoN-mediated regulation of gene expression  
 
The model successfully predicted Smad signalling in cells harbouring reduced levels of SnoN 
protein (Section 6.6.1), but it remained to be clarified whether SnoN-mediated feedback 
operates via complex formation between Smad2 and SnoN, as suggested by the model. 
Complex formation between SnoN and Smad2 in wild-type cells was simulated for various 
stimulation conditions, and the amount of SnoN co-immunoprecipitated with Smad was 
measured by Peter Nickel to test for the model predictions. The simulated time courses were 
again in quantitative agreement with the experimental measurements (Fig. 6.11), thus 





Fig. 6.13 Differential expression of TGFβ-induced target genes after perturbation of SnoN feedback.  
Fold changes in JunB, CTGF, PAI-1, and RhoB mRNA levels after stimulation with 1 ng/ml TGFβ for 8 h or 24 h are expressed 
as fold-changes relative to the unstimulated state. For the siRNA-mediated SnoN knock-down in wild-type cells (left panel), 
values for SnoN siRNA (black bars) and control siRNA (white bars) are shown. For the mutant/wild-type comparison (right 
panel), mRNA levels in cells from knock-in mice harbouring the Smad binding deficient mSnoN mutant (black bars) and wild-




It remained to be determined by which mechanism the heteromerisation of Smad proteins 
could be efficiently modulated by SnoN, even though SnoN is expressed at much lower 
levels than the Smad proteins (Fig. 6.3). To this end, the best-fit model was analysed 
numerically. According to the simulations, the concentration of nuclear Smad homo- and 
heterotrimers is approximately 10-fold lower than that of nuclear Smad2 monomers (Fig. 
6.12A). As nuclear Smad trimers are specifically targeted by SnoN-mediated feedback 
inhibition (Section 6.4.4), the effective Smad/SnoN ratio shifts in favour of SnoN by 
approximately 10-fold. The interacting populations of nuclear SnoN and nuclear Smad 
trimers are thus present at similar levels of some thousand molecules per cell. This explains 
why low amounts absolute amounts of SnoN can have a substantial impact on Smad 
complex formation. The results shown in Fig. 6.12A imply that Smad trimerisation is 
inefficient for the Smad2 and Smad4 concentrations prevailing in hepatocytes. Some support 
for this hypothesis comes from co-immunoprecipitation studies of endogenous Smad2 and 
Smad3 proteins in various cell lines. More specifically, it was shown that immunoprecipitates 
of endogenous Smad3 protein contain negligible amounts of Smad2 when compared to 
Smad3 [365] . Given that Smad2 and Smad3 are structurally and functionally very similar, 
one would expect efficient Smad2-Smad3 complex formation (i.e., co-immunoprecipitation) if 





Fig. 6.14 Model predictions for perturbed SnoN feedback regulation.  
(A – C) The total cellular SnoN expression level in response to stimulation with 1 ng/ml TGFβ is simulated for the best-fit model 
(‘wildtype cells’), for a model with 10-fold increased basal SnoN expression, and for a mutant model devoid of Smad-induced 
SnoN degradation (i.e., SnoN in Smad complexes is degraded with the same rate constant as free SnoN). The experimentally 
measured data points shown in (A) are the same as those in Fig. 6.8A. (D – F) The amount of Smad4 co-immunoprecipitated 
with Smad2 is plotted for the three model variants mentioned above. The experimentally measured data points shown in (D) are 
the same as those in Fig. 6.5C. (G – I) The levels of active nuclear Smad trimers (solid lines; sum of homo- and heterotrimers) 
and repressing SnoN-bound nuclear Smad trimers (dashed lines) are shown for the three model variants mentioned above. The 
ratio of active nuclear Smad trimers and repressing SnoN-bound nuclear Smad trimers is likely to reflect Smad-induced gene 
expression, as both species are expected to compete for the same promoter sites (see Section 6.6.2). Note that the plots in 
each row have the same y-axis scaling, and are thus directly comparable.  
 
 
Complex formation between Smad trimers and SnoN is thought to be necessary and 
sufficient for SnoN-mediated inhibition of gene expression, as SnoN binding interferes with 
the recruitment of histone acetylases to Smad trimers [366] . The dynamic interactions 
between nuclear Smad trimers and nuclear SnoN were therefore investigated by numerical 
simulations (Fig. 6.12B). To get insights into SnoN-mediated regulation of gene expression, 
the analysis was focused on the ratio of active free Smad trimers to repressing SnoN-bound 
Smad trimers. Both species are expected to compete for the same promoter sites, as SnoN 
family proteins do not interfere with DNA binding of Smad trimers [367,368] . Thus, the 
transcription of Smad target genes will be efficiently blocked in case that the ratio of free to 
SnoN-bound Smad trimers is low. The simulations, shown in Fig. 6.12B, suggest that SnoN-
bound trimers dominate over free Smad trimers in wild-type cells, while the opposite is true in 
hepatocytes transfected with siRNA directed against SnoN mRNA. Thus, the model predicts 
that Smad-induced gene expression is significantly enhanced in SnoN siRNA cells, and, in 




It was therefore determined experimentally by Peter Nickel whether depletion of SnoN has a 
significant effect on TGFβ-induced gene expression. To this end, the two perturbation 
conditions of siRNA-mediated SnoN knock-down and the Smad binding deficient mSnoN 
mutant were again employed. Hepatocytes were stimulated with 1 ng/ml TGFβ for 8 h and 24 
h, and the induction of known TGFβ target genes (JunB, CTGF, PAI-1 and RhoB) at the 
mRNA level was measured by RT-PCR. Fold changes in mRNA levels over the unstimulated 
state are shown in Fig. 6.13. Firstly, siRNA-mediated knock-down of SnoN was performed in 
wild-type primary hepatocytes and a knock-down using siRNA against Renilla luciferase was 
used as a negative control (Fig. 6.13, left panel). Secondly, hepatocytes isolated from knock-
in animals harbouring the Smad binding deficient mSnoN mutant were compared to 
hepatocytes from wild-type mice (Fig. 6.13, right panel). Compared to unperturbed control 
stimulations (Fig. 6.13, white bars) all four genes showed a clear tendency for enhanced 
upregulation if inhibition of Smad signalling by SnoN was partially or fully disrupted (Fig. 
6.13, black bars). This SnoN-dependent effect on mRNA induction tended to be more 
pronounced after 24 h than after 8 h of TGFβ treatment. In conclusion, the quantitative 
mRNA measurements in Fig. 6.13 clearly demonstrate that SnoN is involved in the regulation 
of TGFβ-induced genes at the transcriptional level in primary hepatocytes. This strongly 
supports the model prediction that SnoN regulates the physiological TGFβ-Smad signalling 
responses in primary hepatocytes despite being present at sub-stoichiometric 
concentrations. It should, however, be noticed that SnoN depletion did not affect the 
expression of all TGFβ target genes analysed (not shown), suggesting that SnoN acts to 
regulation Smad-induced transcription in a promoter-specific manner. 
 
 
6.7 Conclusions and outlook 
 
In the present chapter, a systems biological approach was applied to get insights into 
transcriptional feedback regulation of TGFβ signalling. Putative transcriptional feedback 
loops were identified by genome-wide expression profiling (Fig. 6.2). Analysis of TGFβ-
induced expression changes at the protein level (Fig. 6.3) allowed to further narrow the 
number of transcriptional feedback loops, and indicated that SnoN is the major transcriptional 
feedback regulator in primary mouse hepatocytes. Autocrine TGFβ stimulation of primary 
mouse hepatocytes could be discarded as a feedback mechanism, as the amount of 
extracellular TGFβ decayed monotonically (Fig. 6.5A), most likely due to receptor-mediated 
ligand degradation. Moreover, the strong induction of Smad7 at the mRNA level was 
surprisingly not accompanied by increased Smad7 protein expression (Fig. 6.3), possibly due 
to regulation at the post-transcriptional level, e.g., by microRNA. For several cell lines, 
Smad7 has been discussed as a crucial transcriptional feedback regulator leading to the 
termination of TGFβ-Smad signal transduction by blocking TβRI-mediated R-Smad 
phosphorylation as well as by triggering receptor dephosphorylation and degradation [47] . In 
primary mouse hepatocytes, Smad7 can indeed inhibit Smad signalling, as strong adenoviral 
overexpression of Smad7 by Peter Nickel almost totally abolished TGFβ-dependent 
activation of Smad2/3 (not shown). On the other hand, transgenic hepatocytes expressing a 
functionally impaired form of Smad7 [369]  did not display a significant increase in Smad2/3 
activation (Peter Nickel, not shown). This indicates that Smad7 might not even act as a 
transcriptionally unregulated negative modulator of TGFβ-Smad signalling in primary mouse 
hepatocytes, despite being constitutively expressed at high levels (Fig. 6.3). Accordingly, it 
has recently been reported that physiological levels of Smad7 are insufficient to inhibit 
Smad2/3 signalling in endothelial cells [370] .  
 
A mathematical model of TGFβ-Smad signalling (Fig. 6.4) was implemented in order to get 
further insights into SnoN-mediated transcriptional feedback regulation. Smad3 was not 
explicitly considered in the modelling approach for several reasons. First, the absolute 
concentration of Smad3 is substantially lower than that of Smad2 (Fig. 6.3). Second, the 
general dynamics of Smad3 phosphorylation closely resembled those of Smad2 in primary 
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hepatocytes (Peter Nickel, not shown). Finally, Smad2 and Smad3 are known to be highly 
homologous in their sequence and structure, and are thought to be largely equivalent in their 
binding affinities for TGFβ receptors, Smad4 and SnoN [366,371] . It should, however, be 
noted that Smad2 and Smad3 are not redundant and have been described to be differentially 
involved in the regulation of various physiological processes [372] , despite being highly 
similar. For example, hepatocyte-specific Smad2/3 knock-out models suggest a central role 
of Smad2 in suppressing hepatocyte growth in the basal state, while Smad3 seems to be the 
primary mediator of TGFβ-dependent apoptosis [373] . Thus, future model versions taking 
into account phenotypic responses induced by TGFβ stimulation must distinguish between 
Smad2 and Smad3. 
 
The kinetic model of TGFβ-Smad signalling was fitted to quantitative measurements of total 
SnoN, total Smad2, Smad2 phosphorylation, of the amount of Smad4 co-immunoprecipitated 
with Smad2/3 and of TGFβ in the medium (Figs. 6.5 – 6.9). Based on published experimental 
measurements, a physiological relevant range was defined for each parameter (Tables F.1 – 
F.3), and a single set of parameters was able to simultaneously describe all time courses. 
Fitting analyses during the construction of the final model revealed that (at least some of) the 
relatively stringent parameter ranges in Tables F.1 – F.3 were required to obtain a 
physiologically relevant and predictive optimisation result. For example, the selective 
decrease in Smad4 co-immunoprecipitated with Smad2 in actinomycin-treated cells despite 
unchanged Smad2 phosphorylation (Fig. 6.5) could also be explained by an alternative 
model devoid of SnoN feedback if Smad4 is assumed to be very unstable (with a half-life in 
the order of minutes). Then, actinomycin D reduces Smad2-Smad4 complex formation by 
inducing a rapid Smad4 decay. Published experimental studies, however, revealed that 
Smad4 mRNA and protein are relatively stable (Table F.2). Moreover, the experiments in 
SnoN-depleted cells (Figs. 6.9 and 6.10) strongly favour SnoN-mediated stabilisation of the 
Smad2-Smad4 complex, and argue against a mechanism with Smad4 decay. In conclusion, 
the fitting analyses indicate that parameter estimation in systems biology requires a definition 
of physiologically relevant parameter ranges, and cannot solely be based on unconstrained 
optimisation of the χ2-value.  
 
Many of the experimental data sets used for model calibration were actually required to 
obtain a physiologically relevant and predictive optimisation result. For example, total 
Smad2, was analysed in cytoplasmic and nuclear compartments, in addition to 
measurements in whole-cell lysates. It turned out that two of three data sets (whole-cell, 
nuclear, cytoplasmic) were required for a reasonable fitting result, as: (i) whole-cell data 
reveals whether the intracellular Smad2 pool is subject to stimulus-induced synthesis or 
degradation; (ii) nuclear and/or cytoplasmic data provides insights nucleo-cytoplasmic 
shuttling of Smad proteins. Accordingly, early fitting attempts using cytoplasmic data only 
failed to predict nuclear and whole-cell data (both in a quantitative and qualitative sense). 
Thus, a critical number of experiments are necessary to generate predictive data-based 
models for systems biology. In my opinion, the particular choice of experiments depends on 





Fig. 6.15 Model analysis of TGFβ signalling in HaCaT cells.  
Top: SnoN-mediated feedback regulation was eliminated from the original model (Fig. 6.4) in order to describe TGFβ signalling 
in HaCaT cells, which do not show significant transcriptional feedback regulation. The expression levels of the TGFβ receptor, of 
Smad2 and Smad4, and several kinetic parameters were altered relative to the hepatocyte model to match experimental 
measurements in HaCaT cells (see panels A-I). More specifically, the reaction parameters for protein synthesis (receptor, 
Smad2 and Smad4), for endosomal sorting of receptor-ligand complexes, for lysosomal degradation, and for Smad trimer 
degradation (referred to as parameter set 1 below) were fitted to HaCaT data, as indicated by the black symbols in the model 
scheme. (A – B) Time courses of Smad2 phosphorylation in whole-cell lysates (A) and nuclear extracts (B). Data points in (A) 
are taken from [342]  and those in (B) from [311,374] . The solid line represents the model trajectory. (C – F) Time courses of 
cytoplasmic and nuclear Smad2 and Smad4 pools (data points taken from [338] ). Note that the same y-axis scaling was used 
in panels (C) and (D), and for panels (E) and (F). Two model fits are shown in each panel: The grey line represents a model, 
where only parameter set 1 (see above) was fitted to HaCaT data, while the nuclear import and export reactions of Smad2 and 
Smad 4 were additionally optimised for the black line (note that all other fits in panels A – B and G – I look very similar for both 
fits). Numerical simulations of a mutant model devoid of any Smad trimerisation (dotted lines) are also shown in panels (C) and 
(D). (G – H) Time courses of Smad2 phosphorylation in whole-cell lysates in cells treated with the proteasome inhibitor MG132 
(grey line and data points) are compared to control cells (black line and data points). Cells were either continuously incubated 
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with TGFβ (G), or the ligand was washed out by medium exchange after 30 min (H). Data was taken from [345] . (I) Time 
courses of Smad2 phosphorylation in whole-cell lysates in cells treated with the TGFβ receptor inhibitor SB431542 (black solid 
line and circles), treated with the TGFβ receptor inhibitor SB431542 together with a protaesome inhibitor (black dotted line and 
triangles), or treated with the TGFβ receptor inhibitor SB431542 after a shRNA-mediated knock-down of the nuclear Smad2 
phosphatase PPM1A (grey solid line and circles). Data was taken from [342] . Error bars were generally calculated using an 
error model with typical relative and absolute error values (Erel = 10% and Eabs = 10%; see Section 6.5.2). Errors bars are not 
shown in panel (I) for clarity.  
 
 
experimental design algorithms (even though these algorithms might in some cases be 
helpful for model discrimination).   
 
Mathematical modelling strongly suggested that transcriptional feedback via SnoN modulates 
Smad signalling at the level of Smad trimerisation, and thus downstream of Smad 
phosphorylation. In line with the model prediction, SnoN-depleted cells showed reduced 
Smad2-Smad4 complex formation when compared to wildtype cells, while Smad 
phosphorylation was unchanged (Figs. 6.9 and 6.10). Remarkably, the effect of SnoN 
depletion (Fig. 6.9) on Smad phosphorylation and trimerisation was qualitatively and 
quantitatively similar to the effect of actinomycin D treatment (Fig. 6.5), thus suggesting that 
SnoN is the major transcriptional feedback regulator in primary mouse hepatocytes. The 
functional relevance of SnoN-mediated feedback was further corroborated by the finding that 
depletion of SnoN enhances Smad-induced gene expression (Fig. 6.13).   
 
A variety of tumors constitutively release large amounts of TGFβ and thereby suppress 
immune responses or induce angiogenesis, while being themselves insensitive towards the 
growth-inhibitory effects of autocrine TGFβ stimulation [46] . The SnoN oncogene is 
commonly overexpressed in tumors, and might contribute to such TGFβ insensitivity by 
inhibiting the anti-proliferative Smad signalling pathway [366] . Constitutive SnoN 
overexpression was simulated in the best-fit model by increasing the basal SnoN synthesis 
rate by 10-fold, while leaving the kinetic parameters of Smad-induced SnoN expression 
unchanged. The model predicts that constitutive SnoN overexpression has little effect on the 
amount of SnoN-repressed Smad trimers in response to stimulation (Fig. 6.14B, E and H), 
and thus on TGFβ-induced gene expression. Previous literature studies indicated that SnoN 
overexpression can be insufficient to fully suppress TGFβ signalling [343] , and thus support 
the simulation results.  
 
SnoN is subject to incoherent feed-forward regulation in response to TGFβ stimulation, as 
both the synthesis and the degradation rates of SnoN are strongly enhanced by Smad 
signalling (each by more than one order of magnitude in the best-fit model). This raises the 
possibility that the cellular sensitivity towards TGFβ is mainly governed by the Smad-induced 
synthesis and degradation rates of SnoN, while the basal synthesis and degradation rates 
play no major role. Therefore, numerical simulations were performed for hypothetical primary 
mouse hepatocytes devoid of Smad-induced SnoN degradation. More specifically, SnoN in 
Smad complexes was assumed to be degraded with the same rate constant as free SnoN. 
The results, shown in Fig. 6.14C, F and I, reveal that Smad-induced SnoN degradation has 
indeed a large impact on the amount of SnoN-bound repressive Smad trimers (Fig. 6.14I), 
and thus on Smad-induced gene expression. These simulation results are corroborated by 
experimental studies showing that overexpression of non-degradable SnoN inhibits TGFβ 
signalling much more efficiently than overexpression of wildtype SnoN [343] .  
Taken together, the simulation results in Fig. 6.14 indicate that the Smad-induced (but not 
the basal) synthesis and degradation rates of SnoN determine the cellular TGFβ sensitivity. 
Accordingly, it has recently been proposed that a loss of TGFβ-induced SnoN degradation 
enables various tumours to escape TGFβ-induced growth inhibition [375,376] . The 
predictions in Fig. 6.14 can be tested for by overexpressing SnoN in primary mouse 
hepatocytes (panels B, E and H) and by treating cells with proteasome inhibitors (panels C, F 
and I). It has previously been shown that TGFβ-induced SnoN degradation can be blocked 
by proteasome inhibitors such as MG132 and Lactacystin [358,359,362] . Given the relatively 
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slow turnover of Smad proteins and the strong receptor saturation in primary mouse 
hepatocytes (see above), proteasomal inhibition is expected to mainly affect SnoN 
degradation, and not other parts of the Smad signalling cycle. Experiments employing a 
combination of proteasomal inhibitors and actinomycin D (to simultaneously block SnoN 
induction and degradation) might be used to further test for the model predictions.          
 
It was surprising to see that sub-stoichiometric amounts of SnoN efficiently regulate the 
much larger pools of Smad2 and Smad4 (Figs. 6.3, 6.9 and 6.10). The mathematical model 
presented in this chapter indicates that this due to relatively inefficient trimerisation of Smad 
proteins. The simulations predict that the concentration of nuclear Smad homo- and 
heterotrimers is approximately 10-fold lower than that of nuclear Smad2 monomers (Fig. 
6.12A). As SnoN-mediated feedback specifically targets nuclear Smad trimers (Section 
6.4.4), the effective Smad/SnoN ratio shifts in favour of SnoN, so that the interacting 
populations of nuclear SnoN and nuclear Smad trimers are present at similar levels. The 
nuclear translocation of Smad4 in response to TGFβ stimulation depends on its ability to 
heteromerise with Smad2/3 proteins [377]  (Fig. 6.4). Given the weak trimer affinity in the 
model, it was not surprising to see that only low amounts of Smad4 translocate into the 
nucleus in the best-fit hepatocyte model (not shown). While weak Smad4 translocation in 
primary mouse hepatocytes remains to be confirmed experimentally, it is well established 
that significant amounts of Smad4 translocate into the nucleus in other cellular systems such 
as HaCaT cells [338] . Numerical simulations were therefore performed to investigate 
whether low Smad trimerisation efficiency is, in principle, consistent with pronounced 
stimulus-induced Smad4 translocation. More specifically, it was analysed whether a model 
with weak trimerisation affinity is able to describe quantitative time course measurements in 
HaCaT cells from the literature (Figs. 6.15A – I). 
 
The HaCaT cell model, schematically depicted in Fig. 6.15, contains most of the reaction 
steps of the hepatocyte model, and the majority of kinetic parameters were assumed to be 
equal in both models as well. The differences between the HaCaT and the hepatocyte 
models are summarised in the following: (i) SnoN-mediated feedback was eliminated from 
the HaCaT model, as pre-treatment of HaCaT cells with the translation inhibitor 
cycloheximide does not dramatically affect the dynamics of TGFβ-induced Smad signalling 
[49,374] . (ii) The expression levels of Smad2 and Smad4 were altered such that they equal 
values experimentally measured in HaCaT cells [378] , and the TGFβ receptor expression 
level was fitted to match time course data from HaCaT cells (Figs. 6.15A – I). (iii) The 
cytoplasmic and nuclear volumes were set to values relevant for HaCaT cells [339] . (iv) The 
constitutive and ligand-induced receptor degradation rates were fitted to match time course 
data from HaCaT cells (Figs. 6.15A – I). (v) Smad2 degradation was shown to be enhanced 
upon TGFβ stimulation in HaCaT cells [345] , most likely due to recruitment of ubiquitin 
ligases to Smad trimers. The degradation rates of cytoplasmic and nuclear Smad trimers 
were therefore assumed to be larger than those of the corresponding monomeric Smad 
species, and fitted to match time course data from HaCaT cells (Figs. 6.15A – I). Taken 
together, the kinetics of the core Smad signalling cycle were kept unchanged in the HaCaT 
cell model, and only some protein synthesis and degradation rates were assumed to be 





Fig. 6.16 Memory effect in TGFβ signalling.  
(A) The time course Smad2 phosphorylation in the cytoplasm in response to TGFβ stimulation for 3 minutes (followed by a 
ligand washout by medium exchange) was simulated using the best-fit hepatocyte model (solid line; see Tables F.1 – F.3 for 
kinetic parameters). The model predicts that the cytoplasmic pSmad2 continues to rise even after the ligand has been washed 
out (see inset), and this prediction could be verified by experimental analyses of primary mouse hepatocytes (data points; 
measured by Peter Nickel). (B) Same as (A), but a 10 min ligand pulse was simulated and measured, respectively.     
 
 
The multi-experiment fitting results (solid lines in Fig. 6.15) indicate that the modified model 
is able to describe the Smad signalling dynamics in HaCaT cells reasonably well. The model 
quantitatively matches the experimentally measured Smad2 phosphorylation time courses in 
whole-cell lysates and in nuclear fractions, respectively (Fig. 6.15A). Moreover, 
measurements of Smad2 and Smad4 in the nucleus and in the cytoplasm are qualitatively 
reproduced by the model (grey solid lines in Figs. 6.15C – F). In particular, a pronounced 
translocation of Smad4 into the nucleus is observed, despite weak Smad trimerisation 
efficiency in the model. However, a quantitative match between model and experiment was 
not possible, mainly because the nucleo-cytoplasmic distribution of Smad proteins in 
unstimulated HaCaT cells differs from that in primary mouse hepatocytes [339,364] . This 
could be corrected by fitting the nuclear import and export rates of Smad2 and Smad4 in 
addition to the parameter changes (i – v) listed above (black solid lines in Figs. 6.15C – F). 
Note that all other trajectories in panels A – B and G – I look very similar for both fitting 
results, with and without import/export optimisation, so that the model with import/export 
optimisation will be discussed in the following. It has been shown experimentally that a 
trimerisation-deficient Smad2 mutant does not translocate into the nucleus in TGFβ-treated 
HaCaT cells [339] . Numerical simulations of a mutant HaCaT model devoid of any Smad 
trimerisation indeed revealed that Smad2 translocation is abolished (dotted lines in Figs. 
6.15C and D), thus further supporting that the shuttling dynamics are correctly described. In 
conclusion, it seems that inefficient trimerisation is not per se is not inconsistent with 
pronounced Smad4 translocation. HaCaT cells express 5–10 fold higher levels of Smad2 
and Smad4 when compared to hepatocytes [378]  (Fig. 6.3). This, together with more 
efficient Smad2 phosphorylation (due to increased TGFβ receptor expression in the HaCaT 
model), shifts the Smad equilibrium towards trimerisation and thus allows for pronounced 
Smad4 translocation into the nucleus in the HaCaT cell model. However, measurements of 
Smad protein complexes under non-denaturising conditions, e.g., fractionation according to 
the molecular weight by ultracentrifugation or gel filtration, are required to directly prove that 




The ligand washout measurements in Figs. 6.6J – L reveal that primary mouse hepatocytes 
maintain elevated Smad signalling for a couple of hours after TGFβ has been removed from 
the culture medium. Such memory effects might be common to many cellular systems, as 
slow Smad dephosphorylation was also observed in HaCaT cells subjected to medium 
exchange (Fig. 6.15 H; black line) [341,345] , and in Xenopus occytes [326] . Experiments in 
primary mouse hepatocytes and in HaCaT cells reveal that the memory effect arises at the 
receptor level, and not within the core Smad activation cycle: Smad2 phosphorylation 
declined rapidly if receptor activation was terminated using a small-molecule inhibitor of the 
TGFβ receptor (Figs. 6.6G – I and Figs. 6.15H and I). Interestingly, the memory effect in 
HaCaT cells is enhanced in the presence of the proteasome inhibitor MG132 (Fig. 6.15 H; 
grey line). The dotted line and the triangles in Fig. 6.15I demonstrate that MG132 does not 
affect the dephosphorlyation kinetics of the Smad cycle in response to TGFβ receptor 
inhibition, thus excluding that proteasome inhibitors enhance the memory effect by affecting 
signalling downstream of the TGFβ receptor. This strongly suggests that MG132 prolongs 
the Smad activation memory by acting at the level of receptors, most likely by blocking 
proteasome-mediated targeting of TGFβ receptors to the lysosomal degradation pathway 
[326,379] . Taken together, these data support the hepatocyte and the HaCaT models where 
the memory effect arises from slow degradation of the non-recyclable pool of receptor-ligand 
receptors in late-endosomes (TRle). Accordingly, it has recently been reported for Xenopus 
oocytes that the basis for memory is the long-lasting residence of active receptor-ligand 
complexes in the endo-lysosomal pathway [326] . To further investigate the memory effect, 
pulse stimulation experiments were simulated numerically using the hepatocyte model (Fig. 
6.16). For a TGFβ washout 3 min after stimulation, the model predicted that cytoplasmic 
Smad2 phosphorylation continues to increase by approximately 3-fold after ligand removal 
(solid line in Fig. 6.16A). Preliminary pulse experiments done by Peter Nickel indeed 
confirmed that such an overshoot in cytoplasmic Smad2 phosphorylation occurs after the 
ligand had been washed out, thus confirming the model prediction (data points in Fig. 6.16A). 
By contrast, the model predicted that no pronounced overshoot should be observed for a 10 
min pulse, but that the peak activation level observed at 10 min should be roughly 
maintained for 1 h (solid line in Fig. 6.16B). Again, this prediction was in reasonable 
agreement with preliminary measurements done by Peter Nickel (data points in Fig. 6.16B). 
In conclusion, the data presented in Fig. 6.16 strongly suggests that the memory effect arises 
from a non-recyclable endosomal compartment on the way to lysosomal degradation. 
Moreover, it seems that a mathematical model using physiologically relevant kinetic 
parameters for receptor trafficking (Table F.1) is able to quantitatively describe memory 
formation and receptor-ligand degradation within the endosome. However, more experiments 
are required to further prove the proposed mechanism: First, the simple medium exchange 
procedure for ligand washout should be replaced by a more stringent acid wash procedure, 
which completely removes all ligand possibly remaining bound to cell surfaces or to the 
culture dish. Second, it should be tested whether the memory can be prolonged by inhibiting 
receptor trafficking, e.g., by a temperature-shift to 15°C or by treating cells with inhibitors of 
lysosomal degradation.    
 
The mathematical model presented in this chapter was useful to investigate whether a large 
number of quantitative experimental measurements (Figs. 6.5 – 6.8) can be simultaneously 
described by a single mechanistic model using a set of physiologically relevant kinetic 
parameters (Tables F.1 – F.3), and thus serves as a consistency check for the present 
biochemical knowledge. Moreover, the model was used to generate experimentally testable 
predictions regarding SnoN feedback (Figs. 6.9 – 6.11, 6.14), Smad trimerisation affinity (Fig. 
6.12A), Smad-induced gene expression (Fig. 6.12B) and regarding memory effects upon 
ligand removal (Fig. 6.16). The model also provided mechanistic insights into Smad complex 
formation within the nucleus that cannot easily be analysed experimentally (Fig. 6.12), and 
thus might help to minimise the number of expensive and time-consuming measurements.  
 
A future aim is to extend the present model to Hepa-16 liver cancer cells that are closely 
related to primary mouse hepatocytes. These cells exhibit transient Smad2 phosphorylation 
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and nuclear translocation (for ~ 180 min), and signalling can be switched from transient to 
sustained upon incubation with the general transcription inhibitor actinomycin D (Peter 
Nickel, not shown). This indicates that transcriptional feedback inhibiting signalling at the 
level of receptor operates in Hepa-16 to terminate Smad2 phosphorylation early after 
stimulation. Interestingly, it has been reported that the anti-proliferative action of TGFβ 
requires sustained Smad signalling [49] , so that model analyses of Hepa-16 cells might 
provide insights into how cancer cells escape growth control by TGFβ. 
 
The results presented in Sections 5 and 6 reveal how transcriptional feedbacks shape the 
dynamics of signal transduction. Intracellular signals typically elicit phenotypic responses by 
regulating the expression of downstream target genes that are, for example, involved in cell 
cycle regulation. Sections 7 and 8 are focussed on the dynamics of gene expression, and 
thus might provide insights into how intracellular signals are decoded at the genomic level.   
In many cases, specific target gene expression patterns and thus specific phenotypic 
responses are induced depending on the quantitative aspects of upstream signalling 
pathway activation [380] . For instance, it is known that the duration of Erk or Smad signalling 
can determine whether a cell divides or not [49,381] . In Section 7, it is analysed how the 
dynamics of gene expression are affected by small non-coding RNAs which regulate gene 
expression at the post-transcriptional level. The results reveal that small RNAs filter out short 
transcription pulses, and might thus help to explain how cells discriminate transient vs. 
sustained signalling.     
 Many of the downstream target genes induced by signalling pathways are transcription 
factors, thus giving rise to a complex transcriptional regulatory network [67] . In Section 8, a 
reverse engineering approach is applied to get insights into a transcription factor network that 
is regulated by oncogenic Ras and involved in the regulation of cell division. The results 
represent a first step towards an integrated model including both, upstream signal 

















   
 

























































7 Small RNAs Establish Delays and Temporal Thresholds 
in Gene Expression 
 
This chapter is the result of a collaboration with Dennis Dienst, Annegret Wilde and Ilka 
Axmann from the Institute for Biochemistry of the Humboldt University Berlin. All experiments 
were performed by Dennis Dienst and Ilka Axmann in the lab of Annegret Wilde. The 





Non-coding RNAs are crucial regulators of gene expression in prokaryotes and eukaryotes, 
but it remains poorly understood how they affect the dynamics of transcriptional networks. In 
this Section, the temporal characteristics of the cyanobacterial iron stress response are 
analysed by mathematical modelling and quantitative experimental analyses. A recently 
discovered small non-coding RNA, IsrR, is shown to be responsible for a pronounced delay 
in the accumulation of isiA mRNA encoding the late-phase stress protein, IsiA. Moreover, it is 
demonstrated that IsrR ensures a rapid decline in isiA levels once external stress triggers are 
removed. These kinetic properties allow the system to selectively respond to sustained (as 
opposed to transient) stimuli, and thus establish a temporal threshold, which prevents 
energetically costly IsiA accumulation under short-term stress conditions. Biological 
information is frequently encoded in the quantitative aspects of intracellular signals (e.g., 
amplitude and duration). The simulations presented in this Section reveal that competitive 
inhibition and regulated degradation allow intracellular regulatory networks to efficiently 





Non-protein-coding RNA regulators such as microRNAs (miRNA) and short interfering RNAs 
(siRNA) control diverse processes in metazoans including development, cell differentiation, 
and cell proliferation [63,64] . Recent research revealed that small non-coding RNAs 
(sRNAs) also play important roles in bacteria [65,66] , where they are mainly involved in the 
modulation of stress responses. Approximately 80 sRNAs have been identified in E. coli, 
many of which are evolutionary conserved [382] . sRNAs are typically less than 200 
nucleotides in size and are either encoded in cis or in trans. Cis-encoded sRNAs are 
transcribed from the antisense strand of their target mRNAs, and are thus perfectly 
complementary, while trans-encoded sRNAs have only limited complementarity [66] . Most 
sRNAs inhibit gene expression employing a non-catalytic mechanism of action: Base-pairing 
with target mRNAs either interferes with ribosome binding and thus with target mRNA 
translation, or even induces degradation of the whole sRNA-target complex [66,383] . 
 
Previous mathematical modelling indicated that sRNA-mediated regulation may allow for 
faster control over gene expression than transcriptional and post-translational regulation 
[384] . Moreover, it was shown theoretically and experimentally that small non-coding RNAs 
efficiently suppress steady state target mRNA accumulation if the mRNA transcription rate is 
low, while they have little impact at higher mRNA transcription rates [385,386] . Levine et al 
(2007) argue that this phenomenon, termed a “threshold-linear response”, efficiently prevents 




Figure 7.1: Theoretical analysis of gene expression regulation by small RNAs.  
(A) Schematic representation of the mathematical model. The target mRNA associates with a small non-coding RNA (‘sRNA’) to 
form a heteroduplex (‘pair’). Molecular species and events relevant for the cyanobacterial stress response (ROS = reactive 
oxygen species; iron depletion; isiA and IsrR) and kinetic parameters are indicated in grey. (B) Steady state (top) and dynamical 
(bottom) response to varying stimulus strength. The top graph indicates the steady state levels of (free) sRNA (dashed-dotted 
line) and target mRNA (solid line), and reveals a mutually exclusive expression pattern characterised by a sharp threshold. For 
comparison, the gradual target mRNA dose-response curve in the absence of sRNA expression is also shown (dotted line). The 
bottom graph shows the response time of total target expression (i.e., sum of target and pair) as a function of the stimulus level. 
The solid line (‘upregulation’) depicts the response time t50 required to reach 50% of the difference between old and new steady 
state upon a step-like increase in the stimulus level from no stimulation to the level indicated on the x-axis. Similarly, t50 was also 
calculated for a step-like drop in the stimulus level from the value on the x-axis to no stimulation (‘downregulation’). The dotted 




In this Section, the impact of sRNAs on the temporal regulation of gene expression is 
analysed. Theoretical predictions derived from mathematical modelling are confirmed by 
quantitative experimental analyses of the iron stress response in a cyanobacterial organism 
(Synechocystis sp. PCC 6803). The IsiA (iron stress induced protein A) stress response 
protein, which is transcriptionally induced upon iron depletion or oxidative stress [387]  is 
controlled by a naturally occurring antisense sRNA, IsrR (iron stress repressed RNA) [388] . 
By comparing strains expressing different levels of IsrR sRNA, it is shown that IsrR is 
responsible for a pronounced delay in isiA induction. This delay ensures that iron stress 
proteins are expressed in a temporally ordered manner, with the “emergency” protein IsiA 
accumulating only if the stress duration exceeds a critical temporal threshold. Moreover, it is 
shown that IsrR sRNA ensures a rapid decline in isiA levels once external stress triggers are 
removed. IsiA expression must be tightly controlled, as it reduces photosynthesis efficiency 
in unstressed cells and becomes highly abundant under stress conditions. The results in this 
chapter reveal how the IsrR sRNA ensures that isiA accumulation is restricted to severe, 
prolonged and ongoing stress conditions.  
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7.2 Model Implementation  
 
A mathematical model of sRNA-mediated regulation was implemented (schematically 
depicted in Fig. 7.7.1A). The model comprises synthesis and degradation of target mRNA 
and sRNA, and also takes reversible association between mRNA and sRNA as well as 
degradation of the resulting heteroduplex (‘pair’) into account. In contrast to published 
models [384,385] , the heteroduplex concentration was treated as a dynamic variable, mainly 
because the experimental analyses of the cyanobacterial iron stress response did not allow 
to distinguish between free and sRNA-bound isiA mRNA. Previous studies indicated that 
heteroduplex association and dissociation proceed with rapid kinetics when compared to 
protein synthesis and degradation [389,390] . A rapid-equilibrium assumption was therefore 
applied, so that the model depicted in Fig. 7.7.1A reduces to a two-variable system (see also 




tot syn,T deg,T tot deg,P
tot syn,S deg,S tot deg,P
d[T ] dt  = v  - k [T ]-[Pair]  - k [Pair]
d[S ] dt  = v  - k [S ]-[Pair]  - k [Pair]
⋅ ⋅
⋅ ⋅
    (7.1) 
 
Here, [Ttot] and [Stot] indicate the dynamical variables of the system which represent the total 
intracellular concentrations of the target mRNA and sRNA, respectively. More specifically, 
[Ttot] equals the sum of the concentrations of free and sRNA-bound target mRNA (i.e., [Ttot] = 
[Target] + [Pair]), and [Stot] = [sRNA] + [Pair] is defined similarly. Owing to the rapid 
equilibrium assumption, the concentration of the heteroduplex (i.e., [Pair]) is given by (see 
Appendix G):  
 
( )2tot tot d,P tot tot d,P tot tot[Pair]=1 2 [T ]+[S ]+K - [T ]+[S ]+K 4 [T ] [S ]⎛ ⎞⋅ − ⋅ ⋅⎜ ⎟⎝ ⎠   (7.2)    
Equations (7.1) and (7.2) constitute a reduced differential equation system that depends on 
the dynamical variables [Ttot] and [Stot] only. From the total RNA concentrations, [Ttot] and 
[Stot], one can calculate back to the individual concentrations (i.e., [Target], [sRNA] and [Pair]) 
by using Eq. 7.2 and the mass conservation definitions of [Stot] and [Ttot]. Numerical 
simulations were generally done using the units nM for intracellular concentrations and h for 
time. In Figs. 7.1 and 7.2, the concentrations on the y-axes are given in arbitrary units (A.U.), 
because no absolute experimental quantification of RNA expression was available.        
 
The cyanobacterial stress response protein IsiA is induced by reactive oxygen species 
(ROS) and by iron depletion, and its expression is further modulated by a small non-coding 
RNA, IsrR (Fig. 7.1A). The kinetics of isiA regulation was measured to confirm the model 
predictions (see below). The input functions in the model were therefore chosen such that 
they reflect those in the cyanobacterial stress response. IsiA expression is known to be 
transcriptionally regulated by the iron-sensitive Fur (ferric uptake regulator) repressor, while 
the activity of the promoter controlling the antagonizing sRNA, IsrR, is not affected by cellular 
stress (Wolfgang Hess, pers. comm.). The synthesis rate of target mRNA (vsyn,T) is therefore 
modelled to be controlled by external stimuli, as indicated in Fig. 7.1A. For simplicity, it is 
assumed that the regulation of the isiA promoter activity occurs on a much faster time scale 
than downstream RNA synthesis and degradation. Thus, extracellular stimulation was 
simulated by a step-like change of vsyn,T from one value to another. The Michaelis-Menten 
equation (vsyn,T = Vmax,synT ⋅ Stimulus / (KM,synT + Stimulus)) was employed to simulate dose-







7.3 Theoretical Analysis of Steady State and Dynamical Behaviour 
 
The steady state and dynamical behaviour of the sRNA circuit was systematically analysed 
by numerical simulations. The following analysis will mainly focus on the scenario, where the 
heteroduplex is much less stable than the monomeric sRNA and target species, as such 
behaviour was recently reported for the cyanobacterial stress response [388] . However, the 
main conclusions drawn in this chapter remain valid even if the sRNA merely acts as a 




Figure 7.2: Experimental verification of simulated dynamical behaviour (A and B) and physiological 
relevance (C and D).  
(A) Regulation by small RNAs establishes a delay in target mRNA accumulation. The time course of isiA target mRNA 
accumulation in response to H2O2 treatment was measured in wild-type cells (circles), in cells harbouring reduced amounts of 
IsrR sRNA (squares), and in cells overexpressing IsrR sRNA (crosses). The measurements agree well with the corresponding 
simulations (lines; see Table 7.1 for kinetic parameters). (B) The decline in target mRNA (isiA) levels is faster in wild-type cells 
(circles) when compared to cells depleted of IsrR sRNA (squares), as expected from corresponding simulations (lines; see 
Table 7.1 for kinetic parameters). Accumulation of isiA target mRNA was induced by iron starvation (48h), and then isiA 
expression was blocked by iron re-addition at t = 0 (see text). (C) Regulation by small RNAs gives rise to a sharp, spike-like time 
course of free target mRNA in response to step-like pulse stimulation (solid line), when compared to a system without sRNA 
(dashed line). In particular, target mRNA accumulation is completely suppressed until all sRNA is degraded (indicated by black 
circle). (D) Small RNAs establish pulse filtering in gene expression. Target mRNA accumulation in response to step-like stimuli 
of different duration (but of constant strength) was simulated, and the time course maximum or the integral similar to the 
hatched area in C (inset) is plotted as a function of pulse length. Highly ultrasensitive pulse duration decoding (Hill coefficient nH 
≈ 3.5) is seen in the presence (solid line), but not in the absence (dashed line), of sRNA-mediated regulation. See Appendix G 
for kinetic parameters.  
 
Recent work by Levine et al. [385]  revealed that sRNAs establish sharp thresholds in the 
steady state stimulus-response behaviour of gene regulatory circuits. Similarly, the 
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simulations in Fig. 7.1B (top, solid line) also yielded an all-or-none expression pattern of the 
target mRNA if physiologically relevant kinetic parameters were assumed. As discussed 
previously [385] , sRNA-mediated regulation efficiently suppresses mRNA accumulation as 
long as the sRNA synthesis rate exceeds that of the target mRNA (i.e., if vsyn,T < vsyn,S). In 
Fig. 7.1B, the condition vsyn,T = vsyn,S is fulfilled if the stimulus level equals unity, so that a 
threshold is observed for stimulus = 1. As expected, the threshold disappeared in the 
absence of sRNA (dashed line) or in case the affinity of the heteroduplex was too low (not 
shown). Moreover, sharp thresholds were typically accompanied by a mutually exclusive 
expression pattern of target mRNA and sRNA (solid and dashed-dotted lines in Fig. 7.1B). 
Previous experimental work revealed that the isiA mRNA and its modulator, the IsrR sRNA, 
accumulate in a mutually exclusive manner under various stimulation conditions [388] . 
Further experiments, where amounts of isiA and IsrR were measured for varying iron 
concentrations in the medium, revealed that IsrR sRNA starts to accumulate only if isiA 
mRNA falls below a certain level (Appendix G). Finally, a comparison of wild-type cells with 
IsrR knock-down cells reveals that IsrR completely suppresses residual isiA levels under 
unstressed conditions (compare circle and square at t = 0 in Fig. 7.2A). Taken together, 
these data strongly suggest that a sharp threshold exists in the cyanobacterial iron stress 
response, and that the system operates near this threshold under physiological conditions.   
 
The temporal dynamics around the threshold were investigated in order to derive 
experimentally testable predictions from the model. The analysis was focused on the time 
required to pass from one steady state to another (‘response time’). Step-like increases in 
the external stimulus were applied, and the response time t50 required to reach 50% of the 
difference between old and new steady state was calculated for the target mRNA. The dotted 
line in Fig 7.1B (bottom) reflects the response time of a reference system without sRNA, and 
is valid for both input scenarios considered: (i) a step-like stimulus increase from no 
stimulation to the value indicated on the x-axis (‘upregulation’); (ii) a stimulus decrease from 
the value indicated on the x-axis to no stimulation (‘downregulation’). The simulations of the 
sRNA circuit revealed that sRNAs speed up the upregulation kinetics for subthreshold 
stimuli, while they establish a delay upon suprathreshold stimulation (solid line). Moreover, 
Fig. 7.1B indicates that sRNAs always accelerate target downregulation even for 
suprathreshold stimuli (dashed line). 
 
In the subthreshold regime the sRNA is present in excess over the target mRNA. Under 
these conditions, the sRNA can be assumed to be constant, so that mRNA degradation via 
the Pair intermediate behaves like a first-order decay reaction, which dominates over the 
much slower direct mRNA degradation step (see Appendix G). The response times of mRNA 
up- and downregulation are known to be solely determined by the (fastest) first-order decay 
rate [391] , which explains why sRNA-mediated regulation accelerates target regulation in 
both directions under subthreshold stimulation conditions. The dynamic phenomena 
observed upon strong stimulation originate from nonlinear threshold effects in the sRNA 
circuit. The upregulation time lag arises, because the residual pool of free small RNAs needs 
to be cleared before the target mRNA can accumulate. Small RNAs accelerate 
downregulation, since the mRNA concentration quickly falls into a subthreshold range, where 
sRNA-mediated regulation efficiently degrades residual mRNA. This results in an abrupt 
termination of the mRNA expression time course, as can be seen from solid line in Fig. 7.2B. 
Moreover, the initial phase of mRNA down-regulation is accelerated in the presence of small 
non-coding RNAs (compare solid and dotted lines in Fig. 7.2B), as the pair intermediate is 
turned over at a higher rate than the free mRNA. Taken together, the simulations suggest 
that IsrR sRNA delays isiA induction upon stress, but speeds up isiA downregulation when 




7.4 Experimental Verification of the Simulated Dynamic Behaviour 
 
Quantitative experimental analyses were performed to confirm the simulations in Fig. 7.1B. 
The impact of sRNA-mediated regulation was investigated by comparing the kinetics of isiA 
mRNA accumulation in mutant strains expressing different levels of IsrR sRNA. The data 
points shown in Fig. 7.2A are densitometric quantifications of measurements of isiA induction 
in response to hydrogen peroxide stress previously published by the Wilde group [388] . 
These data revealed that the delay in isiA accumulation seen in wild-type cells can be further 
enhanced in cells overexpressing IsrR, while it is abolished in IsrR-depleted cells. The 
measured time courses thus agree well with the simulation result that sRNAs decelerate 
target mRNA induction. 
 
Table 7.1 Kinetic parameters of the best-fit model. 
Figure Fig. 7.2A Fig. 7.2B 
vsyn,T [nM h-1] 247.2 (basal level) 
1136 (after stimulus 
increase) 
996.9 (basal level) 
41.9 (after stimulus 
removal) 
kdeg,T  [h-1] 0.42 0.42 
vsyn,S [nM h-1] 516.6 (red line) 
706.9 (green line) 
145.3 (blue line) 
516.6 (red line) 
145.3 (blue line) 
kdeg,S [h-1] 0.35 0.35 
KD,P [nM] 0.0045 0.0045 
kdeg,P [h-1] 13.75 13.75 
 
 
The time course of isiA target mRNA downregulation after removal of the stress trigger was 
also measured (see Appendix G for corresponding Northern Blots). Hydrogen peroxide could 
not be used as the stimulus in these experiments, since it induces irreversible oxidation of 
cellular components so that stress might actually persist even after hydrogen peroxide is 
removed. isiA accumulation was therefore induced by iron depletion (48 h), and isiA 
expression was subsequently downregulated by iron re-addition (t = 0 in Fig. 7.2B). The time 
course measurements after relief from iron stress were in accordance with the model 
predictions, as the decline in isiA levels was faster in wild-type cells when compared to 
knock-down cells harbouring reduced levels of IsrR sRNA (Fig. 7.2B).  
 
Having established a qualitative agreement between experiments and simulations, it was 
then analysed whether the model could also quantitatively reproduce the dynamics of isiA 
target mRNA up- and downregulation. The model parameters were estimated from the time 
course data shown in Figs. 7.2A and B using PottersWheel, a multi-experiment fitting toolbox 
for Matlab programmed by Thomas Maiwald (www.potterswheel.de). The trajectories of the 
best-fit model (solid lines in Figs. 7.2A and B) indicate that all measurements can be 
accurately described by a single set of kinetic constants. Remarkably, the best-fit 
parameters, summarised in Table 7.1, suggest that the heteroduplex is rapidly degraded, 
while the single stranded forms of isiA and IsrR are predicted to be much more stable than 
typical bacterial RNAs [392] . A long half-life of isiA directly follows from the slow isiA 
downregulation kinetics in sRNA-depleted cells (Fig. 7.2B; blue line), while the stability of 
IsrR cannot be as straight-forwardly deduced from the time course data. The half-life of IsrR 
sRNA was therefore directly measured in unstressed cells, which express negligible amounts 
of isiA target mRNA [388] . Very little degradation of IsrR occurred within a 45 min time 
interval after incubation of cells with the general transcription inhibitor Rifampicin (see 
Appendix G for corresponding Northern Blots). These data confirm that IsrR sRNA is stable 




7.5 Pulse Filtering Properties of sRNA Circuits  
 
The above RNA measurements (Figs. 7.2A and B) did not discriminate between IsrR-bound 
(‘pair’) and free (‘target’) isiA RNA. In order to get more direct insights into the regulation of 
isiA action by IsrR sRNA, time courses of free (i.e., biologically active) isiA target mRNA 
were simulated using the best-fit parameters. Figure 7.2C shows model responses to a step-
like suprathreshold pulse stimulation, and reveals that regulation by small RNAs gives rise to 
a sharp, spike-like time course (solid line), when compared to a system devoid of sRNA 
(dashed line). More specifically, target mRNA accumulation is completely suppressed until all 
sRNA is degraded (indicated by black circle), and the mRNA decline terminates abruptly, 
once the sRNA (re-)starts to accumulate.  
 
Taken together, the simulations indicate that IsrR-mediated control serves to prevent 
premature and unnecessarily prolonged isiA synthesis. This is consistent with the hypothesis 
that IsiA establishes a second line of defence against iron depletion, and with the fact that its 
expression occurs relatively late during iron stress [393] . The delay established by sRNA-
mediated regulation thus enables cells to induce both early- and late-phase stress proteins in 
response to a single stress trigger in a temporally ordered manner.  Two lines of evidence 
further suggest that spike-like isiA expression (Fig. 7.2C) is beneficial to the cellular energy 
budget. First, isiA becomes the most abundant transcript in cells subjected to oxidative stress 
[394] . Second, IsiA expression saves photosynthesis in stressed cells, but decreases 
photosynthesis efficiency and thus energy production in non-stressed cells [393] . The 
present analyses indicate that IsrR sRNA-mediated control allows avoiding lavish isiA 
accumulation unless cells are subjected to severe and prolonged stress.  
 
Further simulations were performed to confirm the hypothesis that sRNA circuits suppress 
short stimuli, but efficiently transmit prolonged inputs. The time courses of target mRNA 
expression were simulated for step-like stimulus pulses, and the time course maximum was 
analysed as a function of pulse duration (Fig. 7.2D). The best-fit model (Table 7.1) indeed 
responds to the pulse duration in a highly ultrasensitive manner (Hill coefficient nH ≈ 3.5), 
while a much more gradual duration response is seen for a system without sRNA. Here, the 
Hill coefficient nH was estimated by using the formula nH = log(81) / log(D90/D10), where D90 
and D10 are the stimulus durations required for the target amplitude to reach 90% and 10% of 
the steady state, respectively [19] . Similar ultrasensitive behaviour was also observed when 
the integral under the target mRNA time courses was analysed (Fig. 7.2D, inset). This further 
confirms that sRNAs establish pulse filtering and temporal thresholds in biochemical 





Using a combination of mathematical modelling and quantitative experimental analyses, it 
was shown in this chapter that sRNAs establish delays and (steady state and temporal) 
thresholds in gene expression. In order to allow for a comparison of the simulations with 
experimental data from wildtype and knock-down cells, the dynamical behaviour of the wild-
type model was mostly compared with that of a model devoid of sRNA. It should be noted 
that, from a systems theoretical point of view, the dynamical behaviour of both models (+/- 
sRNA) is not directly comparable for a given stimulus level, as they differ in their steady state 
dose-response curves. However, it can be seen in Fig. 7.1B that sRNA-mediated regulation 
still establishes a delay in mRNA upregulation and accelerates mRNA downregulation if both 
models  (+/- sRNA) are compared for a given suprathreshold steady state activation level. In 
this context, it is important to note that the up- and downregulation response times of the 
model without sRNA are stimulus-invariant (dashed horizontal line in Fig. 7.1B, bottom).    
 
The key finding of the present chapter is that sRNA-mediated regulation establishes a sign-
sensitive delay for supra-threshold stimulation (Figs. 7.2A and B), and this conclusion does 
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not depend on the precise dose-response behaviour or on the kinetic parameters chosen. 
Here, the term ‘sign-sensitive delay’ denotes that a delay is observed exclusively for mRNA 
upregulation, but not for mRNA downregulation [395] . This sign-sensitive delay is 
responsible for the pulse-filtering behaviour shown in Figs. 7.2C and D: The delay in mRNA 
upregulation helps to filter out short supra-threshold transients. However, ultrasensitive 
pulse-filtering with a Hill coefficient significantly larger than unity additionally requires that no 
such delay and in particular no memory effects arise if the stimulus is removed. The 
experimental data presented in the paper rules out that mRNA downregulation occurs with a 
delay (Fig. 7.2B), and thus strongly supports that ultrasensitive pulse-filtering occurs in the 
cyanobacterial iron stress response. However, the mRNA downregulation kinetics might 
depend on the history of the system (e.g., short vs. long mRNA upregulation), so that explicit 
pulse-stimulation experiments are required to further prove the existence of ultrasensitive 
pulse-filtering. 
 
The analysis was mainly focused on the scenario, where the heteroduplex is less stable than 
the single stranded sRNA and target species. However, several bacterial sRNAs do not 
enhance target degradation, but merely act as competitive inhibitors of translation [383] . 
Importantly, small RNAs acting in this way still establish sharp thresholds and delays, as 
translation of subthreshold target mRNA levels is efficiently suppressed by sequestration into 
the heteroduplex [16]  (Appendix G). Eukaryotic miRNA action can also be described by the 
model scheme depicted in Fig. 7.1A, as miRNAs either competitively inhibit translation or 
induce mRNA degradation. However, miRNAs frequently remain intact after target 
degradation, and can guide the recognition and destruction of additional messages [64] . 
Further numerical analyses revealed that the kinetic properties described above remain valid 
even if a fraction of the sRNA remains intact during the pair degradation reaction (Appendix 
G) [385] . Thus, the main results in this chapter apply for eukaryotic systems as well, 
although this remains to be confirmed in more detailed models of miRNA action [396] .  
 
In Figs. 7.1 and 7.2, the dynamic characteristics of mRNA expression were analysed. 
However, the kinetic properties of the sRNA circuit may be obscured by a slow response at 
the level of protein expression. It was therefore investigated numerically whether the 
conclusions regarding pulse-filtering continue to hold at the protein level. The simulation 
results (shown in Appendix G) demonstrate that for the best-fit parameters pulse-filtering is 
preserved at the protein level even if IsiA protein is assumed to be relatively stable, with a 
half-life of 10 h. Up to now, studies focusing on the stability of IsiA protein are missing in the 
literature. However, half-life measurements of the CP43 photosynthesis protein homologous 
to IsiA revealed a half-life of about an hour under stress conditions [397] , and a similar rapid 
turnover was also reported for another photosynthesis protein, D1 [398] . These data suggest 
that IsiA protein is short-lived in the experimental setup chosen here, and that the pulse 
filtering property discussed here for the RNA level is observed at the level of proteins as well. 
 
Cells face a specificity problem, as broadly overlapping signalling pathways are activated by 
diverse stimuli. Biological information is therefore encoded in the quantitative aspects of the 
signal, such as amplitude and duration [380,381] . An important role for the signal duration in 
the initiation of cell fate decisions was described for various biological networks including 
MAPK signalling [381] , TGFβ signalling [49] , cAMP signalling [42] , and NF-κB signalling 
[43] . Previous work indicated that multistep regulation in the form of feed-forward loops [59]  
and multisite phosphorylation [15,60]  allows cells to discriminate transient and sustained 
stimuli. In this chapter, competitive inhibition and/or regulated degradation were identified as 
alternative plausible mechanisms for duration decoding (Fig. 7.2D). Further functional 
analysis of small RNAs might explain why some genes are selectively transcribed upon 
sufficiently long stimulation [43,58] . The results are likely to be of broader relevance, 
because regulation by protein-protein interactions frequently involves competitive inhibition 




The simulations shown in this chapter demonstrate that mathematical modelling can help to 
get qualitative and quantitative insights into the functioning of small transcriptional regulatory 
units. However, these simple transcriptional motifs typically interact in complex transcriptional 
regulatory networks, many of which remain poorly understood. In the following chapter 
(Section 8), it is described how systems biological approaches allow deriving the topology of 













8 Modular Response Analysis of a Ras-regulated 
Transcription Factor Network 
 
This chapter is the result of a collaboration with Iwona Stelniec, Oliver Raudies, Oleg 
Tschernitsa and Reinhold Schäfer from the Institute for Pathology at the Charité Berlin. The 
knock-down experiments were performed by Iwona Stelniec in the lab of Reinhold Schäfer, 
and the array measurements were done by Iwona Stelniec and Oleg Tschernitsa. Pål 





Gene expression profiling studies revealed that extracellular stimuli or oncogenic activation 
events typically induce hundreds of genes. Many of these induced genes are themselves 
transcription factors, giving rise to a complex network of transcriptional regulation that cannot 
be understood intuitively. In this chapter, modular response analysis (MRA), a recently 
proposed reverse engineering method, is employed to derive the topology of a transcription 
factor network that mediates proliferation downstream of oncogenic Ras. Statistical analyses 
of the MRA results strongly suggest the existence of a linear HMGA2 → Fra-1 → Copb → 
JunB transcription factor cascade. Experiments that allow verifying the predicted regulatory 
interactions are proposed, and the possibility to extend the MRA calculations to downstream 





Biochemical and cell biological analyses are typically focussed on specific parts or even on 
single proteins of the intracellular regulatory network. In many cases, systems biological 
approaches help to integrate such detailed biological knowledge, and allow gathering 
quantitative insights into the functioning at the network level. A less well developed field of 
systems biology is reverse engineering, where regulatory interactions are deduced from 
high-throughput data using a top-down approach.  
  
Modular response analysis (MRA), a reverse engineering approach recently proposed in [68] 
, allows to reconstruct the network structure from an experimentally measured global 
response matrix by assuming a linear model. As schematically depicted in Fig. 8.1A, the 
global response specifies the experimentally measurable response of a species (B, C, or D in 
Fig 8.1A) towards a perturbation in another species (A in Fig 8.1A). The global response 
considers both direct and indirect regulatory interactions, while the so-called local response 
(Fig 8.1B) considers only direct interactions, and thus specifies the network structure. MRA 
allows to compute the local response from experimental data provided that the global 
responses have been measured for all possible perturbations (i.e., if the full matrix of global 
responses is available). In Fig. 8.1A, this means that each of the species A – D needs to be 
perturbed, e.g., by RNAi-mediated knock-down, and that the responses of A – D need to be 
measured for each of these perturbations.     
  
An inherent weakness of the top-down strategy underlying MRA is that the predicted 
regulatory interactions cannot straightforwardly be tested using conventional biochemical 
assays. For example, it cannot be deduced from MRA calculations whether the inhibition of B 
by A in Fig. 8.1 occurs by direct binding or through a multi-step chain of regulatory events. In 
other words, direct interactions in the sense of MRA are not necessarily direct in a 
biochemical sense. Moreover, MRA gives no clue about the biochemical mechanism of 
regulation (e.g., protein-protein interactions, promoter regulation, covalent modification), and 
this further complicates experimental verification. Accordingly, a positive feedback loop 
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predicted by MRA in a recent study focussing on MAPK signalling in PC12 neuronal 
precursors could only be confirmed by indirect experimental evidence [24] .  
 
 
Figure 8.1: Deriving experimentally testable predictions from modular response analysis (MRA).  
(A) The global response specifies the response of a species (e.g., species C) towards a perturbation in another species (e.g.., 
species A), arising from both direct and indirect regulation (the latter occurring via species B). (B) The local response considers 
only direct interactions, and thus specifies the network structure. MRA allows to calculate the local response from experimental 
data provided that the global responses have been measured for all possible perturbations (i.e., if the matrix of global responses 
is available). This means that each of the species A – D needs to be perturbed, e.g., by RNAi-mediated knock-down, and that 
the responses of A – D need to be measured for each of these perturbations.  (C) A comparison of the local and global 
response coefficients provides further insights into the network structure. Similar local and global responses indicate that weak 
indirect regulation relative to direct regulation (although more complicated explanations are conceivable), while significantly 
different local and global responses reveal an important role for indirect regulation. For example, the A globally inhibits C (grey 
bar) despite local activation (black bar), as the indirect inhibitory pathway via species B dominates over direct activation. (D) 
Thus, the global inhibition of C by A should be convertible into a global activation if indirect regulation via species B is blocked, 
and this prediction can be confirmed in B knock-out cells. The regulatory interaction A → D seems to be less well suited for 
experimental verification of MRA, as multiple indirect pathways may require a simultaneous knock-out of species B and C.  
 
 
In this chapter, MRA is applied to a Ras-regulated transcription factor network. Constitutive 
Ras activation is observed in ~30% of all tumours, and allows cells to proliferate in the 
absence of external growth stimuli (see Section 2). The signal transduction networks 
activated by oncogenic Ras have been extensively studied, but the transcription factor 
networks ultimately leading to Ras-induced changes in gene expression remain poorly 
understood. Using customised arrays, Oliver Raudies found that ~50 transcription factors are 
transcriptionally upregulated after transfection of normal ROSE 199 rat epithelial cells with 
constitutively active Ras (these Ras overexpressing cells will be termed ROSE A5/2 cells 
hereafter). Seven of these transcription factors (i.e., Gfi-1, Otx-1, RelA, Fra1, Copeb, JunB 
and HMGA2) were chosen for further analyses, and were individually knocked down by 
Iwona Stelniec in ROSE A5/2 cells using an RNAi approach. Array measurements in each of 
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the knock-down cell lines yielded a matrix of global responses, and thus allowed to calculate 
the network structure using MRA.  
 
Table 8.1: Transcription Factor Expression in Response to siRNA-mediated knock-down.  
 
 Gfi-1 Otx-1 RelA Fra1 Copb JunB HMGA2 
KRas 1,3836 2,2965 0,395 1,963 1,1763 0,893 2,6798 
(overexp) 5% 12% 18% 3% 2% 5% 3% 
Gfi-1 -1,3405 -0,414 -0,3716 -0,2992 -0,9826 -0,047 1,5741 
(siRNA 1) 7% 20% 20% 20% 3% 20% 3% 
Gfi-1 -1,0455 0,0973 0,4137 -0,4758 -0,494 0,3014 1,0287 
(siRNA 2) 9% 20% 20% 20% 5% 20% 6% 
Otx-1 0 -2,0879 -0,3022 0,7863 -0,7082 -0,2263 1,049 
(siRNA 1) 20% 4% 20% 3% 5% 20% 5% 
Otx-1 0 -1,4339 -0,2746 0,707 -1,346 -0,2031 0,771 
(siRNA 2) 20% 10% 20% 3% 8% 20% 7% 
RelA 0 -0,28 -0,804 0,9055 1,01 0 0,4404 
(siRNA 1) 20% 20% 6% 6% 5% 20% 20 
RelA 0 0 -0,905 1,3767 1,23 0 0,4137 
(siRNA 2) 20% 20% 10% 14% 9% 20% 20% 
Fra1 1,089 0,9655 -0,865 -1,947 -0,974 -1,346 0,836 
(siRNA 1) 10% 12% 13% 5% 6% 11% 4% 
Fra1 0,8265 0,5017 -0,48 -1,368 -0,687 -1,068 0,538 
(siRNA 2) 11% 15% 14% 5% 5% 5% 5% 
Copb 0 0 0,215 1,01 -0,94 -0,772 0,783 
(siRNA 1) 20% 20% 20% 5% 5% 5% 5% 
Copb 0 0 -0,1237 0,8647 -0,8541 -0,805 0,763 
(siRNA 2) 20% 20% 20% 5% 5% 5% 7% 
JunB -0,731 0 0,023 0,2359 -0,293 -0,985 0,54 
(siRNA) 11% 20% 20% 20% 20% 9% 12% 
HMGA2 0 -0,0014 0,0657 -1,205 -0,868 -0,907 -2,342 
(siRNA 1) 20% 20% 20% 9% 5% 9% 15% 
HMGA2 0 0,069 -0,481 -1,107 -0,702 -1,105 -1,748 
(siRNA 2) 20% 20% 20% 5% 5% 10% 7% 
The first row specifies the alterations in transcription factor expression in ROSE 199 cells induced by an overexpression of 
mutationally activated K-Ras. The resulting Ras-transformed cells (ROSE A5/2) were then perturbed by siRNA-mediated 
transcription factor knock-down against individual transcription factors as indicated in the following rows (transfections with 
different siRNA constructs against the same target are indicated by 1 and 2). Each column contains the average perturbation-
induced changes in mRNA expression measured by microarray 48 h after transfection on a log2-scale (upper number), and 
lower number the corresponding standard deviation (σ of mean out of 6 replicates) in per cent  (lower number). Bold font refers 
to significant expression changes, where the log2-fold change is larger than the cut-off of 0.7 or smaller than -0.7 (lower cut-offs 
were used for the K-Ras overexpression experiment due to a larger number of replicates). Thin black and thin grey font 
indicates that the expression changes are not significant, either because they are less than 0.7 (thin black) or because the dye 
swap did not work (thin grey). Based on experimental data, the non-significant responses are generally assumed to have a 




The following strategy was used to derive experimentally testable predictions from the MRA 
calculations. The regulatory interactions were sub-classified into two groups depending on 
whether their local and global responses are significantly different or not. Significantly 
different local and global responses imply that indirect regulation is important in addition to 
direct regulation. For example, Fig. 8.1C indicates that an experimental perturbation in A 
results in an inhibition of C (global response), while MRA predicts that A directly activates C 
(local response). It can be seen in Fig. 8.1A that this discrepancy in the local and global 
responses emerges from a dominance of indirect inhibition (via B) over direct activation, 
resulting in an inhibitory global response. Thus, the global inhibition of C by A should be 
convertible into a global activation if indirect regulation via B is blocked (Fig. 8.1D), and this 
prediction can be confirmed experimentally in B knock-out cells. It was the aim of this chapter 
to identify relatively simple network alterations such as a knock-out of a single species (B in 
Fig. 8.1D) that allow testing for the results of MRA. The analysis revealed the existence of 
transcription factor cascade that is likely to play a key role for Ras-mediated transformation, 





Figure 8.2: Modular Response Analysis of a Ras-regulated Transcription Factor Network.  
Each bar graph indicates how a single transcription factor (indicated on the top) is controlled by the other species of the system 
(as indicated on the x-axis). The y-axis corresponds to the strength of regulatory control (i.e., to the response coefficient). The 
grey bars indicate the median local response coefficients obtained by MRA (Eq. 8.2), which quantify direct regulatory effects 
only, and thus specify the network structure. The black bars refer to the normalised global response coefficients (Rij = dlnxi / 
dlnxj), which quantify the net effect from both direct and indirect regulatory interactions. Normalisation of global response 
coefficients was done dividing each column of the global response matrix Rij (Eq. 8.1) by its diagonal element Rjj. The error bars 





Table 8.1 shows how siRNA-mediated knock-down of each transcription factor affects the 
mRNA expression levels of all other transcription factors as measured by customised arrays 
in ROSE A5/2 cells. These experimentally measured mRNA expression changes arise from 
both direct and indirect regulation and are thus global responses (Fig. 8.1A), so that Table 
8.1 could be used as the input for MRA.  
 
The change in the steady state concentration (xi) of each component in the network in 
response to a perturbation (pj) is given by the global response matrix Rij = dlnxi / dlnpj, whose 
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where xi(0) and xi(1) are the steady-state concentrations of component xi before and after 
perturbation pj, respectively. Thus, the matrix Rij is only a reformulation of Table 8.1. 
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Thus, each element of rij quantifies how a change in the steady state concentration of xj 
affects the steady state concentration of xi. Importantly, rij refers to the hypothetical case 
where all other intermediates in the network (xk with k ≠ i, j) are kept constant, so that the 
elements rij quantify only direct regulatory interactions. This is in contrast to the matrix of 
global responses Rij which additionally takes indirect regulatory effects (via xk with k ≠ i, j) 
into account. In other words, the local response matrix gives a hint about the network 
structure [68] . In this work, rij was calculated from the matrix of global responses Rij by a 
total least squares (TLS) approach [400] . TLS incorporates biological replicas (i.e., different 
siRNA-transfections) and optimises the solution rij such that it is in maximal agreement with 
all available biological replicas.  
 
Technical errors arising during the microarray measurements were taken into account as 
described previously [24] : Random realisations of the fold expression changes were drawn 
from a normal distribution with mean and standard deviation equal to those measured 
experimentally (given in Table 8.1). Local response matrices rij were calculated for 106 
random realisations and the histograms of the resulting local response coefficients rij were 
analysed. The median of these histograms was taken as the average response coefficient. 
The 68% confidence interval (which corresponds to one standard deviation of a normal 
distribution) was also calculated from the histograms in order to determine the error of 
response coefficient estimation. The lower bound of the confidence interval was estimated by 
the value below which 16% of the realisations were found, and the upper bound corresponds 
to the value below which 84% of the realisations occur.  
In addition to TLS, the local response matrix rij and the confidence intervals were also 
calculated by the simpler, but (in case of noisy data) less accurate matrix inversion method 
[68,400] . This control implementation gave qualitatively similar results as TLS (not shown).   
 
 
Figure 8.3: Interactions with high average local response coefficients.  
The local responses given in Fig. 8.2 (grey bars) were classified based on their median response coefficients. The solid lines 
indicate strong interactions with median response coefficients over 1 or below -1. Dashed lines indicate medium interactions 
with median response coefficients over 0.5 or below -0.5. Grey blunted arrows indicate inhibition, while black arrows denote 
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activation. The black dots on the arrows mark interactions with high average response coefficients, which are characterised by 
high confidence response coefficients (termed HA-HC interactions; see main text and compare Fig. 8.4).   
 
 
8.3 Calculating the network structure using modular response analysis (MRA) 
 
Identification of key regulatory interactions: MRA was performed for a transcription factor 
network comprising Copb, RelA, Fra1, Gfi-1, HMGA2, JunB, and Otx-1. The knock-down 
matrix given in Table 8.1 allowed calculating the global response matrix (using Eq. 8.1) which 
was used as the input for MRA (see Section 8.2). Figure 8.2 summarises the results of MRA 
(i.e., the elements of the local response matrix rij). Each Subplot shows how a single 
transcription factor is controlled by the other players of the systems (see x-axis). The 
response coefficient indicated on the y-axis corresponds to the strength of regulatory control. 
A value of zero means no control, while positive and negative values correspond to activation 
and inhibition, respectively. A value of one refers to linear control, a value of two means 
quadratic control, and so on.  
 
 
Figure 8.4: Interactions with high confidence local response coefficients.  
The local responses given in Fig. 8.2 (grey bars) were classified based on the confidence intervals of their response 
coefficients. The solid lines indicate high confidence interactions whose complete error bar is above 0.5 or below -0.5. The 
dashed lines indicate medium confidence interactions with complete error bars over 0.2 or below -0.2. Grey blunted arrows 
indicate inhibition, while black arrows denote activation. The black dots on the arrows and the numbers mark high confidence 
interactions which are additionally characterised by a high average response coefficients (termed HA-HC interactions; see main 
text and compare Fig. 8.4). 
 
 
The grey bars in Fig. 8.2 are the elements of the local response matrix rij, and thus quantify 
the network structure, i.e., if and to what extent a transcription factor is directly controlled by 
the species of the system (Fig. 8.1A). For example, Fig. 8.2A implies that Gfi-1 has 
essentially no direct control over Copb, while Copb is strongly induced by Otx-1. In order to 
identify the most relevant regulatory interactions in the network, the local responses were 
classified based on their median response coefficients using cut-offs. Interactions with 
median response coefficients below 0.5 were neglected, while those with median response 
coefficients above 0.5 and 1 are schematically depicted in the network diagram in Fig. 8.3 as 
medium and strong interactions, respectively.  
 
Noisy experimental data might give rise to uncertainties in the network structure predicted by 
MRA. The local response coefficients were therefore classified according to their error bar 
ranges in order to identify high confidence interactions in the network (Fig. 8.4). A regulatory 
interaction was defined to be reliable if its complete response coefficient error bar is above 
0.2 (or below -0.2). This implies that the corresponding local response coefficients have a 
84% probability to be above 0.2. These reliable interactions were further sub-classified into 
medium and high confidence interactions, and are accordingly drawn into the network 
diagram in Fig. 8.4. 
 
A comparison of Figs. 8.3 and 8.4 reveals that regulatory interactions with high average 
response coefficients often also exhibit high reliability, as may be expected. These HA-HC 
(high average - high confidence) interactions are expected to be particularly relevant from a 
physiological point of view, and the corresponding arrows are thus marked by a dot on the 
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arrows in Figs. 8.3 and 8.4. The HA-HC interactions were chosen for further robustness 
analyses and were used to predict further experiments as outlined in the following.     
 









































Cobp siRNA * * * * * * + + + - + + + + + + + + + + 
Fra1 siRNA + + + + * * + + * * + - * * + - * * + ~ 
Gfi-1 siRNA + + + + + + + + ~ - * * * * ~ ~ + + * * 
HMGA2 siRNA + + + + + + + + + - + + ~ - * * * * * * 
JunB siRNA + + * * + + * * * * ~ ~ + + + + + + + + 
Otx-1 siRNA * * + + + + + + + + + + + + + + + + + ~ 
RelA siRNA + + + + + + * * + ~ * * + + * * + + ~ + 
The table summarises whether the HA-HC interactions derived from Fig. 8.3 and 8.4 retain high mean and/or high confidence 
even if less knock-down data is included in the calculations. MRA was repeated for 7 different reduced global response 
matrices, each of which lacks one of the siRNA perturbation experiments (i.e., all of its replicas). Each row corresponds to such 
a calculation, and the siRNA experiment not considered is indicated on the left. The column numbering on the top corresponds 
to the reaction numbers given in Fig. 8.4. The abbreviations m and c refer to mean response coefficient and to the confidence 
level, respectively. The symbols in the table indicate if the numbered reactions in Fig. 8.4 are still highly significant if less knock-
down data is used for calculation. A (+)-symbol indicates that a reaction is still characterised by a large mean local response 
coefficient (absolute value > 0.5) or that the whole error bar is still above 0.2 or below -0.2. The notation (~) indicates that the 
mean local response coefficient has the same sign as in Fig. 8.3 or that the whole error bar range has still the same sign as in 
Fig. 8.4. The (-)-symbol indicates that even these conditions are no longer fulfilled, and thus indicate that the corresponding 
regulatory interaction might not be structurally robust. Finally, the notation (*) indicates that no results could be obtained for the 
corresponding reaction, because one of the participating molecules (i.e., the responses to its knock-down) was not included in 
the calculations.  
 
 
Structural Robustness Analysis: In the previous paragraphs, the robustness of the MRA 
results with respect to experimental error and to biological variability was analysed by 
calculating error bars. It is also possible that the interactions predicted by MRA are highly 
sensitive to the number of input experiments, that is, to the number of siRNA experiments 
made. To empirically test whether the method is sensitive towards the structure of the input 
matrix, MRA was repeated for seven reduced versions of Table 8.1, each of which lacks one 
of the siRNA knock-down experiments. As a measure for robustness, it was analysed 
whether the HA-HC interactions retain high average and high confidence response 
coefficients even if reduced matrices are used for calculation. More specifically, it was 
determined whether the HA-HC interactions still fulfil the cut-off criteria defined in the caption 
of Figs. 8.3 and 8.4.  
 
The results, summarised in Table 8.2, indicate that the MRA indeed yields quite robust 
predictions for the regulatory interactions within the network. From seven reduced matrices, 
a total of 50 calculation results were obtained for the HA-HC interactions. 38 of the results 
retained both high average and high confidence response coefficients as indicated by the 
(+)-notation in Table 8.2, and thus exhibit strong robustness. In 4 of the remaining 12 
calculations both the high average and the high confidence of the response coefficient were 
lost simultaneously, thus indicating structural sensitivity. Nevertheless, Table 8.2 reveals that 
the average response coefficients are in general a structurally robust property of the HA-HC 
interactions, because in all 50 cases they retain at least the same sign when compared to 
Fig. 8.2 ((~) notations in Table 8.2). In contrast, the error bars show more prominent changes 
in the reduced calculations. In 6 out of 50 cases the error bar extends into the range of 
response coefficients with opposite sign ((-) notation in Table 8.2), so that a high confidence 
distinction between activation and inhibition is in principle no longer possible. However, more 
detailed analyses of the reduced calculations indicated that these error bars only slightly 
















 (Range) z-score 
Fra-1 → JunB 0.74 0.65 to 0.88 (activation) -0.29 
-0.5 to -0.13 
(inhibition) 4.12 
HMGA2 → Copb 0.44 0.38 to 0.5 (activation) -0.21 
-0.35 to -0.05 
(inhibition) 2.95 
Cobp → Fra-1 -1.01 -1.22 to -0.84 (inhibition) 0.45 
-0.11 to 1.08 
(activation) 2 
Otx-1 → JunB 0.13 -0.05 to 0.35 (undetermined) -0.47 
-0.75 to -0.24 
(inhibition) 1.46 
RelA → JunB 0.00 -0.38  to 0.38 (undetermined) 0.81 
0.56 to 1.12 
(activation) 1.29 
Gfi-1 → Copb 0.49 0.38 to 0.83 (activation) 0.04 
-0.25 to 0.3 
(undetermined) 1.22 
Fra-1 → HMGA2 -0.42 -0.52 to -0.34  (inhibition) 0.13 
-0.25 to 0.6 
(undetermined) 1.2 
Otx-1 → HMGA2 -0.56 -0.68 to -0.44 (inhibition) 0.15 
-0.42 to 0.89 
(undetermined) 1.03 
The local and the global response coefficients shown in Fig. 8.2 (grey and black bars, respectively) were compared for each 
regulatory interaction. Listed are those interactions where the whole error bar of the local response coefficient is completely 
non-overlapping with the error bar of the normalised global response coefficient. The list is sorted according to the z-score, 
which is given by z = |medianglobal – medianlocal| / (σglobal + σlocal), and thus expresses the difference between the local and the 
global responses as multiples of the standard deviation. The local standard deviation was estimated using the formula σlocal = 
|medianlocal – max(rangelocal)| if medianlocal < medianglobal or by σlocal = |medianlocal – min(rangelocal)| if medianlocal > medianglobal. The 
standard deviation σglobal was calculated similarly. 
 
 
Taken together, the results summarised in Table 8.2 indicate that the HA-HC interaction are 
fairly robust towards the number of siRNA input experiments used for MRA. Especially, 
reactions 1, 2, 3, 4 and 9 in Fig. 8.4 retain a high average response coefficients and high 
confidence for all calculations (Table 8.2), and are thus expected to be particularly reliable.  
 
 
8.4 Deriving experimentally testable predictions from modular response 
analysis (MRA) 
 
Comparison of local and global responses: In many cases, the computed direct regulatory 
interactions (grey bars in Fig. 8.2) will trivially reflect the experimentally observed global 
response (given in Table 8.1). However, both quantities can differ if indirect regulation plays 
a significant role in addition to direct regulation (Fig. 8.1C). As discussed in the context of 
Fig. 8.1D, these differences between local and global responses could be used to derive 
non-trivial, experimentally testable predictions from MRA. Therefore, the local and the global 
responses within the transcription factor network will be systematically compared in the 
following.   
 
The experimental results in Table 8.1 were processed such that they are directly comparable 
to the local response coefficients obtained by MRA. This was done by normalizing each 
column of the global response matrix Rij (Eq. 8.1) by its diagonal element Rjj. The resulting 
normalised global response matrix has the same form as the local response matrix (Eq. 8.2), 
but the condition that all other network species (xk with k ≠ i, j) are kept constant does no 
longer hold. The normalised global response coefficients are plotted in Fig. 8.2 (black bars), 




Table 8.4: Indirect pathways explain differences in local and global responses.  











Fra1 → Copb → JunB 
2 HMGA2 → Copb Weak Inhibition (-0.21) 
Activation 
(0.44) HMGA2 → Fra1 → Copb 





Copb → JunB ⎯| Fra1 
(Copb ⎯| HMGA2 → Fra1) 
(Copb → JunB → Gfi1 ⎯| HMGA2 → Fra1) 
(Copb ⎯| Gfi1 → Fra1) 
 
Activation Pathways: 
(Copb → JunB → Gfi1→ Fra1) 
(Copb ⎯| Gfi1 ⎯| HMGA2 → Fra1) 




Otx1 → Copb → JunB 




RelA ⎯| Gfi1 → Fra1 → Copb → JunB 
RelA ⎯| HMGA2 → Fra1 → Copb → JunB 
 
Activation Pathways: 
RelA ⎯| Gfi1 ⎯| HMGA2 → Fra1 → Copb → JunB 
The five regulatory interactions with the most significant differences between local and (normalised) global response coefficients 
according to Table 8.3 are listed. The local and global effects of the corresponding transcription factor knock-downs on target 
expression are summarised in the 2nd and 3rd columns, and the response coefficients are given in parentheses. The right column 
contains possible indirect pathways which according to Figs. 8.3 and 8.4 might be responsible for the observed differences in 
the local and global responses. Pathways in parentheses do not completely consist of highly reliable HA-HC interactions.   
 
It should be noted that the black bars in Fig. 8.2 also allow for direct comparison among 
siRNA replicate transfections (‘biological replicas’). The black bars in Fig. 8.2 for a given 
regulatory interaction are usually very similar which indicates good reproducibility of the 
perturbation experiments. In some cases, the degree of target mRNA downregulation differs 
significantly from one siRNA replicate to another (see, e.g., siRNA for Otx-1 in Table 8.1). 
Even in these cases the normalized global response coefficients (black bars in Fig. 8.2) are 
typically very similar among replicas. This suggests that the key assumption of MRA (i.e., a 
linearisation in logarithmic space) is indeed fulfilled within the typical range of siRNA-
mediated downregulation.   
 
Table 8.3 shows a compilation of those regulatory interactions whose local response 
coefficients significantly differ from the normalised global response coefficients. Listed are 
those interactions where the whole error bar of the local response coefficient (grey bars in 
Fig. 8.2) is completely non-overlapping with the error bar of the normalised global response 
coefficient (black bars in Fig. 8.2). The list is sorted according to a z-score, which expresses 
the difference between the local and the global responses as multiples of the standard 
deviation. Thus, the regulatory interactions on the top of Table 8.3 exhibit particularly 
significant differences between the local and the normalised global response coefficients.  
 
As discussed in the context of Fig. 8.1, indirect regulatory pathways are likely to be 
responsible for the differences between the local and global response coefficients given in 
Table 8.3. Such indirect regulatory routes within the transcription factor network that might 
compensate for direct local effects are summarised in Table 8.4. For example, the three-step 
pathway Fra1 → Copb → JunB consisting of HA-HC interactions only could explain why Fra1 





Figure 8.5: Experimental Verification by Elimination of Alternative Pathways.  
(A) Shown are the response coefficients for the two top regulatory interactions in Table 8.4 (i.e., Fra1 → JunB and HMGA2 → 
Copb). The black bars are the normalised global response coefficients derived from the experimental data given in Table 8.1 
(already shown in Fig. 8.2). The dark grey bars are the local response coefficients calculated for wildtype cells (already shown in 
Fig. 8.2), and the light grey bars are the normalised global response coefficients for hypothetical Copb and Fra1 knock-out cell 
lines, respectively (calculated by using Eq. 8.3). The light grey and black bars are significantly different from each other, so that 
the knock-out cell line can be used to verify the predicted network structure. (B) The pathway HMGA2 → JunB can also be used 
to verify the network structure. The predicted (normalised) global response coefficients of Fra-1 and Copb knock-out cells (light 
grey bars) are significantly smaller than the (normalised) global response coefficients of wildtype cells. 
 
 
Experimental verification by elimination of alternative pathways: Table 8.4 allows proposing 
new experiments which might verify the transcription factor network depicted in Figs. 8.3 and 
8.4. The indirect pathways listed in Table 8.4 are likely to be responsible for the differences 
in local and normalised global response coefficients. As discussed in the context of Fig. 8.1, 
it should be possible to convert the experimentally observed global response coefficients 
(black bars in Fig. 8.2) into the calculated local response coefficients (grey bars in Fig. 8.2) 
by knocking out intermediates in the indirect pathways in Table 8.4. For example, a knock-
out of Copb is expected to abolish the experimentally observed global activation of JunB by 
Fra-1, and to convert it into a weak inhibition (see regulatory interaction #1 in Table 8.4).  
 
This strategy was further confirmed by calculating the global response matrix Rij (Eq. 8.1) for 
hypothetical knock-out cell lines (e.g., for Copb knock-out cells for the example above). 
Then, a comparison Rij calculated for knock-out cells with the experimentally retrieved 
wildtype Rij (black bars in Fig. 8.1) reveals whether the indirect pathways listed in Table 8.4 
are indeed responsible for the differences of local and normalised global response 
coefficients. The global response matrix Rij with the elements given in Eq. 8.1 can be 
calculated back from the local response matrix rij by using the following formula [68]  
 
( )1ij pR r dgr−= ⋅ − .          (8.3) 
 
Here, dgrp is a matrix with all off-diagonal elements equal to zero. The diagonal elements of 
dgrp equal the fractional change in transcription factor expression induced by siRNA knock-
down against the very same transcription factor, and thereby quantify the efficiency of 
siRNA-mediated knock-down. Importantly, dgrp quantifies only direct knock-down effects, and 
neglects any network feedback effects (i.e., the module is considered to be in isolation). Due 
to the linearity assumption underlying MRA, the diagonal elements of dgrp can be chosen 
arbitrarily, because the analysis was anyway restricted to normalised global response 
coefficients (see Figs. 8.2 and 8.5). The previously calculated local response matrix rij (grey 
bars in Fig. 8.2) was used as an input for Eq. 8.3. Hypothetical knock-out cell lines were 
simulated by eliminating the depleted species from rij. In order to estimate confidence 
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intervals for the global response coefficients, the calculations incorporated the 106 
realisations for rij which were obtained during the calculation of Fig. 8.2 (see Section 8.2). 
Unfortunately, most of the calculations yielded large error bars for the global response 
coefficients in hypothetical knock-out cell lines, so that the proposed experimental verification 
method is not suitable for these cases.  
 
Two exceptions, shown in Fig. 8.5A, are characterised by significantly different global 
response coefficients between wildtype and hypothetical knock-out cell lines. As expected 
from Table 8.4, the global effect of a Fra-1 knock-down on JunB can indeed be weakened by 
a Copb knock-out. Also, the global response coefficient in Copb knock-out cells is predicted 
to be much more similar to the local response coefficient, thus suggesting that Copb is the 
major mediator of Fra1-mediated JunB activation. Likewise, Fra-1 seems to play a key role 
for HMGA2-mediated Copb activation, and this prediction can be tested in Fra-1 knock-out 
cells. The predictions in Fig. 8.5A are based on the simplest assumption regarding 
differences in local vs. global responses, but more complicated relationships between local 
and global responses are conceivable. It was therefore systematically analysed (using Eq. 
8.3) whether any hypothetical single knock-out cell gives rise to a significant shift in any of 
the global response relative to wildtype cells. It turned out that global response of the 
pathway HMGA2 → JunB is significantly lowered in Fra1 and Copb knock-out cells (Fig. 
8.5B). This seems to be due to the fact that strong indirect activation of JunB by HMGA2 via 
the pathways already identified in Fig. 8.5A (i.e., HMGA2 → Copb and Fra1 → JunB) is lost 
in Fra1 or Copb knock-out cells. Moreover, indirect inhibition of JunB by HMGA2 (via RelA, 
Gfi-1 and/or Otx-1) appears to outweigh direct activation of JunB by HMGA2 (dark grey bar 
in Fig. 8.5B), thus giving rise to a significant shift in the global response.  
 
In conclusion, the analysis presented in this section suggest the existence of a multistep 
regulatory pathway (HMGA2 → Fra-1 → Copb → JunB) which appears to play a key 
functional role for the induction of JunB by HMGA2. 
 
 
8.5 Conclusions and outlook 
 
By applying MRA, the network interaction map was calculated from the knock-down data set 
shown in Table 8.1. The strongest and most significant interactions are shown in Figs. 8.3 
and 8.4, and their relevance was further confirmed using the structural robustness analysis in 
Table 8.2. However, the regulatory interactions predicted by MRA cannot straightforwardly 
be tested using conventional biochemical assays, because it cannot be distinguished 
whether transcriptional regulation occurs by proximate promoter binding or through a multi-
step chain of regulatory events. Using the strategy schematically depicted in Fig. 8.1C and D, 
experimentally testable predictions were derived from MRA. Regulatory interactions with 
significantly different local and global responses imply that indirect regulation via other 
species within the network is important in addition to direct regulation. Inhibition of the 
corresponding indirect regulatory pathways should therefore shift the experimentally 
measurable global response towards the local response predicted by MRA. Figure 8.5 shows 
that experimental blockade of indirect regulatory pathways via Copb and Fra1 can indeed be 
used to test for network structure. This network verification strategy, however, requires that 
knock-out cell lines for Copb and/or Fra1 can be established. Here, the term knock-out does 
not necessarily mean that Copb/Fra1 expression needs be totally abolished. More 
importantly, Copb/Fra1 must loose their ability to transmit relative changes in transcription 
factor expression, e.g., by being insensitive to inputs. Then, the system leaves the linear 
regulatory range, and thus corresponds to a knock-out cell line in the context of MRA. There 
are several ways to experimentally establish such MRA knock-out cell lines as summarised 
in the following. A homozygous knock-out of the gene locus completely abolishes 
expression, and thus completely removes the protein from the network. In some cases, 
essentially the same effect can be achieved by overexpression of a dominant-negative 
construct. Alternatively, a strong siRNA-mediated knock-down might be sufficient to drop 
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transcription factor protein expression below a certain threshold, thus kinetically removing the 
protein from the network. Also, exogenous overexpression will render the transcription factor 
pool insensitive towards endogenous induction/repression mechanisms, and thereby 
prevents signal transmission. Finally, the transcription factor can be removed from the 
network by incubating cells using a small-molecule inhibitor, which blocks transcription factor 
action at the protein level. 
 
The analysis presented in this chapter strongly supports the existence of a linear 
transcription factor cascade consisting of HMGA2 → Fra-1 → Copb → JunB. According to 
Figs. 8.3 and 8.4, all interactions within the cascade are characterised by high average and 
high confidence local response coefficients, and are shown to be structurally robust (Table 
8.2). Interestingly, all feed-forward regulatory interactions between the cascade species (i.e., 
HMGA2 → Copb, HMGA2 → JunB, Fra1 → JunB) are small relative to those of the 
interactions within the cascade (i.e., HMGA2 → Fra1, Fra1 → Copb, and Copb → JunB). 
Moreover, the upstream cascade species (HMGA2, Fra1, and Copb) do not strongly regulate 
the external network species Otx-1, RelA and Gfi-1 (Figs. 8.3 and 8.4). This suggest a linear 
multi-step cascade topology devoid of direct or indirect feed-forward regulation (although 
feedback from Copb and JunB might play a role). The published literature supports the 
existence of a HMGA2 → Fra-1 → Copb → JunB transcription factor cascade: HMGA2 
expression is known to enhance Fra1 and JunB transcription [401,402] , and Fra1 expression 
was shown to induce JunB transcription [403] . Accordingly, Fra1 and JunB have been 
reported to be co-expressed at the mRNA level in various tumour cells [402] , and HMGA2 
and Fra1 protein levels correlate in multiple cell lines under different stimulation conditions 
(Christine Sers, unpublished reverse-phase protein array data). Copb (also known as KLF6) 
is a tumour suppressor involved in growth inhibition [404]  that is known to be induced upon 
extracellular stimulation [405,406,407] , much like HMGA2 [408] , Fra-1 [409] , and JunB 
[410] . Recent analyses, suggest that Ras activation promotes alternative splicing of Copb 
[411] , and that the alternatively spliced Copb transcript does not exert tumour suppressor 
functions, but instead acts as a positive regulator of cell division [412] . Likewise, it is known 
that HMGA2, JunB, and Fra1 positively regulate cell cycle progression, at least in part by 
activation of the cyclin A promoter [403,413,414] . Taken together, these data might explain 
why siRNA-mediated knock-down of HMGA2, Fra1, Copb or JunB abolishes Ras induced 
cell growth (Iwona Stelniec, data not shown).   
 
Interestingly, siRNA-mediated knock-down of HMGA2, Fra1, Copb or JunB inhibits 
anchorage-independent cell growth in soft agar (‘3D growth’), but does not affect growth on a 
cell culture dish (‘2D growth’). This is in contrast to knock-down of Otx-1, RelA or Gfi-1, all of 
which inhibit both 2D and 3D growth (Iwona Stelniec, data not shown). The mechanisms 
underlying such perturbation-specific regulation of downstream 2D vs. 3D growth behaviour 
remain to be identified. It has been reported that Cyclin A induction is dependent on cell 
adhesion, and that ectopic Cyclin A expression confers anchorage-independent growth to 
fibroblasts [415] . Given that HMGA2, Fra1 and JunB are known to induce cyclin A (see 
above), it might be worthwhile to complement the theoretical MRA analyses on cell growth by 
experimental measurements of cyclin A expression. The key transcription factors regulating 
growth can, in principle, be calculated using MRA, but a simplifying assumption is required: It 
is technically impossible to perturb the 2D or the 3D growth rate of cells, and to measure the 
resulting response of the transcription factor network. Thus, the full matrix of global 
responses required for MRA is not available. For simplicity, one might assume that cellular 
growth does not affect the transcription factor network under consideration, and therefore set 
the corresponding global responses to zero. Moreover, the subsequent MRA calculations 
need to be constrained in a bottom-up sense such that the elements of the resulting local 
response matrix corresponding to transcription factor regulation by cell growth are always 
zero (i.e., the corresponding arrows in the network structure need to be excluded). 
 
Constrained MRA calculations similar to those mentioned in the last paragraph might also be 
used to include the transcription factor responses towards upstream Ras overexpression (1st 
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row in Table 8.1). It seems reasonable to assume that the downstream transcription factor 
network does not affect the amount of ectopically expressed, constitutively active Ras 
protein, so that the corresponding local and global response coefficients can be set zero as 
well. A further aim is to complement the mRNA data given in Table 8.1 by protein 
measurements of the transcription factor network, which are currently in preparation by 
Iwona Stelniec in the lab of Reinhold Schäfer. A reasonable constraint for MRA calculations 
including mRNA and protein data might be to assume that regulation of protein levels occurs 
by transcriptional regulation (i.e., via the mRNA species) only. Once these network 
extensions included in the calculations, the MRA results will be compared with those of other 
reverse engineering methods [416,417,418]  to further confirm the model predictions. Finally, 
the MRA calculations will be constrained such that the number regulatory interactions 
becomes minimal (by setting multiple local response coefficients to zero in all possible 
combinations). This seems reasonable, as most biochemical networks are not fully 
connected, and will enable us to derive a minimal network topology describing the 
























































































9 General conclusions and outlook 
 
 
9.1 Experimental data for systems biology 
 
This thesis provides insights into the dynamics of signal transduction by combining 
theoretical modelling with various experimental approaches including high throughput data 
(Sections 5, 6 and 8), small-scale time-resolved measurements (Section 6 and 7), 
perturbation by siRNA-mediated knock-down (Sections 6, 7 and 8), and of half-life data 
(Sections 5, 6 and 7). However, further experimental measurement techniques would be 
required to further verify the conclusions drawn and are generally required for 
comprehensive systems biological analyses of living cells.  
 
All measurements mentioned above analyse cellular behaviour on the population level, that 
is, cellular heterogeneity is neglected and population data is assumed to reflect the 
behaviour of a hypothetical average cell. In many cases, however, single cells differ 
significantly from each other. For example, it is known that single-cell caspase activation is 
complete within minutes after initiation of the apoptotic process, and that cellular 
heterogeneity gives rise to a much more gradual time course in population measurements 
[30,419] . Likewise, all-or-none MAPK activation at the single-cell level during Xenopus 
oocyte maturation was shown to be obscured at the population level [136] . Thus, single cell 
measurements are required to prove all-or-none behaviour with respect to time and/or input 
concentration. Ideally, the single-cell techniques are non-invasive, that is, cellular behaviour 
is essentially unaffected by the measurement process, so that an individual cell can be 
tracked over multiple time points. Antibody-based measurements typically do not fulfil this 
requirement, as the cells often need be fixed prior to detection. Therefore, it seems that 
single-cell measurements based on fluorescent reporter substrates [28,30]  or on FRET 
probes [149]  are advantageous for time-resolved systems biological analyses. However, 
some nodes of the network are typically not measurable at the single cell level or only by 
invasive single-cell methods. In such cases, an integrated modelling approach incorporating 
population date and invasive as well as non-invasive single-cell measurements has proven to 
be useful to build a predictive model of apoptosis signalling (Peter Sorger, talk at SBMC 
2006). 
 
Another limitation of the experimental data included in this thesis is the lack of quantitative 
knowledge on sub-cellular compartmentalisation. More specifically, the cytoplasmic, nuclear 
and whole-cell measurements of the Smad proteins in Section 6 are not directly comparable, 
because the relative efficiency of the fractionation protocols is unknown. Moreover, SnoN 
protein could be detected in both, the nucleus and the cytoplasm (Peter Nickel, data not 
shown), so that the model assumption regarding its predominant localisation to the nucleus 
remains speculative. Immunofluorescence measurements of have proven to be useful to 
detect the sub-cellular distribution of SnoN and Smad proteins [338,349] . In particular, the 
Smad shuttling dynamics can be analysed in real-time by microscopic analysis of cells 
expressing low levels of GFP-tagged Smad proteins [339] . Unfortunately, these techniques 
are not applicable in primary mouse hepatocytes, as these cells show strong background 
fluorescence signals, most likely due to high expression of fluorophores. Additionally, the 
behaviour of primary mouse hepatocytes differs from preparation to preparation (i.e., from 
one donor animal to another), and they cannot easily be manipulated by transfection, which 
complicates systems biological analyses. Taken together, it seems that other cellular 
systems are superior over primary mouse hepatocytes when it comes to systems biology. In 
particular, the main argument for analyses of primary mouse hepatocytes, their close 
relationship to the in vivo situation, seems questionable: Ho et al. [420]  reported that GRK2 
is an important transcriptional feedback regulator of TGFβ signalling in primary mouse 
hepatocytes, while we did not find any evidence for such GRK2-mediated feedback (Section 
6). Thus, it seems that the behaviour of primary mouse hepatocytes depends on the isolation 
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protocol, implying that most experiments in hepatocytes are unlikely to fully reflect the in vivo 
situation as discussed previously [421] .    
 
For the analysis presented in Section 5, protein half-life measurements had to be collected 
manually from the literature (Appendix E). Given that the protein half-life is expected to vary 
with the cell type, the culture conditions and with the experimental protocol, the analysis 
presented in Section 5 can only be considered to be a first step towards an integrated 
understanding of gene expression and turnover data. Global measurements of all protein 
half-lives under standard experimental conditions are required to further confirm the results 
obtained in Section 5. Moreover, such data would generally simplify kinetic modelling of 
transcriptional networks, as the time course of protein expression in response to 
transcriptional regulation is known to be determined by the mRNA and protein half-lives [391] 
. In fact, large-scale protein half-life data is already available for yeast [287] , and turnover 
measurements should also be possible in mammalian, e.g., by using mass spectrometry 
[422] . Additional large-scale data resources are required to boost systems biological 
research on protein complex formation as summarised in the following. The relative 
abundances of different proteins in a given cell are central to the control of many phenomena 
including protein complex formation [423] , enzyme catalysis [15] , transcriptional control 
[424] , and feedback regulation (Sections 3 and 4). Thus, measurements of absolute or 
relative protein concentrations for at least one standard cell line are expected to greatly 
improve the predictive power of mathematical models. Such data is already available for 
yeast [425] , and a mass spectrometry-based quantification of several thousand proteins has 
also been reported for mammalian neurons [108] . Ideally, these protein quantifications 
should be complemented by measurements on competitive binding and on relative protein-
protein affinities, at least for central parts of the regulatory network. The results presented in 
Sections 3, 4 and 7, and those obtained by others [399,426]  suggest that competitive vs. 
simultaneous binding of proteins to common binding partners strongly affects the qualitative 
behaviour of biochemical networks. A central problem underlying mathematical models of 
receptor tyrosine kinase (RTK) signalling via multi-adaptors such as insulin receptor 
substrates (IRS) is the lack of knowledge regarding competitive vs. simultaneous binding, 
thus making any RTK model uncertain. Experimentally, competitive binding should be 
measurable on a high-throughput scale by protein microarrays or by comparing yeast two-
hybrid interactions with and without co-expression of a hypothetical competitor. Competitive 
binding can only be significant if the competitor-target interaction affinity is sufficiently high, 
so that quantitative interaction data is required to investigate competition effects. Moreover, 
physiologically relevant parameter ranges generally need to be known to implement and to fit 
realistic mathematical models (discussed in Section 6.7). Protein-protein affinities and 
enyzme-substrate interactions are typically characterised in vitro using truncated protein 
constructs, so that measured kinetic parameter values will, in many cases, not reflect the in 
vivo situation, and are not comparable among each other. More specifically, it is known that 
the affinity of protein-protein interactions is highly dependent on the buffer conditions [427] , 
and that protein truncation can profoundly alter the characteristics of protein-protein 
interactions, e.g., due to loss of multivalent binding [428]  or due to loss of intramolecular 
autoinhibition [429] . One solution to this dilemma might be to measure the binding of 
multiple proteins to a common binding partner in parallel as recently reported for EGF 
receptor signalling [430]  and for cyclin-dependent kinases [431] , thus standardizing the 
buffer conditions and the protein constructs used. More in general, it seems more practical to 
define physiologically relevant ranges for each type of biochemical reaction (e.g., for kinase-
mediated catalysis) based on measurements using full-length proteins in vitro (e.g., [432] ) 
and/or obtained in vivo (e.g., [149,339] ), as described in Appendix F for the TGFβ model. A 
public consensus database containing such parameter ranges would greatly simplify the 
implementation of physiologically relevant mathematical models, especially for newcomers to 
the field. Taken together, the data sets discussed in this section would help to reduce kinetic 
models of cellular processes, as specific reactions could be neglected a priori based on 
reasoning on time scale (protein half-life data; database containing typical parameter values) 
or based on competition arguments (lack of competition, low abundance or low relative 
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affinity). In other words, these high throughput data would allow for a more mechanistic 
simplification of mathematical models, thus decreasing the need for ad hoc assumptions (see 
also Section 9.3).   
 
 
9.2 Testing the quantitative model of signal specificity 
 
It is often claimed that systems biology will simplify drug discovery by enabling for in silico 
identification of potential drug targets (e.g., [433] ). However, such therapeutical applications 
require that the present systems biological models can be extended such that they describe 
long-term phenotypic responses downstream of cellular signalling. So far, successful 
predictions of stimulus-induced cell fate decisions were only obtained using linear 
approaches that ‘simply’ correlate the activation profiles of intracellular signalling molecules 
with phenotypic responses [434] . However, these approaches, though valuable, neglect 
feedback loops from the downstream gene expression machinery involved in cell fate 
decisions to the upstream signalling network. Moreover, they do not provide mechanistic 
insights into how the multiple signalling pathways actually interact by multiple crosstalk 
mechanisms to bring about a stimulus-specific response. The long-term goal is therefore to 
construct mechanistic mathematical models based on high throughput and time-resolved 
protein array data covering many nodes within the network. As phenotypic commitment of 
cells typically requires ongoing signalling for several hours (Appendix A), protein array 
measurements should include both the modification state of signalling proteins and their 
absolute abundance. Based on time-resolved protein array data, we are currently trying to 
understand differential response of a cancer cell line towards different cancer drugs (in 
collaboration with Christine Sers, Charite Berlin). It turned out that parallel microarray-based 
expression profiling at the mRNA level is necessary to mechanistically understand the 
connections between the network species, i.e., to distinguish alternative paths of 
transcriptional regulation and to separate transcriptional regulation from regulation by 
proteasomal degradation.    
 
A first step towards an integrated model incorporating upstream signal transduction and 
downstream phenotypic responses might be to analyse signal decoding at the level of gene 
expression for a specific signalling pathway. As summarised in Section 1.3, the quantitative 
aspects of intracellular signals such as amplitude and duration are thought to determine 
downstream gene expression and phenotypic responses. However, a rigorous experimental 
proof for this quantitative model signalling specificity is lacking for most signalling pathways 
and cell types. In most cases, conclusions regarding quantitative encoding were postulated if 
the time courses for a given signalling molecule (e.g., phospho-Erk) differed between two 
ligands, each of which induces a specific phenotypic response. Importantly, possible 
contributions of other signalling pathways were typically not investigated. Thus, a more 
systematic approach is required, where the amplitude and the duration of a specific 
intracellular signalling molecule can be varied selectively. Such an analysis should, for 
example, be possible in cells expressing a Raf construct (ΔRaf-ER) that can rapidly be 
activated by treating cells with estradiol [435] . Titration with different doses of estradiol 
should elicit a gradual increase in Erk activation in fibroblasts [141] , and the corresponding 
dose-response can be measured using the monoclonal antibody against double 
phosphorylated, active Erk. Using the quantitatively measured Erk signal as the input, one 
can analyse gene expression or phenotypic responses as a readout, and thus relate the 
quantitative aspects of the signal to downstream responses. Importantly, the duration of the 
input Erk signal can easily be controlled by addition of the Mek inhibitor U0126 which 
terminates Erk signalling within minutes. Thus, a three-dimensional map can be generated 
showing phenotypic or gene expression responses as a function of Erk amplitude and 
duration. For instance, it can be investigated in detail whether c-fos indeed acts as an 
ultrasensitive decoder of Erk dynamics [436] . Often two intracellular signals interact in a 
nonlinear fashion to bring about synergistic [437,438] , mutually exclusive [140,439]  or even 
more complex [440]  downstream responses. For example, it is known that Raf and Akt 
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cooperate to bring about much stronger cell cycle progression than either signal alone at 
least in some cells [437] . The interactions between these pathways can be investigated in 
cells expressing estrogen-sensitive Akt and androgen-sensitive Erk constructs [437] , and the 
signals can be terminated using small molecule inhibitors against Akt and Mek, thus allowing 
to generate a four-dimensional input map (Akt amplitude, Erk amplitude, Akt duration, Erk 
duration).         
 
 
9.3 Modelling approaches in systems biology 
 
Systems biology comes in various approaches, ranging from integration of large-scale data 
sets to a mechanistic description of small subsystems. Three classes of mathematical 
models can be distinguished: First, small mechanistic models are used to understand well-
characterised sub-networks (‘motifs’). Second, complex reactions networks are simulated 
using small fuzzy models if experimental data is limiting (‘top-down’ or ‘mesoscale’ models). 
Third, large mechanistic models are used to understand the effects of molecular 
perturbations on complex reaction networks (e.g., to simulate the effects of drugs acting at 
specific sites of the network). All models aim to conceptualise experimental results, and often 
focus on the explanation of non-trivial observations. Further aims might include the cost-
effective design of new experiments and/or the discrimination of alternative reaction 
mechanisms [441] .    
 
Unfortunately, it is hard to objectively compare all these approaches based on the published 
literature. This is due to the fact that, in many cases, some of the predicted data sets were 
most likely known prior to model finalisation, thus giving rise to a bias in model development. 
Moreover, there is often no clear distinction between predicted measurements, and data sets 
used to adjust the model. Especially for large mechanistic models all available data sets are 
typically used for model training, and all simulations are discussed as model ‘predictions’. 
This indicates that large mechanistic models typically do not allow to reliably predicting new 
experiments unless enormous amounts of experimental data are available. For instance, the 
relative contributions of redundant pathways cannot be identified unless experimental 
measurements are performed for each of the parallel branches. Although such 
comprehensive experimental coverage of signalling pathways might be available in the near 
future if protein array measurements become more reliable, the value of large mechanistic 
models remains unclear. More specifically, they often do not provide a qualitative 
understanding of the system behaviour, but merely serve as ‘dumb’ in silico replicates of the 
intracellular regulatory network that can be used to plan new experiments. Taken together, 
large mechanistic models that are generated based on sufficient amounts of experimental 
data might contribute to the design of drugs or experiments targeting specific interactions 
within the network. However, they will probably contribute little to our qualitative 
understanding of the intracellular regulatory network unless new model analysis tools are 
developed.   
 
We recently described a mesoscale model describing the initiation of DNA synthesis during 
liver regeneration [442] . Due to limited experimental data, a simplicistic approach was 
chosen: Post-translational regulation via signalling cascades was assumed to be fast relative 
to transcriptional regulation. Thus, only species induced at the transcriptional level were 
implemented as dynamical variables, while nonlinearities arising in fast signal transduction 
were included implicitly in the rate laws. The model was trained based on knock-out data, 
and the kinetic parameters and rate laws were chosen such that they match these data. 
Moreover, many of the nodes considered in the model were chosen based on the availability 
of corresponding knock-out data. In the retro-perspective, the model of liver regeneration 
reveals several weak points of mesoscale modelling: The simplifications made are often 
completely arbitrarily due to the lack of sufficient experimental data, and the same will be true 
for other mesoscale models (see also Section 9.1). In particular, the rate laws used to 
describe whole signal transduction pathways may or (more likely) may not reflect biological 
 
 115
reality. Moreover, it is impossible to choose a physiologically relevant range for the lumped 
kinetic parameters, because they have no direct physical meaning, thus giving rise to an 
unreasonably large parameter space. Owing to these pronounced topological and 
mechanistic uncertainties, one does not expect that mesoscale models will be predictive at 
present. Recently, two groups applied engineering control theory to get insights into the 
input-output processing by whole signal transduction pathways [443,444] . Such black-box 
approaches may provide a more solid basis for lumping together many molecular steps in 
future mesoscale models.   
 
Based on the above arguments, I believe that mechanistic modelling of small modules or 
motifs will be the most successful application of mathematical modelling in biology (e.g., 
[445] ). Biological sub-networks are often characterised in much detail, thus allowing for 
mechanistic modelling with parameters that have direct physical meaning (Sections 2, 3, 4, 6 
and 8). The resulting models and their possible behaviours can, in many cases, be 
understood in qualitative terms, and the models are expected to have predictive power due 
to their mechanistic basis. However, modelling on a small scale requires that motifs can 
actually be identified within the complex intracellular regulatory network, and that they can be 
analysed experimentally without significant contribution from external interactions. Motif 
identification and separation from the network is particularly relevant for applications such as 
model discrimination and experimental design which are expected to fail for more complex 
reaction networks. Motif identification as the first step of modelling is not straight-forward, as, 
for example, the MAPK cascade, which is often considered to be a module, is far from being 
isolated in living cells. More specifically, it is known that upstream stimuli not only increase 
Raf activity, but that they also directly regulate Mek [446]  and that they control the 
phosphatase activity within the pathway [53] . High throughput analyses suggest that a large 
number of additional MAPK regulators exist in living cells [447] , thus casting further doubt on 
the modularity assumption underlying many MAPK models. The following section briefly 
summarises experimental and theoretical analyses of small regulatory motifs described in the 
literature, and delineates a bottom-up in vitro approach that may be suited to identify and to 
analyse motifs in biochemical signalling networks.   
 
 
9.4 Motifs in signal transduction - a bottom-up approach 
 
Extensive analyses of the E. coli transcriptional regulatory network revealed the existence of 
recurrent regulation patterns, termed network motifs [59,62] . The properties of common 
transcription motifs including  autoregulation and feed-forward loops were then investigated 
numerically, and the predicted behaviour was subsequently confirmed experimentally 
[62,395,448,449] . Likewise, another recurrent motif of gene expression networks, sRNA-
mediated regulation, was analysed in Section 7, and the model predictions regarding sign-
sensitive delay behaviour were subsequently confirmed experimentally.   
 
Unfortunately, the motifs found in protein-protein interaction networks are of little value for 
mathematical modelling, as the data sets do not distinguish between different types of 
interactions (e.g., inhibition vs. activation and catalysis vs. simple binding). Published kinetic 
modelling studies were therefore mainly focussed on basic motifs that have long been known 
to be relevant for signal transduction such as the (de)phosphorylation cycle [14] , multisite 
phosphorylation [167]  and protein kinase cascades [280] . In Section 5, an additional 
recurrent motif of mammalian signal transduction cascades was identified: transcriptional 
autoregulation of signalling cascades generally results in negative feedback, and occurs by 
inhibitor (RFI) upregulation, while transducer downregulation plays no role. The simulations 
in Section 6 reveal another twist in TGFβ-mediated regulation of SnoN: Smad signalling 
enhances SnoN degradation in addition to its transcriptional upregulation, thus giving rise to 
a combination of negative feedback and incoherent feed-forward regulation. Intriguingly, 
such dual induction and degradation has been reported for other RFIs including MKP-3 [450] 
, Sprouty [451] , Smad7 [452]  and SOCS-3 [453] . The simulations in Section 6.7 suggest 
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that strong Smad-induced induction and degradation of SnoN ensures that SnoN selectively 
acts as a feedback inhibitor (‘homologous desensitisation’), while its induction by other 
stimuli (‘heterologous desensitisation’) is predicted to be without significant effect on TGFβ 
signalling. However, more detailed theoretical analyses are required to get further insights 
into the kinetic implications of RFI action.   
 
A recent study in Science revealed that three cyanobacterial circadian proteins, termed KaiA, 
KaiB and KaiC, oscillate with a 24h period when the respective recombinant proteins were 
mixed in vitro [454] . Subsequent mathematical modelling studies provided detailed 
mechanistic insights into the functioning of the cyanobacterial clock (e.g., [168] ). The 
theoretical analyses were greatly simplified and corroborated by the fact that potential 
additional regulatory factors present in living cells could be excluded. Moreover, in vitro 
mixtures of recombinant proteins are advantageous, because they behave like single cells, 
so that heterogeneity effects, typically arising in population measurements, can be neglected. 
In conclusion, it seems that in vitro reconstitution systems provide valuable tools for the 
quantitative analysis of regulatory network motifs. In collaboration with Lee Bardwell 
(University of California, Irvine), we are currently investigating the behaviour of the Erk 
(de)phosphorylation cycle by mixing the kinase (Mek), the substrate (Erk) and the 
phosphatase (MKP-3). Our preliminary results indicate that the Erk phosphorylation level 
responds to changes in the Mek and MKP-3 concentration in a highly ultrasensitive fashion. 
Another well-established in vitro system is the caspase cascade comprising Apaf-1, caspase-
9, caspase-3 and XIAP that was analysed by mathematical modelling in Section 4 [201] . The 
relevance of experimental and theoretical results obtained in vitro needs to be confirmed in 
living cells, where multiple additional regulatory factors might play a role. This can be done in 
a step-wise manner: Experiments in cytosolic extracts can easily be manipulated by addition 
of recombinant proteins or by antibody-based protein depletion, and heterogeneity effects 
can again be neglected. Thus, extract experiments are directly comparable to the results 
obtained in vitro, and such a comparison might allow verifying the central assumption that a 
simple regulatory motif under consideration is separable from the rest of the network. Such 
experiments in cytosolic extracts already proved to be useful for analyses of the MAPK 
cascade in Xenopus oocytes [12]  and of the apoptotic caspase cascade in mammalian cells 
[175] . As a final step, the results obtained in vitro and in extracts might be compared to 
those in living cells which are harder to manipulate (e.g., by overexpression or knock-down). 
The proposed approach might fail for regulatory motifs that require transcription and 
translation, even though protein biosynthesis can, in principle, be maintained in vitro and in 
extracts. In such cases, synthetic biology approaches (e.g., [455] ) might help to analyse 
motif behaviour in isolation by expression of motif constituents in heterologous organisms. In 
conclusion, it seems that one of the major benefits of synthetic biology could be the 
separation of functional modules from the rest of the intracellular regulatory network, and 


















































































A Additional material on time scales of signal transduction 
 
 
Table A.1 Duration of intracellular signals.  
Signal Event Stimulus  
Condition 
 Signal Duration Reference 
Erk phosphorylation Growth Factors Cell culture 10’ – 24h 
[456]  
[36]  




> 70 h [123]  




up to 72 h [457]  
PI3K 
activity insulin Cell culture 10’ - 8h [458,459]  
Akt phosphorylation NGF Cell culture 10’ - 15h [459,460]  
cAMP increase or 
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Minutes to 




















~ 10 h [465]  
The time a given signal remains significantly elevated over the basal level was estimated from literature studies. The data reveal 











Table A.2: Transcription/translation inhibitors sustain intracellular signals.  





NF-κB binding  
to DNA IL1beta epithelial ActD ~320’ [466]  
NF-κB binding  
to DNA IL1beta epithelial CHX ~320’ [466]  
Smad2 




phosphorylation TGFbeta BAECs CHX ~120’ [370]  
STAT3 binding  
to DNA IL-10 Macrophages ActD ~60’ [467]  
STAT5 
phosphorylation G-CSF 32D ActD ~20’ [468]  
STAT5 
phosphorylation G-CSF 32D CHX ~20’ [468]  
STAT5 binding  
to DNA G-CSF 32D ActD ~20’ [468]  
STAT5 binding  
to DNA G-CSF 32D CHX ~20’ [468]  
Erk  
phosphorylation EGF Swiss 3T3 CHX ~45’ [469]  
Erk  
phosphorylation serum fibroblasts CHX ~120’ [470]  
Erk  
phosphorylation EGF HeLa CHX ~30’ [67]  
Erk  
phosphorylation HRG MCF7 CHX ~120’ [471]  
Nuclear Erk 
phosphorylation serum CCL39 ActD ? [472]  
Nuclear Erk 
phosphorylation serum CCL39 CHX ? [472]  
Erk kinase  
activity Angiotensin II VSMC ActD ~60’ [473]  
JNK 
phosphorylation EGF HeLa CHX ~30’ [67]  
JNK 
phosphorylation H2O2 293T ActD ~240’ [39]  
JNK 
phosphorylation H2O2 293T CHX ~240’ [39]  
JNK kinase  
activity TNFα Mesangial ActD ~20’ 
[474]  
 
JNK kinase  




phosphorylation EGF HeLa CHX ~30’ [67]  
Listed are literature studies where time courses of signalling protein activity was measured in the presence and in the absence 
of a transcription inhibitor (actinomycin D = ActD) and/or a translation inhibitor (cycloheximide = CHX). In all studies actinomycin 
and cycloheximide treatment prolonged signalling which supports the relevance of transcriptional negative feedback regulation 
in the mammalian signalling network. The column ‘signal duration (no inhibitor)’ indicates the time of signal termination in cells 




Table A.3: Commitment Times in Intracellular Signalling.  
Signal Event Cellular  Response 
Stimulus 
(cell type) Method 
Threshold 
time Reference 




addition 14 h 
a [456]  




addition > 8 h 
d [475]  




addition > 4 h 
a [122]  







13 h a [458]  




addition > 30’ 
b [476]  




addition 4 h 
b [477]  
Mek activity Differentiation TPA (K562) 
Inhibitor  
addition 18 h 
b [478]  
Mek activity Differentiation M-CSF (myeloid) 
Inhibitor  
addition > 24 h 









addition > 24 h 
b [123]  
TGFbeta receptor 




addition 12-14 h 










addition ~8 h 
a [480]  




addition < 2 h 








addition > 30’ 
b [476]  




addition 4 h 












~1 h b,c [35]  
Listed are literature studies where activity of signalling intermediates was blocked at different stimulation times (stimulus 
addition at t = 0 h) by incubating cells with rapidly-acting small-molecule inhibitors. The threshold times indicate the signal 
duration required to irreversibly commit the cell population to the given phenotypic response (stimulation occurred at t = 0 h). 
Importantly, the signalling events are primary in the sense that they activated within minutes after stimulation, that is, the 
threshold time reflects the true signal duration. The data suggests that decision making in mammalian cells will be profoundly 
affected by slowly acting transcriptional feedback mechanisms. Superscript legend: (a) half of the cells perform cellular 
response if signal is terminated at the threshold time; (b) no response observed if signal is terminated at the threshold time; (c) 
Erk dependency of late-phase gene expression verified by Erk inhibitor; (d) half-maximal thymidine incorporation is observed if 
signal is terminated at the threshold time; (e) complete commitment occurred before the indicated threshold time. Note: One 
study [35]  employed a different experimental approach: low and high doses of LPA induce transient and sustained Erk 
phosphorylation, respectively, and some Erk-dependent downstream genes (e.g., Fra1) were shown to be selectively expressed 





Table A.4: Commitment Times for Extracellular Stimulation.  








exchange ~6 h 






exchange ~6 h 






exchange ~6 h 






exchange ~6 h 















exchange  20 h 















Thymocytes Medium exchange ~8 h 
a [480]  
FGF  
deprivation Differentiation Myoblasts 
Medium 
exchange ~2.5 h 






exchange ~24 h 
a [31]  
IL-3  
deprivation Apoptosis myeloid 
Medium 
exchange ~24 h 
a [485]  




Min6 Medium exchange 2-3 h








30’ b [475]  
TNF-alpha RANTES expression Fibroblasts 
Medium 
exchange ~2 h 
b [43]  
 
Listed are literature studies where extracellular stimuli were removed (or re-added) at different stimulation times, e.g., by 
medium exchange. The threshold times indicate the signal duration required to irreversibly commit the cell population to the 
given phenotypic response (stimulation occurred at t = 0 h). Importantly, the signalling events are primary in the sense that they 
activated within minutes after stimulation, that is, the threshold time reflects the true signal duration. The data suggests that 
decision making in mammalian cells will be profoundly affected by slowly acting transcriptional feedback mechanisms. 
Superscript legend: (a) half of the cells perform cellular response if signal is terminated at the threshold time; (b) no response 
observed if signal is terminated at the threshold time; (c) half-maximal thymidine incorporation is observed if signal is terminated 









B Additional material on kinetic mechanisms for tumour 
suppression and oncogene cooperation  
 
 
B.1  Default model without Ras sequestration 
 
The mathematical model used for the numerical simulations in Figs. 2.1B and 2.2A was 
previously described by Stites et al. [10] . The model is schematically depicted in Fig. 2.1A 
and the differential equations are given in Equations B.1.  
 
Table B.1 Kinetic parameters.  
Parameter [unit] Description Intrinsic Model GEF-GAP model 
GTP [mol/l] Cellular GTP conc. 1.8 ⋅ 10-4 1.8 ⋅ 10-4 
GTP [mol/l] Cellular GDP conc. 1.8 ⋅ 10-5 1.8 ⋅ 10-5 
Ras [mol/l] Cellular Ras conc. 4 ⋅ 10-7 4 ⋅ 10-7 
GEF [mol/l] Basally active GEF conc. 0 10-10 
GAP [mol/l] Basally active GAP conc. 0 5 ⋅ 10-9 
    
khyd [s-1] 
Rate constant of 
intrinsic Ras GTPase 
3.5 ⋅ 10-4 
 0 
kd,GDP [s-1] 
Rate constant of 
GDP dissociation 1.1 ⋅ 10
-4  0 
kd,GTP [s-1] 
Rate constant of 
GTP dissociation 2.5 ⋅ 10
-4 0 
ka,GDP [(mol/l)-1s-1] 
Rate constant of 
GDP association 2.3 ⋅ 10
6 0 
ka,GTP [(mol/l)-1s-1] 
Rate constant of 
GTP association 2.2 ⋅ 10
6 0 
    
kcat,GDP [s-1] 
kcat for exchange 
(RasGDP → RasGTP) 0 3.9 
kcat,GTP [s-1] 
kcat for exchange 
(RasGTP → RasGDP) 0 0.72 
KM,GDP [mol/l] 
KM for exchange 
(RasGDP → RasGTP) 3.86 ⋅ 10
-4 3.86 ⋅ 10-4 
KM,GTP [mol/l] 
KM for exchange 
(RasGTP → RasGDP) 3 ⋅ 10
-4 3 ⋅ 10-4 
    
kcat [s-1] 
kcat for GAP  
activity on Ras 0 5.4 
KM [mol/l] 
KM for GAP  
activity on Ras 2.3 ⋅ 10
-7 2.3 ⋅ 10-7 
 
Listed are the kinetic parameters used for the simulations depicted in Figs. 2.1B and 2.2A (see Equations B.1 for differential 
equations). The column ‘Intrinsic model’ indicates the parameters used to calculate the grey line in Fig. 2.1B, while the column 
‘GEF-GAP model’ lists the parameter set underlying the black lines in Fig. 2.1B and Fig. 2.2A (some parameters were varied as 
indicated in the figure captions).   
 
 
In contrast to Stites et al., competitive binding of an effector to RasGTP was neglected, and 
the concentration of RasGTP was used as the readout. The GTPase reaction intrinsic to Ras 
was modelled with first-order kinetics. GTP and GDP were assumed to be present in excess, 
so that the spontaneous nucleotide exchange reactions follow linear kinetics as well. The 
GEF- and GAP-catalysed reactions were modelled by using the reversible and irreversible 
Michaelis-Menten equations, respectively.  
 
d(RasGDP)/dt =   khyd ⋅ RasGTP - kd,GDP ⋅ RasGDP + ka,GDP ⋅ Ras ⋅ GDP - (GEF ⋅ (kcat,GDP / (KM,GDP / D) ⋅ RasGDP - kcat,GTP / (KM,GTP 





d(Ras)/dt =    kd,GDP ⋅ RasGDP - ka,GDP ⋅ Ras ⋅ GDP + kd,GTP ⋅ RasGTP - ka,GTP ⋅ Ras ⋅ GTP 
 
d(RasGTP)/dt =  - khyd ⋅ RasGTP - kd,GTP ⋅ RasGTP + ka,GTP ⋅ Ras ⋅ GTP + (GEF ⋅ (kcat,GDP / (KM,GDP / D) ⋅ RasGDP -  kcat,GTP / 
(KM,GTP / D) ⋅ RasGTP) / (1 + RasGDP / (KM,GDP / D) + RasGTP / (KM,GTP / D))) - (GAP * kcat,GAP ⋅ RasGTP / 
(KM,GAP / D + RasGTP)) 
  
Equations B.1 Differential equations of the Stites model.  
The grey terms indicate intrinsic Ras GTPase activity and spontaneous nucleotide exchange, while the black terms refer to 
GEF- and GAP-catalysed reactions. The membrane correction factor, D, takes into account that protein-protein interactions are 
strongly enhanced if both interaction partners are localised to the membrane, and was set to 250 [10] . The kinetic parameters 
used for numerical simulations are given in Table B.1. 
 
 
B.2  Model including Ras sequestration  
 
In Section B.1, the GEF- and GAP-catalysed reactions were modelled using the Michaelis-
Menten equation. This implies that the concentrations of the GEF-Ras and GAP-Ras 
complex are assumed to be much smaller than the concentrations of RasGTP and RasGDP, 
so that sequestration of Ras in enzyme-substrate complexes is insignificant. In contrast, the 
numerical simulations in Fig. 2.3 were obtained using an elementary step description of the 
GEF- and GAP-catalysed reactions. In other words, the enzyme-substrate complexes are 
included as dynamic variables (Equations B.2), so that Ras sequestration becomes 
significant provided that the GEF and/or GAP concentrations are sufficiently large. The 
sequestration model neglects intrinsic GTPase and nucleotide exchange reactions, and also 
assumes that the GEF irreversibly catalyses exchange of GDP for GTP. The kinetic 
parameters (given in Table B.2) were chosen similarly to those in Table B.1.   
 
Table B.2 Kinetic parameters.  
Parameter [unit] Description Parameter value 
Ras [mol/l] Cellular Ras conc. 4 ⋅ 10-7 
GEF [mol/l] Basally active GEF conc. 3 ⋅ 10-8 (varied) 
GAP [mol/l] Basally active GAP conc. 7 ⋅ 10-7 
   
kcat,GEF [s-1] 
kcat for exchange 
(RasGDP → RasGTP) 3.9 
KM,GEF [mol/l] 
KM for exchange 
(RasGDP → RasGTP) 3.86 ⋅ 10
-6 
koff,GEF [s-1] 
koff for exchange 
(RasGDP → RasGTP) 10 
   
kcat,GAP [s-1] 
kcat for GAP  
activity on Ras 5.4 
KM,GAP [mol/l] 
KM for GAP  
activity on Ras 2.3 ⋅ 10
-7 
koff,GAP [s-1] 
koff for GAP  
activity on Ras 10 
 
Listed are the kinetic parameters used for the simulations depicted in Figs. 2.3A (see Equations B.2 for differential equations). 






d(RasGDP)/dt   =   vcat,GAP - von,GEF + voff,GEF 
d(GEF)/dt   =   - von,GEF + voff,GEF + vcat,GEF 
d(RasGDP~GEF)/dt  =   von,GEF - voff,GEF - vcat,GEF 
 d(RasGTP)/dt  =   vcat,GEF - von,GAP + voff,GAP 
d(GAP)/dt   =   - von,GAP + voff,GAP + vcat,GAP 
d(RasGTP~GAP)/dt  =   von,GAP - voff,GAP - vcat,GAP 
 
von,GEF = (koff,GEF+kcat,GEF) / (KM,GEF / D) ⋅ RasGDP ⋅ GEF 
voff,GEF = koff,GEF ⋅ RasGDP~GEF 
vcat,GEF  = kcat,GEF ⋅ RasGDP~GEF 
von,GAP = (koff,GAP+kcat,GAP) / (KM,GAP / D) ⋅ RasGTP ⋅ GAP 
voff,GAP = koff,GEF ⋅ RasGTP~GAP 
vcat,GAP  = kcat,GEF ⋅ RasGTP~GAP  
  
 
Equations B.2 Differential equations of the sequestration model.  
The enzyme-substrate complexes (RasGDP~GEF and RasGTP~GAP) are included as dynamic variables, so that Ras 
sequestration becomes significant provided that the GEF and/or GAP concentrations are sufficiently large. The intrinsic GTPase 
and nucleotide exchange reactions are neglected, and the GEF is assumed to irreversibly catalyse the exchange of GDP for 
GTP. The membrane correction factor D was again chosen to be 250 (see Section B.1). 
 
 
B.3  Michaelis-Menten constants for mammalian Ras-GEFs 
 
The tumour suppression effect described in the main text requires that the Michaelis-Menten 
constant of the GEF-catalysed reaction (KM,GEF) is close to or even below the intracellular 
Ras concentration. The KM,GEF in the default model was measured for Cdc25Mm on 
unprocessed Ras [98] . However, it is well established that post-translational Ras 
farnesylation drastically enhances the Ras-GEF interaction [99,100,101] . Moreover, it is 
known that Michaelis-Menten constants of other GEFs than Cdc25Mm are lower, especially if 
Ras is farnesylated [99,101,102,103] . Kinetic measurements taken from the literature (Table 
B.3) indicate that the KM,GEF will often be two or more orders of magnitude lower than that 
used in the default Stites model, so that the KM,GEF will be close to or even below the 
intracellular Ras concentration.   
 
 
Table B.3 Experimentally measured KM-values of GEF-catalysed nucleotide exchange. 
Enzyme Substrate KM Reference 
mouse CDC25Mm H-Ras (unprocessed) > 11 µM [486]  
mouse CDC25Mm H-Ras (unprocessed) 386 µM [98]  
mouse CDC25Mm Ras2p-[GDP] (yeast, unprocessed) 70 nM [102]  
hSos1 K-Ras-[GDP] (prenylated) 225 nM [101]  
hSos1 H-Ras-[GTP] (unprocessed) 2.2 µM [103]  
Ras GRF K-Ras-[GDP] (processed) 680 nM [99]  









C Additional material on competing docking interactions 
can bring about bistability in the MAPK cascade 
 
 
C.1  Sequestration Model Used for Calculation of Figs. 3.2 and 3.3 
 
The sequestration model which is depicted in Fig. 3.1D includes the previously described standard 
MAPK model (‘basic model’) [150] , and additionally takes Mek sequestration by un-
/monophosphorylated Erk into account. The impact of such Mek sequestration was investigated by 
altering the sequestration factor S, which enters the association rates of the Mek sequestration 
complexes (Mek~Erk, Mek~pErk, pMek~Erk and pMek~pErk). The sequestration factor was set to S = 
0 in Fig. 3.2A (black line) in order to simulate the behaviour of the basic model devoid of Mek 


























































pRaftot: varied for calculation of stimulus-response 
Mektot = 1 (in Fig. 3.2 and 3.3B) or Mektot varied in Fig. 3.3A 
Erktot = 1 (in Fig. 3.2 and 3.3B) or Erktot varied in Fig. 3.3A 
Vmax_PPase_Mek = 0.001 (in Fig. 3.2 and 3.3A) or Vmax_PPase_Mek varied in Fig. 3.3B 
Vmax_PPase_Erk = 0.04 (in Fig. 3.2 and 3.3A) or Vmax_PPase_Erk varied in Fig. 3.3B 
S = 0 (Fig. 3.2A, black line) or S = 1 (Figs. 3.2A (grey line), 3.2B and 3.3) 
 
kon_Raf_Mek          = 0.65; 
koff_Raf_Mek         = 0.065; 
kcat_Raf_Mek         = 0.18; 
KM_PPase_Mek         = 0.1; 
kon_Mek_Erk          = 0.88; 
koff_Mek_Erk         = 0.088; 
kcat_Mek_Erk         = 0.22; 
KM_PPase_Erk         = 0.5; 
 
 
C.2  Extended Sequestration Model Used for Calculation of Fig. 3.4 
 
Figure 3.4 shows that significant competition between Raf and Erk for binding to Mek is required for 
bistability to arise from the proposed mechanism. Additionally, bistability requires that 
bisphosphorylated Erk hardly binds to Erk, i.e., that product inhibition does not occur in Mek-mediated 
Erk phosphorylation. 
 
Non-competitive binding of Raf and Erk to Mek was simulated by considering ternary complexes 
between Raf, Mek and Erk, and Raf-mediated catalysis on these ternary complexes (see Fig. C.1). 
More specifically, pRaf~Mek complexes with Erk (Fig. C.1A), with pErk (Fig. C.1B) and with ppErk 
(Fig. C.1C) were taken into account. The association rate constants of these ternary complexes equal 
those of the binary Raf~Mek complexes (kon,Raf~Mek) of the Mek~Erk complexes (kon,Mek~Erk) multiplied 
by the competition-factor c. The degree of competition was varied by changing c. A value of c = 0 
means pure competitive binding, while a value of c = 1 implies pure non-competitive binding. The 
dissociation rate constants and the catalytic rates of the ternary complexes equal those of the binary 





Product inhibition in Mek-mediated Erk phosphorylation was simulated by considering complexes of ppErk with Mek, pMek, and 
ppMek (see Fig. C.1C). The association rates of these additional complexes equal those of the other Mek~Erk complexes 
(kon,Mek~Erk) multiplied by the product-inhibition-factor p. The degree of product inhibition was varied by changing p. A value of p = 
0 means no product inhibition, while a value of p = 1 implies strong product inhibition. The dissociation rate constants of the 











































































































































iii) Kinetic Parameters / Initial Concentrations 
 
pRaftot: varied for calculation of stimulus-response 
C (= Competition factor) varied 
P (= Product inhibition factor) varied  
S = 1 (= Sequestration factor) 
kon_Raf_Mek = 0.65 
koff_Raf_Mek = 0.065 
kcat_Raf_Mek = 0.18 
Vmax_PPase_Mek = 0.001 
KM_PPase_Mek = 0.1 
kon_Mek_Erk = 0.66 
koff_Mek_Erk = 0.066 
kcat_Mek_Erk = 0.22 
Vmax_PPase_Erk = 0.04 




C.3  Model Used for Calculation of Fig. 3.5 
 
Figure 3.5 shows that the bistability mechanism proposed in Section 3.3 synergises with that proposed 
by Markevich et al. [23] , which arises from enzyme depletion effects in Erk double phosphorylation. 
The models used for calculation of Fig. 3.5 exhibit the topology depicted in Fig. 3.1D.  
 
The models used for the calculation of curves 1 and 2 in Fig. 3.5 exhibit positive cooperativity in Mek-
mediated Erk phosphorylation, so that the (isolated) Erk cycle exhibits weak bistability [153] . More 
specifically, it was assumed that the first and the second phosphorylation steps of ppMek-mediated 
Erk phosphorylation proceed with different kinetic constants. Relatively high affinity (i.e., a low KM,M1), 
but slow catalysis (i.e., a low kcat,M1) for the first phosphorylation step. By contrast, low affinity (i.e., a 
high KM,M2), but very fast catalysis (i.e., a high kcat,M2) was assumed for the second phosphorylation 
step. No phosphorylation-site-specific kinetic differences in phosphatase-mediated Erk 
dephosphorylation were assumed (see maximal velocities, Vm,PP1 = Vm,PP2, and Michaelis-Menten 
constants, KM,PP1 = KM,PP2 below), but dephosphorylation was modelled by a more complex Michaelis-
Menten Mechanism, which takes enzyme competition effects into account [23]  
 
Curve 1 in Fig. 3.5 shows that relatively narrow range of bistability arises from the Markevich 
mechanism alone. In these simulations, the feedback mechanism proposed in Section 3.3 (i.e., Mek 
sequestration in Raf-inaccessible complexes) was switched off by abolishing the formation 
unproductive sequestration complexes (Mek~Erk, pMek~Erk, Mek~pErk and pMek~pErk). This was 
accomplished by setting konMek~Erk = 0. 
 
Curve 2 in Fig. 3.5 demonstrates that the feedback mechanism proposed in Section 3.3 brings about a 
broad range of bistability when combined with that proposed by Markevich et al. [23] . These 
simulations correspond to a system, which includes Mek sequestration into Raf-inaccessible 
complexes (black and grey arrows in Fig. 3.1D). The association rate constant of these complexes 
was set to the measured value konMek~Erk = 0.88 (Table 3.1). This value implies that the affinity of the 
ppMek~Erk-complex, which is the enzymatic intermediate on the first Erk phosphorylation site, equals 
that of the unproductive sequestration complexes (Mek~Erk, pMek~Erk, Mek~pErk and pMek~pErk). 
 
Curve 3 in Fig. 3.5 shows that a relatively narrow range of bistability arises from the feedback 
mechanism proposed in Section 3. These simulations correspond to a sequestration model (black and 
grey arrows in Fig. 3.1D), where positive cooperativity and enzyme depletion effects were eliminated 
from the Erk cycle. This was done by assuming the same catalytic rate constant for the first and the 
second steps of Mek-mediated Erk phosphorylation (kcatM1 = kcatM2 = 1). 
 
















































iii) Kinetic Parameters / Initial Concentrations 
 
pRaftot: varied for calculation of stimulus-response 
Mektot = 1 
Erktot = 10 
kon_Raf_Mek = 0.65 
koff_Raf_Mek = 0.065 
kcat_Raf_Mek = 0.18 
Vmax_PPase_Mek = 0.001 
KM_PPase_Mek = 0.01 
kon_Mek_Erk = 0.88 (curves 2 and 3) or kon_Mek_Erk = 0 (curve 1) 
koff_Mek_Erk = 0.1 
kcatM1 = 0.2 (curves 1 and 2) or kcatM1 = 1 (curve 3) 
KMM1 = 0.35 
kcatM2 = 10 (curves 1 and 2) or kcatM2 = 1 (curve 3) 
KMM2 = 1 
VmPP1 = 0.4 
VmPP2 = 0.4 
KMPP1 = 0.5 








D  Additional material on simultaneous inhibition of initiator 
and effector caspases by XIAP establishes implicit 
bistability in caspase activation 
 
 
D.1  Differential equations for the wild-type and non-competitive models 
 
In the following, the differential equations of the wildtype model are given, 
and it is explained how the wildtype model was extended in Fig. 4.4H and Fig. 4.5 
in order to take non-competitive binding of Casp3 and Casp9 to XIAP into 
account (“Non-competitive model”). 
 
Wildtype Model: The velocities numbered according to Fig. 4.1B and the differential 
equations of the model are: 
 
 






Non-competitive model: XIAP-mediated feedback requires that XIAP binds caspases 
competitively at least to some extent, since otherwise Casp3 cannot sequester XIAP away 
from Casp9 (see main text). In order to analyse the role of competitive binding in more detail, 
the wildtype model (see Fig. 4.1B) was extended according to Fig. D.1. Casp3, Casp9 and 
XIAP form a ternary complex in this ’non-competitive model’ either by binding of Casp3 to 
Casp9-associated XIAP (reactions 33 – 36) or by binding of Casp9 to Casp3-associated 
XIAP (reactions 37-40). While some differential equations of the wildtype model (see above) 
were retained in the non-competitive model, those describing the species marked in red in 




Figure D.1: Model extension in the non-competitive model.  
The wildtype model (Fig. 4.1B) was extended by the black reactions (29 – 42). Accordingly, the differential equations of the red 
intermediates were altered in comparison to the wildtype model (see text), and those of the black intermediates were newly 















Additionally, four complexes between Casp3, Casp9 and XIAP were considered in the non-




   
 






The values chosen for the additional kinetic parameters in the non-competitive model are 
summarised in Table D.1. The association and dissociation rate constants of the ternary 
Casp9-XIAP-Casp3 complexes (reactions 33 – 40 in Fig. D.1) were assumed to equal those 
of the simple caspase-XIAP complexes, Casp3-XIAP (k15, k-15) and Casp9-XIAP (k9, k-9), and 
multiplied by the factors a and d (see Table D.1). Thus, a and d quantify to what extend 
Casp3 and Casp9 bind competitively to XIAP. In Fig. 4.4H, both a and d were assumed to 
equal unity, so that competition does not occur. The competition ratio varied in Fig. 4.5 is 
given by α = a / d, and increasing caspase competition for XIAP (i.e., decreasing α) was 
modelled by simultaneously decreasing a and increasing d to the same extent (fold-
changes). 
 
Table D.1: Additional kinetic parameters used in the non-competitive model.  
The reactions numbered according to Fig. D.1 (Column “#”) are listed and the corresponding reactants and products are 
indicated (Column “Reaction”). The rate constants “k+” describe the reactions from left to right, while “k-” are the rate constants 
for the opposite direction (for reversible reactions). Additionally, the dissociation constants KD are indicated for reversible 
bimolecular reactions. The degradation rates (29 – 31) of the ternary complexes were set equal to those of all other molecular 
species in the model, and association between Casp9 and active Apaf-1 (41 – 42) was assumed to be unaffected by ternary 





D.2  Bifurcation analysis of XIAP-mediated feedback 
 
In this Section, detailed simulations are provided, which show that XIAP-mediated feedback 




Fig. D.2: Bifurcation analysis of XIAP-mediated feedback.  
The steady state concentrations of free Casp3 (C3*; black line in A), of XIAP-associated Casp3 (C3*X; grey line in A), of free 
Casp9 (C9 + A*C9 + C9* + A*C9*; black line in B) and of XIAP-associated Casp9 (C9X + A*C9X + C9*X + A*C9*X; grey line in 
B) are plotted as a function of the stimulus, A*tot. The wildtype model (depicted in Fig. 4.1B) with the parameters given in Table 
4.1 was used for simulations. The solid and dashed lines indicate stable and unstable steady states, respectively.   
 
Upon weak stimulation the vast majority of Casp9 molecules is inhibited by excess XIAP 
(black and grey lines in B), so that Casp3 activation is negligible (black line in A). As the 
stimulus strength is increased above the threshold (~ 3 nM), XIAP is suddenly redistributed 
from Casp9 to Casp3 (grey lines in A and B), and Casp3 and Casp9 activities are switched 
on (black lines in A and B). Caspase activity is maintained even if the stimulus is removed, 
as Casp3, once activated, retains XIAP (grey line in A), and thereby prevents Casp9 
inhibition (black line in B). 
 
D.3  An in vitro Test for XIAP-mediated Feedback 
 
In Section 4, it was predicted that XIAP mediates positive feedback and bistability in the 
intrinsic pathway. This Section contains a description of an in vitro experiment designed to 
confirm that sequestration of XIAP by Casp3 indeed results in feedback amplification.  
 
XIAP is known to suppress the activity of apoptosome-activated Casp9 in vitro [201] , but 
according to the results given in the main text excess pro-Casp3 should reverse this 
inhibition by sequestering XIAP away from Casp9. The proposed experiments (‘Experiment 
1’ and ‘Experiment 2’) are summarised in Table D.2: The pro-Casp9 mutant D330A, which is 
refractory towards feedback cleavage by Casp3, should be activated in vitro by adding cyto 
c, dATP, and Apaf-1 [201] . Full-length XIAP is added to both ‘Experiment’ reaction mixtures, 
while pro-Casp3 is present in Experiment 2 (feedback on), but absent in Experiment 1 
(feedback on). Then, the Casp9 activities (E1 and E2) of both reaction mixtures should be 









The predicted results are shown in Fig. D.3. Here, the ratio of Casp9 activities with and 
without Casp3 (E2 / E1) as a measure of (XIAP-mediated) feedback strength is plotted 
against the XIAP concentration. As expected, XIAP-mediated feedback is especially 
pronounced for intermediate XIAP concentrations, where C9tot < XIAPtot < C3tot (C9tot = 20 nM 
in these simulations). Additionally, an increase in the Casp3 concentration improves 
feedback strength, and also widens the range of XIAP concentrations, where feedback is 
observed. Therefore, the in vitro experiments should be done using low Casp9 
concentrations, high Casp3 concentrations and intermediate XIAP concentrations (XIAPtot ≈ 
¾ C3tot; see Fig. D.3). Additional simulations revealed that the results shown in Fig. D.3 are 
independent of the concentrations of active Apaf-1, but sufficiently high Apaf1-levels should 
be chosen in order to minimise errors.  
 
 
Figure D.3: Predicted results of an in vitro test experiment for XIAP-mediated feedback.  
In vitro behaviour of the caspase cascade with mutant Casp9 (D330A) was modelled by eliminating Casp3-mediated feedback 
cleavage (v4 and v5) and protein synthesis/degradation reactions (v16 - v28) from the differential equations given in Section D.1 






As a control experiment, the whole procedure should be repeated with the XIAP fragments, 
BIR1-BIR2 (specific for Casp3) and BIR3-RING (specific for Casp9), instead of full-length 
XIAP (see Table D.3). These controls mimic non-competitive caspase inhibition, so that the 
feedback strength (C2 / C1) is predicted to equal unity regardless of the protein 
concentrations chosen.   
 
D.4  Casp3-induced Degradation of XIAP Does not Result in Bistability 
 
Experimental evidence suggests that Casp3 activation may result in XIAP cleavage and/or 
degradation, although this seems to be a cell-type-specific phenomenon (see Section 4.6). In 
the following, it is demonstrated that Casp3-induced XIAP degradation (‘inhibition of 
inhibition’ = positive circuit) does not result in physiologically relevant bistability in the 
absence of other feedback amplification loops.  
 
 
Figure D.4: Model of Casp3-induced XIAP Degradation 
 
 
In order to obtain analytical results, a simplified model of Casp3-induced XIAP degradation 
comprising only the black reactions in Fig. D.4 is analysed first. The corresponding 
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The steady state condition of active Casp3 (dC3* / dt = 0) can be written as a quadratic 
equation in C3*, which implies that the steady state of C3* cannot be bistable.   
 
A more realistic model (black and grey arrows in Fig. D.4) considering that XIAP inhibits both 
Casp3 and Casp9 was then analysed numerically. Here, the feedback loops discussed in 
Section 4 (i.e., Casp3-mediated feedback cleavage of Casp9 and XIAP-mediated feedback) 
were assumed to be inactive in order to focus on the role of Casp3-mediated XIAP 
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degradation. Hence, XIAP was assumed to bind to Casp3 and Casp9 in a non-competitive 
manner.  
 
All kinetic parameters were chosen according to Tables 4.1 and D.1 (with α = 1). 
Additionally, Casp3-mediated XIAP degradation (reaction 9 in Fig. D.4) was modelled as an 
irreversible second-order process with the rate constant k9 = 3 * 106M-1s-1, which is the value 
measured for high-affinity substrates of Casp3 [487,488] .  
 
These studies revealed that Casp3-induced XIAP degradation does not result in bistability for 
experimentally measured protein concentrations (Casp3 = 200 nM; Casp9 = 20 nM; XIAP = 
40 nM). Although some bistability could be observed for significantly different expression 
levels (e.g., for XIAP > 100 nM), hysteresis was restricted to a very small stimulus range, so 
that the stimulus-response was virtually indistinguishable from that of a monostable system.  
 
Importantly, the physiological feedback strength (i.e., k9 in Fig. D.4) is likely to be lower than 
that assumed here, as most Casp3 substrates do not match the optimal Casp3 target 
sequence, DEVD [487] . For example, Casp3 cleaves XIAP at a suboptimal site [259] . 
Likewise, Akt, a protein kinase that mediates XIAP stabilisation unless it is processed and 
thereby inactivated by Casp3 [264] , also does not contain the optimal DEVD-target 
sequence [489] . As high feedback strength is required for bistability [197] , it can be 
concluded that Casp3-induced XIAP degradation is unlikely to result in physiologically 
relevant bistability as long as other feedback amplification loops are absent  
 
D.5  The Shared Inhibitor Motif 
 
In Section 4, it was shown that competitive inhibition of Casp3 and Casp9 by XIAP can bring 
about positive feedback and bistability in the intrinsic apoptosis pathway (see Fig. 4.2B, grey 
line; Fig. 4.4F). Similar conclusions regarding positive feedback and bistability also hold in 
general if an inhibitory protein competitively inhibits two consecutive intermediates in signal 
transduction cascades. This ‘shared inhibitor motif’ is schematically depicted in Fig. D.5. A 
stimulus, S, activates the upstream intermediate, U, which then in turn catalyses the 
activation of the downstream intermediate, D. Both active intermediates, U* and D*, are 
subject to negative regulation by the shared inhibitor, I. As indicated in Fig. D.5, the shared 
inhibitor can either be a stoichiometric inhibitor of the intermediates (black arrows in Fig. D.5) 
or alternatively catalyses their deactivation, e.g., dephosphorylation (black and grey arrows in 
Fig. D.5).  
 
 






In general, bistability can arise if the shared inhibitor binds the intermediates competitively at 
least to some extent. Furthermore, bistability requires that only the active downstream 
intermediate, D*, but not its precursor, D, binds to the inhibitor, I. In addition to these 
‘structural’ requirements, the downstream intermediate, D, needs to be significantly more 
abundant than the inhibitor, I, which in turn must exceed the upstream intermediate, U (see 
Section 4). Finally, the inhibitor, I, mediates particularly strong positive feedback if the 
downstream intermediate exceeds the dissociation constant (or the Michaelis-Menten 
constant) of the D*I-complex. 
Table D.3: The ‘Shared Inhibitor motif’, a recurrent motif in cellular signal transduction 
 
Upstream (U) Downstream (D) Shared Inhibitor(s) (I) Type Refs. 
Caspase-9 Caspase-3 X-IAP, c-IAP1/2, Survivin Inhib. [490]  
Caspase-9 Caspase-7 X-IAP, c-IAP1/2, Survivin Inhib. [490]  
FGFR Mek Sef Inhib. [157]  
Grb-2 Raf Sprouty Inhib. [157]  
CyclinD / CDK4/6 Cyclin E / CDK2 p21-CIP1, p27-KIP1, p57-KIP2 Inhib. [491]  
Daxx (-> Ask1) Cytochrome C Hsp27 Inhib. [492,493]  
Cdc42 Rac 10 different GAPs reported GAP [494,495]  
Rac Rho 4 different GAPs reported GAP [494,495]  
Cdc42 Rho 5 different GAPs reported GAP [494,495]  
insulin receptor IRS-1 LAR PP [496]  
EGF receptor HGF receptor LAR PP [497,498]  
CaMK II AMPAR PP1 PP [198]  
Aurora-B kinase Histone 3 PP1 PP [499]  
Aurora-B kinase Ndc10 PP1 PP [499]  
NMDA receptor CaMK II PP1 PP [499]  
p38 Caspase-3 PP2A PP [500]  
Mek Erk PP2A PP [501]  
PKA CREB PP2A PP [148,502,503]  
Mek/Erk CREB PP2A PP [148,502,503]  
Akt CREB PP2A PP [148,502,503]  
CaMK IV CREB PP2A PP [148,502,503]  
SEK1 JNK PP2A PP [148,502,503]  
Akt p70S6K PP2A PP [148,503,504]  
PKA Mek/Erk PP2A PP [148,503,505]  
PKCα Mek/Erk PP2A PP [21,503,506]  
MKK6 p38 PP2C-α PP [507]  
insulin receptor IRS-1 PTP-1B PP [496]  
Epo receptor Jak2 PTP-1B PP [506,508]  
Epo receptor STAT5a/b PTP-1B PP [506,509]  
EGFR IGF-1 receptor PTP-1B PP [497,510]  
IGF-1 receptor EGF receptor PTP-1B PP [497,511]  
Jak2 EGF receptor PTP-1B PP [497,508,512]  
insulin receptor Jak2 PTP-1B PP [497,508,513,514] 
insulin receptor STAT5a/b PTP-1B PP [497,509,513,514] 
PDGF receptor Jak2 PTP-1B PP [497,508,515]  
PDGF receptor STAT5a/b PTP-1B PP [509,512,515]  
CAKβ p130(CAS) PTP-PEST PP [516]  
CAKβ Paxillin  PTP-PEST PP [516]  
EGFreceptor p52Shc TCPTP PP [517]  
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It should be noted that shared inhibitors, which function enzymatically (black and grey arrows 
in Fig. D.5), can be efficiently sequestered by the downstream intermediate, D*, and thereby 
mediate positive feedback and bistability even if the D*I is only transiently formed and then 
broken down by catalysis (as long as the Michaelis-Menten constant is low enough).  
 
 
Table D.3 gives an overview on signal transduction pathways, where the ‘shared inhibitor 
motif’ has been reported to occur. Inhibitory proteins were sub-classified into three groups, 
according to their biochemical mechanism of action: (i) stoichiometric inhibitors (Inh.), which 
reversibly sequester proteins away from their cellular targets; (ii) GTPase-activating proteins 
(GAP), that stimulate the intrinsic GTPase activity of small G proteins, and thereby catalyse 
their deactivation; (iii) Phosphatases (PP), which antagonise protein-phosphorylation 
cascades, are the most prominent group in Table D.3.  
 
Available experimental data suggest that bistability due to sequestration of a shared 
phosphatase can occur in vivo. Most phosphatases exhibit a single active site, i.e., they bind 
their substrates in a competitive manner. Additionally, they usually recognise only 
phosphorylated, but not non-phosphorylated, substrates, so that the structural requirements 
mentioned above are fulfilled. Quantitative measurements of protein abundance in the MAPK 
cascade revealed that the downstream intermediates in this system are (much) more 
abundant when compared to their upstream activators [16,158] . Finally, many phosphatases 
exhibit Michaelis-Menten constants in the sub-micromolar range [154,432] , which suggests 
that strong feedback can be established (see above).  
 
The feedback mechanism proposed in this paper may, for example, contribute to bistability in 
the JNK cascade [135] , since PP2A was shown to dephosphorylate both JNK and its 








E  Additional material on recurrent design patterns in 
transcriptional feedback regulation of signalling cascades  
 
 
E.1  Protein Decay Rates 
 
This Section contains the protein half-live data collected from the published literature which 
was used to generate Figs. 5.1 and 5.2. Two types of half-lives were distinguished: those 
measured under unstimulated conditions (t1/2(basal)), and those measured under stimulation 
conditions (t1/2(stim)). Some protein half-lives had been measured both under stimulated and 
unstimulated conditions with different results. In this case, the half-life under unstimulated 
conditions was used for non-induced proteins, while the half-life upon stimulation was taken 
for transcriptionally induced proteins. The underlying rationale follows: The unstimulated 
state was assumed to be the default situation for the cell, and thus it is the basal protein 
turnover rate of non-induced (i.e., permanently expressed) proteins that should be relevant 
for the cellular energy budget. On the other hand, rapid induction of feedback mediators 
requires short mRNA/protein half-lives, so that the protein half-life measured in stimulated 
cells was taken for induced proteins. In the light of the energy hypothesis, these rapidly 
induced factors can still contribute to free-energy dissipation minimisation if they are much 
more stable in the basal state when compared to stimulation conditions. Qualitatively similar 
results were obtained if the half-lives for stimulated cells were taken for transcriptionally non-
induced proteins. 
 
TGFβ/Activin pathway (Table E.1) 
Symbol Alternative 
Name 
Function t1/2(basal) t1/2(stim) t1/2(used) Ref. 








TGFBR2 TGFRII receptor ~1h 
~1h 
~0.75h 1h [518]  
[316]  


















SMAD3 Smad3 TF >>4.5h 
~6h 
~4.5h 7.5h [522]  
[523]  
























TGIF1 TGIF Inhibitor ~1h 
<0.5h 
 0.75h [530]  
[531]  
SMAD7 Smad7 Inhibitor ~3h ~1h 1h [452]  






0.5h [358]  
[363]  
[343]  







MAP kinase pathway (Table E.2) 
Symbol Alternative  
Names 
















12h [534]  
[535]  
[536]  
MET HGF receptor Receptor ~0.7h 
~5h 
~6h 
 5h [537]  
[538]  
[539]  














Receptor ~8h  8h [544]  
PTPN2 TC-PTP Phosphatase ~12h  12h [545]  
PTPN11 SHP-2 PPase  
Ras activator 
~19h  19h [546]  








26h [547]  
[548]  
[549]  
RAPGEF2 cnRasGEF RasGEF ~10h  10h [550]  
SOS1 mSos1 RasGEF >18h  20h [551]  
SOS2 mSos2 RasGEF ~3h  3h [551]  
RASGRF2 Ras-GRF1 RasGEF ~8h  8h [552]  
NRAS N-Ras MAP4K ~24h  24h [553]  
HRAS H-Ras MAP4K ~19h 
~20h 
 19.5h [554]  
[555]  
NF1 NF1 RasGAP ~24h 60-80h 24h [556]  
RAF1 Raf-1 MAP3K 17.5h 
11h 
 14.25h [557]  
[557]  
MAP3K2 Mekk-2 MAP3K ~1h  1h [558]  
MAP2K6 MKK6 MAP2K >24h  24h [559]  
MAP2K1/2 Mek1/2 MAP2K >>6h  10h [560]  
MAPK3 Erk1 MAPK >60h 
>20h 
>8h 
 22h [561]  
[562]  
[563]  
MAPK1 Erk2 MAPK >60h 
>8h 
>8h 
 10h [561]  
[564]  
[563]  
MAPK15 Erk7 MAPK ~1.7h  1.7h [565]  
MAPK14 p38α MAPK >24h 
>20h 
 24h [559]  
[564]  
MAPK8 JNK1 MAPK >7h  9h [566]  















DUSP4 MKP-2 MAPK PPase 1.2h  
0.75h 
1h [572]  
[568]  











DUSP10 MKP-5 MAPK PPase 4h  4h [572]  
DUSP16 MKP-7 MAPK PPase 1.5h  1.5h [572]  




1.95h [574]  
[575]  
DUSP3 VHR MAPK PPase ~0.5h  0.5h [576]  









STAT pathway (Table E.3) 
Symbol Alternative 
Name 





 5h [577]  
[578]  
IL6ST gp130 receptor ~2.5h 
~2.5h 
 2.5h [546]  
[579]  
IL6R Gp80 receptor ~2.5h  2.5h [579]  
EPOR EpoR receptor 3h  3h [580]  
JAK1 JAK1 Kinase ~3.2h  3.2h [546]  






































STAT5 STAT5 TF >>12h  16h [584]  
CISH CIS Inhibitor ~1h  1h [590]  








SOCS2 SOCS-2 Inhibitor ~1h  1h [546]  












SOCS5 SOCS-5 Inhibitor ~1h  1h [595]  
 
 
PI3K pathway (Table E.4) 
Symbol Alternative 
Name1 
Function t1/2(basal) t1/2(stim) t1/2(used) Ref. 













IRS2 IRS-2 Adaptor ~2h 
>24h 
 13h [563]  
[597]  
PIK3R1 P85α PI-3’-Kinase >8h 
~9h 
 9.5h [563]  
[599]  
PIK3CB p110α PI-3’-Kinase ~7.3h  7.3h [599]  
















TSC2 Tuberin GAP 6h  6h [607]  
FRAP1 mTOR Kinase >>4h  8h [608]  
GSK3A GSK3α Kinase >>12h  16h [609]  





cAMP pathway (Table E.5) 
Symbol Alternative 
Name 
Function t1/2(basal) t1/2(stim) t1/2(used) Ref. 
ADRB1/3 β1- or β3-  
adrenergic 
receptor 
Receptor 25-200h  50h [610]  
ADRB2 β2-adrenergic 
receptor 
Receptor >20h 3h 22h [611]  
ARRB2 Beta-Arrestin2 Modulator  11h  11h [612]  
ADRBK1 GRK2 Kinase ~1h 
~8h 
~2h 
 2h [613]  
[613]  
[613]  
GNAI2 Galpha i2 G-protein  27h 
80h 
41h 
 41h [614]  
[615]  
[616]  
GNAS Gs alpha G-protein  50h  50h [615]  
ADCY2 AC2 Adenylate 
Cyclase 
40h  40h [617]  
ADCY3 AC3 AC 40h  40h [617]  
ADCY4 AC4 AC 40h  40h [617]  
ADCY5 AC5 AC 40h  40h [617]  
ADCY6 AC6 AC 40h  40h [617]  
ADCY8 AC8 AC 40h  40h [617]  




1.2h [618]  
[619]  
PRKAR1A Protein Kinase A 
RI alpha 
Kinase  17h 
20h 
8h 
 17h [620]  
[620]  
[621]  




 19.5h [620]  
[620]  




 3.5h [620]  
[620]  








E.2  Estimate of total protein concentrations 
 
The analyses in Section 5 suggested that a considerable evolutionary pressure exists in 
signal transduction networks, which keeps the turnover of non-induced signalling molecules 
low. One such evolutionary pressure might be energy cost, as the energy expenditure of 
mammalian cells is dominated by protein synthesis and degradation.  
 
In order to show that this energy minimisation is indeed physiologically relevant, quantitative 
measurements of intracellular signalling protein concentrations were collected (see Table 
E.6), where available from non-transformed cell lines. The cellular protein concentrations of 
membrane tyrosine kinase receptors and their downstream signalling molecules are typically 
in the range of 10,000 – 1,000,000 molecules per cell [426,622] . The collection of protein 
abundances listed below is in accordance with this estimate. However, depending on the cell 
type, receptor levels are even lower than 10,000 per cell, which is consistent with a more 
general expression range of 1,000 – 1,000,000 molecules per cell for signalling proteins 
[622] . Additionally, the list reveals that several phosphatases (e.g., PP1, PP2C, SHP-1 and 
CD45), several nucleo-cytoplasmically shuttling transcription factors (e.g., STAT2, RelA and 
the Smads) and several caspases (e.g., Caspases 3, 8 and 9) are also expressed at high 
levels (>10,000 per cell). Finally, Table E.6 demonstrates that there are several outliers 
which can be even (much) more abundant than 1,000,000 per cell (e.g., PP2A, PP2B, Ras 
and Caspase-8).  
 
Taken together, these data suggest that a range of 10,000 – 1,000,000 molecules per cell 
seems to be reasonable for most signalling proteins. Given the large number of kinases, 
phosphatases and receptors in the human genome [3,4,623] , these data suggest that 
signalling proteins make up a significant portion of the total cellular protein, so that their 
production constitutes a central energy sink in the cell.  
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A more quantitative estimate can be derived if one sums up all measured protein 
concentrations listed in the Table below (using the maximal values if a range of protein 
expression is given). This yields ~1.2 108 molecules per cell.   
In this context, it has been measured that there are ~300 pg total protein per cell [624] *. 
Assuming an average protein molecular weight of 60 kDa, one arrives at ~2 109 total protein 
molecules per cell*. Thus, even the few quantitatively measured signalling proteins listed 
below can (theoretically) make up as much as ~6% of total cellular protein. Similarly, the 
weights of the measured molecules add up to 14 pg, corresponding to 5% of the cellular 
protein mass. 
 
To get an independent estimate of the amount of signalling proteins in cells, high-throughput 
proteomics data were also analysed. A meta-analysis of the peptide atlas [625]  revealed that 
about 5% of the small sequenced peptides in the atlas stem from annotated signalling 
proteins (according the gene ontology annotation of the corresponding Ensembl peptide). If 
one assumes that the probability to find and sequence a peptide in such high-throughput 
proteomics measurements are proportional to the abundance of a protein one can conclude 
that signalling proteins constitute about 5% of the cellular protein mass.  
 
Table E.6 Expression of intracellular signalling proteins.  
Name Pathway # per cell Cells Reference 
PDGFR RTK 90.000 NIH3T3 fibroblasts [626]  
EGFR1 RTK 20.000-200.000 Normal body tissue [627]  
EGFR2 RTK 5.000-60.000 Human mammary 
epithelial cells ** 
[628]  
InsulinR RTK 7,000-250.000 3T3-L1 Adipocytes ** [629]  
IGFR1 RTK 2.800-1.200.000 Primary fibroblasts ** [630]  
[631]  
Grb2 RTK 23.000 Thymocytes [632]  
Ras MAPK 20.000-11.000.000 
[400.000] 





Raf MAPK 10.000 Cos cells [16]  
Mek MAPK 360.000-20.000.000 
[800.000] 
[1.800.000] 
HeLa cells ** *** 
[CHO cells] 




Erk MAPK 750.000-20.000.000 
[1.800.000] 
[2.700.000] 
HeLa cells ** *** 
[CHO cells] 




PI3K PI3K 10.000 NIH3T3 fibroblasts [634]  
Protein 
Kinase B 
PI3K 600.000 PC12 cells [635]  
PP1 misc 500.000 Skeletal muscle [154]  
PP2A misc 5.000.000 
-20.000.000 
Various primary tissues  [636]  
 
PP2B misc 1.000.000-20.000.000 Brain ** [154]  
PP2C misc 20.000 Muscle [154]  
PTP1-B misc 10.000 Placenta [154]  




>100.000 Jurkat T cells [638]  
TGFR TGFβ 1.500-80.000 Swiss 3T3 fibroblasts ** [305]  
Smad2 TGFβ 100.000-450.000 HaCaT keratinocytes ** [639]  
[378]  
Smad3 TGFβ 15.000-450.000 HaCaT keratinocytes  ** [639]  
[378]  
[338]  
Smad4 TGFβ 100.000-900.000 HaCaT keratinocytes ** [639]  
[378]  
Calmodulin Ca2+ 5.000.000-10.000.000 PC12 cells ** [640]  




Apaf-1 Apoptosis 100.000-2.000.000 NCI cancer cell panel*** [642]  




























250.000 NIH3T3 fibroblasts [644]  
CREB cAMP 50.000 PC12 cells [645]  
Protein 
Kinase A 
cAMP 720.000 PC12 cells [645]  
p300 cAMP 28.000 Jurkat T cells [646]  
IFN-γ 
receptor 
Cytokine 25.000 A431 carcinoma cells [647]  
Epo 
receptor 
Cytokine 60.000 Endothelial cells [648]  
STAT2 Cytokine 150.000 Jurkat T cells [646]  
STAT3 Cytokine 750.000 Primary Mouse 
Hepatocytes 
[649]  
RelA NF-kB 125.000 Jurkat T cells [646]  
T cell 
receptor 
Immune 30.000 Thymocytes [139]  
Lck Immune 60.000 Thymocytes [139]  
ZAP70 Immune 1.200.000 Thymocytes [139]  
FC 
Receptor 
Immune 700.000 Macrophage cell line [650]  
Absolute protein quantification measurements were collected from the literature. If several cell lines have been measured, the 
cell line with maximum expression is given (indicated by **). Data from cancer cells (indicated by ***) has to be interpreted with 
caution. If available, data from non-transformed cells was also included (in square brackets). 
 
 
About 4000 genes are annotated with the term signal transduction in Ensembl. Assuming a 
typical signalling protein expression of 20.000 molecules per cells (see Table and [426,622] 
), this would sum up to ~4% of total protein. Taken together, these data strongly suggest that 
the energy optimisation principle discussed in Section 5 is physiologically relevant.  
 
* See also: 
 
Alvis Brazma, Helen Parkinson, Thomas Schlitt and Mohammadreza Shojatalab: Basic Biology 
(http://www.ebi.ac.uk/2can/biology/molecules_proteins5.html) 
 





E.3  RFIs act at multiple levels of the network  
 
The analysis in Section 5 suggested that energy minimisation might have contributed to the 
dominance of negative feedback regulation via RFI induction over negative feedback via 
signal transducer downregulation. More specifically, it was reasoned that rapid transcriptional 
negative feedback regulation requires unstable proteins. Therefore, signal transducer 
downregulation is an energetically unfavourable mode of negative regulation, as constitutive 
expression of unstable signal transducers consumes large amounts of energy in the basal 
state. In contrast, rapidly turning over an inhibitor that is selectively induced stimulation will 
only require energy over short time scales. 
Of course, this energetic advantage of RFI induction over transducer downregulation will be 
more pronounced the more nodes in the signalling network are affected by transcriptional 
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feedback. The results in Section 5 already indicated that RFI-mediated feedback operates at 
multiple levels (Fig. 5.2). However, the analysis was limited to published microarray results 
(and thus to particular cell types), and only proteins, where both half-life and gene expression 
data was available, were considered. Thus, cell-type specific and less well studied feedback 
regulators might have been missed in the analysis.  
 
To further substantiate the energy argument, known transcriptional negative feedback 
regulators of growth-factor-induced MAPK signalling and of TGFβ-induced Smad signalling 
were collected from the literature. The results, summarised in Tables E.7 and E.8, reveal that 
transcriptional negative feedback operates at almost all levels of the considered cascade, 
and even single layers are regulated in different ways (e.g., feedback modulates both 
receptor activity and degradation). Moreover, it seems that transcriptional negative feedback 
loops often operate in a cell-type-specific manner. 
 
Taken together, Tables E.7 and E.8 reveal that multiple nodes are subject to transcriptional 
feedback regulation for each signalling pathway. Flexible, cell-type-specific negative 
feedback regulation by signal transducer downregulation would thus require that most of the 
transducers are unstable, and therefore would represent a strong energy burden. This 
suggests that an energy minimisation principle might have contributed to an evolutionary 
selection pressure favouring transcriptional feedback regulation via RFI induction. 
 
Table E.7 Transcriptional negative feedback loops in TGFβ signalling via Smad transcription factors.  
Molecule Mechanism of action Cell line Reference 
Lefty-2 Ligand Inhibition Development [651]  
Follistatin Ligand Inhibition HepG2 [652]  
BAMBI Receptor inhibition HepG2 [653,654]  
Smad7 Receptor inhibition various [655]  
TMEPAI Receptor inhibition AML, NMuMG * 
Smad7 Receptor degradation various [316]  
Smurf2 Receptor degradation HepG2 [656]  
GRK2 Regulation of  Smad2/3/4 accessibility 
Primary 
hepatocytes [420]  
CM184 Regulation of  Smad2/3/4 shuttling Mv1Lu cells [657]  
SnoN Regulation of  Smad2/3/4 shuttling 
Various primary 
cells [343,349]  
Ski Co-Repressor for Smad2/3/4 Fibroblasts [658]  
TGIF Co-Repressor for Smad2/3/4 HuT78 [659]  
SnoN Co-Repressor for Smad2/3/4 various [343,349]  
Smad7 Competition with  Smad2/3/4 for DNA Hep3B [660]  
Smurf2 Smad2/3/4 degradation HepG2 [656]  
Listed are literature studies which reported that negative regulators of TGFβ signalling are transcriptionally induced by TGFβ. 
The mechanism of negative feedback regulation is indicated as well. The reference marked by a star (*) is available online: 










Table E.8 Transcriptional negative feedback loops in growth factor signalling via the Erk-MAPK cascade.  
Molecule Mechanism of action Cell line Reference 
Argos Ligand Inhibition Drosophila Development [661]  
RALT Receptor inhibition 32D [662]  
Sef Receptor inhibition various [663,664]  
LRIG1 Receptor degradation HeLa [535]  
Sprouty1 & 2 Adaptor (Grb2) inhibition various [665,666]  
Sprouty2 & 4 Raf inhibition various [665,667,668]  
Sef Inhibition of Mek-mediated Erk phosphorylation various [669]  
MKP-1 Erk dephosphorylation (nucleus) various [670]  
MKP-3 Erk dephosphorylation (cytosol) various [670]  
Sef Erk sequestration in the cytosol various [671]  
MKP-1/2 (?) Sequestration of inactive  Erk in the nucleus various [672]  
Listed are literature studies which reported that negative regulators of RTK-Ras-MAPK signalling are transcriptionally induced 
















































































































Figure E.1 Gene expression profiles and half-lives of growth factor signalling via the Erk-MAPK cascade.  
Gene expression data from [67,471,673]  was expressed as log2-fold change and the time courses were plotted as heatmaps. 
mRNA half-lives were taken from genome-wide studies [278,279]  and protein half-lives were taken from Tables E.1 – E.5. The 
star (*) indicates that Sprouty1 was shown to be rapidly induced upon Erk activation [674] . Sprouty 1 was thus marked as 















































Figure E.2 Gene expression profiles and half-lives of TGFβ signalling via Smad transcription factors.  
Gene expression data from [675]  and unpublished gene expression data (from GEO repository) was expressed as log2-fold 
change and the time courses were plotted as heatmaps. mRNA half-lives were taken from genome-wide studies [278,279]  and 
protein half-lives were taken from Tables E.1 – E.5. The star (*) indicates that TGIF was shown to be rapidly induced upon 
TGFβ stimulation [659] , and (**) indicates that BAMBI was shown to be rapidly induced upon TGFβ stimulation [654] . TGIF and 
BAMBI were thus marked as induced in the pathway map (Fig. 5.2), but were considered unchanged in the statistical analysis 





















































































Figure E.3 Gene expression profiles and half-lives of growth factor signalling via the PI3K-Akt cascade.  
Gene expression data from [67,471,676]  was expressed as log2-fold change and the time courses were plotted as heatmaps. 




























































Figure E.4 Gene expression profiles and half-lives of JAK/STAT signalling.  
Gene expression data from [677,678,679,680]  was expressed as log2-fold change and the time courses were plotted as 
heatmaps. mRNA half-lives were taken from genome-wide studies [278,279]  and protein half-lives were taken from Tables E.1 
– E.5. The star (*) indicates that SOCS-5 was shown to be rapidly induced upon stimulation of JAK/STAT signalling [595,681] . 
SOCS-5 was thus marked as induced in the pathway map (Fig. 5.2), but was considered unchanged in the statistical analysis 














































Figure E.5 Gene expression profiles and half-lives of cAMP signalling.  
Gene expression data from [682]  was expressed as log2-fold change and the time courses were plotted as heatmaps. mRNA 




Figure E.6 Gene expression profiles of cAMP signalling in yeast.  
Log fold-change after oxidative stress induced by cumene hydroperoxide. Data from Sha, Martins, Laubenbacher, Mendes, 
Shulaev (submitted), available as GSE7645. The inhibitor RGS2 is upregulated on a time scale below cell-cycle time. S.I. is 


















F Additional material on transcriptional feedback regulation 
of TGFβ signalling  
 
 
F.1  Differential equations of the model  
 
 
Equations F.1. Ordinary differential equations (ODE).  
The molecular species depicted in Figure 6.4 and nine additional auxilliary species (asterisks) are listed as variables x1 – x28, 
and the corresponding ODEs are indicated. For definition of reaction velocities vi see Equations F.2. The auxilliary variables are 
necessary to model inhibition of transcription by actinomycin D and to account for a delay in SnoN protein biosynthesis. In the 
model, all species were formally rescaled to cytoplasmic volume, which explains why the nuclear, cytoplasmic and medium 
volumes enter some of the velocities in Eq. F.2 [683] . The initial concentrations of the auxilliary mRNA species were set to unity 
(i.e., x1 = x2 = x3 = x4 = 1), the initial amount of TGFβ is set by the input function u1 (x8 = u1; see Section 6.5.4), and the initial 





Equations F.2. Reaction velocities.  
The rates used for the formulation of the differential equations (see Equations F.1) are listed as v1 – v57. The parameters k6 – k41 
are fitted and defined in Tables F.1 – F.3. The remaining parameters (k1 – k5) are not subject to fitting and are defined as (k1) 
degree of SnoN depletion (see Section 6.5.4), (k2) cytoplasmic volume (set to 10 pl), (k3) nuclear volume (set to 0.5 pl), (k4) 






F.2  Kinetic parameters and ranges used for fitting  
 
 
Table F.1: Parameters for the receptor trafficking module.  








k23 T + R ↔ TR 
Dissociation 
constant 
(koff / kon) 




0.001 - 0.22 nM 
(in the model rescaled 
to cytoplasmic volume) 
0.0098 
nM 
k22 T + R ↔ TR Off-rate (koff) 
0.01 - 1 min-1 
(typical range for receptor-
ligand off-rates) 
[684]  0.01 - 1 min-1 0.1125 min-1 
k20 
TR → TRe 
- 
R → Re 
Rate constant for  
endocytosis (ke) 
~ 0.2 min-1 [312]  [310]  0.1 - 0.5 min




TRe → R 
-  
Re → R 
Rate constant for 
recycling (kr) 
~ 0.1 min-1 
- 
50 - 90% of the total cellular 
TGFβ receptor pool resides 





constant is 1-10x 
smaller than the 
endocytosis rate 
constant 
(1 < k21 < 10) 
0.4040 
min-1 







[686]  0.003 - 0.03 min
-1 0.0124 min-1 
k24 TRe → TRle 
1st order rate 
constant for 
progression from 
early to late 
endosomes 
~ 0.2 min-1 
(value measured for 
LDL and for α2M) 
[687]  0.03 - 1 min-1 0.6667 min-1 
k25 TRle → 
1st order rate 
constant for 
targeting to 
lysosome and thus 
for degradation 
~ 0.007 min-1 
(apparent rate constant for 
lysosomal TGFβ 
degradation in HepG2 and 
Hep3B cells) 
[314]  0.001 - 0.05 min-1 0.0051 min-1 
k18 → Re 
Total number of 








2,000 per rat hepatocyte 
4,500 per HepG2 cell 
1,500 per Hep3B cell 
- 
50 - 90% of the total cellular 
TGFβ receptor pool resides 
















0.0024 min-1 [685]  0.0005 - 0.0015  min-1 
0.0005 
min-1 
The kinetic parameters are numbered according to Equations F.1 and F.2 (column #). Based on experimentally measured 
values, a parameter range allowed during the fitting procedure was defined. The parameter value in the best-fit model is given 













Table F.2: Parameters for the Smad activation module.  








k26 S2 → pS2 
Catalytic rate constant 
(kcat) 
1 - 600 min-1 
(typical kcat of kinases for full-
length substrates) 
[159,688,689] 1 - 600 min-1 1.1391 min-1 
k27 S2 → pS2 
Michaelis-Menten 
constant (KM) 
0.2 - 50 µM 
(typical KM of kinases for full-
length substrates) 
- 
SARA recruits Smad2 to the 
membrane, thereby 
increasing Smad2 affinity for 
the transmembrane receptor 
by ~ 1,000-fold 






2 pS2 + S4 
↔ (pS2)2S4 
- 






(koff / kon) 
~ 1,500 nM2 [365]  [334]  





2 pS2 + S4 
↔ (pS2)2S4 
- 







0.1 - 600 min-1 
(typical range for off-rates of 
intracellular protein-protein 
interactions) 




3 pS2 ↔ 
(pS2)3 
- 




(koff / kon) 
Heterotrimer formation is 
slightly more efficient than 
homotrimer formation in vitro 
- 
Heterotrimer formation can be 
significantly enhanced by 
Smad4 ubiquitination in vivo 
[334]  





than that of 
hetero-
trimerisation 




3 pS2 ↔ 
(pS2)3 
- 





Homotrimer dissociation is 
assumed to proceed with the 
same rate constant as 
heterotrimer dissociation 
- - 0.1029 min-1 
k11 
S2 → nS2 
- 







1st-order import rate 
constant 
0.16 min-1 
(based on FRAP 









nS2 → S2 1st-order export rate constant 
1 min-1 
(based on FRAP 
measurements in 
unstimulated HaCaT cells, 
where 85% of Smad2 is 
cytosolic) 
- 
Smad2 is roughly equallly 
distributed between 
cytoplasm and nucleus in 
primary mouse hepatocytes 
[311,339,364] 
1 - 10x 
import rate 





k16 S4 → nS4 
1st-order import rate 
constant 
0.08 min-1 
(based on FRAP 
measurements in  
unstimulated HaCaT cells, 
where 90% of Smad4 is 
cytosolic ) 




nS4 → S4 1st-order export rate constant 
0.5 min-1 
(based on FRAP 
measurements in HaCaT 
cells) 
[311,339]  
1 - 10x 
import rate 
(1 < k15 < 10) 
0.3009 
min-1 
k31 npS2 → S2 




after administration of a TGFβ 
receptor inhibitor occurs with 
a half-life 
of 15 - 20 min 
- 
0.5 - 600 min-1 











k7 → S2 
Total number of 




80,000 per primary mouse 

















[278]   [279]  0.003 - 0.03 min-1 
0.0273 
min-1 




0.0017 - 0.0056 min-1 
< 0.0019 min-1 
[345]  
[338]  








0.0017 - 0.0056 min-1 
< 0.0019 min-1 
[345]  
[338]  




k13 → S4 
Total number of 




80,000 per primary mouse 
















[278]   [279]  0.005 - 0.05 min-1 
0.0049 
min-1 




< 0.0019 min-1 
0.0028 min-1 








The kinetic parameters are numbered according to Equations F.1 and F.2 (column #). Based on experimentally measured 
values, a parameter range allowed during the fitting procedure was defined. The parameter value in the best-fit model is given 
on the right. The superscript (a) indicates that the anchor protein SARA is assumed to recruit Smad2 to the membrane [327]  











Table F.3: Parameters for the SnoN feedback module.  








k33 → SnoN 





600 per (unstimulated) 
primary mouse 
hepatocyte 
This study 300 - 1,500 per cell 
1489 
per cell 
k36 → SnoNprecursor 
KM of SnoN 
Induction by Smad 
Trimers 
Affinity of Smad trimers 
for target DNA 
sequences is likely to be 
in the nM range or even 




0.1 - 100 nM 






k35 → SnoNprecursor 
Vmax of SnoN 
induction by Smad 
trimers 
Maximal protein 
biosynthesis rate is 
150,000 / cell / min for 
Actin (= 30 nM min-1) 
[692]  0.003 - 300 nM min-1 
0.0298 
nM min-1 







~ 0.01 min-1 This study (not shown) 







Delay in SnoN 
production due to 
protein 
biosynthesis 
Protein biosynthesis  
takes 1 - 25 min 
 
Estimation 
Modelled as a 
multistep process 
with the delay 
τ = 5/k 
- 























constant of the 
heterotrimer-SnoN 
complex 
(koff / kon) 
0.3 – 1,000 nM 
(typical dissociation 




0.3 - 1,000 nM 












constant of the 
heterotrimer-SnoN 
complex (koff) 
0.1 - 600 min-1 
(typical range for off-
rates of intracellular 
protein-protein 
interactions) 








constant of the 
homotrimer-SnoN 
complex 
(koff / kon) 
SnoN-related Ski protein 






0.3 - 3x different 
from the affinity 
of SnoN-
heterotrimer 








constant of the 
homotrimer-SnoN 
complex (koff) 
SnoN dissociation from 
homotrimers is assumed 
to proceed with the 
same rate constant as 
dissociation from 
heterotrimers 























is 1 - 50x larger 
than that of SnoN 
monomers 





The kinetic parameters are numbered according to Equations F.1 and F.2 (column #). Based on experimentally measured 
values, a parameter range allowed during the fitting procedure was defined. The parameter value in the best-fit model is given 
on the right.  
 
 
F.3  Modelling Basal Protein Expression 
 
Several protein species in the model (S2, nS2, S4, nS4, SnoN, R and Re) are expressed at 
non-zero levels even in the absence of stimulation. The basal protein concentrations of these 
proteins are determined by the kinetic parameters. For instance, the expression levels of 
nuclear and cytosolic Smad2 depend on the nuclear import and export rates, and on the 




Figure F.1. Schematic representation of protein expression in the basal state.  
The species C1 is subject to synthesis and degradation, and is additionally interconverted into the species C2, which is then 
eventually degraded. The TGFβ model species corresponding to C1 and C2 in the are given in Table F.4. 
 
 
Table F.4: Basally expressed proteins in the TGFβ model.  
Protein C1 C2 ksyn kdeg,C1 kC1->C2 kC2->C1 kdeg,C2 
























Recycling Endocytosis - (a) 
 






- (b) - (b) - (b) 
Listed are the species in the TGFβ model corresponding to C1 and C2 in Fig. F.1, and the respective kinetic parameters are 
also given. The superscript (a) indicates that no cell-surface receptor degradation occurs in the model, and superscript (b) 
indicates that the cytoplasmic SnoN pool was neglected in the model. 
 
 
Figure F.1 is a general representation of protein synthesis and degradation, which applies to 
all basally expressed proteins in the model. Table F.4 summarises the relationship of the 
parameters given in Fig. F.1 to those in the TGFβ model for each protein. The steady state 




deg,C2 C2->C1 C1->C2 deg,C2 C2->C1 C1->C2
(k +k ) kC1 = C    and   C2 = C
k +k +k k +k +k
⋅ ⋅      (F.3) 
 
In these equations, the synthesis rate ksyn (Fig. F.1) was replaced by the total protein 
expression level (Ctot = C1 + C2), which was observed experimentally for most of the proteins 
(Fig. 6.3). Equation F.3 and Table F.4 were used to calculate the initial conditions (i.e., the 
basal protein expression) for the TGFβ model. The protein synthesis rate in the differential 




deg,C1 deg,C2 deg,C1 C2->C1 C1->C2 deg,C2
syn tot
deg,C2 C2->C1 C1->C2




⋅        (F.4) 
 
 
F.4  Modelling TGFβ signalling in HaCaT cells 
 
The HaCaT cell model, schematically depicted in Fig. 6.15, contains most of the reaction 
steps of the hepatocyte model, and the majority of kinetic parameters was assumed to be 
equal in both models as well. SnoN-mediated feedback described by the velocities v44 – v57 
in Eq. F.1 was completely eliminated from the HaCaT model, as HaCaT cells seem to be 
devoid of transcriptional feedback (see main text). Some protein synthesis and degradation 
rates in the HaCaT model were assumed to be different from the hepatocyte model, as 
summarised in Table F.5. Washout and TGFβ receptor inhibitor experiments in Fig. 6.15 
were modelled as described for the hepatocyte model (Section 6.5.4). MG132 treatment was 




Table F.5: Fitted parameters in the HaCaT cell model.  
# Reaction(s) Parameter description 
Range used 
for fitting 
Value in  
HaCaT 
model 1 
Value in  
HaCaT 
model 2 
k19 Re → Constitutive receptor degradation 0.003 - 0.035 min
-1 0.035 min-1 
0.024 
min-1 
k25 TRle → 
1st order rate constant for targeting to 
lysosome and thus for degradation 0.001 – 0.05 min
-1 0.002 min-1 
0.0029 
min-1 
k18 → Re 
Total number of TGFβ receptors per cell 
(determines receptor synthesis rate) 






k7 → S2 
Total number of Smad2 molecules per cell 
(determines Smad2 synthesis rate) 






k13 → S4 
Total number of Smad4 molecules per cell 
(determines Smad4 synthesis rate) 










Half-life of cytosolic  
Smad2 monomers 
0.0005 - 0.005 
min-1 
same as  
hepatocyte 
model 




(pS2)2S4 →  
- 
(pS2)3 → 
Half-life of cytosolic  
Smad2 trimers 










Half-life of nuclear  
Smad2 monomers 
0.0005 - 0.005 
min-1 
same as  
hepatocyte 
model 









(npS2)3 →  
Half-life of nuclear  
Smad2 trimers 







S2 → nS2 
- 







1st-order import rate constant 0.07 - 0.7 min-1 








nS2 → S2 1st-order export rate constant 
1 - 10x 
import rate 
(1 < k9 < 10) 




k16 S4 → nS4 1st-order import rate constant 0.03 - 0.3 min-1 





   * 
k16 
nS4 → S4 1st-order export rate constant 
1 - 10x 
import rate 
(1 < k15 < 10) 




Listed are those parameter that were allowed to differ between the HaCaT and hepatocyte models, and were thus fitted to the 
HaCaT time course data in Fig. 6.15. The column “value in HaCaT cell model 1” indicates the parameter values obtained 
without fitting the Smad im-/export rates to the HaCaT time course data in Fig. 6.15 (the optimised cytoplasmic and nuclear 
volumes were 1.77 pl and 0.23 pl, respectively). The column “value in HaCaT cell model 2” indicates the parameter values 
obtained with fitting the Smad im-/export rates to the HaCaT time course data in Fig. 6.15 (the optimised cytoplasmic and 





G  Additional material on small RNAs Establish Delays and 
Temporal Thresholds in Gene Expression 
 
 
G.1  Model derivation 
 
Based on the scheme depicted in Fig. 7.1A, a mathematical model for sRNA-mediated 
regulation was implemented. Experimental studies indicated that heteroduplex association 
and dissociation proceed with rapid kinetics when compared to RNA synthesis and 
degradation [389,390] . The model was therefore simplified by applying a rapid-equilibrium 
assumption as described in the following.  
 
The differential equations of the model depicted in Fig. 7.1A read:  
 
syn,T deg,T on off
syn,S deg,S on off
on off deg,P
d[Target] dt  = v  - k [Target] - k [Target] [sRNA]+ k [Pair]
d[sRNA] dt  = v  - k [sRNA]- k [Target] [sRNA]+ k [Pair]
d[Pair] dt  = k [Target] [sRNA]- k [Pair] - k [Pair
⋅ ⋅ ⋅ ⋅
⋅ ⋅ ⋅ ⋅
⋅ ⋅ ⋅ ⋅ ]
  (G.1) 
 
Summing up these differential equations, and using the relationships [Ttot] = [Target] + [Pair] 




tot syn,T deg,T tot deg,P
tot syn,S deg,S tot deg,P
d[T ] dt  = v  - k [T ]-[Pair]  - k [Pair]
d[S ] dt  = v  - k [S ]-[Pair]  - k [Pair]
⋅ ⋅
⋅ ⋅
    (G.2) 
 
The association/dissociation reactions of the pair are assumed to proceed much faster than 
all other steps in the model. Thus, the model species are related by the following equilibrium:  
 
( ) ( )tot totoff,P
d,P
on,P
[T ]-[Pair] [S ]-[Pair]k [Target] [sRNA]K =
k [Pair] [Pair]
⋅⋅
= =     (G.3) 
 
Solving for the pair concentration yields: 
 
( )2tot tot d,P tot tot d,P tot tot[Pair]=1 2 [T ]+[S ]+K - [T ]+[S ]+K 4 [T ] [S ]⎛ ⎞⋅ − ⋅ ⋅⎜ ⎟⎝ ⎠   (G.4)    
Equations (G.2) and (G.4) constitute a reduced form of the differential equation system (G.1) 
for the case that association/dissociation reactions of the pair proceed much faster than all 
other steps (‘rapid equilibrium approximation’). This reduced system was used for all 
numerical simulations shown in Section 7 and in Appendix G.  
 
Analytical approximation for the subthreshold regime: The reduced differential equation 
system comprising Equations (G.2) and (G.4) was further simplified to derive an analytical 
expression for the response time in the subthreshold regime (vsyn,T < vsyn,S). Under 
subthreshold conditions, one can assume that the sRNA is present in vast excess over the 









,         (G.5) 





tot syn,T deg,T deg,P tot
d,P tot d,P tot
[S ] [S ]d[T ] dt  = v  - k 1-  + k [T ]
K [S ] K [S ]
⎛ ⎞⎛ ⎞
⋅ ⋅ ⋅⎜ ⎟⎜ ⎟⎜ ⎟⎜ ⎟+ +⎝ ⎠⎝ ⎠
  (G.6) 
 
Thus, direct mRNA degradation and degradation via the Pair intermediate behave as two 
competing first-order decay terms in the subthreshold regime. For sufficiently large sRNA 
expression (i.e., [Stot] > Kd,P) and/or if the degradation of the pair is faster than that of the 
monomeric mRNA (kdeg,P > kdeg,T) the system further simplifies to 
 
tot syn,T deg,P totd[T ] dt  = v  - k [T ]⋅         (G.7) 
 
Thus, the response time t50 for mRNA up- and downregulation is proportional to the inverse 
of the degradation rate of the pair [391] .  
 
 




Figure G.1: Degradation of transcripts from the isiAB operon.  
(A) Wildtype (Wt) and mutant (Mu) cells lacking the antisense RNA, IsrR, were cultivated under iron-deplete conditions. At time 
zero (0 hours) an iron pulse was given (red arrow), and cells were grown further for 0–24 hours. The isiAB dicistronic precursor 
transcript and the isiA mRNA are degraded directly after iron induction (0-4 hours), whereby the degradation rate of isiA mRNA 
is higher for Wt cells expressing the antisense RNA in comparison to the Mu cells lacking IsrR. (B) Cells were grown under iron-
replete conditions. Although at time zero (0 min) rifampicin was added to non-specifically arrest transcription, accumulation of 
IsrR transcripts is not affected compared to an internal standard (5S rRNA) for at least 45 min, thus indicating a half-life > 45 
min for IsrR. Note that longer measurements are not possible because sustained incubation with rifampicin induces cell death. 
The RNA transcripts were separated on 1.3% formaldehyde-agarose gels and hybridised with an RNA-specific DNA fragment. 
 
 
G.3  Dose-Response Measurements 
 
Figure 7.1B and additional numerical simulations indicated that sRNAs might establish sharp 
thresholds in gene expression (compare [385] ). These thresholds are typically accompanied 
by a mutually exclusive expression pattern of sRNA and target mRNA at least if the pair 
intermediate is significantly less stable than the monomeric RNAs. Previous experimental 
work revealed that the mRNA of the cyanobacterial iron stress protein, isiA, and its 
modulator, the IsrR sRNA, are expressed in mutually exclusive manner under various 
stimulation conditions [388] . Moreover, a comparison of wild-type cells with IsrR knock-down 
cells revealed that IsrR completely suppresses residual isiA expression under unstressed 
conditions (compare circle and square at t = 0 in Fig. 7.2A). These data suggest that a sharp 
threshold exists in the cyanobacterial iron stress response. 
Dose-response experiments were performed to further confirm the existence of such 
thresholds. Cells were cultivated under iron-starving conditions for 48 h to induce isiA 
expression, and then treated with different doses of iron to induce downregulation of isiA 
transcription. The corresponding measurements of isiA target RNA and IsrR sRNA (shown in 
 
 167
Fig. G.2) reveal that IsrR does not accumulate unless the isiA concentration falls a critical 
level (~0.05 in A and B). This conclusion holds in the time domain and in the concentration 
domain. First, the isiA level 2 h after iron re-addition (Fig. G.2A) is higher when compared to 
4 h after iron re-addition (Fig. G.2B), and accordingly IsrR expression is selectively induced 
at 4 h (Fig. G.2C and D). Second, IsrR expression at 4h requires that the iron level exceeds 
a certain threshold (of approximately 0.25 in Fig. G.2B and D). Taken together, these data 
indicate that a sharp threshold exists in the cyanobacterial iron stress response, and that the 
system operates near this threshold under physiological conditions.     
 
 
Figure G.2: Dose-Response behaviour of the cyanobacterial iron stress response.  
Cells were cultivated under iron-starving conditions for 48 h to induce isiA expression, and then treated with different doses of 
iron to induce downregulation of isiA transcription. The expression levels of the isiA target RNA (A and B) or of the IsrR sRNA (C 
and D) were measured after 2h (A and C) and after 4 h (B and D).    
 
 
G.4  Kinetic parameters used for modelling 
 
This section summarises the kinetic parameters used for the numerical simulations in Figs. 
7.1, 7.2, G.3 and G.4. The synthesis of target RNA (vsyn,T) is modelled to be controlled by 
external stress stimuli (Fig. 7.1A). A simple change of the synthesis rate from one value to 
another was used in most simulations (Figs. 7.2A – D, G.3B and G.4B), while the Michaelis-
Menten equation (vsyn,T = Vmax,synT ⋅ Stimulus / (KM,synT + Stimulus)) was employed to 





Figure Fig. 7.1B Fig. 7.2A Fig. 7.2B 
vsyn,T [nM h-1] Modelled by Michaelis-
Menten equation 
247.2 (basal level) 
1136 (after stimulus increase) 
996.9 (basal level) 
41.9 (after stimulus removal) 
Vmax,syn,T [nM h-1] 1.25 - - 
KM,syn,T [nM] 1 - - 
kdeg,T  [h-1] 1 0.42 0.42 
vsyn,S [nM h-1] 0.625 516.6 (solid line) 
706.9 (grey line) 
145.3 (dashed line) 
516.6 (solid line) 
145.3 (dashed line) 
kdeg,S [h-1] 1 0.35 0.35 
KD,P [nM] 0.001 0.0045 0.0045 
kdeg,P [h-1] 10 13.75 13.75 
 
Table G.1b 
Figure Fig. 7.2C Fig. 7.2D Fig. G.1A 
vsyn,T [nM h-1] 0 (basal level) 
1136 (after stimulus increase) 
0 (basal level) 
1136 (after stimulus increase) 
Modelled by Michaelis- 
Menten equation 
Vmax,syn,T [nM h-1] - - 1.25 
KM,syn,T [nM] - - 1 
kdeg,T  [h-1] 0.42 0.42 1 
vsyn,S [nM h-1] 516.6 (solid line) 
0 (dashed line) 
516.6 (solid line) 
0 (dashed line) 
0.625 
kdeg,S [h-1] 0.35 0.35 1 
KD,P [nM] 0.0045 0.0045 0.001 
kdeg,P [h-1] 13.75 13.75 1 
 
Table G.1c 
Figure Fig. G.1B Fig. G.2A Fig. G.2B 
vsyn,T [nM h-1] 0 (basal level) 
1.25 (after stimulus increase) 
Modelled by Michaelis- 
Menten equation 
0 (basal level) 
5 (after stimulus increase) 
Vmax,syn,T [nM h-1] - 5 - 
KM,syn,T [nM] - 7 - 
kdeg,T  [h-1] 1 1 1 
vsyn,S [nM h-1] 0.625 0.625 0.625 
kdeg,S [h-1] 1 1 1 
KD,P [nM] 0.001 0.001 0.001 
kdeg,P [h-1] 1 10 10 
 
 
G.5  Supplemental Numerical Simulations  
 
Competition-only Model: Section 7 was mainly focused on the scenario, where the 
heteroduplex is much less stable than the target RNA. In this case, the sRNA plays a dual 
role in target RNA regulation, as it competitively inhibits translation and additionally induces 
RNA degradation. However, several prokaryotic and eukaryotic non-coding RNAs merely act 
as competitive inhibitors of translation, but do not affect target RNA degradation [64,383,693] 
. In the “competition-only model”, which will be analysed in the following, the target RNA and 






Figure G.3: System behaviour in case that the sRNA competitively inhibits translation, but does not 
enhance target degradation (“competition-only model”).  
(A) Steady state (top) and dynamical (bottom) response to varying stimulus strength similar to Fig. 7.1B. The steady state dose-
response and the response time here were calculated for the free sRNA, while the response times in Fig. 7.1B were calculated 
for the total RNAs (i.e., the sum of free RNA and pair). See Table G.1 for kinetic parameters. (B) Time course of free target RNA 
in response to step-like pulse stimulation similar to Fig. 7.2C. See Table G.1 for kinetic parameters. 
 
 
Figure G.3 shows numerical simulations similar to those in Figs. 7.1B and 7.2C. It turned out 
that the competition-only model also shows the kinetic features discussed in the main text 
when analysed at the level of free sRNA and free target RNA (Fig. G.3). However, these 
features were no longer observed at the level of total sRNA and total target RNA (i.e., the 
sum of free and pair species), as pair formation does not induce RNA degradation, but only 
sequestration. For example, the free RNAs are expressed in a mutually exclusive manner in 
the competition-only model, while the total levels of target RNA and sRNA show overlapping 
expression patterns (not shown).       
 
Partial-Degradation Model: In the default model, it was assumed that both, the sRNA and 
target RNA, are degraded during the decay reaction of the pair heteroduplex. Eukaryotic 
miRNAs frequently remain intact after target degradation, and can guide the recognition and 
destruction of additional messages [64] . The default model was therefore extended such 
that it takes such a more catalytic mode of action into account (‘partial-degradation model’). 
The differential equations of the partial-degradation model are given by:  
 
( )
( ) ( )
tot syn,T deg,T tot deg,P
tot syn,S deg,S tot deg,P
d[T ] dt  = v  - k [T ]-[Pair]  - k [Pair]
d[S ] dt  = v  - k [S ]-[Pair]  - 1-f k [Pair]
⋅ ⋅
⋅ ⋅ ⋅
   (G.8) 
 
where the concentration of the pair is still given by Eq. (G.4). The new parameter f specifies 
the fraction of the sRNA that remains intact during the decay of the pair heteroduplex. For f = 
0, the system reduces to the default model (Eq. (G.2)), while the sRNA is not degraded via 





Figure G.4: System Behaviour in case that the sRNA remains intact during pair degradation (“partial-
degradation model”). The simulations were done by integrating the extended differential 
equation system (G.8) and f was set to 0.8.  
(A) Steady State (top) and Dynamical (bottom) Response to Varying Stimulus Strength similar to Fig. 7.1B. See Table G.1 for 
kinetic parameters. (B) Time course of free target RNA in response to step-like pulse stimulation similar to Fig. 7.2C. See Table 
G.1 for kinetic parameters. 
 
 
Figure G.4 shows simulation results for f = 0.8 (i.e., 80% of the sRNA remains intact during 
pair degradation). The kinetic characteristics reported in the main text are still observed, and 
thus apply for eukaryotic miRNAs as well. Note that the threshold in Fig. G.4A is shifted to 
higher values when compared to Fig. 7.1B, as expected (vsyn,T has the same value for a 
stimulus of 1 in both simulation; compare Table G.1).  
  
 
G.6  Simulation of pulse-filtering at the protein level  
 
The analysis presented in Section 7 suggests that ultrasensitive pulse-filtering occurs at the 
mRNA level. However, it remained to be determined whether pulse-filtering is preserved at 
the level of protein expression. The differential equation system given in Eq. (G.2) was 





tot syn,T deg,T tot deg,P
tot syn,S deg,S tot deg,P
syn,Protein tot deg,Protein
d[T ] dt  = v  - k [T ]-[Pair]  - k [Pair]
d[S ] dt  = v  - k [S ]-[Pair]  - k [Pair]




    (G.9) 
 
Equation G.9, together with Eq. G.4, constitutes a model for sRNA-mediated regulation of 
protein expression, which was analysed by numerical simulations. Duration-response curves 
were calculated and the maximum of the protein time course was taken as the response. 
Figure G.5 shows the protein time course amplitude as a function of the stimulus pulse 
duration (normalised by the half-maximal pulse duration). The duration-response curve was 
calculated for different protein half-lives as indicated in the legend of Fig. G.5, and the protein 
synthesis rate was taken to be ksyn,Protein = kdeg,Protein to ensure the same steady state protein 





Figure G.5: Pulse filtering is preserved at the protein level.  
The time course maximum of protein accumulation in response to step-like stimuli of different duration (but of constant strength) 
was simulated using the differential equation system (G.9). The duration-response curve was calculated for different protein 
half-lives as indicated in the legend, and the protein synthesis rate was taken to be ksyn,Protein = kdeg,Protein to ensure the same 
steady state protein level is achieved regardless of the degradation rate chosen. All other kinetic parameters were chosen as in 
Fig. 7.2D. The x-axis was normalised by the pulse duration required to reach the half-maximal protein amplitude to allow for 
comparison among duration-response curves. The Hill coefficient of each curve was calculated as described in the Materials 
and Methods section, and is indicated in the legend.   
 
 
The simulations in Fig. G.5 demonstrate that pulse-filtering at the mRNA level (solid line in 
Fig. 7.2D) is obscured at the protein level if the protein half-life is 100 or 1000 hours (solid 
and dashed black lines). However, pulse-filtering is preserved at the protein level even if the 
protein has a half-life of 10 hours (Fig. G.5, dashed grey line). The corresponding Hill 
coefficient of 2.37 implies that a ~6-fold change in the pulse duration is sufficient to switch 
the time course from 10% to 90% of the steady state activation level, and thus indicates 
ultrasensitive pulse filtering. More importantly, the simulations demonstrate that a system 
with 10 hour protein half-life completely filters out short pulse durations (Fig. G.5, dashed 
grey line). As may be expected, pulse filtering is more pronounced for even shorter protein 
half-lives (grey solid and black dashed lines in Fig. G.5), and ultrasensitivity at the protein 
and mRNA levels is similar (compare black solid line in Fig. 7.2D). 
 
Degradation studies for the IsiA protein are missing in the literature so far. However, half-life 
measurements of the CP43 photosynthesis protein homologous to IsiA revealed a half-life of 
about an hour under stress conditions [397] , and a similar rapid turnover was also reported 
for another photosynthesis protein, D1 [398] . These data suggest that IsiA protein is short-
lived in the experimental setup chosen in the present analyses, and that the pulse filtering 
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